[
  {
    "page": 2,
    "content": "ITI Treatment Guide Volume 9"
  },
  {
    "page": 3,
    "content": "Editors:\nD. Wismeijer, S. Chen, D. Buser\nITI\nTreatment\nGuide"
  },
  {
    "page": 4,
    "content": "Authors:\nF. Müller, S. Barter\nVolume 9\nImplant Therapy in the Geriatric Patient\nQuintessence Publishing Co, Ltd\nBerlin, Chicago, Tokyo, Barcelona, Istanbul,\nLondon, Milan, Moscow, New Delhi, Paris, Prague, São Paulo, Seoul, Singapore, Warsaw"
  },
  {
    "page": 5,
    "content": "German National Library CIP Data\nThe German National Library has listed this publication in the German National Bibliography. Detailed bibliographical data are\navailable at http://dnb.ddb.de.\n© 2016 Quintessence Publishing Co, Ltd\nIfenpfad 2–4, 12107 Berlin, Germany\nwww.quintessenz.de\nAll rights reserved. This book or any part thereof may not be reproduced, stored in a retrieval system, or transmitted in any form\nor by any means, whether electronic, mechanical, photocopying, or otherwise, without prior written permission of the publisher.\nIllustrations:\nUte Drewes, Basel (CH),\n \nwww.drewes.ch\nCopyediting:\nTriacom Dental, Barendorf (DE),\n \nwww.dental.triacom.com\nGraphic concept:\nWirz Corporate AG, Zürich (CH)\nProduction:\nJuliane Richter, Berlin (DE)\n \n \nISBN:\n978-3-86867-371-5 (epub)\n978-3-86867-311-1 (print)\nThe materials offered in the ITI Treatment Guide are for educational purposes only and intended as a stepby-step guide to\ntreatment of a particular case and patient situation. These recommendations are based on conclusions of the ITI Consensus\nConferences and, as such, in line with the ITI treatment philosophy. These recommendations, nevertheless, represent the\nopinions of the authors. Neither the ITI nor the authors, editors, or publishers make any representation or warranty for the\ncompleteness or accuracy of the published materials and as a consequence do not accept any liability for damages (including,\nwithout limitation, direct, indirect, special, consequential, or incidental damages or loss of profits) caused by the use of the\ninformation contained in the ITI Treatment Guide. The information contained in the ITI Treatment Guide cannot replace an\nindividual assessment by a clinician, and its use for the treatment of patients is therefore in the sole responsibility of the clinician.\nThe inclusion of or reference to a particular product, method, technique or material relating to such products, methods, or\ntechniques in the ITI Treatment Guide does not represent a recommendation or an endorsement of the values, features, or\nclaims made by its respective manufacturers.\nAll rights reserved. In particular, the materials published in the ITI Treatment Guide are protected by copyright. Any\nreproduction, whether in whole or in part, without the publisher’s prior written consent is prohibited. The information contained\nin the published materials can itself be protected by other intellectual property rights. Such information may not be used without\nthe prior written consent of the respective intellectual property right owner.\nSome of the manufacturer and product names referred to in this publication may be registered trademarks or proprietary names,\neven though specific reference to this fact is not made. Therefore, the appearance of a name without designation as proprietary\nis not to be construed as a representation by the publisher that it is in the public domain.\nThe tooth identification system used in this ITI Treatment Guide is that of the FDI World Dental Federation."
  },
  {
    "page": 6,
    "content": "The ITI Mission is …\n“… to promote and disseminate knowledge on all aspects of\nimplant dentistry and related tissue regeneration through education\nand research to the benefit of the patient.”"
  },
  {
    "page": 7,
    "content": "Preface\nWith the previous eight volumes of this series, the ITI Treatment Guides have established their place as a valuable\nreference work for practitioners in the field of implant dentistry. Having dealt with all the classical aspects of implant\ntherapy in those eight volumes, volume 9 closes the life-cycle loop by addressing the situation of the elderly and ailing\npatient.\nIt is a fact that the demographics of society today reflect a significant change: not only do we live much longer while still\nretaining high expectations in terms of health and quality of life, but the ratio of old to young people has also shifted, with\nthe older generation significantly outnumbering the younger.\nThis has brought with it a new set of demands on implant dentistry and on its practitioners, who more routinely encounter\nelderly patients. The treatment of these patients is subject to certain limitations and requires compromises. And along\nwith elderly patients who still lead an active life, there are also those who are more frail, whose health has been\ncompromised, or who require special dental care. This changing situation requires well-considered and adequate\nsolutions.\nVolume 9 of the ITI Treatment Guide series addresses the situation and needs of the elderly patient, from systemic\nchanges and physical and mental limitations to considerations of quality of life, and also illustrates these using well-chosen\nclinical cases."
  },
  {
    "page": 8,
    "content": "Acknowledgment\nWe would like to express our gratitude to Ms. Juliane Richter (Quintessence Publishing) for the typesetting and for the\ncoordination of the production workflow, Mr. Per N. Döhler (Triacom Dental) for the editing support and Ms. Ute Drewes for\nthe excellent illustrations. We also acknowledge Straumann AG, the corporate partner of the ITI, for their continuing support."
  },
  {
    "page": 9,
    "content": "Editors and Authors\nEditors:\nDaniel Wismeijer\nDMD, Professor\nHead of the Department of Oral Implantology and\nProsthetic Dentistry\nSection of Implantology and Prosthetic Dentistry\nAcademic Center for Dentistry Amsterdam (ACTA)\nFree University\nGustav Mahlerlaan 3004\n1081 LA Amsterdam\nNetherlands\nE-mail: d.wismeijer@acta.nl\nStephen Chen\nMDSc, PhD, FICD, FPFA, FRACDS\nClinical Associate Professor\nSchool of Dental Science\nUniversity of Melbourne\n720 Swanston Street\nMelbourne VIC 3010\nAustralia\nE-mail: schen@balwynperio.com.au\nDaniel Buser\nDDS, Dr med dent, Professor\nChair, Department of Oral Surgery and Stomatology\nSchool of Dental Medicine\nUniversity of Bern\nFreiburgstrasse 7\n3010 Bern\nSwitzerland\nE-mail: daniel.buser@zmk.unibe.ch\nAuthors:\nFrauke Müller\nDr med dent, Professor\nDivision of Gerodontology and Removable"
  },
  {
    "page": 10,
    "content": "Prosthodontics\nUniversity Clinics of Dental Medicine\nUniversity of Geneva\n19, rue Barthélemy-Menn\n1205 Genève\nSwitzerland\nE-mail: frauke.mueller@unige.ch\nStephen Barter\nBDS MSurgDent RCS\nSpecialist in Oral Surgery\nClinical Director, Perlan Specialist Dental Centre\nHartfield Road\nEastbourne\nEast Sussex BN21 2AL\nUnited Kingdom\nE-mail: s.barter@gmx.com"
  },
  {
    "page": 11,
    "content": "Contributors\nDaniel Buser\nDDS, Dr med dent, Professor\nChair, Department of Oral Surgery and Stomatology\nSchool of Dental Medicine\nUniversity of Bern\nFreiburgstrasse 7\n3010 Bern\nSwitzerland\nE-mail: daniel.buser@zmk.unibe.ch\nAnthony Dickinson OAM\nBDSC, MSD\n1564 Malvern Road\nGlen Iris VIC 3146\nAustralia\nE-mail: ajd1@iprimus.com.au\nShahrokh Esfandiari\nBSc, DMD, MSc, PhD\nAssociate Dean, Academic Affairs\nAssociate Professor\nFaculty of Dentistry, McGill University\nDivision of Oral Heath and Society\n2001 McGill College Avenue, Suite 500\nMontreal, Québec H3A 1G1\nCanada\nE-mail: shahrokh.esfandiari@mcgill.ca\nRichard Leesungbok\nDMD, MSD, PhD\nHead Professor and Chair, Department of\nBiomaterials and Prosthodontics\nKyung Hee University School of Dentistry\n892, Dongnam-Ro, Gangdong-Gu\n05278 Seoul\nRepublic of Korea\nE-mail: lsb@khu.ac.kr"
  },
  {
    "page": 12,
    "content": "Gerry McKenna\nBDS, MFDS RCSEd, PhD, PgDipTLHE, FDS (Rest Dent) RCSEd, FHEA\nSenior Lecturer/Consultant in Restorative Dentistry\nCentre for Public Health\nInstitute of Clinical Sciences\nQueens University Belfast\nBlock B, Grosvenor Road\nBelfast BT12 6BJ\nNorthern Ireland, United Kingdom\nE-mail: g.mckenna@qub.ac.uk\nRobbert Jan Renting\nTandarts, implantoloog i.o.\nSection of Implantology and Prosthetic Dentistry\nAcademic Center for Dentistry Amsterdam (ACTA)\nFree University\nGustav Mahlerlaan 3004\n1081 LA Amsterdam\nNetherlands\nE-mail: r.j.renting@gmail.com\nMario Roccuzzo\nDMD, Dr med dent\nCorso Tassoni 14\n10143 Torino\nItaly\nE-mail: mroccuzzo@icloud.com\nMartin Schimmel\nDr med dent, MAS Oral Biol, Professor\nDepartment of Reconstructive Dentistry and Gerodontology\nDivision of Gerodontology\nSchool of Dental Medicine\nUniversity of Bern\nFreiburgstrasse 7\n3010 Bern\nSwitzerland\nE-mail: martin.schimmel@zmk.unibe.ch\nShakeel Shahdad\nConsultant and Hon. Clinical Senior Lecturer"
  },
  {
    "page": 13,
    "content": "Department of Restorative Dentistry\nThe Royal London Dental Hospital\nQueen Mary University of London\nTurner Street\nLondon E1 1BB\nEngland, United Kingdom\nE-mail: shakeel.shahdad@bartshealth.nhs.uk\nMurali Srinivasan\nDr med dent, BDS, MDS, MBA\nLecturer\nDivision of Gerodontology and Removable\nProsthodontics\nUniversity Clinics of Dental Medicine\nUniversity of Geneva\n19, rue Barthélemy-Menn\n1205 Genève\nSwitzerland\nE-mail: murali.srinivasan@unige.ch\nUlrike Stephanie Webersberger\nPriv Doz, Dr med dent, Dr sc hum, MSc\nRestorative and Prosthetic Dentistry\nDental Clinic\nInnsbruck Medical University\nMZA, Anichstraße 35\n6020 Innsbruck\nAustria\nE-mail: ulrike.beier@i-med.ac.at"
  },
  {
    "page": 14,
    "content": "Table of Contents\n1\nIntroduction\n \nF. Müller, S. Barter\n2\nImplant Treatment in Old Age: Literature Review\n \nS. Barter, F. Müller\n3\nAging: a Biological, Social, and Economic Challenge\n \nF. Müller\n4\nThe Benefits of Implant-supported Prostheses in the Elderly Patient\n \nF. Müller\n5\nMedical Considerations for Dental Implant Therapy in the Elderly Patient\n \nS. Barter\n5.1\nIntroduction\n5.1.1\nAging and Multimorbidity\n5.1.2\nPolypharmacy\n5.1.3\nFrailty\n5.1.4\nTaking the Patient’s Medical History\n5.2\nCardiovascular System\n5.2.1\nAge-related Changes\n5.2.2\nTreatment Considerations\n5.2.3\nPharmacological Considerations\n5.3\nHematological System\n5.3.1\nAge-related Changes\n5.3.2\nTreatment Considerations\n5.3.3\nPharmacological Considerations\n5.4\nHematopoietic System\n5.4.1\nAge-related Changes\n5.4.2\nTreatment Considerations\n5.5\nRespiratory System\n5.5.1\nAge-related Changes\n5.5.2\nTreatment Considerations\n5.5.3\nPharmacological Considerations"
  },
  {
    "page": 15,
    "content": "5.6\nAlimentary System\n5.6.1\nTreatment Considerations\n5.6.2\nPharmacological Considerations\n5.7\nHepatobiliary System\n5.8\nRenal System\n5.8.1\nAge-related Changes\n5.8.2\nTreatment Considerations\n5.8.3\nPharmacological Considerations\n5.9\nEndocrine System\n5.9.1\nAge-related Changes\n5.9.2\nPharmacological Considerations\n5.10 Musculoskeletal System\n5.10.1\nAge-related Changes\n5.10.2\nTreatment Considerations\n5.10.3\nPharmacological Considerations\n5.11 Neurosensory System\n5.11.1\nAge-related Changes\n5.11.2\nTreatment Considerations\n5.11.3\nPharmacological Considerations\n5.12 Cancer\n5.12.1\nOsteoradionecrosis\n5.13 Conclusions\n6\nFeatures of Removable Prostheses for the Old\n \nF. Müller\n7\nImplants and Partial-denture Design\n \nF. Müller\n8\nImplant-supported Overdentures for the Edentulous Patient\n \nF. Müller\n9\nSurgical Considerations in the Aging Patient\n \nS. Barter\n10\nOral Hygiene in Geriatric Implant Patients\n \nF. Müller"
  },
  {
    "page": 16,
    "content": "11\nThe Ailing Patient\n \nF. Müller\n12\nManagement of Technical and Biological Complications\n \nS. Barter\n13\nClinical Case Presentations\n13.1 Improving an Existing Implant-supported Denture in an Alzheimer Patient with Bipolar\nAffective Disorder with Moderate Depression and Dementia\n \nU. Webersberger\n13.2 Maxillary Complete Denture and Mandibular Overdenture on Two Implants with\nUniversal Design\n \nR. Leesungbok\n13.3 Improving a Centenarian’s Quality of Life\n \nM. Schimmel\n13.4 Oral Rehabilitation of an Elderly Edentulous Patient with Osteoarthritis Using an\nImplant-supported Mandibular Prosthesis with Locator Abutments\n \nG. McKenna\n13.5 Maxillary Implant-supported Full-arch Removable Dental Prostheses for a Geriatric\nPatient: Sequencing the Treatment for an Optimal Outcome\n \nA. Dickinson\n13.6 Mandibular Overdenture Supported by a CAD/CAM-milled Bar with Long Distal\nExtensions on Two Conventionally Loaded Implants\n \nM. Srinivasan\n13.7 Flapless Guided Surgery: Bar-supported Overdenture on Four Implants\n \nR. J. Renting\n13.8 Prosthodontic Solution for Two Angulated 6-mm Implants Supporting a Removable\nPartial Denture in a 74-year-old Patient\n \nU. Webersberger\n13.9 Rehabilitation of a Mandibular Distal Extension Situation in a 89-year-old Patient with\nan Implant-supported Fixed Dental Prosthesis\n \nD. Buser"
  },
  {
    "page": 17,
    "content": "13.10 Minimally Invasive Treatment of a Patient in Her Nineties After Removing Implants\nAffected by Severe Peri-implantitis\n \nM. Roccuzzo\n13.11 Implant-retained Rehabilitation after Mandibular Rim Resection\n \nS. Shahdad\n13.12 Four Immediately Loaded Mini-implants Supporting a Mandibular Overdenture\n \nS. Esfandiari\n14\nConclusions\n \nS. Barter, F. Müller\n15\nReferences"
  },
  {
    "page": 18,
    "content": "1 Introduction\n \nF. Müller, S. Barter"
  },
  {
    "page": 19,
    "content": "Geriatric dentistry?\nSome readers may wonder what has this to do with the ITI. Is not geriatric dentistry usually all\nabout no treatment? Why would we need a Treatment Guide for this?\nAfter a very successful series of eight previous Treatment Guides, it would seem logical to\nthink about our patients’ destiny as they become old, very old, and finally frail and dependent\non care. This book is testament to the ITI’s holistic approach to implant dentistry and the\nprofessional responsibility it takes—not only for those patients who have aged with implant\nrestorations but also those who have reached an advanced age and may now benefit from the\nprogress in materials and techniques that implant dentistry has to offer today, until late in their\nlives.\nImplants have become an integral part of restorative dental care, and the number of implants\nplaced increases steadily. Worldwide, an estimated 15 million implants are inserted per year\nto replace missing teeth, mostly in the adult and young elderly age groups. Economic growth\nand technological advances in almost all domains of our lives have led to a more exigent\nattitude of adult patients, who increasingly demand higher levels of functional and esthetic\noutcomes from restorative dentistry. Consequently, any treatise on implant therapy in the\nelderly population cannot be restricted to options for edentulous jaws.\nA raised awareness for the biological and physiological value of natural teeth also increases\nthe desirability of prostheses that protect the neighboring dental tissues and avoid the\nunfavorable side effects of removable appliances. Despite the cost involved and the\nphysiological limitations of implant therapy, such treatment can fulfil the high demands of the\nelderly generation. Progress in terms of implant materials and design and also in surgical\ntechniques, including regenerative procedures such as bone grafting, means that almost any\npartially or fully edentulous patient can be restored with a fixed implant-supported restoration,\nprovided that he or she accepts the costs, time, and burden of treatment procedures involved.\nBut what is the future of these complex restorations when the patient ages? And what treatment\nconcepts do we offer patients whose lives are already dominated by age, frailty, and\nmultimorbidity? Treatment concepts for the elderly have to consider their physical and\ncognitive functions, their motivation, and their ability to manipulate and clean a sophisticated\nimplant restoration.\nFor over 25 years, the ITI has produced numerous publications in its mission to promote and\ndisseminate knowledge in all aspects of implant dentistry and related tissue regeneration\nthrough research, development, and education. ITI Consensus Conferences have produced\nsystematic reviews of the latest research resulting in treatment guidelines, distilling the science\ninto practical advice and recommendations for the busy clinician. The widespread use of the\nSAC Classification and the adoption (sometimes in modified form) of this tool by national"
  },
  {
    "page": 20,
    "content": "implant and dental organizations bears witness to the value of the hard work done by the\nscientists and clinicians of the ITI for the benefit of both the patient and the practitioner. Books\nsuch as the Glossary of Oral and Maxillofacial Implants, an impressive reference volume with\nover 2,000 definitions of terms, further help establish common standards that facilitate more\nsharing of information and a better understanding of the fascinating field in which we work.\nThe ITI Treatment Guides have made a major contribution to further education. This ninth\nvolume addresses an aspect of implant dentistry that has received far less attention than others:\nimplant therapy in the elderly patient.\nIt has long been known that age alone is not a barrier to implant placement and that the process\nof osseointegration can be as successful in an older person as in a young adult. There is a\ngrowing awareness that in all fields of healthcare, chronological age alone does not govern the\nhealth status of an individual; rather, aging is a biological process that may progress at a\nvariable rate, which can be affected by genetic and environmental factors and result in a\nconsiderable discrepancy between calendar age and biological age.\nThis is an increasingly relevant fact with a growing elderly global population. Advances in all\nfields of healthcare mean that people live longer, often with conditions that would previously\nhave been life-limiting. Elderly patients frequently have multiple chronic conditions treated\nwith a complex regime of multiple medications. This can bring them a longer period of healthy\nliving in their communities. Quite reasonably, they want and need this to be accompanied by\ngood oral health, function, and appearance, so that they may continue to enjoy life and preserve\ntheir self-esteem. It is possible to provide dental implants for the elderly and to replace\nmissing teeth; a comfortable and effective tooth replacement is also an important aspect in the\nmaintenance of good nutrition.\nThere is considerable evidence to support these statements. Many publications testify to the\nsuccess and usefulness of dental implants in older persons. There is also an, albeit smaller,\nbody of literature that examines the situation of elderly and geriatric patients who, having\nreceived dental implants at a younger, healthier age, now require care for their prostheses in\ntimes of advancing age, frailty, and declining health.\nFew dental treatments last forever. Biological and technical complications will inevitably\noccur with all dental prostheses—whether implant- or tooth-supported. The treatment can be\nmore challenging in the case of implant complications—even when the patient can be seen in\nan ideal facility. The management of complications in cases where there are issues of physical\nor mental health, access to healthcare, and other social or economic considerations may be\nquite different.\nImplant therapy has been a common, successful, and accepted treatment modality for over 30\nyears. It is time to consider the aspects highlighted above. The aim of this Treatment Guide is\nto raise awareness of the inevitability of increasing demands on the profession to provide care\nand treatment for a growing population of patients who, having benefitted from our successes"
  },
  {
    "page": 21,
    "content": "in implant treatment over the past decades, are now growing older with different care needs.\nWe hope you enjoy reading about the real future of implant dentistry!"
  },
  {
    "page": 22,
    "content": "2 Implant Treatment in Old Age: Literature Review\n \nS. Barter, F. Müller"
  },
  {
    "page": 23,
    "content": "Fig 1 Life expectancy in Switzerland since 1982. (Data: Swiss Federal Statistical Office.)\nImplants are used to replace missing teeth. It seems intuitive that their prevalence should be\nhighest in the group of patients with the highest number of missing teeth. However, the\nprevalence of implants in old and geriatric patients is still negligible compared to tooth\nreplacement using conventional fixed or removable dental prostheses. This is even more\nsurprising in that almost 9 out of 10 persons aged 85 years or over are wearing removable\nprostheses in Switzerland, with well-documented functional and esthetic shortcomings\n(Zitzmann and coworkers 2007). Limited financial resources, a negative attitude towards both\ntooth replacement and implants themselves, a lack of knowledge, and reluctance to undergo\ninvasive surgery may be amongst the factors that could explain this situation.\nIn the institutionalized elderly, a loss of autonomy and the consequently complex logistics for\naccess to health care may further limit access to more complex dental treatment. There is\nconsiderable published literature suggesting that chronological age in itself is not a barrier to\nsuccessful implant osseointegration in healthy individuals or in older people with controlled\nmedical conditions (de Baat 2000; Ikebe and coworkers 2009). However, to focus only on the\nsuccess of osseointegration and the ongoing survival of individual implants, which is often the\nlevel of evidence used, fails to consider the wider implications of such treatment. Other\nimportant considerations include patients’ experience and their subjective opinion of the\ntreatment and its benefits, how technical and biological maintenance and complications are\nmanaged in aging patients who are becoming progressively infirm, and the objective oral and\ngeneral health implications, both favorable and unfavorable, of implant-supported prostheses.\nOf at least equal importance are the holistic care of old patients and the need for a proper\nunderstanding of the physiology of aging and its effect on general health and well-being.\nToday’s progress in health care enables elderly patients to survive with conditions that only\nrelatively recently would have caused death at an earlier age (Fig 1). This in turn leads to an\nincreasingly aged population that acquires more conditions, in turn leading to a higher\nprevalence of disability as well as to multiple chronic conditions, known as multimorbidity\n(Barnett and coworkers 2012). Consequently, these patients are placed on longer and more\ncomplex medication regimes, known as polypharmacy (Hajjar and coworkers 2007; Mannucci"
  },
  {
    "page": 24,
    "content": "and coworkers 2014).\nBesides the classic “geriatric giants” (immobility, instability, incontinence, and impaired\nintellect/memory), many other age-related features have been described, such as\nneurodegenerative diseases, sensory decline, adverse drug events or medication non-\ncompliance, frailty, and the multiple organ or systemic diseases mentioned above. We have a\nrole to play not only in the essential consideration of how these conditions may affect our\ntreatment but also vice versa. We must also be aware and vigilant in order for us, as healthcare\nproviders, to contribute to the general care of our population in its later years.\nThis chapter gives a brief overview of the current state of the literature at the time of writing.\nReaders should be aware that limited high-level evidence is available; only recently has there\nbeen a growing awareness of the need for further well-designed studies into many of these\naspects.\nFig 2 Number of missing teeth in different age cohorts. (Data from the Swiss National Health Surveys 1992/93 and\n2002/03, cited after Zitzmann and Berglundh 2008b.)\nAwareness and acceptance of implant therapy\nThanks to improved oral-health education, better preventive intervention, minimally invasive\ndentistry, and the increased quality of medical and dental care available to the populations of\nmany developed countries, as well as increasing financial resources and social security, more\nand more people reach an advanced and very advanced age with their natural teeth. They often\nhave fixed tooth-supported prostheses or, increasingly, fixed and removable implant-assisted\nprostheses (Joshi and coworkers 1996; Petersen 2003). The shift in oral health is reflected in\nthe Swiss health survey: while in the 1992/1993 survey, the 65- to 74-year-old age group was\nmissing on average 15.4 teeth, the same age group was missing only 10.4 teeth 10 years later\n(Zitzmann and coworkers 2008b; Fig 2). Thanks to the newly introduced age group of 85 years\nand over in this health survey, we know that 97.4% of this population group are wearing\ndentures, of which 11.5% are fixed and 85.9% are removable (Table 1). The percentage of\ncomplete-denture wearers in this age group is still 37.2%. A similar situation has been\nreported for most developed countries, where tooth loss also occurs later in life (Mojon 2003;\nMüller and coworkers 2007)."
  },
  {
    "page": 25,
    "content": "Table 1 Prevalence of fixed and removable prostheses in different age cohorts. (Data from the Swiss National Health\nSurvey, cited after Zitzmann and Berglundh 2008b.)\nFig 3 Out of 92 persons interviewed with an average age of 81.2 years, almost half had not heard of implants or could\nnot describe them. (Cited after Müller and coworkers 2012a.)\nDespite the progress in oral health promotion and restorative techniques, tooth loss is still a\nreality in old age; there is a widespread need for tooth replacement in the elderly population\n(Müller and coworkers 2007). Nevertheless, implants in elderly adults are disproportionately\nrare, especially in the very old and institutionalized population (Visser and coworkers 2011;\nZitzmann and coworkers 2007). The prevalence of implants in a representative Swiss\npopulation sample was 4.4% (Zitzmann and coworkers 2008a); in Germany, it was 2.6% in the\n65- to 74-year-old adult population (Micheelis and Schiffner 2006). In Europe, the highest\nfrequency of implants in the edentulous population was found in Sweden, but despite\nsubstantial financial support from the public health system, it did not exceed 8% (Osterberg\nand coworkers 2000).\nEvaluation of the awareness of implants in elderly persons is difficult, as there may be many\nfactors involved in the dissemination of patient information, including the benefits of implant\ntreatment. In a marketing-related study of the Austrian population, 42% of the cohort\ninvestigated was poorly informed and only 4% felt well informed. Approximately one-third of\nthe study participants indicated a desire to receive more information and would prefer it to be\nprovided by their dentist (Tepper and coworkers 2003)."
  },
  {
    "page": 26,
    "content": "Awareness of dental implants is not necessarily correlated with a correct understanding of the\nnature and benefits of treatment. Various studies indicate that approximately 70% of elderly\npatients questioned are aware of the existence of dental implants as a treatment option. The\nnumber of interviewees who had received information direct from a dentist appears to vary for\nreasons not fully understood. In the Tepper study, 68% had received an explanation from a\ndentist, whereas in a US-based study the level was 17% (Tepper and coworkers 2003; Zimmer\nand coworkers 1992). Similar results were found in a survey of Swiss adults in both in\ngeriatric-care facilities and living at home (Müller and coworkers 2012a). The authors\nconfirmed that in the elderly population, knowledge of dental implants is limited: almost half\nof the study participants had never heard of implants or could not describe them (Fig 3). Only\none out of the 92 participants knew that implants were made of titanium (Fig 4). The rate of\nobjection to implant treatment was high, mostly based on cost, the surgical nature of the\ntherapy, and other psychological factors. A limited knowledge of implants as well as a poor\nstate of general health—but not old age in itself—were not associated with a negative attitude\ntoward implant treatment. Identifying further barriers and understanding patients’ reluctance\ntowards implant treatment could improve the acceptance of implant therapy in the elderly\npopulation. Providing further information in appropriate formats, with clearly worded and\nprinted text complemented by simple illustrations, would help elderly patients to reflect on the\nnovel information provided and give informed consent to implant treatment. Furthermore, the\ndevelopment of less invasive surgical techniques is another possible measure that could\ncontribute to a greater uptake of an implant treatment.\nFig 4 Only 1 out of 92 persons interviewed with an average age of 81.2 years knew that implants were made from\ntitanium. (Cited after Müller and coworkers 2012a.)\nOf potentially greater concern is the awareness and understanding of implants and related\nprostheses by the caregivers of patients unable to access regular dental care or to manage\nadequate self-performed oral hygiene (Holtzman and Akiyama 1985). It has been suggested that\nin many elderly-care institutions, few staff members recognize an implant-supported\nprosthesis, let alone know how to handle and clean it. Even with a seemingly simple and\nstraightforward overdenture supported by two implants, if the patient can no longer remove the\ndenture, it is likely that nursing staff will not know how to help, and the denture may end up\nfalling into disuse (Visser and coworkers 2011)."
  },
  {
    "page": 27,
    "content": "Considering the acceptance of proposed implant treatment, many elderly patients do not\nconsider implants a preferred treatment option for reasons of cost. However, cost may not be\nthe only issue, as demonstrated in a study showing that over one-third of patients with\nedentulous mandibles declined free treatment with an implant-supported overdenture. Elderly\npatients often object to surgical intervention, but may also consider any denture “improvement”\nunnecessary (Walton and MacEntee 2005). When presented with different treatment options for\nthe replacement of missing teeth, they are frequently more conservative in their preferences and\nmay be more tolerant of simpler solutions that the clinician may consider a compromise (Ikebe\nand coworkers 2011).\nImplant success in the elderly patient—initial provision of therapy\nThe infinite variability of site- and patient-specific factors, implant and prosthetic designs,\nstudy methodologies and confounding factors, and many other interrelated considerations imply\nthat considerations of age alone as a success factor in implant therapy are difficult to determine\n(Wood and coworkers 2004). A large part of the currently available literature is based on the\ntreatment of the edentulous jaw, often with overdentures, and this does not fully reflect the\nemerging situation of a partially edentulous population with an increasing demand for implant\ntreatment, historically restricted to younger age groups (Dudley 2015). There are also only few\nstudies available that address the rate of biological and technical complications in geriatric\npatients who have previously had implants and prostheses for decades and who are now more\ninfirm; perhaps more importantly, neither is there a body of literature outlining the issues of\nproviding remedial treatment in such situations.\nAs previously mentioned, age alone appears to be unrelated to the success or failure of initial\nimplant integration, with success rates similar to younger age groups but with a seemingly\ngreater incidence of problems in adapting to a new prosthesis (Andreiotelli and coworkers\n2010; Engfors and coworkers 2004). Osseointegration at an advanced age was well\ndocumented in an 83-year-old patient, who received four implants in the edentulous mandible.\nAfter passing away 12 years later, Lederman, Schenk and Buser had the opportunity to\ninvestigate the osseointegration histologically (Ledermann and coworkers 1998; Figs 5a-e). A\nclose-up view confirms the intimate contact of the bone with the titanium implant surface.\nFigs 5a-e This edentulous patient received his interforaminal implants at 83 years; 12 years later, at age 95, he passed\naway and donated his mandible to the University of Bern for histological analysis (Ledermann and coworkers 1998).\nVery few studies have directly compared implant survival in young and old patients. Bryant"
  },
  {
    "page": 28,
    "content": "and Zarb compared peri-implant marginal bone loss in 26- to 49-year-old patients with a\ncohort of 60- to 74-year-olds with fixed or removable restorations and found no difference\nover 17 years (Bryant and Zarb 2003; Fig 6). Hoeksema and coworkers, in a 10-year\nprospective study, followed a group of 52 young patients (age 35 to 50 years) and compared\nimplant survival rates with those of 53 elderly edentulous wearers of overdentures (age 60 to\n80 years). Despite the obvious larger dropout in the older cohort, due in part to death and\nhealth reasons, they found no statistical difference in implant survival and marginal bone loss\nbetween the two groups (Hoeksema and coworkers 2015). Even very old age—80 years and\nolder—resulted in survival rates for fixed implant-supported prostheses that were similar to\nthose of patients below 80 years over a 5-year observation period (Engfors and coworkers\n2004).\nWhile medical conditions exist that are considered relative contraindications that may affect\nsuccessful osseointegration, the relative levels of associated risk may vary in different\npatients. There is a greater incidence of multimorbidity and polypharmacy in the older age\ngroup, and combinations of risk factors may increase the risk of an adverse outcome.\nThe most relevant factor of implant success may actually be the quantity and quality of the bone\nat the surgical site—and these may in part be age-related, reflecting changes in bone structure\nand quite simply the length of time that teeth had been diseased or missing (Bryant 1998).\nA significant confounding factor in attempts to evaluate implant success is the lack of\nconsistency amongst studies regarding what constitutes success. Indeed, many studies actually\nreport implant survival, which is of course based only on the singular fact that the implant\nremains in situ. Different criteria exist for qualifying success, which generally include the\nfollowing factors (Buser and coworkers 1990):\n• Absence of persistent subjective complaints, such as pain, foreign body sensation and/or\ndysesthesia.\n• Absence of recurrent peri-implant infection with suppuration.\n• Absence of mobility.\n• Absence of continuous radiolucency around the implant.\n• Restorability.\nHowever, success at the implant level is not a measure of treatment success, only of the\nbiological achievement of osseointegration. Success has to be also measured at the prosthesis\nlevel and, perhaps most importantly, at the patient level—the patient should remain our prime\nconcern. The possibility of autonomous management of the implant-supported denture,\nincluding proper oral hygiene, should therefore be added to the outcome measures."
  },
  {
    "page": 29,
    "content": "Fig 6 Cumulative peri-implant bone loss in mandibular implant-supported prostheses in a young and an old cohort.\n(Redrawn after Bryant and Zarb 2003.)\nNor can we be reassured by short-term success. Given the increasing life expectancy of the\nmiddle-aged and young-old patients who have received implant treatment, the rehabilitation\nwill inevitably require both maintenance and repair or replacement. Furthermore, with the\ngrowing number of healthy and fit very old persons, implant treatment should not be withheld,\neven at a very high age, if close monitoring of the patient’s denture management and oral\nhygiene are assured and the attachments can be removed easily if necessary.\nImplant success in the elderly patient—maintenance and complications\nThere is ample evidence that the accumulation of bacterial plaque on the surfaces of implants\nand associated restorations can lead to inflammation of the soft tissues and, in susceptible sites\nand individuals, to peri-implant bone loss (Zitzmann and Berglund 2008b). Concerning the\nsusceptibility of an individual to periodontal disease, Mombelli considered whether or not\nthere are specific age-related changes in the oral microbiota that may affect the progression of\nperiodontal disease. He concluded that other age-related general and oral health conditions\nmight have a greater impact (Mombelli 1998). Declining manual dexterity and visual acuity\nmay be associated with a reduced ability to maintain adequate plaque control. Several studies\nhave observed that osseointegration can be maintained even under conditions of poor or\nmoderately successful self-performed or caregiver-assisted oral hygiene procedures (Isaksson\nand coworkers 2009; Olerud and coworkers 2012). The impact of immunosenescence on the\nreaction of the peri-implant tissues to substantial bacterial load remains to be investigated. It is\nalso recognized that the host response is as important a factor in peri-implant disease as it is in\nperiodontal disease (Heitz-Mayfield 2008), and that the risk of biological complications in\nperiodontitis-susceptible patients is greater than in less susceptible individuals (Ong and\ncoworkers 2008). Given the greater difficulty of treating such complications in patients with\ncompromised oral hygiene and general health, it would be unwise to be complacent in\nsituations of inadequate oral hygiene.\nIt is recognized that the role of staff and caregivers in maintaining oral health in such patients is\nimportant (Ettinger and Pinkham 1977; Mersel and coworkers 2000) and is an essential part of\ngeneral healthcare, particularly in multimorbid and fragile elderly patients. An example of this\nis the prevention of complications such as aspiration pneumonia precipitated by oral pathogens\n(Quagliarello and coworkers 2005; Sjögren and coworkers 2008; van der Maarel-Wierink and"
  },
  {
    "page": 30,
    "content": "coworkers 2011; Yoneyama and coworkers 1999).\nAs mentioned above, the awareness of care providers, relatives, and occasionally even\npatients of the presence and maintenance requirements of implants and related prostheses is\nlow (Kimura and coworkers 2015; Sweeney and coworkers 2007). In the multimorbid and\nfragile elderly, adequate oral hygiene may not be the most important factor for the general\nwell-being of the patient, especially when chronic disease and disability dominate daily life.\nHowever, the neglect of oral health can have serious implications, caused for example by the\ninability of some caregivers to as much as recognize the presence of implants. Examples are\ngiven of food refusal and weight loss in patients unable to inform the staff of oral discomfort\nfrom overdenture abutments where the overdenture is no longer worn (Visser and coworkers\n2011). Adequate nutrition and weight are of vital importance for the morbidity and mortality of\nelders, and such incidents can have consequences of greater significance than oral health alone\n(Weiss and coworkers 2008).\nAll studies reporting on technical complications observe that while implant survival rates are\nhigh, there is a considerable rate of technical complications with all implant-retained\nprostheses that increases with the length of time in service (Albrektsson and coworkers 2012;\nBerglundh and coworkers 2002; Brägger and coworkers 2005; Zembic and coworkers 2014a).\nThis has an impact on the health economics of implant treatment and requires considerable\nchairside time. This may be particularly relevant for a patient who is no longer able to access\nthe dental office and/or who may no longer be able to afford the maintenance for an implant-\nsupported denture to which they committed when in a more privileged financial situation.\nTechnical complications may in fact be more prevalent with overdentures than with fixed\nreconstructions, especially regarding the overdenture attachment system (Bryant and coworkers\n2007). However, addressing such issues with an implant overdenture may be considerably\nmore straightforward than with a complex fixed prosthesis in an elderly patient with general or\nmental health conditions that preclude care in a conventional clinical setting.\nImplants in the fully edentulous elderly patient\nAs the population of elderly patients increases, the average age of that population also\nincreases. Improved health care in developed countries reduces the proportion of edentulous\npatients, and this trend is expected to continue (Müller and coworkers 2007). However, there\nare indications that the growing elderly population will still result in many edentulous adults to\ntreat and that these patients may benefit from implant therapy rather than being constrained to\nremovable complete dentures (Turkyilmaz and coworkers 2010). We know that clinicians and\npatients often view the efficacy of treatment differently (Heydecke and coworkers 2003b) and\nthat the acceptance of complete dentures by patients varies considerably, with some adapting\nbetter than others (Boerrigter and coworkers 1995a; Müller and Hasse-Sander 1993). Even\namong those patients who do not report high levels of chewing ability, there are many who do\nnot consider such functional limitations any handicap (Allen and coworkers 2001).\nIt is frequently said that implant-retained overdentures are “better” than conventional complete"
  },
  {
    "page": 31,
    "content": "dentures. However, it is important to distinguish between maxillary and mandibular prostheses,\nas much of the available literature relates to mandibular implant-retained overdentures. Indeed,\nmany reviews of the literature do not explicitly differentiate these two distinct clinical\nsituations.\nIt has been suggested that implant-supported maxillary complete overdentures have few\nadvantages over conventional maxillary complete dentures (Watson and coworkers 1997).\nThere is evidence that the simpler overdenture approach is favored by patients over a complex\nfixed bridge on implants, or even that there is no advantage of an implant-supported complete\nmaxillary prosthesis over a conventional complete denture (de Albuquerque Júnior and\ncoworkers 2000). Few studies include sufficient long-term follow-up to evaluate the\ndifferences between implant and prosthetic success, or between different types of restoration.\nIt is inevitable that the design of a prosthesis will affect the ease of cleaning and the rate of\ntechnical complications, even though there appears to be no correlation between designs and\nimplant survival/success over relatively short observation periods (Bryant and coworkers\n2007).\nNor is there any reliable evidence for an optimal number of implants to support an overdenture\n(Roccuzzo and coworkers 2012). However, there is evidence that implant-supported\nmandibular prostheses are associated with improved clinical and patient-related outcomes\ncompared to mandibular complete dentures. While wellmade replacement conventional\ncomplete dentures can provide improvements in speech, appearance, and comfort, there is\nfrequently little or no improvement in function (Awad and coworkers 2003), and this is\nespecially so in elderly patients (Allen and McMillan 2003).\nThe use of two implants in the interforaminal region of the mandible to support an overdenture\nis well documented. There is reliable evidence for the benefits of this treatment modality and\nits cost-effectiveness (Heydecke and coworkers 2005). Indeed, the two-implant mandibular\noverdenture is now regarded the first-choice standard of care (Feine and coworkers 2002;\nThomason and coworkers 2009) and that a conventional mandibular complete denture may be\ninadequate in terms of comfort and function, with masticatory performance being less than 20%\nof that achieved with a natural dentition (Heath 1982; Kapur 1964).\nA recent review from Andreotelli and coworkers confirmed excellent survival rates for\nimplant-supported overdentures (Andreiotelli and coworkers 2010). The majority of studies in\nthis review concerned mandibular implants placed in the interforaminal region to retain\nremovable overdentures. Observation periods in four of the studies analyzed reached the\ncritical 10-year mark, indicating implant survival rates between 93% and 100%. Although the\nquality of the available evidence often precludes combining the individual study outcomes\nwithin a meta-analysis, it seems that neither the number of implants used nor the attachment\nsystem chosen, or splinting the implants, has a significant impact on the treatment success\n(Meijer and coworkers 2004; Naert and coworkers 2004).\nTreatment concepts for the maxilla, single implant mandibular overdentures (Bryant and"
  },
  {
    "page": 32,
    "content": "coworkers 2015; Kronstrom and coworkers 2014; Srinivasan and coworkers 2016), and short\nor reduced-diameter implants have been less well documented (Müller and coworkers 2015;\nSrinivasan and coworkers 2014a). Although immediate, early, and conventional loading\nprotocols of mandibular implant dentures are predictable treatment modalities, early and\nconventional loading tended to reduce failures of osseointegration within the first year\n(Schimmel and coworkers 2014). From a patient perspective, early loading seems particularly\nattractive, as the time of discomfort due to provisionalization is limited. There is still sufficient\ntime for wound healing, hence the likelihood of a reline being needed shortly after denture\ninsertion is lower than with immediate-loading concepts. It can be concluded that mandibular\nimplant overdentures are a safe and successful treatment modality and present multiple\nfunctional, structural, and psychosocial benefits.\nImplants in the partially edentulous elderly patient\nAs stated, an increasing number of patients in a growing elderly population retain natural or\ntreated natural teeth well into old age. Failing older dental restorations can of course lead to a\npartially edentulous situation; it may be desirable to preserve natural teeth as much as possible\nand to avoid the preparation of teeth adjacent to gaps for tooth-supported fixed prostheses. The\ngreater expectations patients have of dental treatment and their desire to avoid dentures, even\npartial ones, mean that implants in partially edentulous patients are a practical and beneficial\ntreatment option for many. Especially in severely depleted dentitions, where abutment teeth\nmay be positioned unfavorably, additional abutments in the form of implants may greatly\nenhance denture kinetics. The literature is replete with evidence that the same patient- and site-\nspecific factors are the main considerations affecting future implant survival and that age alone\nis not a factor (Kowar and coworkers 2013).\nPatient-centered outcomes in elderly patients\nPatient-centered outcomes are an important measure of the “success” of a treatment, both\nsubjectively and objectively, particularly in regard to health economics (Rohlin and Mileman\n2000). Clinicians and patients often perceive and evaluate the outcome of treatment differently,\nand such variation can lead to problems in treatment planning. Involvement of the patient in\nclinical decision-making can lead to higher levels of satisfaction with treatment (Kay and\nNuttall 1995). It is therefore important to consider patient preferences and attitudes to\ntreatment when selecting treatment (Kay and coworkers 1992). It is equally important to accept\nthat elderly patients will often place different values on the potential benefits of treatment than\nyounger adults, based on medical, social, cultural, and economic considerations. It is\nnecessary to respect their decisions when deciding on the use of implants and the type of\nprosthesis that will produce the most predictable and satisfactory outcome. Respecting the\npatient’s decision becomes even more relevant in patients who have to be considered\nvulnerable, as ethical considerations strongly preclude “forcefully convincing” the patient\ntowards accepting a given treatment plan.\nUnfortunately, most of the current literature in patient-centered outcomes relates to the\ntreatment of the edentulous older adult (Weyant and coworkers 2004). As older adults retain"
  },
  {
    "page": 33,
    "content": "teeth for longer, perhaps losing teeth later in life and demanding implant-supported partial or\ncomplete prostheses, we may need modified assessment tools that are preferably standardized\nto eliminate heterogeneity in results in order to evaluate the true benefit of treatment at the\npatient level.\nAssessing oral health-related quality of life (OHRQoL) essentially measures the degree to\nwhich oral health interrupts the well-being and social functioning of an individual. There are a\nlarge variety of instruments that have been used to assess the social impact of dental disease\n(Hebling and Pereira 2007; Slade 2002).\nFrom the literature, there appear to be two most commonly used indices for evaluating the\nimpact of oral and dental problems on an elderly patient’s quality of life:\n•\nOHIP—Oral Health Impact Profile. Used to evaluate the patient’s perception of the\nsocial impact of poor oral health (Slade and Spencer 1994). Within this tool, there are\nrefined questionnaires to assess different specific treatment modalities such as OHIP-\nEDENT, for edentulous adults.\n•\nGOHAI—Geriatric Oral Health Assessment Index. Used to evaluate the impact of oral\nhealth problems in the older population (Atchison and Dolan 1990).\nThere is evidence to show that after treatment, patient satisfaction with implants is good, even\nwhen there is a substantial need for support in daily living that includes assisted oral hygiene\n(Isaksson and coworkers 2009; Olerud and coworkers 2012; Osterberg and coworkers 2007).\nMandibular implant-supported overdentures seem to provide improved patient-centered\noutcomes from both the patients’ and the clinicians’ perspectives (Boerrigter and coworkers\n1995a; Boerrigter and coworkers 1995b; Emami and coworkers 2009; Meijer and coworkers\n1999).\nOHRQoL outcomes can be similarly improved by providing elderly patients with partial fixed\nand removable implant supported prostheses, depending on the age of the patient and the\nparticular clinical situation (Swelem and coworkers 2014). In a wide ranging “real-world”\npractice-based study evaluating GOHAI indices, marked benefits were perceived by patients\nreceiving either single-tooth replacement, fixed partial dentures, or complete fixed or\nremovable full prostheses (Fillion and coworkers 2013). However, in common with many\nclinical studies, the follow-up period was less than 5 years, so only limited conclusions can be\ndrawn; maintenance is inevitably required and complications may develop, so the level of\nsatisfaction will possibly decline over time.\nPatients with medical conditions that can have a further adverse impact on oral health or\nfunction may also benefit from implant therapy in terms of chewing efficiency and OHRQoL.\nThere are a few case reports and series reporting on patients with neurodegenerative diseases\nsuch as Parkinson’s and Huntington’s disease, or dementia (Faggion 2013; Packer and\ncoworkers 2009), diabetes (Kapur and coworkers 1999), xerostomia, or oral mucosal\nconditions. However, the reported case numbers are so low that they may be considered"
  },
  {
    "page": 34,
    "content": "anecdotal, and no observation beyond 12 months follow-up exists. The supportive maintenance\nof implants and related prostheses may well be important and very difficult in patients with\nsuch conditions. Indications for implant placement must be balanced individually and carefully\nbetween the estimated benefit for the patient and the potential risks from peri-implant infection\nand failure to manage the prosthesis while the underlying medical condition progresses. Where\nthe slightest concern of dropout from the recall and maintenance scheme exists, it seems\nadvisable to opt for a conventional tooth replacement.\nFunctional benefits of implants in edentulous elderly patients\nImprovements in orofacial function with implant-supported dental restorations are well\ndocumented, especially for edentulous subjects with upper complete dentures and lower\nimplant-supported overdentures (Müller 2014). Besides the protection of the peri-implant bone\nthrough reduced atrophy (Bryant and Zarb 2003; Jemt and coworkers 1996a; Lindquist and\ncoworkers 1988; Naert and coworkers 1991), such improvements comprise increased biting\nforce (Muller and coworkers 2013) and improved masticatory efficiency and ability (van der\nBilt and coworkers 2006; van Kampen and coworkers 2004). Furthermore, the positive impact\non oral health-related quality of life (OHRQoL) from supporting complete dentures with\nimplants has been demonstrated (Awad and coworkers 2014). The benefits of implants in\noverdentures will be discussed in more detail in Chapter 3."
  },
  {
    "page": 35,
    "content": "3 Aging: a Biological, Social, and Economic Challenge\n \nF. Müller"
  },
  {
    "page": 36,
    "content": "Fig 1 Drug intake increases dramatically with age; in most elderly patients, the drugs are relevant for the dental\ntreatment.\nFig 2 Most elderly persons need help or special transportation to reach the dental office, so dental appointments\nrequire special logistics.\nFig 3 Macroscopic changes in the bone structures occur with age that are similar to those described in osteoporotic\npatients (displayed here for the vertebral bone).\nTreating the elderly patient inevitably requires some adjustments compared to the treatment of"
  },
  {
    "page": 37,
    "content": "younger adults.\nFirst of all, physiological aging taxes the physiological reserve, and age-related changes\nbecome evident, in terms of both physiognomy and function. Secondly, the prevalence of\nchronic disease and functional handicaps increases with age, requiring adjustments to treatment\nplanning.\nPatients with three or more chronic diseases requiring drug intervention are considered\nmultimorbid (Fig 1). In addition to the impact of the diseases themselves, the side effects of\ntheir treatment have to be taken into consideration. Given the large number of drugs that induce\ndry mouth as a side effect, xerostomia is one of the most prevalent symptoms in geriatric\ndentistry. In addition, the limited mobility of some patients requires special logistics to take\nthem to the dental practice or, more rarely, to treat them at home (Fig 2).\nAge-related functional and structural changes in the orofacial system\nBone and alveolar ridge. Aging results in a reduction in both cortical and trabecular bone\nmass in both men and women (Fig 3). Functional changes related to age imply increased\nbrittleness, leading to a higher incidence of microfractures and fractures. The reduced activity\nof osteoblasts slows down the healing process, and bone remodeling takes longer. The age-\nrelated discrepancy between the activity of osteoblasts and osteoclasts is accelerated in\nwomen during menopause due to a decrease in estrogen levels.\nThe aging alveolar bone is subject to the same changes, but periodontal disease and tooth loss\nmay result in atrophy beyond the physiological aging process. The bone mass responds\npositively to physiological stimulation such as the occlusal loading of natural teeth, which are\nsuspended in the sockets via Sharpey fibers. In contrast, pressure is not considered a\nphysiological stimulus, so occlusal loads from dentures are not an appropriate stimulus to\nprevent atrophy. The maxillary edentulous ridge has been reported to lose substantially less\nvertical height following an extraction than the mandibular ridge. Three to seven years\nfollowing tooth loss, the annuals rate of vertical atrophy of the alveolar ridge are estimated at\n0.2 mm in the maxilla and 0.7 mm in the mandible. In subsequent years, annual rates of atrophy\nslow down to 0.1 mm for the maxillary and 0.4 mm for the mandibular ridge (Tallgren 1972).\nBone atrophy never really comes to a standstill. This is of particular relevance in prosthetic\ndentistry, as the maxillary edentulous ridge tends to become smaller, whereas the mandibular\nalveolar ridge tends to widen, which may present a considerable challenge in setting up teeth\nfor a complete denture (Fig 4).\nAlthough implants are osseointegrated and not surrounded by periodontal tissues such as\nSharpey fibers, they still exert some sort of stimulus to the bone when an occlusal load is\ntransferred to the bone-implant interface, leading to a micro-deformation of the bony tissues\nunder occlusal load or to deformation of the mandible. In the literature, peri-implant bone loss\nhas been reported to be significantly lower than the equivalent loss in vertical height of an\nedentulous alveolar ridge. However, if denture kinetics implies a fulcrum line, bone loss may"
  },
  {
    "page": 38,
    "content": "even be accelerated in non-supported (mostly posterior) regions of the alveolar ridge (de Jong\nand coworkers 2010).\nTemporomandibular joint. The temporomandibular joint has a higher prevalence of\ndegenerative signs and symptoms with age, but mostly without a corresponding clinical\ntreatment need (Tzakis and coworkers 1994). Atrophy of the skull includes the articular\ntuberculum, such that the inclination of the condylar path becomes more closely parallel to the\nCamper plane. The ligaments of the joint, which guide the mandibular border movements, lose\nelasticity in old age, resulting in greater joint mobility. In the prosthodontic treatment of elderly\npatients, these changes translate in a lower inclination of the molars’ occlusal cuspids as well\nas a “freedom in centric” occlusal concept.\nMuscles. One of the most obvious consequences of physiological aging is the loss of muscle\nbulk (sarcopenia); this is also true of the masticatory musculature. When studying the cross-\nsectional area (CSA) of the masseter and lateral pterygoid muscles, a 40% loss in CSA has\nbeen reported between 25 and 85 years of age, and even more pronounced in individuals who\nhave lost their teeth (Newton and coworkers 1993).\nFig 4 Atrophy of the alveolar ridges progresses with age, which finally leads to an unfavorable inclination of the\nintercrestal line. The posterior teeth may have to be set up in crossbite occlusion.\nAccording to the physiological principle of “use it or lose it,” muscles need frequent and\nregular training to maintain their function. The speed of atrophy is well demonstrated when a\nleg is plastered after a fracture, where a significant loss in muscle strength is seen after only a\nfew weeks of inactivity, thus requiring physiotherapy to regain normal function. For the closing\nmuscles of the mandible, accelerated atrophy may also be related to reduced physical exercise,\ncaused for example by poor chewing performance associated with conventional complete\ndentures. Fear of denture displacement limits mandibular excursions, and pain from the\ndenture-bearing tissues restrict the force exerted on the replacement teeth. Occlusal support via\ndental implants limit the immediate load on the denture-bearing tissues and encourage muscle\ntraining while chewing."
  },
  {
    "page": 39,
    "content": "Fig 5 97-year-old patient with significant muscle atrophy after (voluntary) denture abstention during implant\nosseointegration. Once provided with his mandibular overdenture, he regained muscle bulk along with the exercise\nthrough efficient chewing (Schimmel and coworkers 2010).\nA training and detraining effect on thigh muscle bulk was reported for older adults (Tokmakidis\nand coworkers 2009). Little is known about whether masticatory muscle thickness can be\nregained once lost, especially in elderly and frail individuals. A recent case report from our\ngroup showed that 3 months of mandibular denture abstention in a 97-year-old patient induced\na loss of up to 17% of his masseter muscle thickness, but was regained during 6 months after\nchewing function was restored with a mandibular implant-supported overdenture (Schimmel\nand coworkers 2010; Fig 5).\nAging processes in the muscles also include the motor units, which become larger as\nindividual motor fibers disappear and some muscle fibers are adopted by neighboring motor\nunits. With larger motor units, movements become less precise and controlled. Very obvious\nexamples are the handwriting of elderly persons, which graphically depicts the physiological\ndecline in motor control (Fig 6); controlling shoes, handbags, or other objects also becomes\ndifficult (Fig 7). The mandibular closing trajectory can be more erratic, and a carefully\nadjusted balanced occlusion not only helps with denture retention, but also gently guides the\nmandible to centric occlusion. A freedom-in-centric occlusal concept therefore seems most\nappropriate for elderly patients. Impaired muscle skill also affects denture control, especially\nin patients with neurodegenerative diseases such as Parkinson’s disease, dementia, or\nmandibular dyskinesia."
  },
  {
    "page": 40,
    "content": "Fig 6 The deterioration of muscle skill is most obvious in the handwriting of an elderly person. Similar changes occur\nin the motor coordination of mandibular movements.\nFig 7 Motor control deteriorates with age, rendering motor tasks such as denture wearing difficult. This patient even\nhad difficulties to control her shoes.\nSalivary glands. Although physiological aging reduces the total amount of saliva that can be\nproduced by the glands, the quantity produced in healthy elders should be sufficient to keep the\nmouth in good shape. Saliva is also important for the taste; it can be noted that elderly persons\ntend to add more spices and more salt to their dishes. With age, parts of the acinar cells are\nreplaced by connective tissue, and the ratio between active cells and ducts is shifted. The high\npercentage of elderly persons with dry mouth is more related to underlying pathology or to side\neffects of their treatment.\nOral mucosa. With age, the appearance of the oral mucosa becomes pale and thin or delicate,\nwith a silky shine. Histologically, the oral mucosa becomes thinner and less elastic, and more\nfibrous fibres are present with age, with less interstitial fluid, rendering the tissues more\nvulnerable to mechanical injury. A reduced number of cell bodies and increasing surface\nkeratinization can also be noted (Scott and coworkers 1983). The papillae of the tongue\natrophy, and deep macroscopic fissures may appear in the dorsum.\nPeriodontium. Old age alone does not cause gingival recession or the loss of periodontal\ntissues. However, age is often associated with less meticulous oral hygiene; the cumulative\neffect of exposure to biofilm may account for the high prevalence of periodontal breakdowns\nand ultimately tooth loss in old age. In contrast, a true sign of physiological aging of the\nperiodontium is the apposition of cementum—which is even used to determine age"
  },
  {
    "page": 41,
    "content": "forensically.\nTeeth. Of all structures of the orofacial system, the teeth present the most evident signs of\naging. Functionally, teeth become less sensitive to external stimuli, and pulpal tissue becomes\nless resistant to trauma such as cutting with a dental turbine. Attrition, abrasion, and wear lead\nto a loss of hard tissue on the incisal and occlusal aspects, often exposing the underlying\ndentin. Nutritional habits, bruxism, and the hardness of the enamel modulate the extent of these\nchanges.\nFig 8 Young adults have teeth with little wear and a light shade.\nFig 9 Age shows mostly in incisal abrasions and a darker shade; stains and cracks also become more frequent.\nThe tooth surface appears smoother and is less transparent and duller. Abrasive toothpastes\nand certain brushing techniques may accelerate these age-related changes. Hartmann and\nMüller (2004) showed in their studies on the age-related changes in appearance that the\nunrestored tooth of a 21- to 33-year old person is one to two shades lighter than that of 67-\nyear-old volunteers. They also confirmed that aged teeth are more likely to exhibit cracks,\ndiscolorations, abrasions, and crowding of the incisors (Figs 8 and 9; Table 1). A knowledge\nof these age-related changes allows the restorative dentist to suggest an age-appropriate\nappearance to a patient when tooth replacement becomes necessary."
  },
  {
    "page": 42,
    "content": "Table 1 Features like cracks, stains, and defects in a group of young volunteers with unrestored dentitions (n = 64;\nmean age 25.8 years) and a group of older persons (n = 64; mean age 67.3 years) with an unrestored anterior\ndentition (after Hartmann and Müller 2004).\nNerves. The peripheral and central nervous systems also undergo changes along with\nphysiological aging. The conduction speed of the peripheral nerves decreases and the\nsensitivity of mechanoreceptors diminishes. Large particles of food debris can often be found\nin the vestibulum of elderly patients, as they cannot feel the foreign body. However, in\nprosthodontics the most important age-related neurological change is reduced neuroplasticity.\nThe insertion of a new prosthesis implies the stimulation of different mechanoreceptors in the\noral mucosa and requires the modification of existing movement patterns and reflexes. Elderly\npersons with a reduced capacity for adaptation should therefore be provided with replacement\ndentures similar in form and function to the previous well-adapted set. Duplication techniques\nmay be employed to transfer the maximum number of a denture’s successful features to the new\nprosthesis. Mechanical retention may also be helpful, as neuroplasticity is less challenged\nwhen denture function does not rely on motor control (Müller and coworkers 1995).\nMultimorbidity and frailty\nThe transition of the stable stage of life (third age) to the stage of dependency for the activities\nof daily living, also called the fourth age or old age, is generally not linear. Signs of frailty\ninclude rapid weight loss, weakness, fatigue, anorexia, and physical inactivity. Clinically frail\npatients may present with undernutrition, sarcopenia, osteopenia, slow walking, balance\nproblems, and poor physical fitness (Fried and Walston 1998).\nWhereas medical events often initiate the transition from the third to the fourth age, we also\nnote that psychological stress or life events like the loss of a partner or shifting to a new\nresidence trigger a rapid and steep functional decline. Patients may suddenly appear less well\ndressed, poorly shaved, and sometimes a little “smelly.” Their oral hygiene often seems\nunusually neglected, and a severe and comprehensive periodontal breakdown is often the\nconsequence. Whereas healthy adults can regain their pre-event level of functioning, frail\npersons will remain permanently impaired. As frailty progresses, they become dependent on\nhelp for normal activities of daily living (ADL). Their functional decline can be evaluated and\nmonitored by a geriatric assessment comprising a comprehensive battery of instruments. Only a"
  },
  {
    "page": 43,
    "content": "few very commonly used tests are listed here:\nBase activities of daily living can be evaluated by means of\n•\nBarthel Index for the Activities of Daily Living (Mahoney and Barthel 1965)\nCognitive function and psychological health can be assessed by\n•\nGeriatric Depression Scale (GDS) (Sheikh and Yesavange 1986)\n•\nMini Mental State Examination (MMSE) (Folstein MF 1975)\n•\nClock-drawing test (Shulman 2000)\nThe nutritional state may be evaluated by\n•\nMini-Nutritional Assessment (MNA) (Guigoz and coworkers 1994)\nAlthough some of these tests may be not practical in daily dental practice, the well-established\nbut less well-documented “denture-upside-down test” is easy to implement. When a patient is\nhanded a denture upside down and places it in the mouth without first turning it over, this may\nbe a first sign of cognitive impairment, and the patient may benefit from an in-depth\nexamination at a specialized memory clinic (Figs 10a-c).\nThe most common chronic diseases in elderly adults on average 84 years of age who live in\nlong-term care facilities are hypertension (men, 53%/women, 56%), dementia (45%/52%),\ndepression (31%/37%), arthritis (26%/35%), diabetes (26%/23%), reflux (23%/23%),\narteriosclerosis (24%/20%), cardiac insufficiency (18%/21%), cerebrovascular diseases\n(24%/19%), and anemia (17%/20%) (Moore and coworkers 2012). In Switzerland, about half\nof the population over 75 years indicated that they had a permanent health problem. This\npercentage increases steeply in the institutionalized population.\nPhysical limitations\nFrail and multimorbid elderly persons often present with physical limitations when it comes to\ndental treatments. Appointments have to be adjusted to individual habits, not too early in the\nmorning, as dressing takes longer, not during fixed mealtimes, and preferably during daylight\n(Fig 11). Winter months have to be avoided for non-urgent treatments, as falls on slippery and\nicy roads all too often result in hip fractures, an incident with a mortality of 20% in old age.\nAppointments should be made in writing with clear and large letters on a sheet with no\ndistracting advertising. Financial agreements should also be clear and equally made available\nin writing, as children and family often advise their elderly relatives, even if they are not\nofficially appointed as legal representative. Elderly persons should be discouraged from\ncarrying large amounts in cash when they attend for treatment, as they may become easy victims\nfor burglary and violence in the streets. Their physical frailty also precludes long and invasive\ntreatment sessions, and often the necessary dental procedures have to be performed with high\nprecision in a short time, which requires a significant degree of skill and experience on the"
  },
  {
    "page": 44,
    "content": "part of the operator.\nFigs 10a-c Denture-upside-down test."
  },
  {
    "page": 45,
    "content": "Fig 11 Even if older patients’ calendars seem “empty” compared to ours, these patients are not always available for\ndental appointments.\nFig 12 Psychological well-being increases with age beyond 50 years (after Stone and coworkers 2010).\nPsychological and social aging\nThe U-shaped curve of psychological well-being in a cohort of 340,847 participants in the\nUnited States showed that aging is accompanied by a constant increase in psychological well-\nbeing (Stone and coworkers 2010; Fig 12). Little is known about psychological aging, although\nthis may be a very relevant factor in medical treatment outcomes. While everything is not all\nthat marvelous in old age, some suggest the elderly adopt a more accepting attitude and more\nrealistic expectations, along with less stress, which renders them more content. On the other\nhand, there is an increasing prevalence of depression and social isolation in the elderly\npopulation, as their partners and friends pass away, or when relocation to a more age-adequate\nand “practical” abode reduces their usual social contacts and familiar environment. All this\nimplies a certain risk that oral health is neglected, as oral pathologies and functional\nimpairment are no longer correctly perceived. It is well documented that the subjective\ndemand of elderly persons for improvements in their oral health or regarding prostheses is\nless; this is in extreme contrast to the objective judgement of their treatment need by dental\nhealth professionals (Locker and Jokovic 1996; Figs 13a-c)."
  },
  {
    "page": 46,
    "content": "Figs 13a-c “Overadaptation” describes a situation where an elderly person accepts a traumatic and non-functional\ncondition without demanding treatment. (a, b) This patient did not seek treatment to have the pins of his denture\nremoved. (c) The gingiva showed chronic inflammation and keratinization where the pins were located.\nOld patients still have the right of self-determination of their medical treatment; patients may\nchoose to decide against interventions that—from an objective and professional point of view\n—ought to be performed. It is easy to imagine that optional interventions, especially when they\ninclude a surgical procedure, are even less popular in elderly adults. The role of the health\nprofessional is to inform patients on their oral health and to propose, with professional\nknowledge and judgment, adequate treatment options, so that patients know everything\nnecessary to give “informed consent.” Written information sheets give patients the time\nnecessary to thoroughly consider the proposed treatment options and discuss them with family\nand friends (Fig 14).\nOral health in elderly persons\nDespite all prevention and progress in restorative techniques, caries, periodontal disease, and\ntooth loss are still a reality in old age; 97.4% of the Swiss population have some sort of\nprostheses, and 85.9% wear removable dentures at 85 years or over (Zitzmann and coworkers\n2008a). However, the prevalence varies between countries and studies, and comparisons are\ndifficult as age groups and study contexts vary enormously (Müller and coworkers 2007).\nAs mentioned before, there is still a substantial proportion of edentulous persons in the higher\nage groups. In the USA, the total number of cases to treat is even expected to rise due to the\ngrowing percentage number of older persons (Douglass and coworkers 2002). When natural\nteeth are still present, they usually present with the above-mentioned signs of aging, but also\nshow pathologies such as coronal and root caries, occlusal wear, and periodontal disease."
  },
  {
    "page": 47,
    "content": "Oral health in elderly persons is further compromised by a high prevalence of xerostomia, with\nthe accompanying painful infections of the oral mucosa (Locker 2003). The prevalence of oral\nsquamous-cell carcinoma increases beyond the age of 60 years, so regular screening of the oral\ncavity is highly recommended (Dhanuthai and coworkers 2016). Another frequent pathology in\nold age is dysphagia, whose prevalence, 6%–9% in the adult population, rises to 15%–22%\nfor those aged over 50 years and 40%–60% in institutionalized individuals (Aslam and Vaezi\n2013). Dysphagia is the main risk factor for the development of aspiration pneumonia as food\ndebris, biofilm, and saliva risk descending the bronchi (Quagliarello and coworkers 2005). In\nfragile and compromised patients, mortality rates of up to 48% were described for pneumonia\n(Welte and coworkers 2012).\nFig 14 Written information sheets allow the patient to spend as much time as needed to understand the proposed\ntreatments and discuss them with family and friends before taking a final decision.\nAspiration is not limited to small particles or objects. A case was reported where a four-unit\nbridge, failing due to rampant root caries in the abutment teeth, was aspirated by a patient who\nsuffered from Alzheimer’s disease (Oghalai 2002), and even several cases of aspirated\n“missing” dentures are known (Arora and coworkers 2005). Again, the mechanical retention of\na removable denture may effectively prevent these incidents and protect patients with\nswallowing disorders from aspiration.\nFig 15 Particular risks such as swallowing disorders or mandibular dyskinesia have to be considered in treatment\nplanning. This Parkinson’s patient had accidentally aspirated an implant screwdriver (reprinted with permission from\nDeliberador and coworkers 2011)."
  },
  {
    "page": 48,
    "content": "Fig 16 Treatment planning in gerodontology (after Riesen and coworkers 2002).\nTreatment planning\nAs for younger patients, treatment planning for elderly patients starts with an ideal treatment\nplan where the patient’s chief complaints and medical findings are the basis for a first\nsuggestion to satisfy an ideal level of esthetics and function under healthy conditions.\nHowever, even in younger patients, such ideal conditions are rarely present, and a more\nreasonable approach for treatment planning has to be adopted, taking into consideration the\ncost-benefit ratio, patients’ physical and mental condition, and their autonomy in denture\nhanding and oral hygiene. Such a clinical treatment plan may vary considerably from the ideal\none in terms of technical sophistication and invasiveness of a proposed prosthodontic\nrehabilitation. Whereas in younger patients, almost any agreed treatment goal can be achieved\nif the patient accepts the corresponding financial, logistic, physical, and psychological effort,\nthis is no longer the case in elderly patients, or particular risks associated with the patient’s\ncondition may exist. In patients with swallowing disorders or dyskinesia, there may be an\nincreased risk for aspiration—even of dental instruments (Deliberador and coworkers 2011;\nFig 15).\nTherefore, quite often the treatment plan will have to be reduced to a pragmatic level (Riesen\nand coworkers 2002; Fig 16). The treatment goal will have to be modified to what is\nachievable. The subjective treatment demands, the wishes of the family, or the socio-economic\ncontext may limit the available treatment options. The desires of the elderly patient may often\nbe overshadowed by those of the family. Moreover, financial aspects may dominate the\ntreatment options and reduce the reasonable treatment plan to a feasible level. In addition, the\npatient’s physical condition and general health may not allow long and invasive treatment\noptions, which further restricts the available treatment options. A preliminary treatment phase\nmay be helpful to decide on these limits, as elderly persons may have days on which they are\nless resilient. A typical example would be a hot summer day, where elderly persons tend to\ndehydrate as the sensation of thirst diminishes with age. In the dental consultation, they may\nseem confused and disoriented, even though their only actual problem is that they did not drink\nsufficiently. This pre-treatment phase should be understood as a diagnostic tool to be"
  },
  {
    "page": 49,
    "content": "reconsidered in later re-evaluations.\nThe elderly patient in the dental practice\nTreating elderly patients in a dental practice may require some special arrangements. First of\nall, it seems important that the dental practice be equipped to meet the physical handicaps of\nelders, such as reduced mobility and vision. Absence of tripping hazards, good lighting, and\nchairs that are stable and not too deep are essential features of a dental practice. Wheelchair\naccess may also be desirable (Fig 17). Forms should be prepared in a legible font size and the\ndental nurse should assist in filling the forms, if needed.\nOnce in the dental office, placing the patient on the dental chair may also be a challenge; tools\nare available to facilitate this task and prevent accidents. Simple interventions and oral\nexaminations may even be performed with the patient still seated in a wheelchair (Fig 18).\nRadiographs are diagnostic essentials, but some elderly patients may not be able to have a\npanoramic radiograph taken due to their posture, reduced mobility, or fear (Fig 19). In these\ncases, intraoral radiographs may be an alternative.\nCommunication with elderly persons may not only be difficult because of hearing problems; it\nis also important to note that one is talking to a “different generation,” who have many more\nyears of experience and different values (Fig 20). Especially for dental students, it is difficult\nto imagine that their elderly patients may have experienced hunger and war, lived without the\ninternet and mobile telephones. Technical progress, even when it concerns a dental prosthesis,\nmay be regarded with a substantial degree of suspicion. Understanding suggested treatments\nand their implications is a key factor for treatment success and compliance. Finding the right\nwords to explain the advantage of progress in the modern world (and in dentistry) is important\nin having elderly persons participating and benefiting in the recent developments of implant\ndentistry.\nFig 17 The dental office should have sufficient space for elderly patients with reduced mobility and—if possible—\nwheelchair access."
  },
  {
    "page": 50,
    "content": "Fig 18 If the dental unit is sufficiently spacious, simple treatments may even be performed without transferring the\nimmobile patient to the dental chair.\nFig 19 If the patient’s posture or reduced mobility does not allow taking a panoramic radiograph, intraoral\nradiographs may be a good alternative for a radiological examination.\nFig 20 In the treatment of elderly patients it is important to take into consideration that they may have lived in different\ntimes (without internet!) and have had very different experiences (war) and values."
  },
  {
    "page": 51,
    "content": "Fig 21 Clock-drawing test.\nLegal context\nOld age and dependency for the activities of daily living does not automatically imply the loss\nof the individual person’s legal rights in terms of health decisions and financial agreements. As\nlong as no official representative is allocated, old persons remain entitled to make their own\nbusiness and health decisions. However, their family may increasingly wish to be involved and\ninformed on any complex treatment decisions. Although this may be an agreeable arrangement,\ndentists need to be aware that reported elder abuse is frequent and the non-reported incidence\nrate is even higher. Unreasonable withholding of financial resources and psychological\nmanipulation may constitute elder abuse and should be reported to the authorities where noted.\nDentists could also be the first person to suspect the onset of cognitive impairment. A first\nsuspicion can be confirmed by the above-mentioned clock-drawing test (Fig 21). Depending on\nthe results, a referral to a specialized memory clinic for a more comprehensive examination\nmay be indicated. The drawing can be kept in the patient’s file to document a responsible\nevaluation of their cognitive function.\nPlacing dental implants and fabricating a new prosthesis are never emergency treatments. It\ntherefore seems important to give an elderly person sufficient time (at least one week) before\nagreeing to such interventions. Written proposals with a clear statement of the financial\ncommitment can help to avoid allegations and conflicts. If a patient has a legal representative,\nit is important to know that some countries distinguish between “financial” and “other”\ndecisions. So even if the patient’s representative may have the right to take financial decisions,\nthey may not be entitled to agree or disagree to a medical treatment. Elderly patients should\nalso be invited to discuss the treatment options with their family and friends. Only after they\nare completely convinced of the proposed intervention and have signed the agreement should\nthe treatment begin."
  },
  {
    "page": 52,
    "content": "4 The Benefits of Implant-supported Prostheses in the\nElderly Patient\n \nF. Müller"
  },
  {
    "page": 53,
    "content": "The benefits of implant-supported prostheses in elderly patients are most evident in completely\nedentulous patients who have been wearing conventional complete dentures for years or\ndecades. As mentioned before, the decision to extract or keep compromised natural teeth in\nelderly or very old patients is complex, as the possibilities of conventional or implant-\nsupported tooth replacement may be limited by functional, medical, or economic factors.\nHence, all efforts are made to retain an elderly patient’s natural dentition and to apply, where\npossible, the “shortened dental arch” concept (Käyser and coworkers 1981), or manufacture\noverdentures on natural abutment teeth to avoid invasive procedures and overtreatment.\nDespite these efforts, there are still very many fully edentulous persons among the elderly\npopulation, particularly among the very old (Müller and coworkers 2007). Not only do these\npatients require dental prostheses, they also depend on continuous care to maintain oral\nfunction and hygiene and on the progressive adaptation of the denture to the aging oral\nenvironment.\nFunction of conventional dentures\nConventional complete dentures replace teeth and lost tissue, but fall short of restoring oral\nfunction. Mucosally supported dentures rely on three mechanisms. At insertion, they can exert\nphysical suction, obtained by a precise impression with selective tissue compression or the\ncreation of a posterior palatal seal. Physical suction requires the presence of a thin film of\nsaliva, preferably of mucous consistency. Cohesive and adhesive forces are more easily\nachieved in maxillary complete dentures, as the ratio of denture-bearing surface to the length of\nthe border seal is more favorable than with mandibular dentures. However, the physical\nretention decreases over time as the alveolar structures atrophy with age and protracted\nocclusal load (Tallgren 1972).\nWith the decrease of physical retention, denture function is increasingly assured by the second\nmechanism, “muscular” retention—a learned skill to keep the denture in place during function\n(Basker and Watson 1991; Müller and coworkers 2002; Fig 1). To perform this demanding task\nsuccessfully, the brain processes afferent information from the oral cavity, which is then\ntranslated into a purpose-oriented motor activity pattern.\nOral perception is essential for denture control, but the sensitivity of the mechanoreceptors\ndiminishes with age. The absence of this afferent information can be simulated by surface\nanesthesia of the denture-supporting mucosa; pertinent experiments clearly demonstrated the\nfailure of denture control and the inability to speak or chew efficiently (Brill and coworkers\n1959). Complete-denture wearers regularly “refresh” the central nervous system (CNS) with\nthe afferent information on the denture position by unconscious denture-control movements.\nIn addition to physical retention and muscle control, conventional denture function relies on a\nthird mechanism: occlusion. The positive effect of occlusal denture stabilization becomes most\napparent when it is missing, such as when patients wear only their maxillary dentures, when\nsurgical removal of the mandibular hard and soft tissues is required in the treatment of head"
  },
  {
    "page": 54,
    "content": "and neck cancer, or simply when the mandibular denture is not worn because it causes\ndiscomfort. Denture kinetics during swallowing and the mentioned control movements also\nrely on occlusal contact. A bilaterally balanced occlusion helps guide the closing trajectory of\nthe mandible to central occlusion without challenging the denture adhesion with unilateral\nocclusal loads.\nFig 1 Motor control allows wearers of complete dentures to function with poorly fitting dentures, but the required motor\nskills diminish with increasing age and morbidity, and denture control becomes difficult. The image illustrates the reflex\nof stabilizing a dislodged maxillary denture in place (after Basker and Watson 1991).\nBenefits of the implant-supported overdenture Implant-supported overdenture retention\nand stability.\nAll three of the abovementioned mechanisms of denture function are assisted by the conversion\nof a conventional complete denture to an implant-supported overdenture. All implant-\nsupported overdentures (IODs), regardless of implant number and positions, provide\nsubstantial improvement in terms of denture retention and stability. This is a particular\nadvantage in compromised elders with xerostomia, as the available quantity of saliva may not\nbe sufficient to assure denture retention. Despite the benefit of added retention from the\ninsertion of implants, patients with xerostomia may still experience pain and discomfort when\nthe denture base rubs on the dry mucosa during micro-movements.\nIODs are further beneficial when oral motor control deteriorates due to age or disease, such as\nwith Parkinson’s disease or dementia. Also, drug-induced oral dyskinesia can often be\nobserved in fragile and multimorbid elderly persons. This lack of motor control may render\nconventional dentures very difficult to wear, and dentures are worn much less by patients with\nthese conditions. Although rare, reports confirm that complete dentures can even be aspirated\nin the absence of protective motor control, especially when the patient also presents with\ndysphagia (Arora and coworkers 2005). The additional retention and stability provided by\nimplants replaces the need for muscular skill and prevents denture displacement during speech\nand chewing function.\nFinally, implant-supported overdentures alleviate the need for a balanced occlusion. Although\nthis occlusal concept is still adopted in IODs, denture stability is less at risk when the\nmandibular closing trajectory is not well controlled and the teeth contact the antagonistic arch\nin an eccentric position."
  },
  {
    "page": 55,
    "content": "Denture adaptation. As mentioned earlier, the adaptation to replacement dentures comprises\nthree components: psychological adaptation (not perceiving the prosthesis as foreign body),\nphysiological adaptation (habituation, indicating a diminishing reflex response to a continuous\nor repeated stimulus), and muscle skills (indicating motor control of the prosthesis). Whereas\npsychological adaptation is complex and may be overshadowed by various aspects of tooth\nloss and denture wearing, the other two components may be greatly aided by implants.\nImplants can ensure denture retention and facilitate continuous and consistent stimulation of the\nmechanoreceptors, which in turn enhances the habituation, as the reflex response to a continued\nstimulus generally weakens with time.\nImplants also render muscular skills redundant when denture stability and retention are assured\nby way of mechanical attachment systems. Consequently, IODs present less of a challenge to\nthe patient’s neuroplasticity by lowering the amount of new muscular skills that the patient has\nto acquire.\nPrevention of bone atrophy. Numerous scientific studies provide solid evidence on the\nbeneficial effect of implants on the preservation of the peri-implant bone. Alveolar-ridge\natrophy in edentulous persons has rarely been studied, yet long-term observations have\nreported an annual atrophy of 0.2 mm in the maxilla and 0.7 mm in the mandible (Tallgren\n1972) 3 to 7 years after extraction. In the peri-implant area, atrophy is reduced by a factor of\nbetween 7 and 10 when implants are inserted (Jemt and coworkers 1996a; Lindquist and\ncoworkers 1988; Naert and coworkers 1991; Table 1). However, IODs increase the chewing\nand biting forces and may accelerate bone resorption distant to the implant (de Jong and\ncoworkers 2010; Jacobs and coworkers 1992). If the IODs are not regularly monitored and\nrelined if needed, this might lead to an anterior occlusion and eventually even to “combination\nsyndrome” (Kreisler and coworkers 2003; Tymstra and coworkers 2011). The beneficial effect\nof bone conservation through implants depends on the treatment concept in general and the\nocclusal load distribution in particular."
  },
  {
    "page": 56,
    "content": "Table 1 Numerous studies have demonstrated that the annual peri-implant bone loss in overdenture wearers proceeds\nmore slowly than the atrophy of the edentulous mandible in complete-denture wearers.\nChewing efficiency and bite force. Chewing efficiency and bite force with complete dentures\nis significantly impaired when compared to persons with a natural dentition. Analyses of\nmandibular movements revealed that complete-denture wearers present about one-third less\nvertical opening and about half of the frontal width of the chewing cycle compared to dentate\nvolunteers (Hofmann and Pröschel 1982). The limiting factors are denture retention and\nstability, as the complete-denture wearer unconsciously limits mandibular excursions to avoid\ndenture displacement. Furthermore, chewing forces may cause pain on the denture-bearing\nmucosa. Denture-related sore spots are alleviated when chewing forces are transferred to\nimplants rather than fragile mucosal tissues. Supporting overdentures by implants significantly\nimproves masticatory efficiency in independent complete-denture wearers (van der Bilt and\ncoworkers 2010). Experiments with a test bolus consisting of a 5.6-mm silicone cube showed\nthat only half the chewing cycles were necessary to obtain the same particle size, and this was\nindependent of the attachment system (van Kampen and coworkers 2004; Fig 2). In fragile\nelderly patients, this effect is less pronounced, as the weak chewing muscles and occlusal\nwear may overshadow the positive effect of denture stability from implants (Müller and\ncoworkers 2013). The bulk of the chewing muscle diminishes with age, and bite force is\ngreatly reduced. Atrophy is even more pronounced after tooth loss, probably due to the lack of\nphysiological stimulation (Newton and coworkers 1993). According to the physiological"
  },
  {
    "page": 57,
    "content": "principle of “use it or lose it,” it is possible, although unproven, that implant-supported\noverdentures slow down muscle atrophy by providing constant “training” via improved\nchewing activity (Müller and coworkers 2012b; Fig 3).\nFig 2 Number of chewing cycles needed to reduce to half the initial size of a 5.6-mm test bolus after stabilization of the\nmandibular denture with two implants. Significant improvements with all three attachment types (after van Kampen and\ncoworkers 2004).\nFig 3 The well-documented decrease in muscle bulk after tooth loss seems to be partly compensated when implants are\nplaced for fixed or removable restorations. This may be attributed to a training effect following the improved chewing\nfunction. Each group had 20 patients with an average age between 61.5 and 68.2 years (after Müller and coworkers\n2012b)."
  },
  {
    "page": 58,
    "content": "Fig 4 In a cohort of 470 hospitalized patients with an average age of 81.5 years over 4.2 years, the mortality was\nlowest in persons with a body mass index (kg/m²) of over 28 (after Weiss and coworkers 2008).\nNutritional state. Malnutrition is a widespread health problem in the elderly population with\na prevalence of 5%–8% reported for community-dwelling elderly adults and 30%–60% in the\ninstitutionalized population (Guigoz and coworkers 1994), and may be in excess of 60% of\nlong-term care home residents (Pauly and coworkers 2007). However, in elders a BMI of 28\nor above is associated with reduced morbidity and mortality (Weiss and coworkers 2008; Fig\n4). Food intake depends on multiple factors such as appetite, cognitive state, general health,\nknowledge, mobility, financial resources, culture, religious practice, and finally cooking skills.\nChewing efficiency is only one factor affecting food intake. Still, there is an established\ncorrelation between the number of teeth and food intake (Sheiham and coworkers 2001). With\nthe loss of teeth and the accompanying impairment of mastication, a silent change in diet\noccurs, often unnoticed by the denture wearer. This shows most clearly in the large\ndiscrepancy between the answers to the questions “is there any food that is difficult to eat?”\nand “What food do you not eat because it is too difficult to chew?” (Millwood and Heath\n2000).\nDenture wearers tend to shun hard food like nuts, raw carrots, or celery, as well as tough food\nsuch as meat or sticky food such as toffee and chewing gum, which tend to dislodge the\nprosthesis. Equally unpopular amongst denture wearers are foods with pips, like tomatoes,\nstrawberry and raspberry jelly, or cakes and bread with small grains, as they could slip under\nthe denture and cause severe discomfort during the rest of the meal. In public, this may lead to\nembarrassing situations, and it is known that denture wearers are self-conscious about these\nlimitations, sometimes even preferring to eat alone. Although aged individuals have lower\nenergy requirements and therefore need fewer calories, the amount of nutriments such as\nvitamins or micronutrients needed remains the same as in younger persons. This implies that\nthe diet of elderly persons should be “nutrient-dense” (Moynihan 2007). The consumption of\nfruit and vegetables diminishes along with tooth loss, and the recommended five portions a day\nare rarely eaten by elderly denture wearers.\nIt can therefore be assumed that the stabilization of complete dentures by means of\nosseointegrated implants may improve the nutritional state of elderly complete-denture"
  },
  {
    "page": 59,
    "content": "wearers (Morais and coworkers 2003). Implants avoid dislodging of the denture during\nchewing, provide support for the chewing forces and assure an intimate contact of the denture\nbase to the denture bearing tissues, thus assisting in the prevention of food particles\naccumulating under the denture saddles. However, with surprising consistency, the literature\nproves that converting a complete denture to an implant-supported overdenture alone does not\ninfluence the patient’s food choice, although most patients are aware of and are subjectively\nsatisfied with the improved chewing efficiency. The group of Jocelyne Feine in Montréal\nrecently completed a randomized controlled trial where 113 wearers of conventional dentures\nand 103 wearers of conventional maxillary and implant-supported mandibular overdenture\nwere enrolled (Hamdan and coworkers 2013). One year after denture delivery, fiber intake,\nmacro- and micronutrient composition, and consumed energy were assessed. They concluded\nthat implant overdentures alone fail to improve the food intake and the nutritional state of\nedentulous persons.\nNutritional habits and food intake are largely determined by habits. To actively disrupt\nestablished nutritional habits, the patient should be encouraged to try out new recipes and food\nitems after the delivery of the implant-supported denture in order to increase the consumption\nof fruit and vegetable and give more “exercise” to the masticatory muscles (Bradbury and\ncoworkers 2006). Poor masticatory performance is also related to a higher intake of digestive\ndrugs (Brodeur and coworkers 1993) and slower postprandial protein metabolism (Rémond\nand coworkers 2007). Hence, improvements in chewing efficiency might aid the patient’s\ndigestion and overall well-being. Professional counseling by a nutritionist may help increase\nthe patient’s nutritional benefit from an implant-supported overdenture (Bradbury and\ncoworkers 2006).\nDenture stability is not the only factor limiting the nutritional intake of elderly persons. Wear of\nthe acrylic denture teeth may preclude cutting the thin leaves of salad. Food particles might\nstill get under the denture base, even with implants. It has been shown that age-related atrophy\nof masticatory muscles results in lower mandibular chewing forces (Newton and coworkers\n1987). Our chewing movements are already ingrained at the age of 4 to 5 years and remain\nstable throughout over our entire lifetime. However, for every 10 years of aging we add three\nto four chewing cycles to each sequence, leaving mandibular movements and chewing rhythms\nlargely unchanged (Peyron and coworkers 2004). And finally, mastication relies on motor\ncoordination and oral perception, both of which deteriorate with age.\nEsthetic aspects. Can implants improve esthetics? This question seems intriguing, as implants\nare not visible per se. Again, we need to look into the function of the conventional complete\ndenture to highlight the benefit of implants supporting overdentures. In conventional dentures,\nthe maxillary anteriors are set up according to esthetic needs, providing a natural profile and\nlip support, as well as morphological needs, facilitating speech. In contrast, the mandibular\nincisors of a complete denture have to be placed according to functional and static needs, to\naccommodate the orbicularis oris muscle and preclude denture displacement during mouth\nopening. In complete-denture wearers, this may result in a substantial overjet that may even"
  },
  {
    "page": 60,
    "content": "become evident in patient’s profile.\nAlthough the teeth of an overdenture should generally be set up as in a complete denture, the\nstability afforded by the implants allows for a wider range of possible tooth positions, helping\nreconstruct the patient’s very personal profile and look. However, care must be taken to assess\nthe patient’s expectations before inserting the implants, as unrealistic expectations may lead to\nprofound disappointment and may cause the patient to lose confidence in the dentist. Implants\ncannot restore the patient to the young look he or she had on old photos taken with natural teeth\n—very often the wedding picture. Vertical wrinkles in the lips, reduced mandibular lip tone\nwith more mandibular and fewer maxillary front teeth being visible, as well as thinner lips\nwith less vermilion border are signs of physiological aging and cannot be corrected by\nprosthodontic means.\nFig 5 In complete-denture wearers, good retention seems to promote self-confidence in a social context. Being able to\nenjoy a meal in good company may help preventing social withdrawal.\nPsychosocial aspects. Tooth loss and the wearing of a removable prosthesis can have a\nnegative impact on self-esteem and psychosocial well-being. Just imagining the denture to\ncome loose in a social context frightens most denture wearers. The inability to finish a meal\nwithin an acceptable time is feared and may lead to social isolation, even within an\ninstitutionalized environment (Fig 5). Wismeijer and his group achieved the convincing\npsychosocial rehabilitation of 104 complete-denture wearers by stabilizing their mandibular\nprostheses with Straumann implants (Wismeijer and coworkers 1997; Fig 6). Sixteen months\nafter insertion, the patients were significantly more outgoing and sociable, visited their friends\nand family more often, and enjoyed going out to restaurants.\nOral health-related quality of life (OHRQoL) can also be measured with validated instruments\nthat provide consistent information and allow comparing the situation before and after the\ntreatment (Slade 2002). To assess the effectiveness of a treatment on the OHRQoL, a control\nintervention is necessary; it seems intuitive to compare patients with conventional complete\ndentures and patients with conventional maxillary and implant-supported mandibular\noverdentures. When randomized into one of these two treatment arms, both groups perceived\nan improvement in OHRQoL; however, only in the IOD group was the effect statistically\nsignificant. At the end of the 6-month observation period, the IOD patients indicated a"
  },
  {
    "page": 61,
    "content": "significantly better OHRQoL (Heydecke and coworkers 2003b). This effect was confirmed in\na context where patients were not randomized but received their treatment of choice (Rashid\nand coworkers 2011).\nIt seems intuitive to assume that satisfaction with IODs has to do with the cost involved, as\nhumans tend to justify their expenses by expressing a high satisfaction with their purchase.\nHowever, within the context of a study, treatment is provided free of charge to the patient, so\nno financial bias is involved. Also, the higher satisfaction with complete IODs seems to last\nthroughout the wearing period, even until 10 years after denture insertion (Meijer and\ncoworkers 2003).\nFig 6 Edentulous patients who had their mandibular dentures stabilized by two interforaminal implants participated\nmuch more in social activities 16 months after insertion of the overdenture (after Wismeijer and coworkers 1997).\nApprehensions and treatment acceptance\nBesides the known and widespread barriers to oral health care for elderly adults, such as\naccess to care and the lack of financial resources, implant treatment might be limited by poor\ngeneral health. In addition to “objective” barriers, subjective apprehension influences the\nacceptance of implant treatment. Even with the treatment offered at no charge, 36% of elderly\nedentulous subjects refused implants within the context of a clinical study (MacEntee and\ncoworkers 2005). Mostly, the fear of the surgical intervention accounted for the refusal, but\nthere was also a lack of perceived need for improvement. In a survey conducted at the\nUniversity of Geneva, the attitude towards and knowledge of implants and the hypothetical\nacceptance of implant treatment was investigated in 92 volunteers by means of a semi-\nstructured interview. A stepwise backward multiple linear regression analysis revealed that\nnot age as such but rather limited knowledge of implants, wearing (poor) dentures, and being a\nwoman, as well as low autonomy in daily life are the predominant factors that give rise to\napprehension in regard to implant treatment (Müller and coworkers 2012a).\nPatient acceptance could therefore be increased by:\n•\nRaising awareness for oral health and its impact on health and the quality of life."
  },
  {
    "page": 62,
    "content": "•\nProviding professional information (in writing and pictures—neutral, legible).\n•\nSuggesting treatment when the patient is still “fit” enough for the intervention and the\nsurgical intervention is not perceived as an insurmountable burden.\n•\nProposing minimally invasive procedures.\n•\nProposing prosthodontic solutions which are easy to handle and straightforward to clean."
  },
  {
    "page": 63,
    "content": "5 Medical Considerations for Dental Implant Therapy\nin the Elderly Patient\n \nS. Barter"
  },
  {
    "page": 64,
    "content": "5.1\nIntroduction\nThe global population is aging due to decreasing mortality and declining fertility. Globally, the\nproportion of the over-60 population increased from 9.2% in 1990 to 11.7% in 2013 and is\npredicted to reach 21.1% by 2050—more than 2 billion people, of whom 20% will live in\ndeveloped regions (United Nations 2013).\nImprovements in health care and advances in medicine mean that people are living longer, even\nwith chronic diseases; this in turn results in a greater incidence of elderly patients with\nmultiple organ disease and as a consequence, more extensive and complex drug regimes.\nClinicians therefore more frequently see elderly patients with complex medical histories and\nlong medication lists. While this chapter will examine the special considerations in the elderly\npatient for specific organ-system diseases, it must also highlight the need for an awareness of\nthe effects of combinations of disease processes, the potential issues associated with multiple\nmedications, and the impact not only of these issues on the treatment dental practitioners may\nprovide, but also the impact our treatment may have on the general health and well-being of the\npatient.\nQuality of life is in itself important in preserving health, and this can be in part reliant on the\nprovision of good dental prostheses. Our patients frequently refuse to accept the esthetic,\nphonetic, and functional problems caused by the discomfort and limitations of loose complete\ndentures or a failing dentition—and why should they? Esthetics and self-esteem are no longer\nthe privilege of the young. However, the more complex treatment we can now provide using\ndental implants is governed by the need for such treatment to be properly planned, executed\nwith care and precision, and appropriately maintained, even if the aging patients become\nunable to do so themselves.\nThe treatment plan must address the general health and well-being of the patient, and there will\nhave to be special considerations for elderly patients relating to:\n• The elderly patient with a failing dentition and the selection of appropriate treatment\noptions.\n• Surgical considerations for elderly patients with medical problems, both intra- and\npostoperative.\n• The management of medically compromised patients who already have dental implants,\neither for a replacement or modified prosthesis or as a result of biological/technical\ncomplications."
  },
  {
    "page": 65,
    "content": "•\nOur responsibility as health-care providers to recognize possible changes in the overall\nhealth of a patient and notify other health-care providers accordingly.\nA holistic approach to treatment is arguably even more important in elderly patients, where\nage-related vulnerability can mean a significant impact from treatment that in younger patients\nwould be relatively innocuous; for dental implantology, this will include important\nconsiderations in the planning of surgical procedures. However, the prosthetic aspects of\ntreatment will require equally careful planning to ensure that patients are able to cope with the\nassociated procedures and to ensure that the prosthesis itself provides adequate comfort,\nfunction, ease of plaque control, and continuing mucosal health. We have a duty to ensure that\nin our efforts to “help” patients, we do not cause problems that become more significant as\npatients become increasingly frail.\nSuccess (or more commonly, survival) rates for implants in healthy individuals have been\nreported as being as high as 99% over 15 years when implants are placed under ideal\nanatomical conditions (Lindquist and coworkers 1996). However, there is a lack of scientific\nliterature regarding the use of dental implants in medically compromised patients, where\noutcomes can be significantly less favorable, and even less evidence relating to the elderly\ncomplex medical patient.\nIt is well documented that advanced age in itself is not a contraindication to successful implant\ntreatment (Zarb and Schmitt 1993, de Baat 2000). However, one of the most important\nconsiderations related to the success of implant treatment is the matter of patient-related\nfactors, of which the individual’s medical health and the associated pharmacological\nconsiderations are paramount. This is especially so in elderly patients, when the increasing\nburden of age, multiple health issues, and increasing frailty result in a more complex series of\ninteractions that may complicate the safe and successful provision of implant treatment and that\ncan make a decision to provide implant-based treatment questionable. We have also to\nconsider potential later problems in the maintenance of dental implants or the future treatment\nrequired for implants and related prostheses provided at an earlier age.\nWhile most patients presenting for treatment with dental implants will be categorized\naccording to the classification system of the American Society of Anesthesiology (ASA 2014)\nas P1 (normal healthy) or P2 (mild systemic disease), elderly patients with polymorbidities\nand polypharmaceutical therapies may increasingly move into P3 status (severe systemic\ndisease). There is little evidence yet for the short and long-term performance of dental\nimplants in these patients and even less for the practicality of such therapy. While we may\nreasonably decide that the initial provision of dental implants in more severely medically\ncompromised patients should be delayed or abandoned, we can undoubtedly expect to see an\nincreasing number of people who have received implant therapy in the past, are aging and\nbecoming more medically compromised, but may require treatment for peri-implant diseases.\nSuch treatment may be surgical, relating to the development of peri-implant disease, and could\nhave important considerations regarding the patient’s medical health. It has been observed that\nthe elective dental treatment of patients classified as P4 (severe systemic disease that is a"
  },
  {
    "page": 66,
    "content": "threat to life) or higher should ideally be postponed until the patient’s medical condition has\nstabilized and improved to at least P3 (Maloney and Weinberg 2008).\nOften, the goal of dental implant studies in medically compromised patients is to assess the\nsuccess or survival of the implant itself. To ignore the possibility of wider health implications\nin providing surgical treatment with potential long-term care issues would be quite\ninappropriate. It is recognized that older adults require a different approach to oral health and\ndental treatment and that the dentist requires a more comprehensive knowledge of the effects of\nmedical conditions and their treatment on oral health (Koller 1994). The progressive change in\nthe health status of an increasing number of patients with dental implants presents a new\nchallenge. Studies have shown that in the institutional setting there is little awareness of what\ndental implants are or how they should be cared for, although it was recognized that there were\ndifficulties in caring for implants as compared to natural teeth (Kimura and coworkers 2015).\nIt is therefore hoped that the present chapter will be helpful in highlighting the many interacting\nconsiderations governing the provision of care for the elderly patient who is considering, or\nhas already received, implant therapy.\n5.1.1\nAging and Multimorbidity\nThere is a greater prevalence of chronic, non-communicable disease and of disability in\nelderly people, and most developed countries already have significant aged populations that,\nmoreover, are aging further. The global proportion of “oldest old” (persons 80 years or over)\nwas 14% in 2013 and is predicted to rise to 19% by 2050—392 million people (United\nNations 2013). As we age, our bodies undergo progressive changes in biology and physiology\nthat will be influenced in different ways by psychosocial and genetic factors, functional and\nnutritional considerations, the side effects of drugs used to treat medical conditions, and both\nphysical and mental disabilities. There are endless permutations of these factors, which makes\nit difficult to construct algorithms to deal with what has been described as comorbidity. Most\nguidelines are based on the diagnosis and treatment of single diseases and are often\ninapplicable to the polymorbid patient (Lugtenberg and coworkers 2011). The term\n“comorbidity” implies that a patient may have one major disease and one or more additional\nconditions or diseases that may or may not be interrelated. However, the real situation is of\nmultiple chronic disorders in one patient—“polymorbidity” (or “multimorbidity”)—all of\nwhich may interact on a constant, dynamic basis.\nPopulation aging will have a significant effect on the prevalence of polymorbidity. One\nestimate based on the US population estimates between 2000 and 2030, the number of\nAmericans with one or more chronic conditions will increase from 125 million to 171 million,\nan increase of 37% (46 million people) (Robert Wood Johnson Foundation 2010).\nIn a cross-sectional study of more than 175,000 patients, examining data on 40 conditions, it\nwas reported that 65% of 65- to 84-year-olds have two or more diseases and that 82% of\npersons over 85 years have three or more diseases (Fig 1). However, the current total number"
  },
  {
    "page": 67,
    "content": "of people with polymorbidity is highest in those younger than 65 years (Barnett and coworkers\n2012; Table 1).\nFig 1 Number of chronic disorders by age group (Barnett and coworkers 2012).\nThis is an important consideration, as it brings the possibility that as these patients age, the\nnumber of elderly polymorbid patients will increase further. Polymorbidity is most prevalent\nin women, the very elderly, and in patients from lower socioeconomic classes (Marengoni and\ncoworkers 2011), where polymorbidity is increasingly found in young and middle-age groups\n(Barnett and coworkers 2012). The prevalence of mental health disorders, including\ndepression, is also greater in polymorbid individuals (Moussavi and coworkers 2007).\nScientific understanding of the combinations of diseases is poor due to innumerable\npermutations of the factors discussed above (van den Akker and coworkers 2001). Medical\nspecialization can lead to the diseases rarely being investigated for their combined effect\n(Nobili and coworkers 2011). The interaction of two or more disease processes can be greater\nthan the effect of each individual disease or it can be inhibitory, such as the effect of\nneurodegenerative disease on some neoplastic diseases (Plun-Favreau and coworkers 2010).\nThe polymorbid elderly individual requires a more patient-centered approach in medicine,\nrather than the disease-centered approach engendered by the development of medical\nsubspecialties.\nIt could perhaps be considered that there are not “seven ages of man” (Shakespeare) but three:\nbiological, chronological and dental. There is evidence to suggest that polymorbidity will have\na greater impact on immune function than age alone (Castle and coworkers 2005). Results of\nstudies assessing surgery outcomes among the elderly do not support making decisions based\nonly on patient age. In general, for surgical patients it appears that preoperative medical fitness\nis of greater importance than chronological age (Seymour and Vaz 1989).\nMultimorbidity is certainly correlated with increasing mortality. It also seems clear that\npolymorbidity in the elderly is associated with an increased rate of functional decline, and this\nmay be taken into consideration when planning implant treatment.\nThe most prevalent polymorbidity is that of cardiovascular disease (including hypertension),"
  },
  {
    "page": 68,
    "content": "type 2 diabetes, and depression, and this cluster is associated with poor physical and mental\nhealth outcomes, significant morbidity, and mortality (Katon and coworkers 2010; Gallo and\ncoworkers 2005). Indeed, depressive illness can have a greater detrimental impact on health\nthan chronic angina, arthritis, asthma, or diabetes. Depression combined with other\ncomorbidities will worsen health more than the same comorbidities without depression\n(Moussavi and coworkers 2007).\nSuch patients can be challenging to treat when considering complex dental rehabilitation, and\nexpectation management with clear communication of the outcome that can realistically be\nachieved, is of paramount importance.\nIn addition, polymorbid patients have higher rates of disability and adverse drug events\n(ADEs) or lower health-related quality of life (Vogeli and coworkers 2007). Comorbidities\nsuch as coronary artery disease, diabetes mellitus, or anticoagulation may compromise wound\nhealing. The main causes of deep neck infections are odontogenic (Boscolo-Rizzo and\ncoworkers 2012); elderly polymorbid patients with dentoalveolar abscesses or deep peri-\nimplant infections may present the surgeon with difficulty in the management of severe\ninfections, which can develop and worsen rapidly."
  },
  {
    "page": 69,
    "content": "Table 1 Odds ratios (OR) for any mental health disorder by age, sex, socioeconomic status, and number of physical\ndisorders (Barnett and coworkers 2012)\nThere is little evidence to provide a scientific basis for the evidence-based care of patients\naffected by polymorbidity. Reports in the surgical field tend to be conditionor procedure-\nbased, with no data being available that could be used to provide collaborative guidelines.\nClinicians continue to find it difficult to apply disease-specific guidelines to elderly patients\nwith multiple conditions and to reconcile perceived clinical needs with patients’ treatment\npriorities (Fried and coworkers 2011a).\nThe most commonly used prognostic tool in clinical research for assessing risks from\npolymorbidity is the Charlson index. Although first published over 25 years ago (Charlson and\ncoworkers 1987), it is increasingly viewed as the gold standard in assessing and highlighting"
  },
  {
    "page": 70,
    "content": "the clinical risk of the burden of multiple illness (de Groot and coworkers 2003).\nModels for the successful treatment of elderly patients with polymorbidities have been\ndemonstrated as successful, designed as they are around multidisciplinary teams working in\nvery close collaboration. However, the uptake of such programs will likely be restricted by\noperational and financial barriers, as well as by the low availability of experts in chronic care\n(Boult and coworkers 2009).\nIn the dental field, in particular where systemic risk factors for implant therapy are concerned,\nthere is little information on the use of oral implants with individual systemic diseases, nor in\nsituations of polymorbidity (Cochran and coworkers 2009). Risks of implant complications are\nfrequently reported, but there is little associated reporting of general medical complications,\nwith the possible exception of conditions such as osteoradionecrosis or bisphosphonate-\nrelated osteonecrosis. There is a need for the reporting of complications; calls for well-\ndesigned prospective trials may be unrealistic, given the cohort-based problems of studying\nthis subject. However, clinicians must be encouraged to submit case reports in a structured\nmanner that may allow the gathering of useful data.\nWe need to be aware of the wide-ranging possible issues that may affect our patients, and we\nmust be vigilant. In assessing the multiple factors of implant treatment for the geriatric patient,\ndentists must understand the prevailing medical conditions, their pharmacologic management,\nand possible functional limitations in terms of patients’ ability to cope with and contribute to\ndifferent aspects of care, as well as pitfalls that may arise (Shay 1994). Examples of such\nconsiderations are listed in the following sections of this chapter.\nIn conclusion, polymorbidity affects more than half of the elderly population, with increasing\nprevalence in the oldest old, women, and people from lower social classes. Very little is\nknown about risk factors for polymorbidity; however, it is recognized that polymorbidity can\nhave a major impact on functional impairment, poor quality of life, and increased usage of\nhealth-care services, with a detrimental impact on health economics.\n5.1.2\nPolypharmacy\nOlder patients are more likely to be taking medications, and inevitably greater numbers of\ndrugs, for multiple chronic conditions, with prevalence increasing for each decade of aging\nafter the age of 60. The incidence of adverse drug effects (ADEs) associated with\nunexpectedly high plasma concentrations is increased in the elderly, as is the rate of reactions\nto normal therapeutic blood levels, although drug allergies are no more prevalent than in\nyounger age groups (Iber and coworkers 1994). This requires an understanding of the effects of\nthe drugs and the possibility of interactions with drugs prescribed by the dentist.\nThe effects of drugs are different in elderly patients when compared to younger adults, with\nsignificant variation in sensitivity to certain drugs. Absorption rates may be similar in the two"
  },
  {
    "page": 71,
    "content": "age groups, but changes in body fat and water composition may affect therapeutic drug levels.\nAs fat stores increase, the half-life of lipid-soluble drugs also increases. Similarly, as total\nbody water content decreases with age, the concentration of water-soluble drugs may increase.\nThe metabolism and excretion of drugs will also change with age-related hepatic and renal\nchanges. For example, drugs that bind to plasma proteins (for example digoxin) produce effects\nonly from the unbound portion of the drug, so in elderly patients with malnutrition or\npolymorbidity, a decrease in serum albumin levels may result in higher therapeutic levels and\nan increased effect of the drug.\nPolypharmacy has been variously defined as “the practice of administering many different\nmedicines, especially concurrently (as in the treatment of a single disease or of several\ncoexisting conditions),” (Merriam-Webster 2015), “the use of inappropriate medications”\n(Farrell and coworkers 2013) and “the use of more medications that are medically required”\n(Tjia and coworkers 2013).\nTable 2 Examples of age-related pharmacokinetic and pharmacodynamic changes (after Nobili and coworkers 2011)\nPharmacokinetics\nAge-related changes\nClinical considerations\nAbsorption\nDecreased gastric and saliva\nsecretion; delayed gastric\nemptying; decreased\nmesenteric blood flow,\nimpaired absorption and\nactive transport, reduced\nhepatic blood flow\nGreater effect of acid labile drugs\n(penicillin, erythromycin)\nReduced absorption of actively\ntransported drugs (calcium folate,\nB12); reduced rate of absorption;\nincreased effect of drugs\nundergoing first-pass metabolism\nDistribution\nReduction in total body\nwater, increase in body fat.\nChanges in plasma-protein\nbinding (reduced serum\nalbumin, increase in α-1-\nacid glycoprotein)\nHigher serum levels of water\nsoluble drugs (digoxin,\ntheophylline, aminoglycosides)\nLower serum levels of lipid\nsoluble drugs\nMetabolism\nReduced hepatic blood flow,\nvolume, and rate of liver\nphase-I metabolism (phase-II\nrelatively unaffected)\nHigh clearance rate drugs retained\nlonger; reduction in phase-I\nmetabolized drugs (SSRIs,\nbenzodiazepines\nExcretion\nReduction in renal blood\nflow, (in excess of decrease\nin cardiac output) mass,\nGFR, hence a 40% to 50%\nAccumulation of drugs excreted in\nun-metabolized for (gabapentin,\naminoglycosides); reduction in the\nexcretion of other drug metabolites"
  },
  {
    "page": 72,
    "content": "decrease in renal function\nwith age\nor those eliminated by tubular\nsecretion (penicillin, cimetidine)\n \nPharmacodynamics\nAge-related changes\nClinical considerations\nSensitivity/tolerance\nIncreased sensitivity to\nbenzodiazepines\nSedation, confusion, falls risk\nDrug/receptor\ninteractions\nIncreased sensitivity to\nanticholinergic effects\nAgitation, confusion, orthostatic\nhypotension\nAge-related change\nin target system\nGreater inhibition of\nvitamin K synthesis by\nwarfarin\nIncreased bleeding\nThe presence of concomitant multiple diseases frequently results in the provision of multiple\nmedications, which is of course a common form of polypharmacy. However, there appears to\nbe no currently accepted definition of the number of concurrent medications that constitute\npolypharmacy (Hajjar and coworkers 2007).\nRegardless of the lack of consensus on definitions, the prevalence of multiple-drug regimes is\nindisputable. A national survey in the USA concluded that 57% of women over 65 years were\ntaking more than 5 medications per day, and 12% of those women more than 10 medications\n(Kaufman and coworkers 2002). In Europe, it has been estimated that more than half of the\nelderly population is taking more than 6 medications per day (Fialová and coworkers 2005).\nAll medicines have the potential for harm as well as benefit; a medication that may be very\nbeneficial in the treatment of one specific condition may have a less beneficial effect, or even\ncause harm, in a situation of multiple diseases. Multiple-drug regimes can give rise to risks\nsuch as adverse effects, drug-drug interactions, drug-disease interactions, and dose errors, any\nor all of which can cause additional morbidity (Gandhi and coworkers 2003). Such ADEs also\nhave a significant impact on health-care economics.\nPolypharmacy is as prevalent in the outpatient setting as it is in institutions. An elderly patient\nwith heart failure and COPD will usually be taking at least five prescription medications\n(Boyd and coworkers 2005). A US-based outpatient study found that 36% of women and\n37.1% of men aged 75 to 85 years took at least five prescription medications with\napproximately half also taking non-prescription medications (Qato and coworkers 2008).\nIn the hospital setting, polypharmacy may be more prevalent, with reports of up to 58.6% of\npatients taking one or more medications that were unnecessary (Rossi and coworkers 2007); it"
  },
  {
    "page": 73,
    "content": "is possible that the number of prescribed medications for an individual will actually increase\nas a result of hospitalization for medical conditions (Hajjar and coworkers 2005).\nThere is less evidence for the occurrence of polypharmacy in the institutional setting (Tjia and\ncoworkers 2013). Some have suggested that the prevalence may be lower (Bronskill and\ncoworkers 2012), particularly amongst the very old (over 85 years) (Dwyer and coworkers\n2010). Other research has shown that more than 90% of community-residing residents were\nexposed to a potential error in their medication (Zermansky and coworkers 2006).\nIn 2008, about 1.9 million people in England had more than one long-term condition managed\nwith a number of different medicines (Department of Health UK 2012) and this figure is\nexpected to reach 2.9 million by 2018, approximately one quarter of whom will be aged 65\nyears or older. The UK National Institute for Clinical Excellence (NICE) has published figures\nindicating that 30%–50% of medicines prescribed for long-term conditions are not taken as\nintended. The guidance notes that “when patients move from one care setting to another,\nbetween 30 per cent and 70 per cent of patients experience an error or unintentional change to\ntheir medicines.” The same report found that 5% to 8% of all hospital admissions are due to\npreventable ADEs or interactions with other medicines (NICE 2015).\nThere are many unanswered questions, including benefit-to-harm ratios inherent in\npolypharmacy and the health priorities of an individual patient—future mortality may be of less\nconcern to the patient than quality of life (Fried and coworkers 2011b; Kuluski and coworkers\n2013).\nMany prescribing guidelines are inevitably based on a disease-specific approach, and the\nprevalence of events associated with multiple medications is probably underestimated, since\nthe available data reflect only recognized ADEs. Much remains unknown about the wider\nphysical, cognitive, psychological, and other effects that may yet be unrecognized (Tinetti and\ncoworkers 2004).\nThis is particularly so in elderly patients with multiple health conditions, who are often\nexcluded from randomized controlled trials (Gross and coworkers 2002). Consequently, there\nis little evidence-based information on the effects of multiple drugs on adverse events,\nhealthcare economics, quality of life, and mortality, as coexisting conditions are often only\nconsidered if they have an impact on the target condition of the study (Jones and coworkers\n2009; Guyatt and coworkers 1994).\nHowever, it is recognized that the impact of polypharmacy on patients over 65 years is greater\n(Beijer and de Blaey 2002). Factoring in the increasing age of a patient adds further\ncomplicating issues, such as the differences in pharmacokinetics and pharmacodynamics of\ncertain medications in the elderly, leading to increasing susceptibility and sensitivity with age\n(Hanlon and coworkers 2010). Inappropriate drug prescriptions are relatively common in the\nelderly community (Stuck and coworkers 1994). Patients frequently do not know why they are\ntaking a particular medicine. Elderly patients are less likely to recognize insidious and slowly"
  },
  {
    "page": 74,
    "content": "progressive changes in their health and report these to their physician. Missed interaction\nbetween patient and general medical practitioner, a lack of knowledge, or misunderstandings\nrelated to the complexity of the current drug regime can lead to further complications (Gandhi\nand coworkers 2003)—such as falls, cognitive impairment, urinary incontinence, malnutrition\n(Maher and coworkers 2014), or conditions that result in further prescriptions and the\ndevelopment of a “prescription cascade,” where a drug is prescribed to treat a side effect of\nanother (Farrell and coworkers 2013).\nThere is evidence to suggest that patients on combinations of drugs for multiple medical\nconditions only manage to take about 50% of their medications correctly as prescribed and that\n“medication adherence” (the ability to take the correct medications at the right time and dose)\nonly worsens as the number of drugs increases (Haynes and coworkers 1996). Various\ncompliance aids can be used to help reduce non-adherence (Barat and coworkers 2001;\nClaxton and coworkers 2001). These may include drug-list checks with a pharmacist, who can\nthen provide a medication timetable for the patient or caregiver. The dental professional\nshould provide clear and appropriate information on how their own prescribing should fit in\nwith their patients’ ongoing medication. However, there will be particular considerations in\npatients suffering from dementia or living alone. Complex prescription regimes in combination\nwith memory loss or cognitive decline can severely affect the ability to comply with doses and\nfrequencies or adhere to other treatment recommendations.\nAs a health-care professional, the dental practitioner has an important role to play in being\nalert for any situation that may affect patients’ general health. The most common ADE are\ninevitably associated with the most commonly prescribed drugs. One paper identified a rate of\nadverse drug events of 50.1 per 1,000 person-years of exposure, of which 38% were serious,\nlife-threatening, or fatal, and more than 25% were preventable (Gurwitz and coworkers 2003);\nthe most common medications associated with ADEs are frequently taken by patients receiving\nimplant therapy:\n•\nCardiovascular medications\n24.5%\n•\nDiuretics\n22.1%\n•\nNon-opioid analgesics\n15.4%\n•\nHypoglycemics\n10.9%\n•\nAnticoagulants\n10.2%\nAntibiotics, steroids, opioids, anticholinergics and benzodiazepines are also frequently\ninvolved in ADEs.\nThere are important potential side effects and interactions between drugs in these groups and\ncommonly prescribed analgesics and antibiotics used in dental implant surgery. Equally\nimportant considerations apply to the medications a patient may be taking and surgical implant\nprocedures. For example, a survey of complications associated with the dental use of local\nanesthetics indicated that, while the incidence in patients with no risk factors was 3.3%, this"
  },
  {
    "page": 75,
    "content": "more than doubled to 6.9% in patients taking more than two medications per day (Daubländer\nand coworkers 1997). Lower body weight or changes in drug metabolism in the elderly can\nmore easily result in overdoses of local anesthetics, particularly if inappropriately long\nprocedures are performed. It is generally recommended that maximum local anesthetic doses\nbe halved in patients over 65 years due to reduced liver function. Other important and relevant\nexamples of such considerations are described in each of the sections below.\nIt is also necessary to consider what non-prescription medications a patient may be taking in\naddition to the prescribed drugs—this may contribute to the rate of polypharmacy in the\ngeneral public and is often not considered (Batty and coworkers 1997). Over-the-counter\n(OTC) medications are used more frequently by elderly patients (Sihvo and coworkers 2000),\nwho—as previously described—frequently suffer from polymorbidity and prescription\npolypharmacy.\nIn one example of a population-based study, in older age groups (75 to 85 years) taking at least\none prescription medication, 47.3% reported the use of an OTC medication, and 54.2%, of a\ndietary supplement (Qato and coworkers 2008). Other studies reported 90% of elderly patients\ntaking at least one OTC drug (Stoehr and coworkers 1997); rates of use of dietary supplements\napproach 60%, and of herbal supplements, 14% (Kaufman and coworkers 2002).\nPatients often regard OTC medications as safe, with no significant side effects (Wawruch and\ncoworkers 2013) and regularly fail to read the package information leaflets (Hanna and\ncoworkers 2011). However, studies have shown that up to 50% of elderly patients taking OTC\nmedications were at risk of ADEs (Olesen and coworkers 2013).\nCommonly used OTC medications in the elderly include analgesics (e.g., acetaminophen,\nibuprofen, acetylsalicylic acid), which are known to significantly contribute to ADEs in the\nelderly. Also implicated are cold and cough medications (e.g., pseudoephedrine,\ndiphenhydramine), dietary supplements (e.g., multi- and single-vitamin supplements,\nglucosamine), antacids, and laxatives. Herbal medications are also commonly taken by elderly\npeople (e.g., ginseng, Ginkgo biloba extract, St. John’s wort). All of these can have potentially\nsignificant ADEs when taken alone or in combination with prescribed medicines.\nThe role of community pharmacists in assisting patients with OTC medications is important;\npharmacists gather specific information about patients’ medication profiles, health conditions,\ncharacteristics of the problem, and past treatments in order to make a recommendation (Chui\nand coworkers 2013).\nSome publications list drugs that are unwise to use in elderly patients and generally “safe”\ndrugs that can occasionally cause problems, and these can be useful points of reference (Beers\nand coworkers 1991; Fick and coworkers 2003).\nIt is clear that there is a complex web of interactions between medical conditions, the\nmedications used in their treatment, and the physiological effects of aging, with an almost"
  },
  {
    "page": 76,
    "content": "infinite number of possible permutations. The situation will be dynamic; for example, given the\nperiod of time over which even a simple implant therapy may take place, there may be a\nchange in medication or dose. This can cause significant problems in the complex management\nof the elderly patient for medical professionals in the primary-care setting (Del Fiol and\ncoworkers 2014).\nIt is easy to consider only the possible impact of drug changes on the procedure we as dental\npractitioners are about to undertake. However, in doing so we may miss subtle changes in the\nwell-being of the patient, such as increasing confusion, which could be dismissed as “getting\nold” but might in fact be a result of a minor prescription change or the introduction of an OTC\nmedication. The changes could have wider consequences—which could be as straightforward\nas patients not understanding the postoperative instructions you have given them, with events\nthat could potentially lead to treatment failure.\n5.1.3\nFrailty\nThe syndrome of frailty has been described as a state of increased vulnerability towards\nstressors in older individuals, leading to a heightened risk of adverse health outcomes (Fried\nand coworkers 2005). However, there is no accepted consensus on the definition of frailty.\nFrailty is considered highly prevalent in old age and is associated with a high risk of falls,\ndisability, hospitalization, and mortality. Frailty has previously been considered synonymous\nwith disability and comorbidity, but it has been recognized that it may have a biologic basis\nand be a distinct clinical syndrome, with an intermediate stage identifying persons at risk of\nbecoming frail (Fried and coworkers 2001). Comorbidity is a known risk factor in the\ndevelopment of frailty; together, frailty and comorbidity are strongly related to impaired\nimmunological status and periodontal disease (Charlson and coworkers 1987).\nPhysiological reserves are lower in frail patients and may become inadequate for the\nmaintenance and repair of multiple systems in the aging body (Lang and coworkers 2009).\nMultiple authors have identified characteristics of frailty to include wasting (loss of muscle\nmass and strength, with consequent weight loss), loss of endurance, decreased balance and\nmobility, slowed performance, relative inactivity, and potentially decreased cognitive function.\nFrailty is a distinct entity from aging; symptoms are multiple and may include appearance\n(whether or not consistent with age), nutritional status (thin, weight loss), subjective health\nrating (health perception), performance (cognition, fatigue), sensory/physical impairments\n(vision, hearing, strength), and current care (medication, hospital). Increasing frailty is\nconsidered potentially reversible. Given the need for good nutrition to combat several of the\nabove symptoms, adequate masticatory function and good oral health are important factors in\nthe prevention of increasing frailty (Saarela and coworkers 2014).\nA combination of aging and frailty can make it difficult for patients to access conventional care\n(Vernooij-Dassen and coworkers 2011) in both the dental and medical fields."
  },
  {
    "page": 77,
    "content": "Misunderstanding the concept of frailty by health care providers can result in an increased\nlevel of care being required by the frail patient. Loss of hearing, visual impairment and\ncognitive decline can compromise compliance by the patient, as can social factors such as\nliving alone and economic difficulty (Nobili and coworkers 2011).\nCoordination between clinicians and caregivers, with clear communication of clinical and\ntherapeutic decisions for the frail elderly patient is vitally important in successful short-term\nand long-term health-care efficiency (Kripalani and coworkers 2007).\nFrail and vulnerable elderly people have a higher risk of oral diseases; their treatment needs\nare often complicated by medical, functional, and psychosocial factors. They may be unable to\nexpress their needs or the fact that they are in pain; they may be incapable of performing simple\noral hygiene procedures. Care providers are often unaware of the importance of oral health\nand are frequently unlikely to understand the nature of even simple implant-based\nrehabilitations.\nWe should remember that the treatment of the aging, polymorbid, or frail patient is not just a\nconsideration of whether or not to provide implant treatment. We are inexorably moving\ntowards a population of such patients already treated with dental implants. This cohort will\nrequire maintenance therapy, replacement of prostheses, or treatment of technical and\nbiological complications such as fractured prostheses, components, implants and the\ndevelopment of peri-implant disease. Such treatment is frequently not simple, and in the case\nof the latter conditions it may require surgical intervention.\nIn this patient group, it will be important to consider such factors as the timing of treatment in\nrelation to other health-care needs, the length of the procedure (which may be directly related\nto the experience and proficiency of the surgeon), the ability of patient to cope with the\ntreatment, and the balance between breaking down the treatment into shorter sessions versus\nconsiderations such as the modification of prescribed medications, or the need for anesthesia\nor sedation and their impact on the patient’s general health.\nComprehensive medical assessment of the geriatric patient, and in particular the effects of\npolymorbidity, polypharmacy, and frailty, is an essential component in the provision of safe\nand effective dental care. Obtaining an accurate history will be essential.\n5.1.4\nTaking the Patient’s Medical History\nPatients should be assessed in the context of all their problems, including:\n• Dental problems (such as pain, difficulties with function, comfort, patients’ needs and\nwishes).\n• Medical problems, polymorbidity and polypharmacy considerations, past surgical issues,\netc."
  },
  {
    "page": 78,
    "content": "•\nPsychosocial factors (see Chapter 3).\n•\nPlanning for decline and the effect on/impact of our treatment (see Chapter 11).\nHowever, obtaining a clear medical history from a geriatric patient can sometimes be\nchallenging, especially if there is a lot of history to unravel. It may be wise to plan consultation\nappointments of greater length, as more time will be required. In a busy primary-care setting,\nthis may seem impractical, but time spent on getting the patient’s history gives a greater chance\nof identifying and preventing complications later. It may be easier to be wise in hindsight, but\nforesight and planning make for happy patients, better economics, and fewer sleepless nights\nfor clinicians.\nMany factors could influence this process, including sensory impairment; patients with hearing\nloss may need induction loops to render hearing aids more effective. That soothing in-surgery\nmusic could be counterproductive, and other extraneous noise (suction, outside traffic, etc.),\nwhile merely “background” to you, may be a cacophony that prevents the patient from hearing\nnot only what you say, but also the way you say it. Misunderstandings and confusion can result,\nadding to the stress and to the problem of obtaining or imparting important information. A quiet\nroom is essential; sitting closer to the patient, ensuring they can see your face, and talking\nclearly and slowly in an even tone is helpful. Stop frequently to check understanding—both\nyours and theirs.\nAnother factor in getting the patient’s medical history is that elderly patients may have\ncognitive impairments and quite simply cannot remember when their dentures were made or\nwhen a tooth first began to hurt. Elderly patients may find it difficult to describe a problem or\nsymptom, so particular complaints may seem vague; this could be the sign of a change from\ntheir normal “baseline” and could be important.\nA structured approach to getting a medical history will help both the clinician and the patient\nalong. A template is highly recommended, as it acts as a checklist to make sure that there are no\nerrors or omissions, particularly with patients who are poor historians, confused, or simply\ndelighted to have a rare opportunity of social contact and will provide a verbal autobiography\nspanning many decades of their life. Most clinicians will have experienced the difficulty of\nfiltering important information from a rambling but enthusiastic account of a patient’s lifetime\nmedical and dental experiences.\nDesigning a history template will depend a lot on the clinical setting, personal preference,\nculture, and many other factors. However, there are useful strategies that can be employed to\nobtain the required information, including:\n•\nReview past records in advance. It is not possible to listen well and read old records at the\nsame time. In addition, there may be notes in past records that may indicate a specific line\nof questioning that needs to be pursued.\n•\nProvide a self-administered questionnaire in advance. While such questionnaires have"
  },
  {
    "page": 79,
    "content": "been shown to be useful (Scully and Boyle 1983), elderly patients may have difficulty with\nsuch questionnaires due to visual impairment or memory loss (Kilmartin 1994). Providing\nthe questionnaire in advance allows the opportunity for family members or caregivers to\nhelp in the accurate completion of the form and prevent omissions.\n•\nObtain a current repeat prescription/medication list. Perhaps from the patient, caregiver\nor general medical practitioner.\n•\nSpecifically ask about “alternative” medications. Gingko biloba, St. John’s wort,\nEchinacea, vitamin, and mineral supplements may be considered “safe” and therefore\nunimportant by the patient, but they may cause interactions.\n•\nBring a family member/caregiver/friend. Elderly patients sometimes have a poor social\nnetwork. Slow changes in chronic conditions will often go unnoticed in the patient, and\nconfused patients may be unable to identify new problems. Having someone present at a\nconsultation who knows the patient well can be very helpful in both obtaining a good\nmedical history and in terms of imparting information, as well as facilitating the matter of\nconsent.\n•\nUnderstand when to use open and closed questioning. Also, understand when cognitive\nissues may make answers unreliable.\n•\nConsult with other clinicians. Confirming important details and filling in the information\ngaps is achieved by communicating clearly and promptly with the patient’s general medical\npractitioner, referring dentist, and other specialists.\nThe following sections will deal with considerations related to the elderly patient and,\ninevitably, are stratified by organ system. The irony of the classification is not lost on the\nauthor, given the previously discussed problems in adopting a disease-specific approach to\npatient care and the need for a wider consideration of the interactions between diseases, the\nmedications used to treat, and the multiplicity of patient-specific factors. While aging is a term\nused in different ways, the occurrence of age-related changes to a specific organ system\nresulting in decreased efficiency is known as “senescence.”\nSenescence is associated with a lack of physiological reserves in the organ system, with a\nconcomitant decrease in repair or regeneration, decreased ability to cope with stressors, and\nan increase in susceptibility to disease or infection. The functional decline of one organ system\nwill lead to the decline of other organ systems and consequent further considerations in\npolymorbid geriatric patients.\nEach section will consider:\n•\nThe medical background of the condition and normal age-related changes.\n•\nThe impact of disease on implant dentistry (both placement and long-term maintenance) and\nvice versa.\n•\nTreatment considerations.\n•\nThe drugs to treat the disease and the impact of medication on implant therapy."
  },
  {
    "page": 80,
    "content": "•\nPossible interactions with drugs commonly used in dentistry."
  },
  {
    "page": 81,
    "content": "5.2\nCardiovascular System\n5.2.1\nAge-related Changes\nCardiovascular aging is a continuous and irreversible process, which remains the most\ncommon cause of death and is likely to remain so in the near future (World Health Organization\n2011). The rate of cardiovascular decline is affected by other physiological changes that occur\nwith advancing age, the sequelae of previous health events, and lifestyle (Ribera-Casado\n1999).\nAge-related changes in the heart include structural and conduction issues, such as thinning and\nweakening of the myocardium, increased atrioventricular conduction time, decreased resting\nand maximum heart rate, decreased baroreflex, and an increase in ectopic atrial and ventricular\nbeats.\nThe prevalence of cardiovascular disease increases with age in both men and women. For\nmen, prevalence increases from 3.3% at age 16–24 to 53.8% at age 85 and above. For women,\nprevalence increases from 4.8% at age 16–24 to 31.1% at age 85 and above (Oyebode 2012).\nCardiovascular disease includes conditions such as hypertension, atherosclerosis, coronary\nartery disease, atrial fibrillation, and chronic heart failure, all of which are prevalent in the\nelderly population (Aronow 2002).\nThe main age-related structural and functional changes are in the cardiac tissue, the conduction\nsystem, and the coronary arteries. However, there is a general decrease in blood supply to all\ntissues due to age-related vascular narrowing and peripheral vascular disease. Atherosclerotic\nchanges result in decreased blood flow and consequent reduction in oxygenation of tissues.\nWound healing is dependent on angioneogenesis, collagen formation, and macrophage activity,\nall of which in turn depend on good oxygenation (Gottrup 2004). Good tissue perfusion and\noxygenation is also important in preventing infection (Rabkin and Hunt 1988).\nCoronary artery disease is an atherosclerotic narrowing of the vessels resulting in ischemic\nchanges in the cardiac muscle, which causes angina. It has been suggested that the prevalence\nof symptomatic ischemic heart disease is only 10% to 50% of the true prevalence in older\npatients, who may not exercise sufficiently to experience angina or dyspnea due to\nmusculoskeletal or other medical problems (Andres and coworkers 1990)."
  },
  {
    "page": 82,
    "content": "Myocardial infarction can result from severe narrowing or can occur more suddenly if an\natherosclerotic plaque detaches and forms a thrombus that blocks an artery. Ischemic cardiac\ntissue becomes necrotic and results in functional deficits of the muscular structure of the heart\nwall. Survival rates after myocardial infarction remain low but are improving, and after a\nperiod of healing and with appropriate treatment, patients can return to relatively normal\nfunction. However, approximately 75% of sufferers of a myocardial infarction (MI) have\nfurther complications in the following days or hours, such as arrhythmias, cardiogenic shock,\npericarditis, myocardial rupture, or progressive heart failure (Schoen 2005)\nHypertension is a widespread form of cardiovascular disease with an increased prevalence in\nelderly patients due to age-related structural and physiological changes in the cardiovascular\nsystem, including arteriosclerosis and atherosclerosis. It is potentially fatal, with a 2-mmHg\nrise in systolic pressure being associated with a 7% increased risk of fatality. Hypertension\nincreases the risk of ischemic heart disease and cerebrovascular events, chronic renal disease,\nand cognitive decline. It has been shown that blood pressure rises during or after medical or\ndental visits (“white-coat syndrome”)—and particularly during oral surgical procedures.\nBaseline and intraoperative blood-pressure monitoring may be useful in the overall monitoring\nof the elderly surgical patient (Kilmartin 1994; Lambrecht and coworkers 2011).\nRecent evidence suggests that the effect of lifestyle on the risk of myocardial infarction is more\nsignificant than genetic factors or a family history of, for example, coronary artery disease\n(Horne and Anderson 2015). Hypertension, hyperlipidemia, obesity, and type 2 diabetes are\nprevalent conditions in the aging population that are predicted to result in an increasing number\nof older patients with cardiovascular disease (CVD) (Pandya and coworkers 2013).\n5.2.2\nTreatment Considerations\nThere are anatomical and histological changes resulting from vascular changes in aging bone\nand decreased tissue oxygenation. It has been demonstrated that in the edentulous mandible\nthere may be a significant deterioration of the inferior alveolar artery, with periosteal stripping\nfor dentoalveolar surgery potentially compromising the predominant vascular supply, resulting\nin poor bony healing and a risk of osteonecrosis (Bradley 1981). Decreased oxygenation of\ntissues results in a reduction of fibroblast activity, collagen production, angioneogenesis, and\nmacrophage activity, all of which may increase the risk of postoperative infection.\nHowever, there is evidence to suggest that there is no increased risk of osseointegration failure\nin patients with well-controlled cardiovascular disease (Khadivi and coworkers 1999; Moy\nand coworkers 2005; Alsaadi and coworkers 2007; Alsaadi and coworkers 2008).\nHistorically, established guidance has been to delay dental treatment for six months following\nmyocardial infarction (Hwang and Wang 2006), as it is important to avoid stress, which could\ntrigger post-ischemic complications (Niwa and coworkers 2000). Advances in the treatment of\nischemic heart disease including thrombolytic therapy and coronary artery bypass grafting,"
  },
  {
    "page": 83,
    "content": "which increase the rate of reperfusion and salvage ischemic tissue, have recently improved the\ntreatment of patients with the disease. There are indications that patients with unstable angina\nor a recent MI may safely undergo minimally invasive dental treatment if appropriate\nprecautions are taken, including monitoring and anxiety management such as sedation (Niwa\nand coworkers 2000). However, 10% of the patients treated experienced a cardiovascular\ncomplication either during the dental procedures or in the first week thereafter.\nOther studies support the opinion that it may be not be necessary to delay potentially beneficial\ntreatment for so long and that a post-MI patient who has been medically assessed as having no\nrisk of continued ischemia may be allowed to undergo dental surgery with the support of the\ncardiologist as early as six weeks after an MI. Such treatment would need to be carried out\nwith prophylactic nitrates, continuous supplementary oxygen (in the absence of\ncontraindicating respiratory conditions, author’s comment), monitoring of oxygen saturation,\nblood pressure, and heart rate, adequate local anesthesia, perioperative pain medication, and\nstress reduction measures, in a hospital setting (Roberts and Mitnitsky 2001).\nIt is important to note that such studies investigate the effects of only relatively simple dental\ntreatments of up to 30 minutes that are minimally invasive; the procedures were performed in\nhospitals with appropriate specialist support. The recommendation remains that more\nprolonged or invasive non-essential elective procedures, such as implant placement, be\ndelayed for three to six months after an MI and planned in conjunction with the patient’s\nphysician or cardiologist.\nStress or anxiety management and adequate pain control are key factors in the safe management\nof patients with ischemic heart disease (Findler and coworkers 1993). Following invasive\ndental procedures, these patients may suffer post-infarction angina, arrhythmia, or left\nventricular failure demonstrated by a reduced ejection fraction. Such events are more frequent\nin elderly patients (Niwa and coworkers 2000).\nWhile elderly patients may satisfactorily tolerate normal stress, they may not cope well with\nsevere stress because of a lack of organ system reserves. For example, although resting cardiac\nfunction in a healthy elderly patient will normally be adequate for physiological needs, normal\nor almost normal cardiac output in the elderly has to be maintained under stress by increasing\nthe stroke volume and the ejection fraction—i.e. the heart is “working harder.” As with any\nmuscle working harder, increased oxygenation is required, as may be an augmented cardiac\nfilling (preload) (Ribera-Casado 1999). The myocardial muscle responds favorably to preload\nup to a point, beyond which, rather than increasing cardiac output, it may fail, giving rise to an\nischemic event.\nThe stress of treatment and related pain results in catecholamine-mediated hypertension and\ntachycardia, which can affect the oxygen tension in the myocardium, induce cardiac spasm, and\nincrease platelet aggregation (Muller and coworkers 1989). Hypertensive events are the main\nrisk factors for complications in cardiovascular events precipitated by stressors such as dental\nor surgical treatment, and elderly patients, particularly those who are polymorbid, are"
  },
  {
    "page": 84,
    "content": "frequently high-risk cardiovascular patients. Some researchers have highlighted the value of\nmonitoring the heart rate, blood pressure and oxygen saturation during outpatient oral surgery,\nfinding that in 0.6% of patients (n = 3,012) the procedure had to be discontinued due to\nsignificant hypertension or cardiac arrhythmias (Lambrecht and coworkers 2011). Prophylactic\nanxiety control with appropriate medications may also be useful.\nWhile there are cardiac effects associated with epinephrine-containing local anesthetics, these\nare usually slight. It has been argued that significant effects occur in CVD patients or those on\nbeta-blockers, but the clinical significance of the reported effects is debatable—for example,\ninteractions in patients on beta-blockers have only been demonstrated when excessively large\ndoses of epinephrine-containing local anesthetics have been used. There is also evidence that\ninadequate local anesthesia and pain control will result in even greater endogenous\ncatecholamine release (Scully 2014).\nIt is preferable to avoid general anesthesia in patients with cardiovascular disease, especially\nelderly patients, and intravenous sedation is commonly used for anxiety control. For the\ncardiac patient, such techniques can be useful and may prevent excessive intraoperative\nhypertension (Taguchi and coworkers 2011). However, intravenous midazolam does not\nprevent the occurrence of certain cardiac arrhythmias during procedures such as the placement\nof dental implants (Romano and coworkers 2012), although the arrhythmias noted did not\npresent a serious clinical risk.\nHypotensive events such as syncope are also associated with dental treatment and are more\nprevalent in elderly patients (Soteriades and coworkers 2002), where orthostatic hypotension\ncan occur as a result of lengthy immobility during prolonged treatment (Ungar and coworkers\n2009). Hypotension reduces coronary-artery perfusion and increases the risk of thrombotic\nocclusion. Fainting in the elderly patient can have many causes, including cardiopulmonary or\ncerebrovascular events as well as pharmacological ones.\nCongestive cardiac failure is the leading cause of hospitalization in people over 65 years, with\na 10% mortality rate. Symptoms include dyspnea due to pulmonary hypertension and\npulmonary edema. Treating such patients in a supine position for prolonged periods is\ninadvisable, and coughing may complicate treatment itself. Advanced congestive cardiac\nfailure in the elderly patient can, like other forms of CVD, result in reduced cerebral perfusion\nand disorientation or confusion.\nAppointment planning for implant treatment in elderly patients with CVD therefore has to be\nmanaged carefully and systematically, bearing in mind those risks. One possibility is to\nschedule appointments for the late morning, when endogenous epinephrine levels are falling,\nand to have the patient’s glyceryl trinitrate spray readily available or even used\nprophylactically if necessary. Shorter appointments that are less stressful or require less chair\ntime may be preferable to prolonged treatment sessions. The skill and experience of the\nsurgeon performing the invasive aspects of implant treatment will of course also have a\nsignificant impact on the duration of the surgical procedure."
  },
  {
    "page": 85,
    "content": "5.2.3\nPharmacological Considerations\nThere are many possible oral and systemic side effects (SE) or adverse effects (ADEs) from\nmedications commonly used in the treatment of CVD; these are summarized in Table 3, with\nimportant considerations for the elderly patient.\nAs can be seen, there are some important interactions between routinely used prescription\ndrugs and medications frequently prescribed in the dental clinic. For example, the use of non-\nsteroidal anti-inflammatory drugs (NSAIDs) for postoperative pain relief is contraindicated in\npatients with hypertension or heart failure—acetaminophen may be safer. Some commonly\nused antibiotics are contraindicated with certain cholesterol-lowering drugs.\nIn addition, the clinician may need to consider the need for endocarditis prophylaxis. Valvular\ndisease and replacement, and both congenital and surgical cardiac shunt conditions, have been\nconsidered risk factors for endocarditis where prophylactic antibiotic cover should be\nemployed. This practice has been questioned in some countries; both guidelines and the\nwidespread acceptance across disciplines are variable. In the UK, guidelines by the National\nInstitute of Clinical Excellence (NICE) advise that there is no evidence to support the need for\nroutine antibiotic prophylaxis in many situations. However, the American Heart Association\nmaintains advice to give antibiotic cover when there is a risk. As is the case with antibiotic\nprophylaxis for orthopedic joint replacements, guidance from both clinical and medicolegal\nauthorities varies considerably between different countries, and a risk assessment should be\nundertaken and fully discussed with the patient before any surgery."
  },
  {
    "page": 86,
    "content": "Table 3 Important drug considerations in the elderly patient\nFinally, the clinician should be aware that the patient might be taking one or more medications\nfor anticoagulation as part of the prevention of, or treatment for cardiovascular disease."
  },
  {
    "page": 87,
    "content": "5.3\nHematological System\n5.3.1\nAge-related Changes\nAge is a known risk factor in prolonged bleeding, together with gender, arterial hypertension,\ncardiac disease, cerebrovascular disease, pulmonary embolism, active cancer, chronic liver\nand renal disease, diabetes mellitus, a previous history of major bleeding, recent surgery, and\nhematological disorders such as anemia or thrombocytopenia (Leiss and coworkers 2014).\nBone marrow diseases such as leukemia, immune disorders or immunosuppression, and\npolypharmacy may also result in a tendency to increased bleeding.\nPurpura may be caused by solar exposure, diabetes, acetylsalicylic acid, steroids,\nthrombocytopenia, or connective-tissue disorders. Senile purpura typically affects elderly\npatients due to atrophy of the dermal tissue and increasing fragility of blood vessels, resulting\nin a tendency to bruise easily with minimal trauma. This is not necessarily a clinical sign of an\nincreased bleeding tendency, and the same is true of intraoral purpura (“angina bullosa\nhaemorrhagica”). However, antiplatelet drugs may exacerbate the condition.\nCongenital bleeding disorders are generally diagnosed in childhood. Acquired coagulation\ndefects, while generally less severe (with the exception of coagulation problems due to liver\ndisease) are more likely to be prevalent in an elderly population as a result of age-related\nanticoagulant and fibrinolytic activities (Bauer and coworkers 1987).\nDue to the increased rate of cardiovascular or cerebrovascular disease in aging patients, the\nclinician will often encounter the use of different individual anti-clotting medications or indeed\ncombinations of such drugs, which can be broadly divided into antiplatelet drugs and\nanticoagulants.\nAntiplatelet drugs\nAntiplatelet drugs may include acetylsalicylic acid, monoclonal antibody drugs,\nphosphodiesterase inhibitors, and thienopyridines.\nAcetylsalicylic acid inhibits platelet cyclooxygenase enzymes, which via further pathways\nirreversibly reduces platelet aggregation. It is the first line drug for prophylaxis of\nthromboembolic disease and MI. Acetylsalicylic acid is not only a common OTC medication\nin generic form, but is also an active ingredient in numerous proprietary OTC preparations,\nand patients who are unaware of this fact can easily consume an excessive amount. There is no"
  },
  {
    "page": 88,
    "content": "evidence to suggest that cessation of prophylactic acetylsalicylic acid therapy is necessary in\nadvance of oral surgical procedures.\nMonoclonal antibody drugs used in antiplatelet therapy are GP IIb/IIIa inhibitors, which\nprevent platelet cross-linking and include abciximab. Such drugs are used parenterally and can\nhave significant side effects.\nPhosphodiesterase inhibitors include dipyridamole, which decreases platelet agglomeration.\nIt is often used in conjunction with acetylsalicylic acid or warfarin in the prophylaxis of\nthromboembolic disease.\nThienopyridines act by inhibiting platelet activation via the ADP dependent pathway, such as\nclopidogrel, used to prevent post-MI atherosclerotic events or CVA. Clopidogrel is an\nexample, commonly used in the control of CVA/atherosclerotic post-MI risk, post CABG\nsurgery, or in established peripheral vascular disease.\nThe life cycle of a platelet is seven to ten days, and so cessation of therapy for drugs used as\nprimary prevention of thromboembolic disease one week before the procedure can normally be\nconsidered safe. However, when the drug is used for the treatment of previous ischemic or\nthromboembolic disease, cessation should only be considered in consultation with other\nrelevant specialists. Hemorrhage from antiplatelet drugs or platelet disorders is usually less\nsevere than when caused by a clotting disorder. There is no evidence to suggest that continuing\nsingle antiplatelet therapies such as acetylsalicylic acid, clopidogrel, or dipyridamole\nsignificantly increases the risk of postoperative hemorrhage with dental extractions; simple\nimplant surgery could be considered in the same way.\nThe risk increases with combination therapy of acetylsalicylic acid and clopidogrel, but this\nregime is generally used in patients at higher risk of thromboembolism and so specialist advice\nshould be sought.\nStraightforward implant placement for a patient with platelet count of greater than 100,000/µl\nshould be possible with only local hemostatic measures and monitoring. However, procedures\nsuch as sinus lifting may require consideration of platelet transfusions and the use of\npostoperative tranexamic mouthwash.\nAnticoagulant drugs\nAnticoagulation therapies are used in the prevention and treatment of thromboembolic disease.\nThey are also used, for example, in atrial fibrillation and other heartvalve\ndisease/replacement, CVD, CVA, DVT, and PE. The most common drugs prescribed are\nwarfarin for long-term use and heparin for short-term use.\nHeparins potentiate the effect of antithrombin-III and thereby inhibit clotting factors II, IX, X,\nand XI. Two forms are used: unfractionated (UFH) or low-molecular-weight heparins\n(LMWH), with the latter being the more commonly used."
  },
  {
    "page": 89,
    "content": "Heparins are used for example in the prophylaxis of deep-vein thrombosis (DVT) and for\nbridging therapy if it is necessary to stop warfarin for a time for surgical reasons. There is an\nimmediate but short-lived effect on blood clotting.\nWarfarin is a vitamin K antagonist whose main anticoagulant effect arises from a reduction in\nfactor II, although it also affects factors VII, IX and X. The effect of warfarin therapy is\nmeasured by INR, the ratio of the patient’s prothrombin time (PT) to an international\nnormalized PT. A recent INR should be obtained before surgery, preferably within the previous\n24 hours. It is important to be aware of the many polypharmacy considerations affecting\nwarfarin and therefore patients’ INR.\nOlder patients may show an exaggerated anticoagulant response to warfarin (Gurwitz and\ncoworkers 1992). The half-life of the drug is approximately 40 hours; if the drug is stopped for\nsurgery to take place, it may take several days for the INR to reach the pre-cessation level,\nduring which time the patient may be at risk of a thromboembolic event. While vitamin K or\nfresh frozen plasma can be used to reverse the drug effect, it is generally accepted that\ncessation in order to reduce the risk of bleeding in dental procedures is unnecessary (Lockhart\nand coworkers 2003).\nHowever, there is evidence to demonstrate a higher risk of major and less severe but clinically\nrelevant bleeding due to polypharmacy in elderly patients due to drug interactions (Leiss and\ncoworkers 2014), and the need for NSAIDs or antibiotics should be carefully reviewed in\norder to prevent life-threatening complications such as CVA.\nElderly patients may demonstrate greater inhibition of the synthesis of vitamin K-dependent\nclotting factors at similar plasma concentrations of warfarin, although the mechanisms are not\nclear (Shepherd and coworkers 1977). Such a relationship with plasma heparin concentration\nand anticoagulant effect does not appear to vary with age (Whitfield and coworkers 1982).\nNovel oral anticoagulants (NAOCs) include direct thrombin inhibitors such as dabigatran and\nanti-factor Xa drugs such as rivaroxaban and apixaban, which have minimal drug interactions\nand which are less affected by diet; they are increasingly used as a replacement for warfarin.\nThey do not require monitoring, are fast acting and irreversible, but have a shorter half-life of\n12–14 hours in elderly patients.\n5.3.2\nTreatment Considerations\nThese drugs are given to prevent important, potentially life-threatening conditions. The dentist\nmust understand that the desire for oral implants does not necessarily justify interrupting the\ntherapy (Hwang and coworkers 2006).\nHemorrhage is a relatively common complication in dental implant surgery. However, there is\nno indication that a bleeding disorder is an absolute contraindication to implant surgery"
  },
  {
    "page": 90,
    "content": "(Napeñas and coworkers 2009).\nImmediate postoperative bleeding is more indicative of a vascular or platelet disorder; later\nhemorrhage is more indicative of a coagulation defect. While there is no data on the\nprevalence of bleeding complications in dental implant surgery, such complications have been\nreported (Kalpidis and Setayesh 2004), including upper-airway obstruction secondary to\nsevere bleeding in the floor of the mouth, which is a rare but potentially life-threatening\ncomplication of implant placement (Givol and coworkers 2000).\nThe risk of serious bleeding complications in implant surgery is generally far less significant\nthan the complications arising from thromboembolism, and so the decision to stop therapy\nshould only be taken by consultation with the appropriate specialist if the risk of hemorrhage is\ngreater than the risk of a thromboembolic event. It is also important to understand those groups\nof drugs where INR measurement is not possible and to be aware of appropriate local\nhemostatic measures that can be employed.\nHeparins have a short half-life (3–4 hours for UFH, 24 hours for LMWH), and there is\nnormally no need to stop therapy for dental procedures with a low risk of bleeding (extraction\nof 1–3 teeth, simple implant placement).\nSimple implant surgical procedures may be considered in patients taking warfarin with an INR\nof less than 3.5 (extraction of up to three teeth, simple implant placement with local hemostatic\nmeasures) in consultation with the patient’s physician (Madrid and Sanz 2009b; Bacci and\ncoworkers 2011).\nProcedures associated with a higher risk of bleeding (bone grafting, sinus lifts, large\nmucoperiosteal flaps), should be considered with appropriate specialist advice; heparin-\nbridging therapy may be required in some circumstances if warfarin is stopped, although this is\nnot applicable to NOACs.\nWhile there is no INR monitoring for patients on NOACs, the bleeding tendency will be\nsimilar to an INR of 4, although there have been no clinical studies to date. Heparinized\npatients have a low risk of bleeding complications (Hong and coworkers 2010).\nIn such patients, it may be wise to avoid regional block anesthesia and use local infiltration\ntechniques, although lingual infiltrations would need to be considered in the same way as an\ninferior dental block; care should also be taken with venipuncture if intravenous sedation is\nused. The patient should be warned of the possibility of more significant postoperative\necchymoses.\nTreatment should be planned for earlier in the day and week so that any problems can be dealt\nwith during normal working hours when full resources are available. It may be wise to\nconsider breaking down the surgical treatment into a multiple simple visits, although this has to\nbe balanced with any requirement for drug interruptions. It may be useful in geriatric patients"
  },
  {
    "page": 91,
    "content": "to assess the response to shorter surgical procedures, if possible, before moving on to more\nadvanced surgery.\nIn general, postoperative analgesia is more safely achieved with acetaminophen or codeine.\nAntibiotic therapy with penicillin V or clindamycin is safe in terms avoiding anti-clotting drug\ninteractions. Appropriate local hemostatic measures, such as microcrystalline collagen\nsponges or oxidized regenerated cellulose, and the availability of tranexamic acid mouthwash\n(10 ml of a 5% w/v solution) should be considered.\nPatients with a mild to moderate bleeding tendency may be treated in the general or specialist\ncare setting, depending on the procedure; those with a severe bleeding tendency or congenital\ncoagulation defects should be treated in a specialist or hospital care setting and be planned in\nclose liaison with the hematologist.\n5.3.3\nPharmacological Considerations\nDrugs that are commonly used in dentistry and oral surgery that can also impair hemostasis by\ninteracting with warfarin or affecting platelet function include:\n• Other non-steroidal anti-inflammatory drugs such as selective COX-2 inhibitors (celecoxib,\nrofecoxib), propionic derivatives (ibuprofen, ketoprofen, naproxen), and piroxicam,\nindomethacin, phenylbutazone, etc.\n• Antifungals (gentamycin, azoles).\n• Many antibiotics such as amoxicillin, ampicillin and derivatives, azithromycin,\nbenzylpenicillin, cephalosporins, isoniazid, rifampicin, sulfonamides.\n• Some antihistamines, chlorpromazine, diazepam, digitoxin, immunosuppressants,\namiodarone, carbamazepine, cimetidine, omeprazole, furosemide, quinine, sodium\nvalproate, tolbutamide, and tricyclic antidepressants may also have an effect, as may\nexcessive alcohol consumption.\nEven acetaminophen can enhance warfarin activity, and the typical regime of 500 mg four times\nper day for a week can result in an increased INR. Codeine may be added safely to enhance\nanalgesia.\nThere are dietary effects on warfarin that may raise or lower INR. The consumption of\n“alternative” medications and supplements is common and compounds such as Echinacea,\ngingko biloba, St. John’s wort, garlic and ginseng may either contain coumarins or interfere\nwith platelet activity."
  },
  {
    "page": 92,
    "content": "5.4\nHematopoietic System\n5.4.1\nAge-related Changes\nThe hematopoietic tissues in the marrow space undergo a progressive decline over the first 30\nyears of life and then stabilize before beginning to decline again from around the age of 70\nyears, for unknown reasons. The number of stem cells decreases with age, and there is a\nreduction in marrow function.\nEvidence suggests that there is no change in the baseline rate of erythropoiesis in old age or in\nthe lifespan of red blood cells, their hemoglobin concentration, and other variables. However,\nthere may be a reduced capacity to compensate for erythropoietic stress such as hemorrhage or\nhypoxia, as the marrow in elderly patients appears to respond less to increased erythropoietic\nstimulation. There is controversy over the association between aging and anemia.\nHowever, numerous studies indicate an increased prevalence of anemia in elderly individuals\n(Guralnik and coworkers 2004) and that in such circumstances there is an association with\nreduced bone-mineral density, skeletal muscle mass, and physical performance, as well as\nwith frailty. Although no causal mechanisms have been defined, there is speculation that\nanemia may be involved in adverse outcomes (Price 2008). Anemia has also been implicated\nin an increased incidence of medication-related osteonecrosis of the jaw (MRONJ) (Tsao and\ncoworkers 2013; Saad and coworkers 2012).\nSenescence of other organ systems can produce changes that may result in anemia. For\nexample, an age-related decrease in the number of nephrons in the kidneys may cause a decline\nin erythropoietin secretion; atrophy of the gastric mucosa reduces B12 absorption due to\nreduced secretion of intrinsic factor, which could give rise to pernicious anemia. Nutritional\ndeficiencies may also cause anemia. Large-scale studies of institutionalized older adults in\nEurope and North America have indicated increases in anemia rates of up to 25% (Patel\n2008).\nThe main causes of asymptomatic anemia in the elderly are iron deficiency and “anemia of\nchronic disease” (Lipschitz 1981). Iron absorption is not impaired in the elderly individual,\nbut iron supplements taken orally are less effective (Marx 1979). It is recommended that\nelderly patients with signs of anemia be investigated for a cause such as deficiency of folate,\niron, or vitamin B12, or underlying disease such as malignancy (Baldwin 1988)."
  },
  {
    "page": 93,
    "content": "Normal bone-marrow changes in the aging patient may or may not result in a decline in the\nnumber of immune cells such as leukocytes and mature lymphocytes; considerable\ndisagreement exists between authors over this subject. However, there is agreement that there\nis a progressive decline in the functionality of the immune system, leading to\n“immunosenescence” characterized by impaired immunity and inflammatory responses\n(Gravenstein and coworkers 2003).\nThis is thought to be primarily due to altered T-lymphocyte function, given that, in elderly\npatients, it will have been some time since thymic atrophy (which is complete by later middle\nage) (Pawelec 1998). This may affect antibody-antigen responses and cellular immune\nfunctions. This progressive decline in the immune system is implicated in several age-related\ndiseases such as osteoporosis, autoimmune disease, Alzheimer’s disease, and cancer (Hakim\nand Gress 2007).\nTherapies such as immunosuppressants and immunomodulatory drugs are more commonly used\nin elderly patients and will also impair immunity, as may radiotherapy and prolonged serious\nillness.\nMorbidity and the prolonged duration of illness also increase with age. Older individuals may\nnot respond as well to therapy for infections and may not present with “typical signs” of\ninfection, such as fever. Instead of pain symptoms, elderly patients may show increased signs\nof confusion, agitation, or withdrawal.\n5.4.2\nTreatment Considerations\nThe clinical relevance of anemia in terms of increased morbidity/mortality is unclear. There\nare suggestions that anemia may lead to increased cardiac output or reduced tissue\noxygenation, or a decline in physical and mental function (Fried and Guralnik 1997). Anemia\nhas also been implicated with an increased risk of osteonecrosis of the jaw in cancer patients\n(Saad and coworkers 2012; Tsao and coworkers 2013).\nHowever, we should be aware of our role in the overall care of the geriatric patient and be\nvigilant for the intraoral manifestations of anemia such as glossitis, ulceration, burning mouth\nsyndrome, and angular stomatitis, as well as denture comfort or any interference with effective\nmastication and consequent nutritional impact. The dentist should also be aware of the general\nsigns such as lassitude, dyspnea, or tachycardia.\nAge-related changes result in altered immune responses to infection, which may start early,\nprogress in an atypical fashion, and take longer to resolve in geriatric patients. Opportunistic\ninfections such as candidiasis or herpetic infections are more common in immunocompromised\npatients.\nOral signs of impaired hematopoietic function may include recurrent or unusually severe"
  },
  {
    "page": 94,
    "content": "bacterial infection (in neutropenia), florid gingivitis, or oral petechiae (thrombocytopenia).\nThere is a greater incidence of neoplastic disease as we age. More than 50% of leukemia\ncases occur in patients aged 65 years and older, and myelodysplastic syndromes occur mostly\nin elderly patients, the most common of which is chronic lymphocytic leukemia (Baker 1987).\nSuch patients are unlikely to present for implant treatment with active symptoms of disease, but\nthere may be some patients with undiagnosed or low-level chronic disease presenting as\ncomplications following dental extractions or implant placement, such as an increased\ntendency to bleed or an unusually severe infection. We also have to consider the development\nof such disease and its future (unknown) impact on the management of later problems with\nprevious implant treatment.\nSedation or general anesthesia in patients with certain types of anemia with reduced\nhemoglobin levels could lead to hypoxia.\nAgranulocytosis has been associated with penicillin and some other antibiotics, some NSAIDs\nincluding naproxen, anticonvulsants (Andersohn and coworkers 2007), and clindamycin has\nbeen associated with pancytopenia (Morales and coworkers 2014).\nThrombocytopenia has been associated with hundreds of medications as a result of impaired\nplatelet production or increased destruction; again, commonly prescribed antibiotics and\nNSAIDs are implicated, as well as anticonvulsants, oral antidiabetic drugs, antirheumatics,\ndiuretics, and antacids such as ranitidine (Visentin and Liu 2007), all of which are common\nmedications in the elderly patient.\nThe immunosuppressive effects of glucocorticoid therapy, such as the inhibition of leukocytes,\nmacrophages, and cytokines, and further hematopoietic effects, including a reduction in\neosinophils and monocytes, may affect the severity and presentation of infections, increase\nsusceptibility to infection, or cause delayed healing."
  },
  {
    "page": 95,
    "content": "5.5\nRespiratory System\n5.5.1\nAge-related Changes\nAs in other organ systems, maximum lung function and capacity decline with age, which has an\nimpact on physiologic reserve. A general weakening of musculature includes the respiratory\nmuscles; the elasticity of the lungs changes and is accompanied by a reduced bronchiolar\ndiameter and enlarged alveolar ducts. The vital capacity of the lungs is reduced with a\nconcomitant decline in peak flow and gas exchange, with lower oxygen saturation. There is\nalso a change in immunological lung defense mechanisms. However, in healthy elderly\nindividuals there are few associated symptoms other than a reduction in capacity for exercise,\nwhich is more affected by cardiovascular functional decline. There is no change in tidal\nvolume with age, as ventilatory capacity is maintained by an increase in respiratory rate.\nAge-related changes in the lungs can compound heart and lung disease or the long-term effects\nof smoking. Older people are more at risk of complications from upper respiratory tract\ninfections.\nChronic obstructive pulmonary disease (COPD) is the collective term for lung diseases,\nincluding chronic bronchitis, emphysema, and chronic obstructive airways disease,\ncharacterized by a persistent productive cough, shortness of breath on exertion (SOBOE) and\nchest infections. The condition normally presents later in life and is very common in elderly\npatients; like other conditions, it is often undiagnosed (Halbert and coworkers 2006). COPD\nalso results in pulmonary hypertension and ventricular hypertrophy, causing dyspnea. It is\nexpected to become the third most common cause of death and disability by 2030 (WHO\n2000).\nAsthma is common in patients over 65 years; in some patients, it may be a new development\nrather than a lifetime condition or a recurrence of previous asthma, although the triggers and\nrisk factors may be similar (Gibson and coworkers 2010). The diagnosis of asthma in an\nelderly patient is often difficult due to the high incidence of COPD in this age group, but the\nprevalence of asthma in the over-75 age group has been estimated at 7% to 9% (Braman and\nHanania 2007).\n5.5.2\nTreatment Considerations"
  },
  {
    "page": 96,
    "content": "A recent publication found that edentulism was associated with a higher frequency of COPD-\nrelated hospitalization and mortality (Barros and coworkers 2013). This was tentatively\nattributed to a possible link between the exaggerated inflammatory response of aggressive\nperiodontitis and a susceptibility to inflammatory events associated with COPD. No causal\nlink was proved, but it is interesting to consider to what extent peri-implant infections in the\nperiodontally susceptible patient may also be a factor. Patients with COPD are more frequently\nmouth-breathers with concomitant gingival dryness and gingivitis.\nPatients with SOBOE and poor mobility or patients who are frequently hospitalized will be\nless willing and able to seek dental treatment or supportive periodontal therapy.\nCOPD is often associated with comorbidities, including cardiovascular disease, osteoporosis,\nand depressive illness (Agustí 2007). Osteoporosis may result in vertebral compression,\nspinal kyphosis, and the typical “dowager’s hump.” This can impede normal thoracic-cage\nexpansion and impair diaphragmatic efficiency. Accessory muscles of respiration are therefore\noften employed by such patients, but this is not possible in a fully supine position.\nIt is consequently advisable to treat patients with respiratory conditions upright in the dental\nchair in order to avoid respiratory difficulty and maintain adequate oxygen saturation. This\nmay present marked technical difficulties, particularly in terms of access for some surgical\nprocedures. In some patients, fluid irrigation of instruments may also compromise breathing or\nexacerbate coughing, requiring frequent stoppages during procedures. Such considerations\nhave to be included as part of the decision as to what treatment may be practically achievable,\nas well as advisable.\nCurrent guidelines suggest caution in the use of epinephrine-containing local anesthetics in\npatients with COPD, with a limit of two cartridges of 2% lidocaine with 1 : 80,000\nepinephrine (45 µg epinephrine) (Brown and Rhodus 2005). Using the patient’s own\nsalbutamol inhaler immediately before treatment may be helpful.\nThe presence of oral pathogens, and in particular anaerobes, in sputum has long been\nestablished as connecting oral and pulmonary diseases (Bartlett and Gorbach 1975; Mojon and\ncoworkers 1997). Dental and oral factors present a significant risk of aspiration pneumonia,\nespecially in elderly patients with diabetes, COPD, or reduced functional status requiring\nassistance with eating. Both periodontal and cariogenic microorganisms have been associated\nwith aspiration pneumonia (Terpenning and coworkers 2001; Brook and Frazier 2003).\nThe frequent use of broad-spectrum antibiotics in patients with COPD can lead to the\nsuppression of normal oral bacteria and result not only in opportunistic infections such as\ncandidiasis but also in colonization by potential respiratory pathogens such as methicillin-\nresistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa (Scannapieco and\ncoworkers 1992).\nGastric reflux is a common comorbidity of COPD and again may require treatment in a more"
  },
  {
    "page": 97,
    "content": "upright position. The importance of good masticatory function to reduce exacerbation of the\nreflux is highlighted. Gastroesophageal reflux may also commonly cause asthma-like\nsymptoms.\nCOPD is strongly correlated with smoking; to quit smoking is the single most effective therapy\nin the treatment of COPD, and the dental professional has an important role to play in\nencouraging the patient to engage in smoking cessation therapy (Devlin 2014).\nThe treatment of the patient with COPD under sedation will require vigilant monitoring of\nblood oxygen saturation with pulse oximetry. A minority of patients are acclimatized to a\ncertain level of hypoxia and their respiratory drive may be suppressed by the use of\nsupplemental oxygen. This may also be a consideration in the event of a medical emergency in\nthe dental office, where the use of supplemental oxygen may result in hypercapnic respiratory\nfailure (Jevon 2014).\n5.5.3\nPharmacological Considerations\nMany of the drugs prescribed for COPD can cause significant adverse effects in elderly\npatients. Also, because elderly patients are often on a polypharmacy of medications,\nmanagement of COPD can be difficult.\nThe first-line drugs used in COPD are bronchodilators such as short- and long-acting β2\nagonists (short: salbutamol, terbutaline; long: salmeratol, formoterol), and inhaled muscarinic\nagents such as ipratropium.\nThe long-term use of steroid inhalers has been implicated in the development of osteoporosis\nin the elderly, and it is recommended that subjects be monitored for reductions in bone-mineral\ndensity.\nInhaled corticosteroids are used in the treatment of severe COPD and asthma, but only 10% to\n20% of the metered dose reaches the lungs, with the greater proportion remaining in the\noropharynx (Barnes 1995). The correct use of an inhaler device can be particularly challenging\nfor an elderly patient. Inhaled corticosteroids are often associated with oropharyngeal\ncandidiasis and have been implicated in poor intraoral wound healing. Patients should be\nadvised to rinse their mouth after use or to use the inhaler with a spacer. As stated, elderly\npatients often have difficulty adhering accurately to pharmacological regimes, particularly\nwhen multiple drugs make the process complex or the patient has memory loss or cognitive\ndysfunction. Nasal inhalers may be used as an alternative in patients who are more at risk of\noropharyngeal candidiasis, such as diabetics or immunosuppressed patients.\nOral mucosal changes resulting from the use of steroid inhalers may also include xerostomia\n(caused by the β2 agonist effect on the salivary glands, anticholinergic effects of ipratropium,\nand steroid effects) caries (as a result of multiple effects of reduced salivary flow), oral"
  },
  {
    "page": 98,
    "content": "ulceration, and dysgeusia.\nIt should be noted that some drugs used in nicotine replacement therapy also cause dry mouth."
  },
  {
    "page": 99,
    "content": "5.6\nAlimentary System\nThe digestive system has considerable physiologic reserves and is therefore functionally less\naffected by aging than other organ systems. However, aging can be a factor in digestive and\ngastrointestinal disorders, both as a consequence of primary disease and as a result of ADEs in\npolymorbid individuals. Furthermore, any factors that affect the ability to eat and that have an\nimpact on nutritional status can be of greater significance in elderly individuals. It has been\nestimated that even in developed countries, 16% of patients over 65 years and 2% of those\nover 85 years are malnourished (London Office for National Statistics 2004). Polypharmacy\nmay also have an effect on nutritional status, with reports identifying 50% of people on 10 or\nmore medications as being malnourished or at risk of malnourishment (Jyrkkä and coworkers\n2010).\nAging results in a loss of muscle mass, and this can have an impact not only on skeletal muscle\nfunction but also on smooth muscle affecting vital organs, including cardiac function. The basal\nmetabolic rate declines, and changes in liver and kidney function can decrease protein\nsynthesis; changes in cytokine and hormonal levels occur and fluid and electrolyte balance\nalters. Malnutrition in elderly people is also associated with reduced cognitive function, poor\nwound healing, delayed recovery from surgery, and mortality.\nElderly people tend to exhibit declining appetite, with average daily food intake decreasing by\napproximately one-third between the ages of 20 and 80 years (Wurtman and coworkers 1988).\nWhile this is often accompanied by a reduction in physical activity and therefore in energy\nexpenditure, in some people this is not the case, and energy expenditure exceeds intake\nresulting in “anorexia of aging” (Ahmed and Haboubi 2010).\nThese and other changes described elsewhere in this chapter mean that effective and\nappropriate nutrition are essential in maintaining health in the elderly person. The importance\nof a healthy mouth with the ability to chew and swallow properly is clear, and the clinician has\nto consider many factors in both the provision of dental implants and the ongoing care of\npatients rehabilitated in this way.\nOropharyngeal changes. The changes in the oral mucosa that occur with age are similar to\nthose of the skin, with a decrease in elastin and increased cross-linking of collagen. The effect\non mucous membranes is somewhat reduced by the moist oral environment. However, normal\nage-related vascular changes reduce the mucosal blood supply, contributing to a thinning of the\nmucosal layer of stratified squamous epithelium, with consequent fragility and greater\nsusceptibility to infection (De Rossi and Slaughter 2007).\nElderly patients with multiple chronic diseases are more likely to be taking medications that"
  },
  {
    "page": 100,
    "content": "can cause mucosal irritation, gingival enlargement, and immunosuppression.\nOlder patients frequently complain of a loss of taste sensation. There is an age-related decline\nin olfactory and gustatory neurologic function, and it is known that the number of taste buds is\nreduced with age, resulting in a decline in taste sensation (hypogeusia). This chemosensory\ndecline is also associated with a change in chemosensory preference: the thresholds for salt\nand bitter taste increase, although those for sweet and sour remain relatively constant. Studies\nhave shown that changes in nutritional status can also affect taste sensation and vice versa.\nFurther effects on taste can be caused by palatal denture coverage and reduced salivary flow,\nwhich can significantly affect food choices and the quality of life. Often older people will add\nsalt or sugar to foods to compensate for decreased taste sensation, which can have adverse\nhealth effects.\nDecreased salivary production (hyposalivation) leading to dry mouth (xerostomia) has been\nconsidered part of the normal aging process and was associated with age-related changes to\nthe parenchymal structure of salivary glands. However, it is now thought that salivary\nproduction and composition are largely unrelated to age; there is no reduction in either resting\nor stimulated salivary flow rates of the parotid, although there is a reduction in other salivary\nglands (Percival and coworkers 1994; Challacombe and coworkers 1995). The prevalence of\nxerostomia increases with age; approximately 30% of individuals over 65 years are affected\n(Ship and coworkers 2002). Causes may include primary diseases such as diabetes, Sjögren’s\nsyndrome, secondary Sjögren’s in rheumatoid disorders such as rheumatoid arthritis,\nscleroderma, or systemic lupus erythematosus, and radiotherapy to the head and neck region.\nDrug-induced xerostomia is common, with an estimated 80% of commonly prescribed\nmedications having a xerostomic effect (Sreebny and Schwartz 1997) It has been estimated that\nmost elderly people take at least one medication that may cause decreased salivary flow\n(Schein and coworkers 1999) and that polypharmaceutical regimes are a common cause of dry\nmouth in older people (Porter and Scully 2000). Elderly people may also present with a dry\nmouth and enlarged parotid glands due to chronic dehydration. Altered perception in dementia\nstates can give rise to complaints of dry mouth even with normal salivary flow.\nThe major functions of saliva are lubrication, buffering and remineralization, immunological\n(saliva contains antifungal and antibacterial proteins), and digestive, including food\nbreakdown with salivary enzymes, bolus formation, and gustatory function. The effects of dry\nmouth are many and varied: functional limitations include dysphagia, altered speech, and\ndifficulty wearing dentures. Physiological effects include mucus/food/plaque retention and\nassociated caries and periodontal disease with a change in oral microbiota and halitosis,\nneurosensory symptoms such as “burning mouth syndrome” and dysgeusia, and a susceptibility\nto opportunistic infections such as candidiasis. Such problems can have a significant effect on\nsocial interaction and quality of life (Turner and Ship 2007).\nThe generalized reduction in motor control and activity in aging individuals is reflected in\nreduced masticatory muscle strength and lip seal, and swallowing can take longer (Ferguson\n1987). The ability to identify food textures and manipulate both food and removable prostheses"
  },
  {
    "page": 101,
    "content": "may be compromised.\nOther age-related changes in the oropharynx include a decline in thirst perception. Along with\ndecreased salivary flow, chewing and swallowing capacity can be markedly impaired, causing\ndysphagia and nutritional defects (Ney and coworkers 2009). The elderly, polymorbid,\npolymedicated, and frail population is known to be at increased risk of aspiration pneumonia\nbecause of poor oral health, impaired resistance to infection, and oropharyngeal aspiration\n(Rofes and coworkers 2010).\nOral mucosal conditions and manifestations of systemic diseases. Examples of systemic\ndiseases with oral manifestations include dermatological conditions, inflammatory connective-\ntissue diseases, hematological problems, endocrine diseases, inflammatory gastrointestinal\ndiseases, and neurological problems. Any condition causing a sore mouth will have an impact\non the ability to chew and swallow food, wear dentures, speak, etc., and this may have a\ngreater significance in an elderly person.\nExamples of systemic conditions that may present with a sore mouth in the elderly include:\n•\nCandidiasis (immunosuppression/immunodeficiency, hematological disorders, diabetes,\nantibiotic usage)\n•\nMucosal atrophy, recurrent painful ulceration (hematological disorders)\n•\nSore tongue (B12/folate deficiency, hematological disorders)\n•\nFlorid gingival inflammation (hematological disorders, Crohn’s disease)\n•\nDrug-related (oncology medications, immunosuppressants, calcium-channel blockers,\nantiepileptics)\nAutoimmune skin conditions are relatively more common in the elderly population, possibly\ndue to immunodysfunction or ADEs related to increased polypharmacy in this age group (Loo\nand Burrows 2004). Some of these conditions can result in oral vesiculobullous lesions, which\nif they burst will result in desquamation appearing as shallow ulcerating erosions. Bullous\npemphigoid is the most common autoimmune blistering mucocutaneous condition that affects\nmainly the over-70 age group. However, oral involvement is rare. Pemphigus vulgaris and\npemphigoid (both bullous and mucous-membrane subtypes) are also more prevalent in the\nelderly and occur more commonly as oral blistering. Oral lichen planus can also cause\ndesquamative gingivitis; such conditions putatively present both a desire for implant-retained\nprostheses and a challenge for their provision.\nCrohn’s disease is an autoimmune chronic granulomatous inflammatory condition that can\naffect the entire alimentary tract. Symptoms include vasculitis, enteritis, arthritis,\nkeratoconjunctivitis and the disease can result in nutritional deficits. Previously considered a\n“lifetime” disease with onset in the young, it is now recognized that this disease can initially\nappear in elderly people, with approximately 15% of diagnoses for inflammatory bowel\ndisease made in the over-60 age group (Gisbert and Chaparro 2014)."
  },
  {
    "page": 102,
    "content": "In the elderly, it is more limited to colonic disease and is less severe. However, older patients\nwith long-standing Crohn’s disease may present for implant therapy when teeth are lost; in\naddition, the management of the disease may change as they age.\nIn the oral cavity, lesions appear as either linear or aphthous ulceration, with swelling of the\nlips and oral mucosa, which may acquire a “cobblestone” appearance. It has also been\nassociated with periodontal lesions (van Steenberghe and coworkers 1976).\nIt has been suggested that dental implants may produce an antigenic response in Crohn’s\npatients, thereby affecting osseointegration (van Steenberghe and coworkers 2002), but in this\ncohort there were multiple comorbid factors. Subsequent studies by the same group indicated\nvarying outcomes for dental implants, and there is scant evidence on which to base any\nconclusions (Bornstein and coworkers 2009).\nOther changes of the digestive tract. The strength of esophageal contractions and of the upper\nesophageal sphincter decreases with age. Although the movement of food seems to be\nunaffected, other age-related changes may combine to cause problems. Age-related decrease in\nsalivary production with a reduced chewing efficiency may mean that food is less macerated\nand drier, making swallowing difficult.\nAlthough food transport is otherwise less affected, elderly people may have difficulty in eating\nin a recumbent or lying position and reflux may occur. The lower esophagus may be less able\nto move refluxed acid back into the stomach, with resulting “heartburn.” This can be\ncomplicated by the presence of a hiatus hernia in older patients.\nGastroesophageal reflux disease is present in up to 80% of older patients with asthma,\nalthough may not always be accompanied by the classic symptoms of reflux (Harding and\ncoworkers 2000).\nOlder people have a reduced volumetric capacity of the stomach due to reduced smooth muscle\nelasticity, which also adversely affects the rate of gastric motility and emptying (Moore and\ncoworkers 1983). Old people are consequently often unable to consume large portions of food\nin one sitting.\nAging of the stomach lining results in a thinner gastric mucosa that is less resistant to damage.\nOlder people have an increased tendency to bleed from NSAID use and are at higher risk of\ndeveloping peptic ulcers. Other drugs that are normally absorbed in the stomach may have\naltered effectiveness.\nAs the gastric mucosa atrophies, it produces less of the intrinsic factor needed for vitamin B12\nabsorption. This increases the risk of pernicious anemia. B12 deficiency is common among\nolder people and may lead to cognitive decline.\nThere is little age-related change in the secretion of gastric acid and pepsin. However,"
  },
  {
    "page": 103,
    "content": "conditions such as atrophic gastritis, long-term use of proton-pump inhibitors, and gastric\nsurgery are more common in the elderly and may result in a reduction in gastric-acid secretion.\nThe resulting increased stomach pH can reduce intestinal calcium absorption.\nThe small intestine undergoes little functional change with age (Fich and coworkers 1989).\nThere is, however, a reduction in lactase secretion, which may lead to intolerance of dairy\nfoods and contribute to calcium deficiency. Reduced gastric-acid secretion can result in\nbacterial overgrowth in the small intestine, which in turn can contribute to malnourishment\n(Parlesak and coworkers 2003).\nDiverticulosis is more common in elderly patients; it is estimated that any person reaching the\nage of 90 has many diverticula. The cause is unknown but thought to be related to smooth\nmuscle spasm due to a diet low in fiber. The muscle spasm causes a balloon-like distension of\nthe intestinal wall, often near a penetrating blood vessel, and can cause painful abdominal\ncramps. If the diverticulum becomes inflamed, intestinal bleeding may occur and manifest itself\nas blood in stool.\nThe large intestine also changes little as we age, although constipation is more prevalent in the\nelderly, sometimes due to comorbidities such as diabetes, but often as a result of a low-fiber\ndiet or due to reduced physical activity and the side effects of drugs given to treat other\nconditions.\n5.6.1\nTreatment Considerations\nOlder people may become insidiously malnourished due to reduced food intake for many\nreasons, including the physiological changes outlined above, depression-related anorexia, or\napathy when living alone. Undernutrition and low intake of protein are common among older\npeople and can lead to conditions such as sarcopenia (loss of muscle mass and strength) and\nosteopenia (reduced bone-mineral density), contributing to the onset of frailty. Immunity may\nalso be impaired as calcium, vitamin E and zinc levels are all commonly reduced amongst\ninstitutionalized and homebound patients. Vitamin D levels are also reduced as a result of\nsenescence of the skin and indoor living.\nConsequently, the quality of the diet becomes more relevant, and higher levels of protein are\nrequired. The importance of a healthy and functional dentition or dental prosthesis is\nsignificant.\nOral mucosal soreness resulting from removable mucosa-supported prostheses in patients with\nxerostomia is a well-recognized problem, particularly in the elderly (Payne and coworkers\n1997). The benefit of implant-supported prostheses in such instances has been highlighted for\nsome time (Isidor and coworkers 1999) and can improve a patient’s quality of life for many\nyears, especially in complete edentulism (Binon 2005). Further benefits of implant-retained\nprostheses are discussed in Chapters 4, 6, and 7."
  },
  {
    "page": 104,
    "content": "There is no apparent contraindication to the placement of implants in patients with Sjögren’s\ndisease; the prosthetic benefits of implant therapy are clear (Binon 2005; Isidor and coworkers\n1999; Payne and coworkers 1997). However, the underlying cause should have been\ninvestigated and associated oral health issues properly assessed as part of comprehensive\ntreatment planning, as with any oral condition.\nThere is little evidence related to the provision and long-term success of dental implants in\npatients with oral mucosal diseases, with reports being limited to case reports or retrospective\nanalyses. In terms of oral lichen planus, reported success rates are high, and implant-retained\noverdentures provided benefits (Czerninski and coworkers 2013; Esposito and coworkers\n2003). One prospective study to date has indicated a tendency to increased incidence of peri-\nimplant mucositis and peri-implantitis in patients with oral lichen planus (Hernández and\ncoworkers 2012).\nThere are limited reports of implant placement in other blistering conditions. Authors have\nreported successful outcomes in the relatively short term (up to 36 months) in epidermolysis\nbullosa (Larrazabal-Morón and coworkers 2009). Fixed reconstructions resulted in less\nmucosal irritation in terms of blistering (Müller and coworkers 2010) than when implant-\nsupported overdentures were used, which was a problem (Peñarrocha-Diago and coworkers\n2000). Scant literature is available on the incidence of surgical complications. In general, no\nsurgical issues were mentioned in the case reports described. Peñarrocha reported “blister\ncomplications” during surgery and that one had to be careful with suction. Flap healing appears\nnot to have been affected (Peñarrocha and coworkers 2007a).\nHowever, this is a disease of younger people and may differ in its etiological factors from the\noccurrence of vesiculobullous lesions in the elderly patient. In the one available but well-\ndetailed report on implant provision in a case of a 70-year-old woman with pemphigus\nvulgaris, surgical difficulties included the placement of sutures due to the friable nature of the\nacantholytic mucosa, but mucosal healing was otherwise uneventful.\nRemovable prostheses will frequently be impossible to wear with any degree of comfort under\nsuch conditions, which will adversely affect quality of life. Tooth- or implant-supported\nprostheses are undoubtedly preferable to minimize mucosal contact (Peñarrocha and\ncoworkers 2007b).\nHowever, such prostheses may require more effective oral hygiene; complex reconstructions\nare of course more challenging in this respect, but the presence of sore oral tissues, or\nassociated secondary conditions such as rheumatoid arthritis, may severely limit the\nopportunity for effective plaque control (Candel-Marti and coworkers 2011)\nThere is clearly a need for well-designed systematic studies into the use of implants in oral\nmucosal conditions, but case reporting should not be discouraged, as they could be the only\nsource of information at any given time."
  },
  {
    "page": 105,
    "content": "5.6.2\nPharmacological Considerations\nAnorexia and weight loss are common findings in the elderly. The physiologic “anorexia of\naging” can progress to pathological anorexia in an elderly person with chronic medical or\npsychological illness; depression is the most common reason for anorexia in the elderly and\nantidepressant medication in the elderly is common (Morley 1996); this may result in\nhyposalivation.\nAs previously stated, dry mouth is most often the result of medications, especially in\npolypharmaceutical regimes, with the most commonly associated drugs being those with an\nanticholinergic effect and this includes proton pump inhibitors used in the treatment of gastric\nreflux. Other commonly prescribed groups of drugs causing dry mouth include\nbenzodiazepines, opioids, many antihypertensives, and diuretics.\nLichenoid drug reactions can be indistinguishable from oral lichen planus and may be caused\nby many drugs commonly prescribed to the elderly, such as allopurinol, antiarrhythmics,\nantihypertensives, antidiabetics, antiepileptics, anti-inflammatories, some antibiotics, and\nlithium. Oral ulceration may also occur with many of these drugs.\nThe list of drugs causing hypogeusia or dysgeusia is extensive and dynamic, and a complaint of\naltered taste sensation should always include a drug review. In an affected patient, replacement\nwith a different drug where possible is useful.\nMucositis can cause severe difficulty with speech, eating and drinking, swallowing, speaking\nand sleeping and can result from chemotherapy/radiotherapy. Maintaining adequate nutritional\nand fluid intake is of paramount importance. Some therapies have proved useful in treating this\ncondition from simple measures, such as sucking on ice chips, to administration of recombinant\nhuman keratocyte growth factor (palifermin) (Keefe and coworkers 2007).\nPatients with oral blistering are often long-term users of corticosteroid or immunosuppressive\ndrugs, with a consequent risk of poor bone quality, poor healing, and susceptibility to infection.\nAdrenal suppression may also be a consideration, requiring adjunctive oral steroid therapy.\nAn age-related reduction in motility, secretion, and absorption in the various parts of the\nalimentary tract is slight and has little effect on drug behavior in the elderly. Liver and biliary\nfunction is of greater significance and is discussed in the relevant section below.\nNSAID analgesia is best avoided in elderly patients due to the increased risk of gastric\nbleeding and renal injury (Wolfe and coworkers 1999). Acetaminophen is the preferred\nanalgesic option, but may be inadequate for effective postoperative pain relief in some cases\nand may be contraindicated in patients with liver disease. The use of a selective COX-2\ninhibitor (e.g., rofecoxib) may be considered (Malmstrom and coworkers 1999).\nThe combination of acetaminophen with an opioid such as codeine may be beneficial, and"
  },
  {
    "page": 106,
    "content": "combination products are often considered safe. However, it should be noted that elderly\npatients have an increased sensitivity to opioids and lower doses should be considered. They\nare also more likely to be taking other medications that may interact. There is a significant\nincrease in side effects such as constipation, sedation, confusion, and falls (Buckeridge and\ncoworkers 2010). More potent opioids such as oxycodone may carry a significant risk of\nrespiratory depression."
  },
  {
    "page": 107,
    "content": "5.7\nHepatobiliary System\nThe liver is responsible for glucose metabolism and the conversion of excess carbohydrate and\nprotein into fat. A greater proportion of body fat is stored in the liver of elderly people, which\nhas been associated with insulin resistance and a higher risk of diabetes (Roubenoff 1999).\nBile is manufactured in the liver and is required for the absorption of fat, vitamins A, D, E, and\nK. It is also important in the manufacture of albumin, complement, hormones, and proteins,\nincluding blood-clotting proteins using vitamin K and B12. It has a role in immunology through\nthe eradication by mononuclear phagocytes of bacteria, fungi, parasites, and other cellular\nmaterial, and water-insoluble toxins are modified to allow excretion by the kidneys.\nHemoglobin, cholesterol, proteins, alcohol, and most drugs are metabolized by the liver; in\nparticular, orally administered drugs absorbed by the gut are modified in a “first-pass”\nmetabolism before they enter the circulatory system, which may activate, inactivate or change\nthe mode of action of the drug.\nThere are several age-related changes in the liver, including a reduction in size and blood\nflow. Liver function tests generally remain normal in healthy aged individuals, with a possible\nrise in serum alkaline phosphatase in older women. There may be less bile formation and\nsecretion, with an increased risk of gallstones. The capacity of the liver to metabolize many\nsubstances decreases with aging. The main effect of this is a reduction in clearance of drugs\nmetabolized in the liver of elderly individuals and an increase in volume and distribution of\ndrugs soluble in lipids. This is associated with a risk of side effects at lower doses than would\nbe seen in younger persons. Doses may therefore need to be reduced (Mangoni and Jackson\n2004).\nAlong with a general lowering of physiological stress reserve in the elderly, reduced hepatic\nreserves mean that the liver is also less able to tolerate increased stress; toxic substances are\nmore likely to cause liver damage, which is also slower to repair.\nExamples of drugs metabolized in the liver include:\n•\nAnalgesics such as acetylsalicylic acid, acetaminophen, codeine, ibuprofen\n•\nAntibiotics including ampicillin, clindamycin, metronidazole\n•\nAzole antifungals such as miconazole, fluconazole\n•\nBenzodiazepines\n•\nLocal anesthetics"
  },
  {
    "page": 108,
    "content": "The prevalence of chronic liver disease is increasing with the aging general population.\nIncreasing alcohol-related liver disease is seen in elderly patients (Seitz and Stickel 2007).\nNon-alcoholic fatty liver disease is associated with insulin resistance and diabetes. Other liver\ndiseases that are not age-related may have more severe initial morbidity and mortality. The\nincidence of liver transplants in patients over 60 has also increased significantly, doubling\nduring the 1990s (Frith and coworkers 2008).\nThere appears to be little effect on the osseointegration of dental implants, even in patients\ntaking cyclosporin, which has been shown to impair the process (Sakakura and coworkers\n2007). However, the evidence base is sparse (Gu and Yu 2011; Gu and coworkers 2011;\nHeckmann and coworkers 2004).\nLiver damage and aging can have an impact on bleeding due to impairment of the vitamin K\nmetabolism, failures in the synthesis of other clotting factors (I, II, VII, IX, X, XI) and\nincreased metabolism of these factors. There may be increased fibrinolysis and a tendency to\nthrombocytopenia.\nVitamin K deficiency is rare in adults, but an elderly patient with obstructive jaundice, chronic\nliver disease, or malabsorption may be at risk of vitamin K deficiency, which can have both\nskeletal and anticoagulation effects; some authors recommend supplemental vitamin K in adults\nover 50 years.\nStructural changes of the pancreas are seen with aging, but no functional age-related changes\nare seen independent of those associated with other diseases or medications."
  },
  {
    "page": 109,
    "content": "5.8\nRenal System\n5.8.1\nAge-related Changes\nThe main functions of the kidneys are in fluid and electrolyte balance, regulation of endocrine\nfunction, waste removal and drug excretion, vitamin D metabolism and stimulation of\nerythrocyte function.\nAs is seen in the liver, overall kidney size tends to decrease with age due to reduced cell\ncounts. There is a decrease in overall blood flow though the kidneys with a reduction in the\nglomerular filtration rate, and this will have an effect on the excretion of drugs.\nChanges to renal function caused by other systemic diseases will have an additional effect on\ndrug elimination. Some drugs commonly prescribed in dentistry, such as penicillins,\nerythromycins, and cephalosporins, may have to be reduced in dose concomitant with renal\nfunction.\nHydration is of increased importance in elderly individuals, who may have a reduced\nsensitivity to thirst and tend not to drink enough fluids. Inadequate fluid intake is a greater\nproblem in individuals with cognitive impairment or physical disability. Age-related\nphysiological renal impairment results in a reduced ability with age to concentrate urine, less\nefficient sodium-sparing capacity, and reduced water excretion. Elders are consequently more\nat risk of problems caused by fluid and electrolyte imbalance such as dehydration.\nChronic kidney disease (CKD), defined as kidney disease resulting in a reduction in\nglomerular filtration rate for more than three months, is a common problem in people with\nglomerulonephritis, hypertension, or diabetes. In the older person, CKD is most often due to\ndiabetes or renal vascular disease secondary to cardiovascular disease; it is also associated\nwith the long-term use of NSAIDs and large doses of acetaminophen. Like many other\nconditions, aging of the global population and more effective treatment of associated diseases\nis causing an increase in the prevalence of CKD in elderly patients, which in some developed\ncountries may be as high as 30% (Coresh and coworkers 2007).\nPatients with CKD have a blunted erythropoietin response to anemia (Adamson and coworkers\n1968), and the risk of anemia may be worsened by the effect of accumulated toxins on bone\nmarrow. Nephrotic syndrome, uremia, and renal insufficiency are all important causes of\nsecondary immunodeficiency in elderly patients as a result of defective phagocyte function;"
  },
  {
    "page": 110,
    "content": "such patients are predisposed to infections, particularly oral candidiasis.\nCKD is associated with an increased bleeding tendency; increased serum urea has an\nantiplatelet effect, and patients with renal dysfunction are often thrombocytopenic.\nVitamin D deficiency is very common in patients with CKD. This is worsened by reduced\nrenal hydroxylation of vitamin D into the active form, 1,25-dihydroxyvitamin D3. Impaired\nrenal phosphate excretion and low serum calcium levels resulting from impaired calcium\nabsorption may result in hyperparathyroidism. The interruption of normal calcium and\nphosphate regulation combined with osteomalacia is known as renal osteodystrophy and can\nhave, in combination with a reduction in fibroblast growth factor 23, a significant effect on\nbone structure (Ott 2012). It has been reported that up to 84% of CKD patients have some\nhistological evidence of bone disease and that 98% of renal dialysis patients have abnormal\nbone biopsies (CKD-MBD Work Group 2009).\nNew evidence has also suggested an autocrine role of vitamin D in the modulation of several\nsystems, including the immune, renal, and cardiovascular systems (Williams and coworkers\n2009).\nDialysis remains the most common treatment for patients with renal failure or end-stage renal\ndisease, although the advances in renal transplants and concomitant immunosuppressive\ntherapy mean that survival after a renal transplant has improved dramatically (Goldman 2006).\nConsequently, older patients with successful transplants are increasingly likely to present for\ncare and treatment; transplantation in the older patient is increasingly common, and pre-\ntransplantation dental disease control will often be required.\n5.8.2\nTreatment Considerations\nChronic kidney disease in later stages may be associated with oral signs and symptoms such as\nhalitosis or a metallic taste disturbance due to uremia, xerostomia, signs of anemia, gingival\nbleeding and oral petechiae because of platelet dysfunction and anticoagulation therapy in\ndialysis patients. Gingival hyperplasia can arise secondary to drugs such as calcium-channel\nblockers and—less often—with cyclosporin, but is less prevalent in older people. Uremic\nstomatitis can occur as painful ulceration of the ventral surface of the tongue and anterior\nmucosa (Proctor and coworkers 2005).\nPoor oral health can lead to poor health outcomes in patients with CKD and is associated with\nmalnutrition including the protein-energy wasting syndrome, which disproportionately affects\nCKD patients (Ruospo and coworkers 2014).\nOral hygiene is often poor in CKD patients, particularly in those on dialysis, due to access\nproblems (Grubbs and coworkers 2012). CKD has been associated with a higher incidence of\nperiodontal disease in patients on renal dialysis (Davidovich and coworkers 2005), although"
  },
  {
    "page": 111,
    "content": "controversy remains with regard to this link. Recent data suggest a higher incidence of\nmortality in dialyzed CKD patients with periodontal disease (Kshirsagar and coworkers\n2009), which may have important implications for elderly CKD patients who develop peri-\nimplant disease. To date, no prospective controlled studies have been published on these\nrelationships, but there is at least one long-term study known to be in progress (Strippoli and\ncoworkers 2013).\nThere may be a reduced incidence of caries arising from the antibacterial effect of urea in\nsaliva (Bots and coworkers 2006). However, in patients with xerostomia, caries experience\nmay be high. There may be an increased accumulation of calculus as a result of high salivary\nurea levels and changes in the calcium or phosphorus metabolism (Gavalda and coworkers\n1999).\nOral infections such as dental or periodontal abscesses tend to be difficult to control in CKD\npatients, and in particular in patients on immunosuppressants. In addition, signs of infection\nmay be masked by steroid therapy. Oral bacterial infections should be treated promptly and\naggressively, but with due consideration for the changes in drug excretion and necessary dose\nmodifications.\nImmunosuppression in transplant patients and those on dialysis may lead to candidiasis, oral\nulceration, and oral leukoplakia lesions. Lichenoid reactions occur and are not always drug-\nrelated. Hairy leukoplakia and an increased susceptibility to epithelial dysplasia may be\nassociated with greater incidence of carcinoma of the lip (Proctor and coworkers 2005).\nBony changes may occur secondary to renal osteodystrophy, especially in the maxilla, with\ndecreased trabeculation and cortical thickness or with ectopic calcification of the soft tissues.\nTooth mobility may also occur (De Rossi and Glick 1996).\nTreatment should be planned in close cooperation with the patient’s physician, particularly in\npatients receiving hemodialysis, so that anticoagulation therapy can be managed accordingly\nand the need for antibiotic prophylaxis can be agreed as requirements vary from country to\ncountry.\nThe effect of CKD on the osseointegration of dental implants has been the subject of animal\nstudies. In uremic mice, a reduced bone-to-implant contact compared to controls was found,\nbut this was only observed in the early stages of osseointegration (2 weeks), and no significant\ndifferences were observed with control subjects at 4 weeks. The authors of one paper\nsuggested that longer healing times should be considered for dental implants placed in CKD\npatients (Zou and coworkers 2013).\nThere are reports of successful implant therapy in renal dialysis and transplant patients\n(Dijakiewicz and coworkers 2007).\nHow the progression of CKD may affect the ongoing success of dental implants that have been"
  },
  {
    "page": 112,
    "content": "in situ for some time is not yet known, although it seems reasonable to assume that the changes\nthat occur around teeth because of poor oral hygiene and osteodystrophy may also be likely to\noccur around implant-supported prostheses. However, the treatment of such implant\ncomplications may be considerably more difficult and could present, in a patient who requires\nstabilization of oral disease prior to renal transplantation, significant challenges.\n5.8.3\nPharmacological Considerations\nPatients with renal disease are often taking antihypertensives such as ACE inhibitors and\nangiotensin II inhibitors. As there is an increased risk of cardiovascular disease,\nacetylsalicylic acid and statin use is also common.\nMany drugs used in patients with renal disease may cause orthostatic hypotension,\nhyperglycemia, or xerostomia, and the effect may be greater in the elderly patient.\nCalcium carbonate and vitamin D supplements/analogs are used to prevent the loss of bone\nmass. Secondary hyperparathyroidism resulting from renal osteodystrophy may mean the\ninitiation of bisphosphonate therapy.\nPatients on renal hemodialysis are often anticoagulated and liaison with the medical team will\nbe required. Adjunctive corticosteroids may be required for those patients on prolonged\ncorticosteroid therapy.\nMany drugs prescribed by the dentist may require dose modification. For a review of drugs\nthat are safe, need dose modification, or should be avoided, see Scully 2014. Due to the\nrapidly changing range of therapeutic drugs, reference to a national formulary should always be\nmade, and consultation with the patient’s physician is recommended."
  },
  {
    "page": 113,
    "content": "5.9\nEndocrine System\n5.9.1\nAge-related Changes\nChanges that occur with age include a decrease in the vascularity of organs and an increasing\nfibrous or connective-tissue replacement of normal glandular structures. This may affect the\nproduction and secretion of hormones, with a potential effect on normal bodily function. A\ntypical example is menopause, where a decrease in overall mass of the ovaries combined with\na reduction in ovarian response to gonadotropin leads to a significant decline in ovarian\nfunction and the production of progesterone and estrogen. This may then lead to the\ndevelopment of osteoporosis (discussed in the section on musculoskeletal changes),\nhyperlipidemia, or atherosclerosis.\nElderly individuals will commonly exhibit reduced muscle mass as a result of decreasing\nvascularity of the anterior pituitary gland, which causes reduced secretion of growth hormone.\nAge-related disability, exhibited by generalized weakness, impaired coordination, balance,\nand mobility, with reduced endurance, defines physical frailty and will affect a person’s\ncontinuing independence into advanced years.\nThymic involution—shrinkage of the thymus with age—is a progressive decline in the size of\nthe thymus that begins during the first year after birth and has been linked to the previously\ndiscussed age-related decline in immunological function in the elderly.\nOne of the most important age-related endocrine changes is a reduction in thyroid function and\nan increased incidence of thyroid disorders, which are often subclinical. Overt hypothyroidism\ncan be associated with a decline in physical and cognitive function, but it appears that\nsubclinical hypothyroidism in the elderly is not. Subclinical hyperthyroidism in the elderly may\nbe associated with abnormalities in bone microarchitecture and fragility fracture, cognitive\nimpairment, coronary heart disease, and atrial fibrillation (Gesing and coworkers 2012).\nThere are some important oral findings in hypothyroidism. Given the high rate of undiagnosed\ndisease, especially in the elderly, the dental professional may have an important role to play in\ndetection. Common oral findings include poor periodontal health, enlarged salivary glands,\nmacroglossia, dysgeusia, and delayed wound healing, although there does not appear to be an\nincreased susceptibility to infection. Hyperthyroidism may arise from iatrogenic\noverprescription of replacement therapy or from a tumor, which may be detected during a\nroutine head and neck examination. Elderly hyperthyroid patients may present with burning-"
  },
  {
    "page": 114,
    "content": "mouth syndrome, mandibular or maxillary osteoporosis (Pinto and Glick 2002).\nHypothyroidism has been shown to result in delayed bone remodeling and repair in rats\n(Fadaei Fathabady and coworkers 2005) and has been implicated in nonunion of mandibular\nfracture (Loftus and Peterson 1979). It is important to note that this appears not to be related to\nlow TSH levels—these may be normal—but to low circulating T3 levels (Bassett and\ncoworkers 2008).\nOther studies have demonstrated a link between hypothyroidism and delayed cortical bone\nhealing around dental implants. However, cancellous bone appeared to be less sensitive to T3\nand T4 levels (Feitosa Dda and coworkers 2008).\nSecretion of parathormone is known to increase in aging men and women (Chapuy and\ncoworkers 1983). The reason for this is unclear, but may be a reaction to reduced plasma\ncalcium levels associated with reduced calcium intake and sun exposure, resulting in reduced\ncalcium absorption in the small intestine, with secondary hyperparathyroidism occurring as a\ncompensatory measure. The principal effect of parathormone is to increase plasma calcium\nlevels by stimulating the release of calcium and phosphate from bone matrix, as well as\nincreasing calcium reabsorption by the kidney, and by increasing the renal production of 1,25-\ndihydroxyvitamin D3 (calcitriol), the effect of which is to increase intestinal absorption of\ncalcium.\nConsequently, the elderly are at high risk of calcium deficiency, which in turn contributes to a\nloss of bone mass as well as muscle weakness, impaired glandular secretion, and degraded\nsynaptic transmission.\nThe adrenal glands become increasingly fibrous with age; production of aldosterone (and, to a\nlesser extent, cortisol) diminishes, although epinephrine and norepinephrine levels remain\nunchanged. Aging appears to be associated with a reduced tolerance to physiological stress\nand an increasing vulnerability to illness and infection (Kale and Yende 2011). Glucocorticoid\nproduction appears to decline, although the circulatory levels appear to remain the same in\nnormal homeostasis. Responses to stress may, however, be blunted in older people, who are\nmore likely to develop infections after stressful events as a result of reduced neutrophil\nfunction (Vitlic and coworkers 2014). Sepsis can rapidly develop into a serious problem in an\nelderly patient, with significant mortality rates (Starr and coworkers 2014). Healing is slower,\nthere is increased morbidity, and infections tend to start early, be late in causing symptoms, and\nbe slow to resolve.\nA reduction in the secretion of the mineralocorticoid aldosterone can result in changes in\nelectrolyte and fluid balance, to which elderly patients may be more sensitive.\nThe glucocorticoid hormones secreted by the adrenal glands have important effects on glucose\nmetabolism and it has been shown that stress hormone responses can induce hyperglycemia\n(O’Neill and coworkers 1991). Age-related decline in levels of the adrenal hormone"
  },
  {
    "page": 115,
    "content": "dehydroepiandrosterone (DHEA), an important hormone for the central nervous system, is\nlinked to declining cognitive performance (Valenti and coworkers 2009).\nIncreasing age is a known risk factor for the development of diabetes and related\ncomplications. Diabetes accounts for significant morbidity and mortality in elderly individuals,\nalthough the impact of diagnosis in later years is not clear (Bethel and coworkers 2007;\nBarnett and coworkers 2006).\nThe global incidence of diabetes mellitus (DM) and in particular type 2 DM is rapidly\nincreasing (Shaw and coworkers 2010). For example, between 1997 and 2010 the number of\ndiagnosed cases in the US increased from 5.1% to 9.2%, and this trend is expected to continue\neven faster, especially in the elderly (Boyle and coworkers 2010). The International Diabetes\nFederation estimates that the global prevalence may be 8.3%, but with 46.3% of cases\nundiagnosed; by 2030, almost 10% of the world’s population will be diabetics (International\nDiabetes Federation 2014).\nSome studies have shown that up to 40% of elderly individuals exhibit impaired glucose\ntolerance, which can be a precursor to diabetes (Harris and coworkers 1998). Blood sugar\nlevels increase more rapidly and take longer to return to normal, which together with a decline\nin cell sensitivity to insulin can result in the development of diabetes.\nAging is often accompanied by reduced physical activity, decreased lean body mass, and\nincreased fat deposition, leading to defective peripheral insulin tolerance; coupled with\nrelatively decreased insulin secretion from the pancreas, large numbers of elderly individuals\nmay have undiagnosed diabetes mellitus. Dietary changes in elderly patients reflecting\nmasticatory difficulty, a reduced taste sensation, eating prepared meals, and other factors can\nresult in an increased intake of refined carbohydrates; combined with age-related decreases in\nglucose tolerance, type 2 DM can develop insidiously in elderly individuals.\nDiabetes is associated with many complications, including myocardial infarction/heart failure,\nperipheral vascular disease, and stroke. Research has indicated that patients with diabetes\nmellitus have a similar risk of myocardial infarction as a healthy person ten years older\n(Lindhardsen and coworkers 2011). Diabetes has also been implicated as a risk factor for\nrenal disease, retinopathy, neuropathy, depression, and dementia and can be a cause of\nsecondary immunodeficiency.\nDM and fragility fractures due to osteoporosis are two of the most important causes of\nmortality and morbidity in older subjects. There appears to be a correlation between fragility\nfracture risk and DM of both type 1 and type 2. Because thiazolidinedione drugs used in the\ntreatment of diabetes may influence a greater differentiation of adipocytes than osteoprogenitor\ncells, elderly patients with type 2 DM and particularly women may be at increased risk of\nreduced bone-mineral density (BMD). Good glycemic control, adequate intake of calcium and\nvitamin D, screening for low BMD, and the prevention and treatment of diabetic complications\nare key elements in the management of osteoporosis in both type 1 and type 2 DM (Montagnani"
  },
  {
    "page": 116,
    "content": "and coworkers 2011).\nDiabetes has also been implicated as a comorbid risk factor in medication-related\nosteonecrosis of the jaw (MRONJ) (Tsao and coworkers 2013; Saad and coworkers 2012) and\nthe more rapid progression of oral infections to serious deep neck space infections in diabetics\n(Boscolo-Rizzo and coworkers 2011).\nIt is recognized that DM is an important complicating factor in implant therapy. Oral symptoms\nassociated with DM include xerostomia with parotid swelling, increased levels of salivary\nglucose and an increased incidence of caries and periodontal disease. Chronic hyperglycemia\nis associated with a reduction in bone formation by impeding osteoblast formation and\ninterfering with bone response to parathormone (Santana and coworkers 2003). There are also\neffects on the production of extracellular matrix and osteoid (Nyomba and coworkers 1989;\nWeiss and coworkers 1981).\nWound healing is slower, and there is an increased susceptibility to implant loss (Fiorellini\nand Nevins 2000). Implant survival rates appear to be lower in diabetic patients, even those\nwith good glycemic control (Moy and coworkers 2005). Despite other review studies\nreporting a lack of evidence for such an association (Chrcanovic and coworkers 2014;\nKotsovilis and coworkers 2006; Alsaadi and coworkers 2007), there is evidence that poor\nglycemic control is associated with higher rates of implant failure (Ferreira and coworkers\n2006).\nIt is easily conceivable that an elderly patient, perhaps with other comorbidities, may present\nas an undiagnosed diabetic. Clinicians should be aware of the signs and symptoms of poorly\ncontrolled or undiagnosed DM. We have an active role to assume in diagnosing and treating\noral signs or symptoms of systemic disease, and in doing so we contribute to the overall health\nof our patients.\n5.9.2\nPharmacological Considerations\nHypothyroid patients with atrial fibrillation may be on anticoagulation therapy and may require\nantibiotic cover for valvular disease. Such patients may be taking replacement therapy in the\nform of l-thyroxine, which can interact with warfarin to produce an enhanced anticoagulant\neffect. INR monitoring of such patients is of increased importance. Thyroxine may also be\naffected by indigestion remedies, iron supplements, antiepileptic drugs such as phenytoin and\ncarbamazepine, tricyclic antidepressants, and rifampicin. There is also an increased sensitivity\nto CMS depressants and barbiturates.\nThe main drugs used for the treatment of hyperthyroidism are carbimazole/methimazole, and,\nless commonly, propylthiouracil. These drugs can cause agranulocytosis or leukopenia; this\nmay present as an apparent exaggerated periodontal/peri-implant inflammation or oral\nulceration."
  },
  {
    "page": 117,
    "content": "Patients on cortisone replacement therapy may require additional doses to prevent adrenal\ninsufficiency and given the reduced stress tolerance in elderly patients, this may be of greater\nsignificance.\nDiabetic patients may require special management, particularly for surgical procedures and\npoint-of-care blood glucose testing devices can be useful. With good glycemic control with a\nnormal diet/injection routine having been taken, insulin-dependent diabetics can be treated\nwithin 2 hours with no adjunctive therapy. Protracted procedures should be performed in a\nhospital setting.\nMedications to be avoided if possible include corticosteroids, which increase blood glucose\nlevels; ciprofloxacin, doxycycline, and tetracyclines can enhance insulin mediated\nhypoglycemia. NSAID use may not be appropriate, as diabetic patients often take\nacetylsalicylic acid for the prophylaxis of ischemic heart disease. NSAIDs also present a risk\nof renal damage in diabetic patients. Many other classes of drug can affect glycemic levels,\nincluding antiepileptics, antidepressants, diuretics, quinolone antibiotics, herbal supplements,\nalcohol, and OTC medications for allergies and head colds/coughs.\nInfections in diabetic patients should be aggressively managed due to the risk of diabetic\nimmunosuppression and rapid progression of infection.\nThiazolidinediones (TZD) such as rosiglitazone and pioglitazone appear to cause bone loss\nand are included in medications known to cause secondary osteoporosis (Lecka-Czernik\n2010)."
  },
  {
    "page": 118,
    "content": "5.10\nMusculoskeletal System\n5.10.1 Age-related Changes\nAge-related decline in muscle mass (sarcopenia) is a common finding in the geriatric patient\n(Evans 1995). Reduced muscle mass is associated with a lack of physical activity, which in\nitself can result in muscle disease and loss of muscle tissue. Hormonal and neurologic\nalterations can also be involved in loss of muscle mass—sarcopenia—as a result of reduction\nin the number of muscle fibers.\nSarcopenia affects the hand muscles in particular, with a concomitant effect on manual\ndexterity. Coordination is reduced, with extended motor reaction times due to slowed\nperipheral nerve transmission.\nMusculoskeletal disease is very prevalent, being the second highest cause of the morbidity-\nrelated global burden of disease (Vos and coworkers 2012). Almost all old people will\nexperience one or more forms of musculoskeletal disorder, often concurrent, and potentially\ndue to many different reasons. Osteoporosis, Paget’s disease, osteoarthritis, inflammatory\nrheumatoid conditions and associated connective-tissue disorders (CTDs), endocrine disease,\nor metastatic carcinoma are all possible causes, as are localized conditions such as\nfibromyalgia.\nOsteoarthritis. Osteoarthritis is very prevalent in the over-75 age group, affecting more than\n80% of this population. It is rarely seen in patients under 40 years (Sharma 2001).\nOsteoarthritis of the hands, hips, knees and spine are increasingly prevalent with aging and can\nprogress to a severely debilitating condition.\nRheumatoid conditions. Autoimmune diseases affecting the soft tissues and bone, such as\nrheumatoid arthritis, and chronic connective tissue diseases such as Sjögren’s syndrome, may\ndevelop in isolation or in conjunction but share similar features in pathogenicity, symptoms,\nand diagnosis; patients requiring implant treatment may require special considerations. These\nconditions are not the preserve of the geriatric patient and most commonly present earlier in\nlife at around 30 to 40 years; however, being progressive, the effects of the disease may be\nmore severe and of increasing significance in the elderly patient.\nThe presence of rheumatoid arthritis has been associated with alterations in skeletal bone mass\nin 30% to 50% of individuals, whether or not they are prescribed steroidal anti-inflammatory"
  },
  {
    "page": 119,
    "content": "medication (Haugeberg 2008), and muscle wasting. Rheumatoid arthritis can be associated\nwith other conditions affecting the heart (conduction defects, myo- or pericarditis),\nhematopoietic system (thrombocytopenia, anemia, leukopenia), renal, hepatic, neurological\n(trigeminal neuralgia), and respiratory systems. Research has indicated that patients with\nrheumatoid arthritis have a similar risk of myocardial infarction as a healthy person who is 10\nyears older, as is the case for example with diabetes mellitus (Lindhardsen and coworkers\n2011).\nSjögren’s syndrome is the most common oral complication in rheumatoid patients and is\ndiscussed in the section dealing with oral medicine.\nThere are studies that have indicated favorable implant success rates in patients suffering from\nautoimmune rheumatoid arthritis, whether or not accompanied by associated connective-tissue\ndisorders. However, in those patients with an accompanying connective tissue disorder, there\nmay be an increased incidence of peri-implant inflammation (Weinlander and coworkers 2010;\nKrennmair and coworkers 2010; there is significant cohort overlap between these two studies).\nSome connective-tissue disorders are only found in aging individuals. Polymyalgia rheumatica\nis a rheumatoid disease that is found only in patients over 50 years, with the average age of\nsufferers being 70 years; it is mainly found in northern European Caucasian populations and is\ntwice as prevalent in women as in men, causing muscular pain, particularly in the shoulders or\nthighs. Treatment is with oral corticosteroids. The disease may “burn out” after a few years,\nbut approximately 20% of cases are complicated by giant-cell arteritis (“temporal arteritis”),\nwith a risk of ocular complications. Anemia is a common finding in patients with polymyalgia\nrheumatica.\nAlterations in skeletal bone\nCalcium and vitamin D are elements of bone physiology that become increasingly important in\nthe maintenance of healthy bones in elderly individuals. It is recognized that many of them have\na “negative calcium balance” and are losing bone mass. Although this may in part be due to a\nlack of weight-bearing activity, there is evidence that inadequate calcium intake is a\ncontributory factor (Heaney and coworkers 1982).\nCalcium uptake is mediated by 1,25-dihydroxyvitamin D3 (also known as 1,25-\ndihydroxycholecalciferol, or calcitriol), which is the hormonal form of vitamin D3\n(cholecalciferol). There is a natural decline in calcium absorption from around the age of 50\nyears. Furthermore, as a consequence of increasing lactose intolerance in elderly people,\ndietary calcium intake may be reduced if they avoid dairy products, a major dietary source of\ncalcium along with green vegetables. Senescence of the skin has far-reaching effects on other\norgan systems, with cutaneous vitamin D production from exposure to sunlight declining in old\nage by as much as 75% in northern European populations; a compounding factor can be the\nreduced amount of time spent outdoors by elderly people. Dietary deficiencies can also play a\npart—vitamin D can also be obtained from cereals, eggs, meat, and oily fish. Chronic renal"
  },
  {
    "page": 120,
    "content": "disease can also result in severe vitamin D deficiency (Williams and coworkers 2009).\nThe effect of hyperparathyroidism on bone has been discussed in the section on endocrine\ndisorders. Parathyroid function increases with age, possibly as a response to reduced dietary\ncalcium and less effective vitamin D production; oversecretion of parathormone results in\nelevated levels of bone resorption, to restore normal plasma calcium levels. This age-related\nhyperparathyroidism emphasizes the importance of calcium and vitamin D supplements,\nespecially in elderly European populations, in preventing loss of bone-mineral density. This is\nthe case not only in long-stay patients but also in ambulatory individuals over 60 years.\nSkeletal tissue loss due to age is more rapid in women, who typically lose 30% to 50% of\ntheir bone mass during their lifetime, compared to 20% to 30% in men. This is characterized\nhistologically by a thinning of the cortical bone layer, a decrease in the density and thickness of\ntrabeculae with an increase in trabecular space, and an increased number of empty osteocyte\nlacunae. The percentage of dead osteocytes in bone increases with age from less than 1% at\nbirth to 75% after age 80 (Tomkinson and coworkers 1997). Osteocyte apoptosis may be\nrelated to the development of osteoporosis (Heino and coworkers 2009) as a result of\nRANKL-mediated osteoclast recruitment (Bonewald 2011). The progressive mineralization of\nlacunae around dead osteocytes spreads to the canaliculi in the immediate vicinity, with the\nresult that the bone becomes sclerotic and brittle. The reduction in vascularity caused by\nsclerosis of the canaliculi leads to decreased oxygenation, which may be important in the\nprocess of osseointegration (Van Steenberghe 2003). The implication of these histological\nfindings on the osseointegration of implants in the elderly is unclear, as multiple studies have\nnot shown any tendency to increased failure rate of implants with age, even in medically\ncompromised patients (de Baat 2000, Op Heij 2003). However, there are significant potential\nconsequences of the medications used to treat declining bone mass, as will be described later.\nA reduction in overall bone mass can be due to two metabolic bone disorders: osteomalacia\nand osteopenia/osteoporosis. Reduced bone mass may also be a consequence of drug therapy\nwith, e.g., corticosteroids.\nThere is also evidence that RA patients have a higher bone turnover and show an increased\nincidence of osteoporosis and vertebral fracture (Nakayama 2007); the prevalence of\nosteoporosis in RA patients may be double the incidence in non-rheumatoid individuals\n(Haugeberg 2008).\nOsteomalacia\nOsteomalacia is a condition characterized by defective mineralization of organic bone matrix\n(collagen) and is frequently associated with hypocalcemia due to vitamin D deficiency.\nHypocalcemia results in increased secretion of parathormone (PTH), and this in turn causes\nincreased renal excretion of phosphorus. Low intraosseous phosphorus concentration impairs\nthe normal processes of bone mineralization. Osteomalacia is therefore characterized by a\nreduction in bone mass and the ratio of bone mineral to bone matrix."
  },
  {
    "page": 121,
    "content": "Radiographic changes characteristic of osteomalacia are thinner cortical plates and decreased\ntrabecular density. Since osteomalacia therefore causes bone characteristics typical of Type IV\nbone, it is possible that such patients may be characterized as merely having “poor bone\nquality,” which has been associated with an increased rate of implant failure by some authors\n(Goiato and coworkers 2014; Alsaadi and coworkers 2007).\nOsteoporosis\nOsteoporosis is a decrease in bone mass due to a reduction in both mineral and organic bone\nstructures, but the ratio of the two remains constant, which is what differentiates osteoporosis\nfrom osteomalacia. Osteoporosis arises from an imbalance between bone resorption and\ndeposition; it results in thinner cortical plates and a decrease in trabecular density and\ndiameter. Trabecular remodeling is normally faster than cortical remodeling, and so a decrease\nin cancellous structure is seen well before any reduction in cortical plate thickness, although\nradiographic changes are unlikely to be seen before approximately one-third of the bone mass\nhas been lost. Special radiographic techniques such as dual-energy x-ray absorptiometry\n(DEXA) or quantitative CT are therefore required for a definitive diagnosis.\nA diagnosis of osteoporosis is made when the T-score (the number of standard deviations from\nthe normal bone density value of an average 25-year-old woman) exceeds –2.5, with\nosteopenia being diagnosed when the T-score is in the range of –1.0 to –2.5 (Glaser and\nKaplan 1997).\nPrimary osteoporosis accounts for approximately 95% of cases in women and 80% of cases in\nmen and is related to family history, racial phenotypes, gender (as a result of hormonal\nfactors), and age. Peak bone mass occurs in an individual’s late twenties and decreases\nthereafter. Secondary osteoporosis accounts for less than 5% of cases but is more prevalent in\nmen than in women and may occur as part of disease processes such as malignancy, COPD,\nCKD, hepatic disease, and certain endocrine disorders, or through the use of certain\nmedications, for example corticosteroids and certain anticonvulsants. Risk factors such as\nsmoking, excessive alcohol intake, dietary deficiencies and chronic inflammatory conditions\nsuch as ulcerative colitis or rheumatoid arthritis may also have an adverse impact (Beikler and\nFlemming 2003).\nAn increased incidence of osteoporosis is seen in the over-50 population. The condition is\nmore prevalent in the elderly individual due to accelerated normal age-related bone-tissue loss\nas outlined above as a consequence of decreased calcium intake and reduced vitamin D levels,\nor for example hyperparathyroidism. It affects nearly half of men and women over 75 years,\nwith women being five times more likely to develop this disease. Postmenopausal women may\nlose up to 20% of their bone mass in 5 to 7 years after the menopause, but by 70 years, men\nand women lose bone at approximately the same rate.\nAn important consideration in osteoporotic individuals is the increased incidence of fragility\nfractures of the wrist, hip, and spine, leading to loss of independence and hospitalization. In\nelderly patients, this has been associated with significantly increased fatality rates. Indeed, the"
  },
  {
    "page": 122,
    "content": "prevention of fragility fractures is one of the major indications for the prescription of\nantiresorptive medications.\nImplant survival in “poor bone quality” is a widely discussed topic. Several classifications\nhave been suggested for bone quality based on bone type (ratio of cortical bone to cancellous\nbone, types I to IV (Lekholm and Zarb 1985), type V bone with no cortical plates (Bahat 2000)\nand density (hard or soft) (Trisi and coworkers 1999), although the most common assessment\nis one made subjectively at the time of implant surgery.\nIn fact, quality of bone is not merely related to density or type; it will also depend on\nhistological attributes such as vascularity, oxygen tension, cell vitality, and associated systemic\nhealth factors that will affect the healing capacity of the bone.\nThere are publications that show little difference in the survival of implants placed in “poor-\nquality” or “good-quality” bone, particularly when using implants with a microrough surface\n(for a review see Stanford 2010), although the level of evidence in all of these situations is\nweak. The level of evidence relating to implant failure in individuals with a diagnosis of\nosteoporosis is similarly low (Bornstein and coworkers 2009), with most reports showing no\nrelationship between osteoporosis and implant failure (Slagter and coworkers 2008) even in\nhighly osteoporotic patients (Friberg and coworkers 2001; Eder and Watzek 1999).\nThere may be a similar lack of association between peri-implant disease and osteoporosis\n(Dvorak and coworkers 2011).\nTreatment of osteoporosis\nHRT (estrogen). Studies have reported conflicting findings regarding implant loss in\npostmenopausal women related to hormone replacement therapy (Minsk and Polson 1998; Moy\nand coworkers 2005). In one study directly comparing implant failure rates in postmenopausal\nwomen with or without HRT and premenopausal women, there was no difference between the\ngroups for mandibular implants. For maxillary implants, the postmenopausal non-HRT group\nhad a significantly higher implant failure rate than the premenopausal and postmenopausal\nHRT-treated group (August and coworkers 2001).\nAntiresorptive medications. While osteoporosis as such may be of questionable concern to\nclinicians involved in dental implant and related surgery, the potential consequences of\nmedications used to treat the condition are significant. Antiresorptive medications may be used\nfor the treatment of osteoporosis/osteopenia, metabolic bone disease (Paget’s disease,\nhyperparathyroidism), or in the treatment of malignancy such as multiple myeloma or\nmetastatic bone disease (such as breast or prostate cancer); there are different forms of\nmedications in current use.\nOne of the most widely used groups of drugs is that of the bisphosphonates, of which there are\ntwo main types: nitrogen-containing (alendronate, risedronate, ibandronate, pamidronate,\nzoledronate) and non-nitrogen-containing (etidronate). Nitrogen-containing bisphosphonates"
  },
  {
    "page": 123,
    "content": "are more potent, as they are not metabolized and are concentrated in the bone, where the drug\nbonds to hydroxyapatite (Russell and coworkers 1999) and has been associated with\nosteonecrosis of the jaw after many years of use (Wang and coworkers 2007).\nThe primary mode of action of bisphosphonates is by targeting osteoclastic activity and\nreducing bone resorption. Oversuppression of bone turnover has previously been postulated as\na possible mechanism in the pathophysiology of osteonecrosis due to bisphosphonates being\nconcentrated in the jaws, where bone turnover is more active (Masarachia and coworkers\n1996; Huja and coworkers 2006). However, recent research suggests that there is no\nsignificant change in bone turnover in the jaws with either bisphosphonates or denosumab\n(Ristow and coworkers 2014; Malan and coworkers 2012).\nThere are clinical reports of a possible toxic effect on other cell types, including oral\nepithelial cells (Reid and coworkers 2007), which could in theory contribute to soft-tissue\nbreakdown. While unbound bisphosphonates are present in tissues other than bone for only a\nshort time, being renally excreted within a few hours, in-vitro studies report toxicity affecting\noral mucosal cells (Landesberg and coworkers 2008). Common ADEs of oral bisphosphonates\nare gastric or esophageal ulcers, further supporting the theory of possible soft-tissue toxicity\n(Lanza and coworkers 2000).\nThe most widely discussed issue of concern to dental implant surgeons is bisphosphonate-\nrelated osteonecrosis of the jaw (BRONJ). Given the increasing use of alternative\nantiresorptive medications, the alternative suggested term is MRONJ—medication-related\nosteonecrosis of the jaw. While the term has been updated, there is still some uncertainty over\nthe pathophysiology of the disease (Ruggiero and coworkers 2014).\nLiterature reviews have supported the opinion that dental implants can osseointegrate and\nremain in good function in patients receiving bisphosphonate therapy (Javed and Almas 2010).\nSystematic reviews of the literature commonly find insufficient high-level evidence to estimate\nthe risks associated with implant therapy in patients receiving oral bisphosphonates (Bornstein\nand coworkers 2009; Chamizo Carmona and coworkers 2012).\nHowever, it is apparent that the type of medication and route of administration, dose, and\nduration are all important factors. Clinicians involved in implant therapy should therefore be\naware of the different medications and their potential impact on the placement or presence of\ndental implants, particularly given the increased likelihood of their use in the aging patient.\nThe combination of bisphosphonates with medications used for comorbidities, such as\nchemotherapy or corticosteroids, has been implicated in the incidence, severity, and\nprogression of MRONJ in animal models (López-Jornet and coworkers 2011; Ali-Erdem and\ncoworkers 2011).\nIt is increasingly recognized that long-term bisphosphonate use can result in atypical fractures\nof the mid-femoral shaft, which may be preceded by thigh pain (Thompson and coworkers\n2012; Schilcher and coworkers 2014). No pharmacological therapy should be considered"
  },
  {
    "page": 124,
    "content": "indefinite and the efficacy of bisphosphonate therapy beyond 5 years use is limited. Given that\nadverse events, including atypical femoral fracture, become more prevalent beyond 5 years of\ntherapy, bisphosphonate holidays have therefore been suggested after 5 years in patients with a\nDEXA-confirmed diagnosis of osteoporosis and no other risk factors, and after ten years\nwhere additional risk factors are present (Cosman and coworkers 2014).\nAs a consequence, the safety of long-term bisphosphonate use is being questioned for reasons\nother than MRONJ, and alternative medications for the prevention of fragility fractures are\nincreasingly common. Strontium ranelate was a common alternative, but is now under review\ndue to possible adverse cardiovascular effects.\nNewer drugs developed for the treatment of osteoporosis include monoclonal antibodies\n(RANKL inhibitors such as denosumab) and antiangiogenic drugs. Denosumab is used six-\nmonthly as a subcutaneous injection for prophylaxis against fragility fractures and monthly in\ncases of metastatic bone cancer. RANKL inhibitors do not bind to bone and their effect is\nsubstantially diminished within six months of treatment cessation. However, MRONJ has been\nassociated with the use of denosumab (Aghaloo and coworkers 2010).\nAntiangiogenic drugs inhibit the formation of new blood vessels and are used in the treatment\nof cancers of the gastrointestinal and neuroendocrine systems. These drugs have also been\nimplicated in MRONJ, given the avascular necrotic nature of the condition. Inhibition of\nangiogenesis or interference with the VEGF pathway has been demonstrated, for example, with\nbisphosphonates such as zoledronate (Wood and coworkers 2002; Santini and coworkers\n2003) and has been reported with novel antiangiogenic medications such as monoclonal\nantibodies targeting VEGF (bevacizumab) and tyrosine kinase inhibitors (sunitinib) (FDA\n2014a; FDA 2014b). Such effects have not been reported with RANKL inhibitors such as\ndenosumab.\nThe most recent update (2014) of the American Association of Oral and Maxillofacial\nSurgeons position paper on medication-related osteonecrosis of the jaw (Ruggiero and\ncoworkers 2014) highlights the low incidence of the condition, given the small number of\nreported occurrences and the large number of patients prescribed intravenous/oral\nbisphosphonates or denosumab for osteoporosis.\nIt now appears to be generally accepted that the risk of MRONJ in patients receiving oral\nbisphosphonate therapy for osteoporosis is low (Lo and coworkers 2010; Mavrokokki and\ncoworkers 2007; Ruggiero and coworkers 2009). However, when such medications are\nprescribed for patients with a relevant comorbidity such as cancer and associated therapy, the\nrisk is higher. Table 4 shows the risk associated with the various drug types and the related\nfactor of whether the medication is used to treat osteoporosis or malignancy.\nReported risk rates vary from 0.00038% (Felsenberg and Hoffmeister 2006) to 0.1% (Lo and\ncoworkers 2010), with the latter group reporting an increased incidence of 0.21% in patients\nwho had been on oral bisphosphonates for more than 4 years. Other authors indicated a lower"
  },
  {
    "page": 125,
    "content": "rate of less than 0.4 cases per 10,000 patient-years of exposure (0.004%) (Malden and Lopes\n2012).\nThe use of intravenous bisphosphonates or denosumab for the treatment of osteoporosis seems\nto give rise to similar rates of MRONJ, in the region of 0.017% to 0.04% (Grbic and\ncoworkers 2010).\nAs a comparison, studies investigating the risk of ONJ in osteoporosis patients who were\ntreated with placebo medications showed a risk of up to 0.02% (Grbic and coworkers 2010\nand 2008).\nThe risk of MRONJ in patients taking antiresorptive medications as part of cancer treatment is\nabout 100 times greater than those who are taking the medication for the treatment of\nosteoporosis alone. The MRONJ risk in cancer patients treated with zoledronate is in the\nregion of 1%, according to systematic reviews and randomized controlled trials (Mauri and\ncoworkers 2009; Qi and coworkers 2014). There are increasing case reports of MRONJ in\noncology patients treated with denosumab (O’Halloran and coworkers 2014).\nAgain for comparison, the incidence of MRONJ in cancer patients receiving a placebo is in the\nregion of 0.02%.\nCombining bisphosphonates with antiangiogenic agents appears to result in an increased risk of\nMRONJ (Saad and coworkers 2012; Guarneri and coworkers 2010).\nTable 4 MRONJ risk with different antiresorptive medication (Ruggiero and coworkers 2014)\nThe duration of medication also seems to be a risk factor in the development of MRONJ. Lo\nand coworkers (2010) reported a low risk of MRONJ in patients on oral bisphosphonates\n(0.1%) that increased to 0.21% in patients who had been taking oral bisphosphonates for more\nthan 4 years, demonstrating a potential increase in risk related to duration of medication that\nhas been highlighted by other authors (Dello Russo 2007; Marx 2008).\nThis would seem logical, given that oral bisphosphonates have a long half-life (up to 10 years)"
  },
  {
    "page": 126,
    "content": "and are concentrated in bone, creating a cumulative effect.\nFor intravenous bisphosphonates there seems to be a plateau effect, with no significant\nincrease after three years of administration (Black and coworkers 2012), an effect that is also\nseen with denosumab (Saad and coworkers 2012).\nOther newer antiresorptive medications in current use include teriparatide, a form of\nrecombinant human parathormone and raloxifene, which is a selective estrogen receptor\nmodulator effective in preventing vertebral, but not hip fractures, also used in the treatment of\nbreast cancer. There are currently no studies investigating the impact of these drugs on dental\nimplant survival or maintenance.\n5.10.2 Treatment Considerations\nSarcopenia can cause a reduction in masticatory strength, and elderly individuals commonly\nhave longer chewing cycles related to reduced muscle activity. Edentulous patients often have\na more significant reduction in masticatory muscle mass and maximum bite capacity, although\nthey may find their function adequate as long as their dentures are effective and comfortable\n(Mioche and coworkers 2004; Newton and coworkers 2004).\nWe should not merely view our patients as “a set of jaws” with a potential risk of\nosteonecrosis. The dentist can play a role in the overall care of the patient by being vigilant to\nboth the signs and symptoms of osteoporosis, which may be undiagnosed until the patient\nsuffers a fracture. Chronic back pain may be due to osteoarthritis, but a vertebral compression\nfracture can present as an acute exacerbation with spinal tenderness in the dental chair. Patients\nwith osteoarthritis may be unable to lie comfortably in a supine position, particularly for long\nappointments; the use of cushions or knee/neck supports may assist. Arthritic joint pain\nstiffness is usually worse in the early morning and improves during the day, so scheduling\nappointments for the early afternoon may be helpful.\nGiven the high mortality rate in geriatric patients who have suffered a hip fracture, it is also\nimportant to be vigilant for a history of falls, which may be part of the reason for seeking\ntreatment (fractured teeth or dental prostheses). Elderly people commonly suffer from\nconfusion, poor coordination, poor vision, and muscle weakness, or orthostatic hypotension as\na result of medication, all of which can be reasons for falling. It may be appropriate for the\nclinician to assist referral to a falls prevention service or other relevant community care.\nThe available studies, mostly restricted to case reports or retrospective case series, suggest\nthat implant placement in patients with rheumatoid arthritis (with or without concomitant\nosteoporosis or connective tissue disorders) is not contraindicated and not associated with a\nhigher implant failure rate, particularly when surface-modified implants are used (Oczakir and\ncoworkers 2005; Alsaadi and coworkers 2008; Krennmair and coworkers 2010). However,\nattention must be paid to medication with corticosteroid or immunosuppressive therapy"
  },
  {
    "page": 127,
    "content": "(Mombelli and Cionca 2006). It is important to consider how different diseases may have an\nimpact on treatment, given polymorbidity and associated pharmacotherapy.\nThere may be a risk of increase peri-implant mucosal inflammation and marginal bone loss in\npatients with rheumatoid arthritis and an associated connective-tissue disorder, notably\nSjögren’s syndrome (Krennmair and coworkers 2010).\nMusculoskeletal disorders are the second most common cause of disability (Vos and\ncoworkers 2012) and patients with impaired mobility may find difficulty in accessing dental\nmaintenance care.\nRheumatoid or osteoarthritis can have an effect on manual dexterity and strength (Sheehy and\ncoworkers 2013). There have been studies showing an increased incidence of inflammation\nand periodontal attachment loss in patients with arthritic hands (Gleissner and coworkers\n1998; Wolff and coworkers 2014). We should therefore consider how well the patient will be\nable to perform the necessary oral hygiene procedures to care for any implants and dental\nprostheses. It may be possible to provide augmented handles for toothbrushes; electric\ntoothbrushes may be of significant help. But what chance would a patient with rheumatoid\narthritis of the hands, with swan-neck deformity and ulnar deviation, have with small\ninterdental brushes or floss? Daily plaque control at home is of course of paramount\nimportance in the maintenance of adequate peri-implant health; a patient with a complex fixed\nrehabilitations may be physically unable to perform the necessary procedures and may require\nassistance from caregivers or more frequent professional dental maintenance.\nWe may consider that removable implant-supported overdentures present a “better” option, but\nwill such a patient be able to grip the denture well enough and have the ability to unclip the\ndenture from the bar or Locator attachments? We may have to consider progressive changes to\nthe attachment system and the degree of retention.\nSuch considerations should be assessed at the outset of treatment, perhaps as simply as offering\na handshake to the patient and testing coordination and muscle strength (Incel and coworkers\n2009) or observing a tremor. Wheelchair patients may exhibit a weakening of the extensor\nmuscles of the wrist and fingers as a result of radial nerve compression caused by resting on\nthe arms of their wheelchair.\nOsteoarthritis can affect the temporomandibular joints, but is rarely of clinical significance,\neven if radiographic evidence of the disease is marked or where the individual has more\nsevere disease of other joints.\nPatients with a history of joint disease will often have received a joint prosthesis. There is no\ngood evidence for prophylactic antibiotic therapy before implant placement in most patients\nwith artificial joint replacements. It has been estimated that the risk of antibiotic adverse\nevents such as gastrointestinal upset (which may include a risk of more severe complications\nin the elderly), anaphylaxis, or development of Clostridium difficile, especially in the elderly"
  },
  {
    "page": 128,
    "content": "patient, with a risk of severe morbidity and mortality. However, patients with a recently placed\njoint prostheses (< 2 years) or a comorbidity affecting immune status, such as corticosteroid\ntherapy, diabetes, rheumatoid arthritis, or chemo- or immunosuppressive therapy, may be at a\ngreater risk of prosthesis infection, and consultation with their orthopedic surgeon on the\nprovision of antibiotic cover is necessary (AAOS/ADA 2014).\nAs is the case with antibiotic prophylaxis for cardiac conditions, guidance from both clinical\nand medicolegal authorities varies considerably in different countries, and a risk assessment\nshould be undertaken and fully discussed with the patient before any surgery. An important\nrecommendation of several publications is that patients have good oral health before joint\nreplacement surgery and that good oral hygiene is maintained.\nImplant placement in osteoporotic patients. The relationship between skeletal bone loss due\nto osteoporosis and loss of mandibular or maxillary bone is unclear. Researchers have\npreviously suggested that there is no link (von Wowern and Melsen 1979; von Wowern and\ncoworkers 1988; Jacobs and coworkers 1996). However, some recent studies have found a\ncorrelation between reduced skeletal bone-mineral density and reduced mandibular alveolar\nbone mass, such that dental radiographs could be an important tool in the detection of\nosteoporosis (Amam and Rustom 2014). This has been confirmed by DEXA measurements of\nthe jaw, which show a high degree of correlation between reduced mandibular bone--mineral\ndensity and typical scan sites such as the proximal radius and lumbar spine (Horner and\ncoworkers 1996). Some authors have noted implant failure in low-density (type IV) bone; they\nconsidered whether this might be related to osteoporosis but found no significant correlation\n(Alsaadi and coworkers 2008). Dental implant integration can be successful even in the\nmandibles of highly osteoporotic individuals (Fujimoto and coworkers 1996; Eder and Watzek\n1999; Degidi and Piattelli 2003; Friberg and coworkers 2001).\nHowever, there have been reports of a greater degree of peri-implant marginal bone loss in\nosteoporotic patients compared with non-osteoporotic patients after 5 years of functional\nimplant loading (von Wowern and Gotfredsen 2001). It is of course important to consider the\nrisk of mandibular fracture when implant surgery is performed in atrophic mandibles (Mason\nand coworkers 1990).\nRisk of MRONJ. MRONJ is undoubtedly a significant complication of dentoalveolar surgery\nthat is difficult to manage and has considerable morbidity. Clinical studies have shown that\nMRONJ can arise spontaneously in patients on antiresorptive medication in the presence of\ninflammation or infection as a result of bacterial disease (Hoff and coworkers 2008). Animal\nstudies have indicated that this may be one of the possible factors in the pathogenesis of\nMRONJ (Aghaloo and coworkers 2011; Aguirre and coworkers 2012; Kang and coworkers\n2013).\nConsequently, while extractions and bony surgery in patients taking such medications carries a\nsmall risk of MRONJ, ignoring a periodontal or peri-implant infection may also carry the same\nor greater risk. The role of complex biofilms that are adherent to exposed bone presents further"
  },
  {
    "page": 129,
    "content": "questions in the treatment of established MRONJ (Sedghizadeh and coworkers 2008 and\n2009). It may therefore be useful to consider risk-reduction strategies when considering\ndentoalveolar surgery in such patients.\nAlthough the usefulness of dental assessment and completion of dental treatment before starting\noral bisphosphonates is questioned by some authorities as the risk of MRONJ is low (Raj and\ncoworkers 2014), in patients who are to be prescribed intravenous bisphosphonates or\nantiangiogenic medications there is evidence to support pre-medication dental assessment and\ntreatment (Ripamonti and coworkers 2009; Dimopoulos and coworkers 2009; Vandone and\ncoworkers 2012).\nBased on current evidence, the risk of MRONJ after dentoalveolar surgery in patients taking\noral bisphosphonates or denosumab for osteoporosis is small, being in the region of 0.45%\n(Kunchur and coworkers 2009). However, there is considerable variation in opinion. A recent\ncase-control study reports that there may be an increased incidence (odds ratio 13.1; 95% CI\n4.4–39.3; p < 0.001) of delayed healing after extractions in patients taking oral\nbisphosphonates, which may progress to osteonecrosis (Borromeo and coworkers 2014).\nThere is limited data on the risk of MRONJ following the placement of dental implants, or\nafter periodontal or endodontic surgery. Expert advice is that the risk associated with flap\nelevation and bone manipulation approximates the risk associated with dental extractions\n(Ruggiero and coworkers 2014). The placement of implants in osteoporosis patients taking\noral bisphosphonates for up to 3 years appears to carry little risk of MRONJ (Jeffcoat 2006;\nGrant and coworkers 2008; Madrid and Sanz 2009a).\nHowever, as stated, there is a significantly greater risk in patients with comorbidities or those\non intravenous antiresorptive therapy. Although there is little data relating to implant placement\nin patients on intravenous bisphosphonate therapy, most authors believe that given the risks,\nimplant placement is contraindicated (Dello Russo and coworkers 2007; Bornstein and\ncoworkers 2009). Relevant comorbidities may include simultaneous medication with\ncorticosteroids, diabetes, or in cancer patients possibly anemia (hemoglobin < 10 g/dl) (Tsao\nand coworkers 2013; Saad and coworkers 2012). Smoking may also be considered a relevant\nfactor due to reduced tissue oxygenation.\nIt is therefore important to consider social issues, polypharmacy, and polymorbidity as\nindividual “warning lights,” with the risk increasing as the number of warnings increases.\nThe incidence of MRONJ following a dental extraction in cancer patients on intravenous\nbisphosphonates is higher, with one prospective study showing a rate of 2.8% (Mozzati and\ncoworkers 2012). Overall, it has been estimated that up to 61% of MRONJ cases in cancer\npatients on intravenous bisphosphonates (Vahtsevanos and coworkers 2009) were precipitated\nby dental extractions.\nDentures have also been associated with MRONJ in cancer patients treated with intravenous"
  },
  {
    "page": 130,
    "content": "bisphosphonates (Vahtsevanos and coworkers 2009; Kyrgidis and coworkers 2008).\nDrug holidays. At present, it is not clear whether cessation of oral antiresorptive medication\nbefore dentoalveolar surgery is beneficial. It is important to consider the medical risks to the\npatient of not taking the medication for some time. It has been reported that there is no evidence\nto support cessation of oral bisphosphonate therapy in osteoporosis patients before\ndentoalveolar surgery (FDA 2011). A recent consensus conference concluded that a “drug\nholiday” might be beneficial in high-risk patients with long-term exposure to antiresorptive\nmedication or in patients with comorbidities such as smoking, diabetes, steroid therapy, or\nrheumatoid arthritis (Khan and coworkers 2015).\nThe question of cessation of drug therapy in cancer patients on antiresorptive medication in\ncombination with other pharmacotherapy is unlikely to be of relevance in terms of dental\nimplant surgery. Such procedures are unlikely to be appropriate in oncological patients. These\npatients may require extractions, but elective invasive dental treatment should only be\nconsidered as part of a multidisciplinary approach with the specialists involved in the care of\nthe patient. Given the growing elderly population, in which many may have had implants\nplaced earlier in life—before developing a condition that requires the use of antiresorptive\nmedications—it is conceivable that we will face problems in the future as we treat patients\nsuffering from MRONJ associated with peri-implant infections. The challenge of a situation\nwhere implant removal may be required but will carry a significant risk of serious\ncomplications could present the clinician with difficult decisions regarding the optimal\ntreatment for the patient.\nRegularly updated guidelines list details of useful resources, the staging of treatment strategies,\npreventive measures, and algorithms for the management of patients with MRONJ. Implant\npractitioners should ensure that they are aware of the current guidelines, as there can often be\nsignificant changes over relatively short periods as new knowledge becomes available\n(Ruggiero and coworkers 2014).\nPaget’s disease (osteitis deformans). After osteoporosis, Paget’s disease of the bone is the\nsecond most common bone disorder in elderly patients, with an incidence of 10% in patients\nolder than 80 years. It is characterized by an imbalance in the bone-remodeling process: while\nosteoclastic resorption increases, new bone formation increases even more. However, the\nnewly formed bone is highly vascularized woven bone with enlarged trabecular space,\nmeaning that it is weaker and more susceptible to fracture. There appears to be a genetic and\nenvironmental component, and the condition is more prevalent in Caucasian populations of\nEurope, North America, and Australasia, with the axial skeleton, including the bones of the\nskull, being the most common site affected.\nMost patients with Paget’s disease are asymptomatic. However, as the disease progresses,\nbone pain is common and the increased vascularity may lead to overlying erythema. Cranial\nPaget’s disease may lead to cranial nerve damage due to compression, and malocclusion, optic\nchanges, vertigo, and tinnitus. Antiresorptive medications such as bisphosphonates are the"
  },
  {
    "page": 131,
    "content": "first-line treatment; patients may be hyperresponsive to vitamin D and calcitonin. Sarcomatous\nchange is possible, although rare, in the jaws and may be treated with radiotherapy.\nImplant placement in patients with Paget’s disease is not extensively documented. The above\nconsiderations regarding antiresorptive medications apply. However, the guidelines relating to\nimplant placement for patients on intravenous bisphosphonates are generally derived from\nresearch where cancer is a comorbidity. Paget’s disease is often managed with a single\ninfusion of intravenous zoledronate, and it has been reported that such a dose may equate to\nsimilar accumulative concentrations of bisphosphonates as five years of oral therapy (Madrid\nand Sanz 2009a). Reduced bone density may present difficulties, but there are a few reports of\nsuccessful implant placement under these conditions (Rasmussen and Hopfensperger 2008;\nPirih and coworkers 2009; Torres and coworkers 2009; Mattheos and coworkers 2013).\n5.10.3 Pharmacological Considerations\nMany drugs used to treat rheumatoid arthritis can have oral adverse effects, such as lichenoid\nreactions, ulceration, and dysgeusia, all of which may be worse in an elderly patient with\nreduced salivary flow.\nNon-steroidal anti-inflammatory drugs are commonly used in the treatment of inflammatory\nmusculoskeletal diseases, with a concomitant increased bleeding effect. To prevent gastric\nbleeding, proton pump inhibitors such as omeprazole may be prescribed and have been\nassociated with an increased incidence of fragility fractures in at-risk groups (Eom and\ncoworkers 2011). Patients who take other antacids (e.g., aluminum hydroxide) may be at risk\nfor hypophosphatemia, which is a more uncommon cause of osteomalacia.\nThe main therapeutic agent in osteoarthritis is acetaminophen due to the risk of upper\ngastrointestinal tract bleeding with NSAIDs, especially in polymorbid patients with, for\nexample, COPD, heart disease, or diabetes. Acetaminophen doses need to be reduced in\npatients with chronic renal disease.\nCorticosteroid therapy is also employed in the treatment of rheumatoid arthritis and\nmusculoskeletal inflammatory conditions and can be associated with oral candidiasis.\nSecondary osteoporosis may also occur as a side effect of glucocorticoid therapy. It is\nrecognized that corticosteroid therapy is a major risk factor for osteoporosis (NICE CKS\n2014) Corticosteroids reduce intestinal calcium absorption and increase renal calcium\nexcretion; there is a compensatory increase in parathormone (PTH) secretion and an increased\nbony response to circulating PTH, resulting in reduced bone mass. Corticosteroids are\nassociated with an increased risk of MRONJ (Saad and coworkers 2012; Tsao and coworkers\n2013). However, more recent studies suggest that the use of polypharmaceutical regimes\nincluding calcium and vitamin D supplements with antiresorptive medications such as\nbisphosphonates, may reduce the incidence of steroid-induced osteoporosis over a two-year"
  },
  {
    "page": 132,
    "content": "period (Jacobs and coworkers 2015).\nData from observational studies and ADE reporting suggests that although there is no high-\nquality evidence, long-term use of anticonvulsant drugs such as carbamazepine, phenytoin, and\nsodium valproate may be associated with decreased bone-mineral density. Patients taking these\ndrugs may consequently also be prescribed vitamin D (Lee and coworkers 2010).\nDiabetes- and osteoporosis-related fractures are two of the most important causes of mortality\nin elderly patients. There is clinical evidence that bone-mineral density is decreased in type 1\ndiabetes and increased in type 2 diabetes mellitus, although even type 2 diabetic patients\nappear to be at a higher risk of fracture (Montagnani and coworkers 2011). In addition,\nthiazolidinediones (TZD) such as rosiglitazone and pioglitazone appear to cause bone loss and\nare included in medications known to cause secondary osteoporosis (Lecka-Czernik 2010).\nThyroid hormone affects the rate of bone replacement; hyperthyroidism can result in normal\nosteoblastic function being unable to compensate for excessive bone resorption and can result\nin osteoporosis, especially in postmenopausal women. It has been shown to result in fragility\nfractures. While hypothyroidism is not associated with osteoporosis, excessive replacement\ntherapy with thyroxin can result in depressed TSH secretion and has been implicated in\nosteoporosis. Subclinical thyroid dysfunction has no effect on bone-mineral density (Grant and\ncoworkers 1993), but there is evidence of an increased incidence of hip fractures in patients\nover the age of 70 years who are taking high doses of levothyroxine (Ko and coworkers 2014).\nLong-term heparin-induced osteoporosis can result in up to 30% of patients displaying a\nsubclinical reduction of bone-mineral density and 2% to 3% experiencing a fragility fracture\n(Muir and coworkers 1996), with vertebral fractures being the most common (Handschin and\ncoworkers 2005).\nUnfractionated heparin remains in the bone, and the consequent reduction in BMD may be\nirreversible (Rajgopal and coworkers 2008).\nHIV infection is no longer considered a life-shortening disease. Antiretroviral therapies can\nnow provide patients with normal life expectancy, meaning that these patients are more likely\nto reach advanced age. However, HIV patients are more likely to suffer a disease-related loss\nof bone-mineral density, and antiretroviral treatment may contribute to a reduction in BMD\n(McComsey and coworkers 2011).\nCigarette smoking is an established risk factor in osteoporosis. Its cumulative effects on many\naspects of bone metabolism and healing can be significant in elderly individuals with a long\nhistory of smoking (Yoon and coworkers 2012; Abate and coworkers 2013). Tobacco use is\ncontroversial as a risk factor for MRONJ, with some authors finding tobacco use approaching\nnear statistical significance as a risk factor for ONJ in cancer patients (Kyrgidis and\ncoworkers 2008). Other studies have not found an association between tobacco use and ONJ\n(Vahtsevanos and coworkers 2009; Tsao and coworkers 2013)."
  },
  {
    "page": 133,
    "content": "Intranasal calcitonin is used in the treatment of osteopenia/osteoporosis and for short-term pain\nrelief after osteoporotic fracture, as it produces an endorphin effect. Reported side effects have\nincluded oropharyngeal burning or tingling sensation and jaw pain."
  },
  {
    "page": 134,
    "content": "5.11\nNeurosensory System\n5.11.1\nAge-related Changes\nThere is a progressive loss of brain neuronal tissue throughout life. Although the amount and\nlocation vary, this loss is principally of grey matter rather than white matter (Lim and\ncoworkers 1992). Short-term memory loss and a reduced capacity to learn new things occur\nrelatively early, with a decline in verbal ability beginning from approximately the age of 70. In\nthe absence of neurological issues, intellectual ability will not usually begin to decline until\nage 80. The resulting forgetfulness, reduced reasoning ability, and declining neuroplasticity\n(adaptability) are generally termed “cognitive decline” and may progress to depression,\ndementia, or Alzheimer’s disease, although there is considerable individual variation in the\ndegree and rate of decline due to many medical, social, and environmental factors.\nSome of these risk factors include chronic inflammation, insulin resistance, endothelial\ndysfunction, and oxidative stress from free radicals. Declining hormone levels affecting\nandrogens, thyroid hormones, dehydroepiandrosterone (DHEA), and other neurohormones are\nalso implicated.\nBlood flow to the brain decreases by around 20% with age, but may be greater in\natherosclerotic patients with cerebrovascular disease, which is more common in smokers,\ndiabetics, or those with hypertension or hypercholesterolemia. Large cohort studies suggest a\nrelationship between an increased risk of cognitive impairment and dementia in patients with\ncardiovascular disease, perhaps as a result of cerebral hypoperfusion or embolic stroke\n(Abete and coworkers 2014).\nAging brings impaired neuronal function due to myelin degradation and reduced synaptic\ntransmission, resulting in impaired neuromotor function and increased reaction times. A\ngeneralized decrease in peripheral sensory nerve cells means that sensory impairment is also a\nnormal part of aging (Hubbard and Squier 1989).\nIn elderly people, the sense of smell markedly decreases because of a reduction in the number\nof olfactory neurons. The incidence of upper respiratory tract infections over a lifetime and\nother factors such as allergic rhinitis can also contribute; consequently, there is an alteration in\ntaste sensation, which can also be worsened by complete denture wearing, xerostomia, or\nmedications. All these factors can have a negative impact on nutritional status in the elderly\n(Winkler and coworkers 1999)."
  },
  {
    "page": 135,
    "content": "Hearing and visual impairment are more a result of age-related changes in the eyes and ears\nthan a change in nerve pathways. A decline in visual acuity occurs as the lens of the eye\nbecomes less flexible with age due to fluid loss, making it less able to focus, particularly on\nclose objects. Pupillary size is also reduced, and the pupillary light reflex may be slower;\nupward gaze is limited, and to a lesser extent downward gaze. Eye movements may be jerky\nwhen tracking an object. Macular degeneration may result in a significant reduction in the\ncentral vision necessary for more delicate tasks, such as oral hygiene procedures or accurate\ndenture placement, while adequate peripheral vision may be maintained for walking, sitting,\netc.\nVisual impairment can be a significant handicap in the elderly, who may then consequently be\nunable to detect and recognize early oral disease. The performance of normal oral hygiene\nprocedures, the insertion and replacement of dentures, and even the perceived need for\ntreatment are all affected. Access to dental care may be difficult due to mobility, access issues,\nand fear, as well as cost. It has been reported that although over 80% of a cohort of blind\npatients stated that they needed no help in tooth brushing, 21% had dental pain or denture\nproblems, and 32% had denture-related pathology (Schembri and Fiske 2001).\nCranial nerve evaluation in the elderly may be difficult because of non-neurologic age-related\nchanges, such as diabetes, which also affects peripheral nerves. Facial pain may affect up to\n50% of the elderly population (Madland and coworkers 2001).\nOropharyngeal dysphagia is prevalent in elderly people and may be a risk factor for other\ndiseases (Charlson and coworkers 1987). Studies on otherwise healthy patients over 80 years\nfound that aging impaired the swallowing response (Nagaya and Sumi 2002). It may be further\nimpaired by certain neurological disorders such as stroke or dementia (Logemann 1998), or it\nmay be medication-induced (for example by neuroleptic drugs) or a side effect of drugs. As\npreviously stated, this presents a risk of aspiration pneumonia in the elderly (Cabre and\ncoworkers 2010; Almirall and coworkers 2013).\nStroke. A “stroke” (cerebrovascular accident, CVA) can be due to embolism, thrombus, or\nhemorrhage (subarachnoid or cerebral). Subarachnoid hemorrhages are more commonly found\nin younger age groups.\nHypertension and atherosclerosis, which are frequent in the elderly population, are common\ncauses of CVA such as cerebral thrombosis. Embolitic CVA can arise from an embolus formed\non a damaged cardiac wall following a myocardial infarction or on a heart valve in atrial\nfibrillation. Clinicians should be aware of the signs and symptoms, as urgent medical attention\nwill be required; 15% of patients die within the first three months of a CVA.\nPost-stroke complications include unilateral limited mobility and, if the left hemisphere is\naffected, speech difficulties. Oral complications include sensory deficits and motor impairment\nwith possible loss of gag reflex, functional difficulty with chewing and swallowing, reduced\ndenture tolerance and inability to perform adequate oral hygiene (Ostuni 1994)."
  },
  {
    "page": 136,
    "content": "Transient ischemic attack (TIA) is a known precursor to stroke and is often a result of carotid\nartery stenosis. TIA’s will present as a short-lived and more focal neurological disturbance,\noften in the form of a temporary “vacant” episode. Any neurological deficit is usually\nrecovered within days or hours.\nParkinson’s disease. Parkinson’s disease is caused by dopamine deficiency due to\ndegeneration of the pigmented cells in the substantia nigra and can be age-related or a\nconsequence of cerebral damage from trauma or a CVA; it not just a disease of the elderly. It is\ncharacterized by muscle rigidity, tremor of the arms and hands, gait disturbances such as\nshuffling or rigidity, bradykinesia (slower movement), and akathisia (restlessness). It may\nresult in sialorrhea (Chou and coworkers 2007) and hypotension due to impaired autonomic\nfunction. Dysphagia can arise in up to 80% of Parkinson’s patients, who may also experience\nother gastrointestinal problems such as reflux, nausea, and anorexia (Edwards and coworkers\n1991).\nDementia. The likelihood of developing mental illness increases with age (Berr and\ncoworkers 2005), with dementia affecting approximately 7.1% of the above-65 age group,\napproximately 20% of the above-80 age group, and 32.5% of the above-95 population in the\nUK. The main cause of dementia is Alzheimer’s disease, with vascular and other forms of\ndementia such as those associated with Parkinson’s disease being less prevalent (Alzheimer’s\nSociety 2014).\nDementia is not a normal part of aging and can be due to cerebrovascular disease or\npathological processes such as Alzheimer’s disease.\nAlzheimer’s disease initially manifests as temporal and spatial disorientation with memory\nloss. As the disease progresses the patient develops intermittent problems with speech and\nverbalization; apraxia (loss of coordination) and the ability to perform activities of daily\nliving, including oral hygiene declines. In the final stages, the patient becomes disoriented,\napathetic, and bedridden.\nConfusion in the elderly patient can be due to these processes or a result of chronic disease\nsuch as diabetes, acute illness, infection, or dehydration, which can produce behavioral\nchanges. It can be difficult to distinguish between the different causes of confusion; for\nexample, in elderly patients with dementia, confusion may arise from that condition or from\nadvanced aging. However, it may be due to an unrecognized infection and if left untreated for\ntoo long, such infections may spread to septicemia more rapidly than in a less old person.\nDepression is common in elderly people, variably as a result of bereavement, Parkinson’s\ndisease, stroke, chronic pain, and changes in life patterns brought on by aging and illness.\n5.11.2\nTreatment Considerations"
  },
  {
    "page": 137,
    "content": "Reduction in food and fluid intake contributes to further neurologic deterioration, so\nmaintaining oral comfort and the ability to process food is the prime objective in caring for\npatients with neurological disorders and aging patients in general. Patients with Parkinson’s\ndisease as well as post-stroke and dementia patients may have great difficulty even in\nmanaging dentures that were previously comfortable, and more so in adapting to new dentures.\nA gradual decline in neuroplasticity associated with aging can create problems in otherwise\nhealthy elderly patients tolerating new dentures, even those dentures that are technically\nperfect.\nMany patients with neurological diseases will not have any form of cognitive impairment; they\ncan be greatly helped by the improvements in oral comfort and masticatory function offered by\nimplant-supported prostheses. However, special considerations will inevitably have to be\nmade in terms of treatment and ongoing maintenance, particularly in relation to any future\nprogressive deterioration in the patient’s condition. Treatment planning and decision-making\nmay need to involve not only the patient but also family members or caregivers. Close\ncooperation between the dental professional and the psychogeriatric team is needed in\nachieving successful outcomes (Welsh and coworkers 2000).\nVisual impairment and deafness as well as cognitive decline, confusion, and the complexity of\na lifetime of medical issues can make communication and understanding more challenging in\nelderly patients. A patient who appears confused or mentally impaired in conversation may\nactually be deaf or dysphasic because of a stroke. A patient with dementia may be able to\nmaintain adequate social graces from instilled long-term practice to give plausible answers to\ncertain conversational questions and appear unaffected. When speaking with patients, it is\nimportant to sit in front of them, not wear a mask, and speak slowly and clearly. Advocacy and\nconsent are discussed in the chapter on psychosocial challenges.\nIt is important to realize that patients with Parkinson’s disease may not have any form of\ncognitive decline and are otherwise fully functioning individuals. This can often be forgotten,\ngiven the inexpressive facial tone that is characteristic of the disease. They will be slower to\nperform normal tasks as a result of the disease and can become frustrated. Dental implants may\nprovide significant benefits in both mastication and predigestion capacity (Heckmann and\ncoworkers 2000). However, patience and compassion are necessary when providing treatment,\nas emotional stress can exacerbate the symptoms. Parkinson’s patients often suffer from\nsialorrhea (excess saliva production), which can make treatment difficult. They are also at risk\nof hypotension with postural implications, and the characteristic head position or dyskinesia in\norofacial musculature can cause treatment problems.\nPatients who have suffered a CVA may have reduced swallowing or gag reflexes, which has\nimplications not only for the treatment but also for the safety of removable appliances or small\ncomponents. Sensory or motor defects affecting the oral cavity may result in food accumulation\nand poorer plaque control on the affected side. Post-stroke patients often suffer from\ndepression (Gupta and coworkers 2002), which may affect motivation, attendance, and\ncompliance, with a consequent adverse impact on treatment objectives."
  },
  {
    "page": 138,
    "content": "Access and mobility may be impaired in stroke patients; communication can be affected by the\npresence of dysarthria, and aphasia can give the impression of confusion or memory loss. It is\noften recommended that elective dental treatment be avoided in the first six months following a\nstroke. Such patients will be anticoagulated and interference with this regime may be\ninadvisable. In addition, avoidance of stressful procedures is advisable (Little and coworkers\n2002), so shorter appointments are preferred. Patients are susceptible to further events as a\nconsequence of hypertension; blood pressure should be monitored, and it is important to use\nminimal doses of epinephrine-containing local anesthetics. If complex interventions are\nnecessary, the use of conscious sedation may be considered with appropriate medical advice\nand monitoring, given the risk of respiratory depression. In cases of marked impairment of gag\nreflex, coughing, and swallowing, it may be necessary to consider inpatient general anesthetics\nwith airway protection via intubation.\nThere are no specific oral manifestations in Alzheimer’s disease or other dementia conditions\nother than those related to drugs that may be taken. However, such patients are increasingly\nunable to manage self-performed oral hygiene, and special precautions are necessary (Fiske\nand coworkers 2006).\nImplant treatment in patients with neurodegenerative disease can provide benefits and\nproblems (Faggion 2013).\nTreatment can be challenging; these patients prefer known people and places and are easily\ndisoriented and upset. While there is no absolute contraindication to implant placement,\ncareful consideration is required as to the appropriateness of introducing complex treatment,\nparticularly surgical, in a situation that will only decline further, making care and maintenance\never more difficult.\nThe effective use of intricate oral hygiene aids such as floss or small interdental brushes may\nbe impossible in many of these conditions. When planning treatment, the ability of the patient\n(or caregiver) to perform adequate plaque control is a basic tenet in all individuals. But it is\nparticularly important in elderly patients with visual impairment, cognitive decline, dementia,\nsarcopenia-related weakness of the hand muscles, or reduced manual dexterity, perhaps due to\nParkinson’s disease, where a significant impact on peri-implant health parameters may arise.\nOf course, such handicaps may develop after placement of a complex prosthesis earlier in life,\nand custom maintenance plans involving the patient and caregivers will need to be prescribed.\nProfessional maintenance will be required more frequently and managed in the most accessible\nsetting. Finally, revision of the prosthesis in good time to a simpler form, while such therapy is\nstill practicable, may be advisable in certain cases.\nDepression itself can present challenges for dental treatment, in particular complex treatment\nthat requires many appointments over a long time. Oral complaints such as facial pain,\ndysesthesia, perceived mysterious fluid or slime secretions, and dysgeusia have all been\nattributed to depression and treated with antidepressants, although with variable success. The"
  },
  {
    "page": 139,
    "content": "appreciation of outcomes of treatment or progress made may not always be present in\ndepressed patients and meeting patients’ expectations may be very difficult.\n5.11.3\nPharmacological Considerations\nThe oral effects of many drugs used in the treatment of neurological disorders have been\ndiscussed in the section on the alimentary tract. Xerostomia and dysgeusia may result from\nanti-Parkinson drugs, antidepressants, sedatives and tranquilizers.\nStroke patients may be hypertensive or may be taking anticoagulant medication.\nParkinson’s disease patients are often treated with levodopa, which can interact with the\nepinephrine in dental local anesthetic and induce cardiac arrhythmias or tachycardia, and\nhypertension. Non-epinephrine containing local anesthetic should be used in these patients.\nMacrolide antibiotics can interact with bromocriptine, also used in the treatment of\nParkinson’s disease.\nTricyclic antidepressants (TCAs) such as amitriptyline, imipramine, and dosulepin cause\nxerostomia. They can also cause severe hypotension in the elderly, especially orthostatic\nhypotension and other side effects such as arrhythmias, neurological disturbance, neutropenia\nand jaundice are more serious in older people. Acetaminophen can inhibit the metabolism of\nTCAs. Selective serotonin reuptake inhibitors (SSRI) such as sertraline may be used as an\nalternative to TCAs, but may still cause a side effect of dry mouth.\nMonoamine oxidase inhibitors (MAOIs) used in the treatment of depression are now rarely\nused due to many, often dangerous, side effects.\nSt. John’s wort has been shown to be effective in the treatment of mild depression. However, if\ntaken with serotonin reuptake inhibitors, there is an increasing risk of serotonin syndrome in\nolder adults. As previously mentioned, this can also interfere with warfarin and digoxin.\nElderly people generally require less sleep but often suffer from chronic insomnia.\nBarbiturates may be used to treat insomnia or anxiety in the elderly. Diazepam is lipid-soluble\nand has a long half-life. In older patients, the effect may be enhanced, leading to a risk of\ndependency, confusion, or falls and related fractures. Presurgical anxiety control should\nemploy alternatives with a shorter half-life, such as midazolam."
  },
  {
    "page": 140,
    "content": "5.12\nCancer\nThe most common malignancies affecting the elderly population are pulmonary,\ngastrointestinal, and genitourinary (Hansen 1998). Oral manifestations of these cancers are not\nseen, but the treatment of malignancy can have effects in terms of chemotherapy and\nradiotherapy. Oral cancer is primarily a disease of the over-50 population in developed\ncountries (Koch and coworkers 1995).\nSuccessful implant placement has been described and may be very useful in the reconstruction\nof deformity and morbidity caused by resective treatment for oral cancer. However, implant\nsurvival rates may be significantly compromised by comorbidity, and implant loss is more\nfrequent (Barrowman and coworkers 2011; Nelson and coworkers 2007; Kovács 2000). As\nalways, careful and comprehensive planning of treatment, taking into account the medical,\nsurgical, and psychosocial factors relating to the individual patient, is mandatory.\nChemotherapy causing bone-marrow suppression may cause thrombocytopenia and have an\nimpact on hemostasis, and leukopenia, resulting in an increased tendency to infection. Proper\npreoperative assessment will be required. Radiotherapy may cause xerostomia, hypogeusia,\ndysgeusia, trismus, and osteoradionecrosis (Rankin and Jones 1999).\nApproximately 80% of patients undergoing radiotherapy to the head and neck region and 40%\nof patients in chemotherapy will experience oral mucositis as a consequence (Dodd and\ncoworkers 1996).\n5.12.1 Osteoradionecrosis\nWhile not the preserve of the elderly, and with increasing incidence in younger patients in\nsome countries such as Scotland—perhaps due to social factors such as smoking and alcohol\nuse—rates of oral cancer are still significant in elderly people (Cancer Research UK 2014).\nSurvival rates following treatment of head and neck cancer with resective surgery,\nchemotherapy, and radiotherapy have improved slightly over the past decade in developed\nnations—from approximately 50% to 57% in the USA, for example (Oral Cancer Foundation\n2012).\nHowever, quality of life may be adversely affected by resective surgery, and radiation\ntreatment can have an adverse effect on the salivary glands, oral mucosa and the bones of the\njaws. The clinician has to consider not only the provision of dental implants in irradiated bone,"
  },
  {
    "page": 141,
    "content": "but also the effect that radiotherapy may have on implants placed before radiotherapy, even\nmany years previously. Damage to salivary tissue, in particular the parotid glands, can lead to\nhyposalivation and increased dental caries; this increases the potential need for dental\nextractions, with a concomitant risk of ONJ. Post-radiation periodontal attachment loss may\noccur (Epstein and coworkers 1998; Marques and Dib 2004) and may be exacerbated by\ndifficulty in performing effective oral hygiene, due to trismus, soreness of tissues and a lack of\nmotivation. All these can increase the risk of tooth loss. A combination of oral mucosal\ndamage and hyposalivation can lead to patients then experiencing great difficulty in wearing\nconventional removable prostheses.\nRadiotherapy for head and neck oncology typically consists of a dose of 60–70 Gy over a four-\nto six-week period, in five daily doses with breaks of two days. Radiotherapy can cause\ndamage to the microvasculature of the bone, with a consequent reduction in tissue oxygenation\nand nutrition, and deficiencies in cellular repair capacity. This can result in the development of\nosteoradionecrosis (ORN), which has a specific pathophysiologic sequence (Harrison and\ncoworkers 2003). Radiation-induced tissue damage results in oral soft tissues that are highly\nsusceptible to trauma, for example from denture wearing. Non-healing ulceration of tissues\nresults in areas of exposed, necrotic bone that can become secondarily infected, as is the case\nwith MRONJ. ORN is thought to occur in approximately 3% to 35% of patients undergoing\nradiation therapy to the head and neck (Marx and Johnson 1987).\nThe risk of ORN increases with both radiation dose and with time as a result of progressive\ndeterioration in tissue oxygenation following irradiation. Consequently, ORN may arise many\nyears after radiation therapy following dental extractions, in periodontal disease, or from\ndenture pressure sores; it may also arise seemingly spontaneously (David and coworkers 2001;\nMeraw and Reeve 1998; Marx and coworkers 1987).\nThe onset of ORN may be affected by the site of the tumor and the irradiated region, as well as\nother systemic and social factors such as chemotherapy, smoking and alcohol intake. The\nmandible appears to be more susceptible to ORN as a result of its reduced vascular supply\ncompared to the maxilla and a consequential increased susceptibility to endarteritis obliterans.\nConsequently, implant placement in an irradiated area carries a risk of defective wound\nhealing due to osteoradionecrosis.\nThere is evidence to show that radiotherapy can significantly affect successful dental implant\nhealing (Linsen and coworkers 2012), and that the long-term impact of radiotherapy on bone\nquality and implant failure may be unfavorable (Alsaadi and coworkers 2008). A retrospective\nstudy found that implant failure rates in irradiated bone might be approximately double that of\nimplant placed in non-irradiated bone (Granström 2005). Failure rates may also increase in the\nyears after implant placement in irradiated bone (Jisander and coworkers 1997), reflecting the\nincreased incidence of ORN with time since radiation therapy, presumably due to the\naforementioned progressive degradation of tissue oxygenation. The occurrence of ORN after\nimplant surgery is a complication with equally significant morbidity as MRONJ and may be\nunderreported (Granström 2003), although some studies report no increased incidence of ORN"
  },
  {
    "page": 142,
    "content": "with implant placement (Wagner and coworkers 1998).\nThe available literature should be interpreted with caution; success rates ranging from 40%\n(Ali and coworkers 1997) to 100% (Esser and Wagner 1997) have been reported, but\nsignificant confounding variables are frequently left unconsidered.\nJust as intraoral implant failure varies according to the characteristics of the bone at the\nimplant site, the same is true of implants used to retain extraoral prostheses (Granström and\ncoworkers 1992; Granström and Tjellström 1997).\nHyperbaric oxygen therapy (HBO) has in the past been claimed to assist in the treatment and\nprevention of ORN by increasing oxygen tension in wounds and, as a consequence, also\nincreasing the rate of angioneogenesis and fibroblast proliferation; implant placement has been\nsuccessful when such a protocol was employed (Larsen 1997). However, recent research\nquestions the clinical benefits of HBO (Keller 1997; Donoff 2006; Esposito and Worthington\n2013).\nRecent evidence supports the established belief that head and neck radiotherapy may be linked\nto an increased failure rate of implants, compared to failure rates in patients who had not\nundergone radiotherapy. Failure rates may be higher in the maxilla and HBO therapy does not\nappear to improve implant survival. A systematic review of 15 trials, comprising 13 case\nseries and 2 RCTs, produced 10,150 implants, with 1,689 (14.3%) placed in irradiated\nmouths. Mean survival rates of implants ranged from 46.3% to 98% with pooled estimates\nindicating implant failure to be statistically significantly higher in irradiated patients,\ncompared to patients who had not undergone radiotherapy (an increase of 174%) with a risk\nratio of 2.74 (95% CI: 1.86, 4.05; p < 0.00001). In maxillary sites, the risk ratio was 5.96\n(95% CI: 2.71, 13.12; p < 0.00001) with the risk of loss increasing to 49.6%. There were\nthree studies with patients receiving HBO finding that HBO did not reduce the risk of implant\nfailure, with a risk ratio of 1.28 (95% CI: 0.19, 8.82). However, the authors pointed out the\nlow level of evidence; neither of the RCTs was rated as at low risk of bias, and none of the\nobservational studies were of high quality; in addition, many of the papers included examined\nmachined surface implants. The authors were therefore unable to state whether HBO has a\nmeaningful effect on implant survival (Chambrone and coworkers 2013).\nSuccessful implant integration will depend on many factors, such as the radiation dose,\ncomorbidities and associated polypharmacy, smoking, implant site, and the timing of surgery\nrelative to the radiation therapy. Studies assessing the relative failure rates for implants placed\nbefore and after radiation therapy report difficulties in differentiating heterogeneous factors\nsuch as these and the type of prosthesis used. The failure rates of implants placed before and\nafter irradiation appear similar, although outcomes were less favorable in the maxilla than in\nthe mandible (Colella and coworkers 2007).\nSome authorities recommend waiting for at least 12 months after radiotherapy to the head and\nneck region before considering implant placement, despite recognizing the lack of reliable"
  },
  {
    "page": 143,
    "content": "evidence (Claudy and coworkers 2015). Other authors examined the difference in implant\nfailures when implants had been successfully integrated for a time before radiotherapy\ncompared to implants in irradiated bone. They concluded that while the site of placement may\nbe relevant, there appears to be no significant difference related to timing. In patients with\npreviously placed implants, radiotherapy performed from 4 months to 19 years later appeared\nto have a similar ultimate effect on the implants (99.2% survival rate) as pre-implantation\nradiotherapy (88.9%). Maxillary sites exhibited lower success rates than mandibular or\ngrafted sites (78.9%, 93.3%, and 87.5%, respectively). In grafted sites, vascularized free flaps\nappeared to have better implant survival (89.3%) than non-vascularized grafts (87.1%). HBO\ndid not appear to make a difference to overall implant survival. None of these differences was\nstatistically significant (Nooh 2013).\nThere does appear to be a correlation between total radiation dose and implant failure with\ndoses of higher than 45–55 Gy (Harrison and coworkers 2003; Colella and coworkers 2007;\nNooh 2013) with an increased risk of ONJ at doses above 66 Gy (Harrison and coworkers\n2003).\nAs can be seen, findings for ORN following dental implant surgery and for the integration of\nthe implants are variable. Long-term implant survival may also be affected by other effects of\nradiotherapy such as reduced salivary flow and increased plaque deposits. However, implant\nplacement may significant improve the quality of life outcomes following resective surgery, as\nimplants may be used to retain both intraoral and extraoral prostheses. Conventional tissue-\nsupported intraoral prostheses are often unable to provide adequate function due to altered\nanatomy, mucosal fragility, or reduced salivary flow (Weischer and Mohr 1999).\nDeformities caused by major resective surgery coupled with deficiencies in speech, function,\nand comfort can all adversely affect quality of life and may have an impact on mental and\nphysical health. Despite lower implant survival rates, implants may therefore be an\nappropriate option for rehabilitation in oral cancer patients who have been treated with\nradiotherapy (Mancha de la Plata and coworkers 2012).\nCaution should be exercised when considering implant placement in patients who have\nreceived radiotherapy in the head and neck region, with appropriate specialist advice being\nsought. Although there is no current consensus, some authors have recommended defined\nprotocols (Granström 2003):\n•\nImplant surgery is best carried out > 21 days before radiotherapy.\n•\nTotal radiation dose should be < 66 Gy if the risks of ORN are to be minimized or < 50 Gy\nto reduce osseointegration failure: avoiding implant site/portals.\n•\nHyperbaric oxygen should be given if > 50 Gy radiation is used.\n•\nNo implant surgery should be carried out during radiotherapy.\n•\nNo implant surgery should be carried out in the presence of radiation mucositis.\n•\nDefer implant placement for 9 months after radiotherapy."
  },
  {
    "page": 144,
    "content": "•\nUse implant-supported prostheses without any mucosal contact.\n•\nAvoid immediate loading.\n•\nEnsure strict asepsis.\n•\nConsider antimicrobial prophylaxis.\nNewer radiotherapy techniques may offer the opportunity to reduce undesirable collateral\ntissue damage. Intensity-modulated radiation therapy (IMRT) is a computer-controlled RT\nmodality with more accurate targeting of rapid beams of different intensity radiation. This can\noffer better parotid tissue preservation and prevent hyposalivation, thereby reducing the\nincidence of “radiation caries.” Altered fractionation schedules are also under investigation,\nbut different schedules appear to have widely varying risks and benefits in terms of ONJ\nincidence after dental extractions (Nabil and Samman 2011)."
  },
  {
    "page": 145,
    "content": "5.13\nConclusions\nImproved management of medical conditions and greater longevity mean that aging patients can\nenjoy better health for longer.\nThe purpose of this chapter has been to highlight the effect of advancing age on implant\ntreatment planning in elderly patients. It can be seen that people “age” at different rates.\nCombining the many general health variables outlined above with the varying needs and\nexpectations of patients makes treatment planning very difficult in many cases.\nIndeed, the needs of the patient may well change with further aging or medical issues. The\n“idealistic” treatment plan may not be the ideal treatment plan in an aging patient, particularly\none who is, or will likely become, more frail. Furthermore, what appears to be an ideal\ntreatment plan at the time of treatment delivery may result in considerable difficulty in dealing\nwith complications that arise many years later, when that patient is elderly and polymorbid or\nfrail.\nFor most medical conditions, it is the degree of systemic disease control rather than the\npresence of the condition itself that is the most relevant consideration in implant therapy and in\nimplant success or survival (Seymour and Vaz 1989; Diz and coworkers 2013). However,\nimplant treatment is elective, non-essential, invasive surgery, and to perform surgery on a\npatient with an active and uncontrolled disease process carries a risk of more serious\ncomplications. In elderly patients, the margin between safety and danger can be eroded by the\nindividual and compound effects of polymorbidity, polypharmacy, and frailty.\nA careful risk-benefit analysis is required before complex and stressful procedures are\nundertaken. In older patients with good disease control, the considerations may not be very\ndifferent from younger patients. In more medically compromised elderly individuals, the\nconsideration of the large number of additional factors outlined above may mandate significant\ncompromise in the treatment plan that has to be accepted by clinicians and patients alike.\nSimplification may be necessary to ensure that the treatment remains the most suitable as\npatients age further or become frailer.\nWe have an ultimate duty of care to ensure that we do not employ a technique-driven focus in\nthe treatment of our patients. Everything we could do will have both advantages and\ndisadvantages. There is no more important reason to ensure a patient-driven care plan than the\nproper consideration of the present, and likely future, medical condition of our aging patients,\nwhere progressive decline is the only certainty. Our task is to ensure good dental quality of"
  },
  {
    "page": 146,
    "content": "life, to maintain self-esteem, and facilitate proper nutrition, without unwittingly adding\nproblems that could adversely affect our patients on a daily basis.\nWe do not have a crystal ball, and hope is not a strategy; a comprehensive assessment of both\nthe immediate and future needs of elderly implant patients with careful, meticulous planning—\nnot only of the treatment, but the manner in which it is provided—is essential in a successful\noutcome. Only in this way can we be sure that the functional, esthetic, and quality-of-life\nbenefits that may be provided by implant treatment will outweigh the potential risks in the\nprovision of treatment."
  },
  {
    "page": 147,
    "content": "6\nFeatures of Removable Prostheses for the Old\n \nF. Müller"
  },
  {
    "page": 148,
    "content": "Prospective planning\nDental prostheses for geriatric patients should not generally be designed any differently from\nthose for younger adults (Müller 2010a). Of course, the general rules and guidelines for the\nconstruction of removable prostheses also apply to dentures for elderly and geriatric patients.\nHowever, we should also consider the patient’s general health and any physical or cognitive\nimpairment. Of similar importance are the patients’ autonomy in performing essential oral\nhygiene and their ability to manage removable dentures. Unfortunately, nursing staff has often\nhad very little if any training in handling what they consider “high-tech” dentures—and even a\nmandibular two-implant overdenture may fall into this category.\nThe following testimony from the daughter of a patient who had recently received an implant-\nsupported overdenture and who was hospitalized for stroke recovery highlights this situation:\n“… I had also asked why Dad has lost so much weight, and the doctor explained to me\nthat this is due to the low-calorie diet and his lack of appetite. But that is not so bad,\nbecause it would facilitate his ability to move. But then Gertrud told me that she often\nnoticed that his “new teeth” were not seated well, and I could imagine that he cannot\nchew properly. On the new ward, there is only one caregiver who knows how to handle\n“high-tech” dentures. Anna had asked him several times to train the others, but it seems\nthat it has not worked out…”\nEven for fit and active elders, prospective planning is important. While anyone can have an\naccident or a stroke any day, there is still a stronger likelihood for an 80-year-old to become\ndependent in the following 15 years than for a 50-year-old patient. Of course, 80- and even 95-\nyear-old fit patients can be provided with fixed implant-supported prostheses, but these should\nallow for a “back-off” strategy when the onset of dependency requires simplification. Fixed\nimplant-supported bridges should preferably be screw-retained to allow replacement by a\nremovable prosthesis later in life. Implants should be placed where they could be useful when\nthe fixed implant-prosthesis is converted to an implant-supported overdenture.\nThe choice of implants is equally crucial. A two-piece system with a choice of available\noverdenture abutments is preferable, as these abutments are easier to retrieve and replace with\nanother version.\nIn short, dental prostheses for elderly adults should have the following attributes:\n• Easy to insert and remove\n• Easy to clean\n• Freedom in centric occlusion with shallow cuspal inclines"
  },
  {
    "page": 149,
    "content": "•\nPolished surfaces without too much detailing that creates niches and fosters plaque adhesion\n•\nAge-appropriate dental appearance\n•\nHighest retention that still permits autonomous handling by the patient\nTable 1 lists possible age-appropriate features from which practitioners may adopt those they\nconsider appropriate for a particular patient.\nAs aging and functional decline are very individual and may vary from patient to patient, it is\nimportant to note that this list does not apply to all old patients equally and categorically.\nThere is no specific age after which a patient is considered “geriatric” and will need a\nremovable prosthesis!\nTable 1 Possible age-appropriate features for a partial or complete removable denture for geriatric patients.\nDenture design\nSimple and flexible, allowing modification in case of potential\nfuture tooth loss or the onset of dependency for activities of\ndaily living (ADLs)\nDenture stability\nSolid, resisting clumsy handling without a need for immediate\nrepair\nDenture-base material\nPolymethyl methacrylate (PMMA) to allow for repair,\naddition of teeth or other parts, as well as relines\nRetention components\nUse only the best and well-documented materials and\ncomponents to reduce material failure and wear in late life\nDenture surface\nPolished surfaces to facilitate cleaning and avoid adhesion of\nbiofilm and food debris (no surface details, no papilla\nrecession)\nPalatal plate\nPolished, unless problems with speech or taste are present\nDenture management\nand retention\n“Removal aids” to help the removal of the prosthesis if\nmanual dexterity is reduced. Retention only as strong as can be\nmanaged by the patient themselves Retention should be\n“weakened” progressively along with functional decline\nOcclusal plane\nShould be on or below the equator of the tongue. As for the\nlength of the incisors, bear in mind that the upper lip becomes\nlonger with age and the edges of the incisors should not be\nlonger than the upper lip.\nOcclusal breakdown with a loss in vertical dimension has to be"
  },
  {
    "page": 150,
    "content": "corrected for a coherent occlusal plane\nVertical dimension\nThe less coordinated and controlled the mandibular\nmovements, the lower the occlusal vertical dimension\nOcclusion\n“Freedom in centric” concept to accommodate the increased\nfreedom of the temporomandibular joints and poorer motor\ncoordination\nCanine guidance or group function for partial dentures;\nbalanced occlusion for complete dentures and implant-\nsupported overdentures\nIn difficult anatomical situations, the central bearing point\nmethod should be used for the registration of centric relation\nDenture teeth\nCuspal inclination of 20° or less, preferably acrylic teeth\nAbutment teeth\n“Bikini design”—cover as little tooth structure as possible to\nallow access of saliva to the enamel\nAbutment teeth with severe attachment loss should be\nendodontically treated and decoronated for a more favorable\ncrown/root ratio\nWhere possible, keep healthy filled roots as overdenture\nabutments (except for molars)\nDenture kinetics and\nocclusal load\nThe mandibular denture should be “stronger” and more stable\nthan the maxillary denture\nMake an effort to keep strategically important teeth, especially\nmandibular canines Plan occlusal load to be transferred to\ndenture saddles rather than abutment teeth to keep the latter for\nas long as possible\nAdopt a fail-safe principle for clasps to protect abutment teeth\nAppearance\nAge-appropriate appearance with abraded incisal edges and a\nshade of 3 or above\nLabeling\nIndividual labeling of denture with name (and matching set of\ndentures) for the institutionalized patient\nComfort\nOral comfort should be assured even when the denture is not\nworn during the night (e.g., no sharp edges from attachments)\nDenture design"
  },
  {
    "page": 151,
    "content": "Any removable denture such as conventional partial, implant-overdenture or conventional\ncomplete should be designed to be as simple and adaptable as possible. Although tooth loss is\nnot part of physiological aging, the statistical likelihood is high that oral hygiene deteriorates\nalong with functional decline, the immune defense weakens and tooth loss occurs. Often this\ncoincides with the transition from the third to the fourth stage of life, where dependency for\nnormal activities of daily life (ADL) becomes evident. In this context, it is important to be able\nto adapt the existing denture to accommodate impaired function, rather than provide a new\nprosthesis. Neuroplasticity may already be diminished, and the patient should not have to\nendure multiple long and invasive clinical sessions. Avoiding major changes in occlusal\nvertical dimension, intercuspation, the shapes of the dental arch and denture body, lip support,\nand overall appearance makes accommodating to a new denture a smooth and atraumatic\nprocess for the patient.\nDenture stability\nRemovable prostheses replace not only the lost teeth, but also lost hard and soft tissues. As\natrophy of the alveolar crest progresses with age, most geriatric patients present with a\nnoticeable degree of atrophy and consequently require a denture body that presents very little\nfracture risk. Partial dentures should also have a robust design that resists occasional clumsy\nhanding by an elderly patient. Dental technicians often take pride in manufacturing delicate and\nelegant cast-metal framework. Although such efforts are to be admired, they are not adequate\nfor elderly patients with reduced manual skills and vision. The tactile sensitivity of the mucosa\ndiminishes with age. Elderly patients are less sensitive to bulky clasps or lingual bars and\noften do not mind a “solid” framework for a partial denture.\nDenture-base material\nAlthough polymethyl methacrylate (PMMA) denture bases provide the greatest flexibility for\nrepairs, relines, and additions, a chromium or titanium base may provide more comfort and\nrestore the sensation of heat and taste. If needed, it could later be replaced by a PMMA denture\nbase.\nWhile providing advantages concerning PMMA allergies, vinyl chloride and vinyl acetate\ndenture materials (Luxene; Astron Dental, Lake Zurich, IL, USA) do not allow modifications\nand are therefore less favorable for elderly patients.\nRetention components\nElements such as precision attachments or implant components should be of the best quality\nand have scientifically well-documented designs. Biological complications may still occur\nlater in life, but mechanical failure and wear should be prevented as far as possible. It is also\nimportant to have replacement components at hand for the future, and so the choice of implant\nsystem is important. Material failure may profoundly disrupt elderly patients and impair their\nconfidence in both the denture and the dentist.\nDenture surface\nAlthough enormous efforts are made in prosthetic dentistry to copy nature, surface details such"
  },
  {
    "page": 152,
    "content": "as stippling, interproximal spaces, or gingival sulci usually exceed the elderly patient’s ability\nand willingness to clean. Removable dentures for geriatric patients should therefore be well\npolished and present no niches for the adhesion of biofilm and food debris. Although recession\nof the interdental papilla with “black triangles” is frequent in an aged natural dentition, it is\nalso not recommended to imitate this in a removable denture. There is perhaps nothing worse\nfor an interlocutor than a residual leaf of spinach stuck between two incisors! Therefore, the\ndenture papillae should be of a more juvenile form, filling the available space apical to the\nproximal contacts, providing a morphology where food glides off rather than being stuck. As\nthe pink acrylic risks showing between the anterior teeth, most denture teeth are now\nmanufactured with long proximal contacts to lower the level of visible denture resin. Polished\nsurfaces are not only useful for avoiding food retention but also to provide greater ease of\nbiofilm removal. Deposits of biofilm on a removable prosthesis may present a considerable\nrisk for aspiration pneumonia, especially in elderly patients with swallowing disorders and\ncompromised health (Quagliarello and coworkers 2005).\nPalatal plate\nMost dentures with full palatal coverage have a polished palate without rugae. This is\nappropriate for elderly patients, as it is easy to clean. However, the addition of palatal rugae\nmay be helpful to improve taste, because it facilitates pushing the food to the taste receptors\nlocated deep down in the papillae of the dorsum of the tongue (Fig 1). Individual palatal\nfeatures of a patient to a removable denture base can easily be added by taking a silicone\nimpression of the edentulous palate, pouring this silicone key with pink wax, peeling the sheet\nof wax off the silicone, and adding it to the denture palate. What an experience for the patient\nto discover the familiar palatal pattern on the denture plate! Another addition to the palate may\nbe indicated when pronouncing the “S” sound becomes difficult because the thickness of the\nartificial palate precludes a sufficient airflow in the “S canal.” The addition of an acrylic\nincisal papilla to the denture palate helps lower the tongue during phonation and creating space\nfor the airflow necessary for the “S” sound. Both the palatal rugae and an incisal papilla can\nbe well polished, so they do not increase the risk for plaque adhesion.\nFig 1 Palatal rugae are only applied to improve taste and speech."
  },
  {
    "page": 153,
    "content": "Figs 2a-c An orthodontic ball clasp may serve as a removal aid if manual dexterity is compromised in an elderly patient.\nFig 3 A removal aid (GeriaDental, Borken, Germany) may be a useful tool for patients whose fingernails are too brittle\nto remove a partial denture with clasps.\nDenture management and retention\nImpaired vision, reduced tactile sensitivity, and failing manual dexterity may render the\nremoval of a partial or implant-supported overdenture difficult. Furthermore, the fingernails of"
  },
  {
    "page": 154,
    "content": "elderly patients become brittle and ill suited to insert under a metal clasp for denture removal.\nRemoval aids may be a welcome feature to facilitate denture management. These can be\nfabricated using an orthodontic ball clasp polymerized into the papilla between the premolars,\nbut could also be just a simple notch a finger is able to grip (Figs 2a-c). Whereas a younger\npatient might be disturbed by such an addition, elderly patients are less aware of these\nfeatures, as the tactile sensitivity of the mucosa reduces with age. Special tools like\nDentureLifter are available for those who do mind removal aids (Fig 3). An overly retentive\ndenture may cause considerable panic in an elderly denture wearer, especially when\naccustomed for many years to a prosthesis lacking in retention.\nDenture retention must be no stronger than to allow the patient to insert and remove the\ndenture autonomously. The weaker the hand force and dexterity, the lower the maximum\ndenture retention.\nAs a rule, the older the patient, the less denture retention is required. This is of particular\nimportance for implant-supported dentures, where the strength of retention is a choice rather\nthan a given feature of the available abutment teeth. Of course there are individual exceptions.\nFigs 4a-b The upper lip loses elasticity and lengthens with age. Maxillary incisors are therefore mounted without\nexceeding the length of the lip in a relaxed position.\nOcclusal plane\nWhen determining the occlusal plane for an elderly person’s complete or implant-supported\nprosthesis, it is important to remember that the upper lip loses elasticity and the front teeth\nwear with age (Figs 4a-b). In the horizontal plane, the incisors should therefore not exceed the\nlength of the upper lip. In the sagittal plane, the occlusal plane is still parallel to the Camper\nplane, the equator of the tongue, and the bipupillary line.\nWhere natural teeth are still present, it is very important to re-establish a coherent occlusal\nplane when tooth loss has created a collapsed vertical dimension. Elderly patients often\npresent with overerupted teeth and a locked occlusion, leaving little space for a prosthetic\nrestoration and preventing a dynamic occlusion without interference.\nVertical dimension"
  },
  {
    "page": 155,
    "content": "The rule that a complete or implant-overdenture should provide the patient with 2 to 3 mm\nfreeway space also applies to elderly patients. Yet in a geriatric patient with poor motor\ncontrol, we may want to choose a reduced vertical dimension of occlusion with increased\nfreeway space. The risk of overload and injury to the denture-bearing tissues and pressure\nspots is lower, and unfavorable sounds from unintentional tooth contact during dyskinetic\nmandibular movements are avoided.\nOcclusion\nAlong with age-related slackening of the ligaments in the temporomandibular joint and atrophy\nof the articular tubercles, the precision of mandibular guidance decreases. At the same time,\nmotor coordination diminishes, so that the mandibular closing trajectory of geriatric patients is\nmuch less precise than in adults. A “freedom in centric” concept is more forgiving of the\nincreased range of mandibular movements (Fig 5).\nFig 5 Rather than a locked occlusion with tripod contacts for supporting cusps (a), the occlusion for an elderly\npatient’s prosthesis should adopt a “freedom in centric” concept (b) to meet the needs of the aged temporomandibular\njoint and the deteriorated motor coordination."
  },
  {
    "page": 156,
    "content": "Figs 6a-c The upper template is prepared with a writing pin plate that is heated and melted into the wax rim (a). The\nheight of the pin can be adjusted, as it is threaded into the plate (b). For registration, the pin should exceed the upper\nwax rim by about 2 mm (c).\nAs in younger patients, the centric relation (CR) is the position of choice for reconstructing the\ndentition. However, in patients with Parkinson’s disease, mandibular dyskinesia, or severe\ndementia, a “comfort occlusion” in a slightly more anterior position can be adopted without\napparent problems. If no CR can be determined (as may happen in geriatric patients) or if\npatients cannot “find” their CR position, monoplane teeth may be the last resort to provide a\nfunctional denture. Although the chewing efficiency is less favorable than with anatomical\nteeth, they provide stability in almost every occlusal position the mandible “happens to adopt”\n(Abduo 2013).\nAs for a dynamic occlusion, a bilateral occlusion is adopted for implant-supported\noverdentures, just as for conventional complete dentures, and a canine-guided or group\nfunction is adopted for partial dentures with or without implants.\nThe more advanced the atrophy of the alveolar ridges, the more difficult it is to perform a"
  },
  {
    "page": 157,
    "content": "centric relation registration because the bases of the occlusal rims are not seated firmly. A\nmanually guided registration may create different pressures on each side and the templates may\neven dislodge horizontally. Loading the templates centrally by means of a “central bearing\npoint” method has some “self-centering” effect, not only for the denture-bearing tissues but\nalso for the condyles. The more difficult the anatomical situation of an edentulous patient, the\nmore advantageous is the technique of registering the CR using the central bearing point (Figs\n6a-j). If implants are present, they may of course be used to hold the templates in place.\nTemporary female parts or simply a silicone rubber or tissue conditioner may be used to\nstabilize the registration templates (Figs 7a-d).\nFigs 6d-g The lower writing plate is melted onto the wax rim, slightly below the occlusal plane so that lateral movements\ncan be performed (d). The patient performs the mandibular border movements, and the Gothic arch is traced. The tip of\nthe arch is marked with a cross (e), and the procedure is repeated (f). The CR is located and a plastic plate determines\nwhere the upper writing pin should be situated (g)."
  },
  {
    "page": 158,
    "content": "Figs 6h-j The patient closes with the writing pin at the tip of the Gothic arch (h). Plaster or silicone keys are\nmanufactured and both templates are retrieved, preferably as one block. It must be verified that there is no contact\nbetween the upper and lower wax rims, other than via the pin and the plaster key (i). Finally, the casts are mounted in\nthe articulator (j).\nFigs 7a-d To facilitate the retention of the registration templates, provisional female housings may be created in silicone\n(Retention Seal; Bredent, Senden, Germany).\nDenture teeth\nThe above-mentioned atrophy of the articular tubercle in the temporomandibular joint leads to\na flattening of the condylar path. Therefore, the denture teeth should not have a cuspal\ninclination of more than 20°. Acrylic teeth are preferable if the mandibular movements are\npoorly coordinated. As an added advantage, the fracture risk is lower when the denture with\nacrylic teeth is accidentally dropped during cleaning.\nAbutment teeth\nIf natural abutment teeth are present, they present a valuable source of partial-denture retention;\nall efforts should be made to retain these teeth for as long as possible. The “bikini design”\nconcept for cast chromium frameworks is adopted—the natural tooth structures are covered as\nlittle as possible to provide access for saliva and to prevent caries."
  },
  {
    "page": 159,
    "content": "Abutment teeth often present substantial attachment loss and very long clinical crowns, which\nis unfavorable for partial dentures. The final impression for the prosthesis may be extremely\nretentive. In the mandibular anterior region, there is often very little space for a lingual bar.\nFurthermore, there will be “black triangles” between the abutment teeth and the denture teeth,\nwhich may severely compromise esthetics. In the phonetic zone, these spaces may even\ncompromise speech and create occasional “spitting.” Lastly, the high crown-to-root ratio\npresents an unfavorable lever for tooth survival.\nA reduction of the clinical crown height after root filling may reduce the leverage on these\nabutment teeth. Periodontally healthy but endodontically treated teeth can be kept as\noverdenture abutments, providing occlusal support, tactile sensitivity, and physiological\nstimulation for the bone tissues. The root canal should be sealed with a plastic filling or a cast\nroot coverage with or without retentive elements, the latter options usually being limited to\npremolars, canines, and incisors.\nFig 8 The “fail-safe” principle protects the abutment tooth, as the retentive part of the clasp is closer to the distal-\nextension saddle than the direct rest seat. On occlusal loading, the clasp disengages and protects the abutment tooth\nfrom extrusive forces.\nFig 9 The tooth shade should be 3 or above, and the tooth shape could be chosen according the old denture or a photo\nof the patient’s own natural teeth.\nDenture kinetics and occlusal load\nAlthough evaluating the prognosis of every single tooth is an essential exercise in treatment\nplanning, it is even more important to judge the overall distribution of occlusal forces in the\nentire dentition. Overerupted maxillary molars, for example, may apply unfavorable loads on a"
  },
  {
    "page": 160,
    "content": "mandibular distal-extension saddle.\nAs a rule, the mandibular prosthesis should be sturdier and stronger than the maxillary\none.\nMaxillary dentures have a better prognosis and are better tolerated by patients. The load\ndistribution for a maxillary removable denture is more favorable, as the available surface for\ndenture support is 1.5 times larger than for the mandibular denture. This concept may be\ndifficult for the patient to understand, and it is frequently necessary to explain that it is wiser to\ninvest in implants for the mandibular than for the maxillary denture. Strategic planning is the\nkey for balanced force distribution in a dental restoration, and efforts should be concentrated\non strategically relevant teeth, such as the mandibular canines.\nIn partial dentures for younger patients, the occlusal load is preferably transferred to the\nabutment teeth via rigid connections such as precision attachments or telescopic crowns. This\nconcept protects the bony tissues from occlusal loads and provides high chewing efficiency\nand denture comfort. With no visible clasps and very good denture retention, these prostheses\nprovide substantial esthetic and psychosocial advantages.\nThe abutment teeth in elderly patients are often too fragile to carry the occlusal load. To\nprotect the abutment teeth, dentures are preferably constructed with a rotational axis,\ntransferring the occlusal load on distal-extension saddles to the denture-bearing tissues rather\nthan the abutment teeth. For further protection, the clasps adjacent to an extension saddle\nshould be planned according to the “fail-safe” principle, which implies that its retentive part\nshould be located closer to the denture saddle than the direct rest seat that accounts for the\nfulcrum line (Fig 8). When the denture saddle is loaded, the clasp disengages and protects the\nabutment tooth from extrusive forces. Despite the atrophy of the masticatory muscles, the\nocclusal load on an extension saddle may harm the fragile mucosa of the denture-bearing\ntissues. Hence, implants play an important role in converting a partial denture with a rotational\naxis to an entirely tooth/implant-supported partial denture.\nAppearance\nAge has a significant impact on dental appearance, as described in Chapter 3. An age-\nappropriate dental appearance may adopt one or several of the following features:\n• Tooth shade of 3 or above (Fig 9)\n• Abrasion of the incisal edges\n• Large proximal contacts\n• “Crowded” mandibular incisors\n• Stronger visibility of mandibular rather than maxillary incisors"
  },
  {
    "page": 161,
    "content": "Figs 10a-d A photograph from the “old days” on which the teeth can clearly be seen helps incorporating individual\nfeatures in the anteriors of a complete denture. It also helps understanding the patient’s life and background (a, b). By\nthe way: the grumpy baby has grown into a very gentle adult daughter who regularly accompanies her mother to the\ndentist (a). The new denture was designed with age-appropriate and individual features according to the photograph\n(c) and gives the patient a happy smile (d).\nA photograph of the natural dentition or a plaster cast are the most valuable records to\ncustomize tooth shapes and positions (Figs 10a-d). Lacking these documents, the old denture\nmay serve as reference for the desired dental appearance. It would seem pragmatic to apply\nvisible changes only in agreement with the patient and their close advisors. Further individual\nage-appropriate features may be added at the patient’s request.\nFigs 11a-b In the case of institutionalized patients, most personal items that may get lost, for example glasses (a), are\nlabeled, but dentures are rarely marked with the patient’s name (b).\nLabeling\nIn the context of an institution, most personal belongings such as glasses (Fig 11a), walking\nsticks, and wheel chairs are labeled, allowing easy return to their owner once lost. However,\ndentures are rarely marked with the patient’s name, although this is very easy to do (Fig 11b).\nAlso, sets of matching maxillary and mandibular dentures could be marked if the patient has"
  },
  {
    "page": 162,
    "content": "several pairs of dentures (e.g., old or new). When providing an elderly patient with implant-\nsupported dentures, it seems helpful to provide the patient with the exact type of implant and\nabutment used, in case they are moved to a different domicile and have to be treated by a\ndifferent dentist.\nComfort\nOne important issue in the design of removable prostheses for elderly persons is the matter of\ncomfort when the denture is not worn. We surely cannot expect patients to sleep without their\ndentures if they feel uncomfortable with this in the presence of their partners. In this case, the\npatient must be aware that maintaining meticulous oral hygiene is essential. Most elderly\npatients, however, would not mind sleeping without their dentures. A recent study revealed that\nnocturnal denture wearing doubles the risk of pneumonia in very old persons (Iinuma and\ncoworkers 2015). As for the denture design, there should be no sharp edges from precision\nattachments or implant abutments, which may cause injury to the unprotected oral tissues while\nthe denture is not worn during the night."
  },
  {
    "page": 163,
    "content": "7\nImplants and Partial-denture Design\n \nF. Müller"
  },
  {
    "page": 164,
    "content": "Fig 1 Basic principle: The supporting polygon.\nImplants and partial dentures\nAt first glance, combining implants and removable partial dentures (RPDs) may not seem\nlogical. If you have abutment teeth, why place implants? And if you place implants, why not\nopt for a fixed reconstruction rather than a removable dental prosthesis (RDP)?\nFurthermore, the “shortened dental arch” (SDA) concept suggests that not all lost molars need\nto be replaced in elderly patients (Kayser 1981). However, the possibilities introduced to\npartial denture design by dental implants are tempting, as the treatment adopts minimally\ninvasive and preventive paradigms widely established in other dental disciplines. Basically,\ndental implants can be used for three purposes: to provide support for improved denture\nkinetics, to improve retention, and to enhance esthetics by avoiding visible clasps.\nVery little high-level scientific evidence exists concerning the design of RDPs. This subject\ntaught to dental students largely based on tradition, and basic principles and subjective beliefs\nare passed from one generation to the next.\nLarge differences in RDP design exist between countries and schools. The major shortcoming\nof all concepts is that they are dominated by predominantly mechanical paradigms, which take\nlittle note of the biological structures of the orofacial system. Before discussing the use of\ndental implants in RDP design, it is therefore expedient to outline some of the basic principles\nof RDP design (Budtz-Jørgensen and Bochet 1998).\nGiven the lack of scientific evidence for either concept, we do acknowledge that other\nconcepts of partial-denture design may perform equally well in a clinical context.\nSupporting area\nBasic principle: The denture-supporting polygon should be as large as possible, and\nideally “frame” the prosthesis (Fig 1)."
  },
  {
    "page": 165,
    "content": "If abutment teeth are available adjacent to an edentulous space, these will support the denture\nsaddle. If no abutment tooth is available at one end of the edentulous space, a cantilever saddle\nwill be necessary to replace the lost teeth. This may also be the case in tooth-delimited\nedentulous spaces if some parts of the denture will be outside the supporting area due to\ncurvilinear ridges, for example in a Kennedy class IV situation with missing anterior teeth. The\nsupporting area will therefore no longer “frame” the denture, compromising stability by\ncreating a cantilever in an orofacial direction.\nBecause the cantilever saddle is not supported by teeth but by resilient mucosa, any occlusal\nload will compress the denture-bearing tissues, causing the denture to rotate around a fulcrum\nline defined by the closest “direct” rest seats on the abutment teeth. The length of the cantilever\nsaddle has an inherent influence on the rotation torque. The lever principle states that the\nlonger the force lever, the lower the force needed for compressing the cantilever saddle (Figs\n2a-b). The surface area of the latter is also part of the equation, in that a larger surface is good\nfor pressure distribution (a principle well known from skiing or snowshoeing). The length of\nthe denture saddle (force arm) also plays a role. Shrinking the distal occlusal table, for\nexample by not setting up a second molar on the cantilever saddle, may reduce the torque on\nthe abutment tooth.\nFigs 2a-b Occlusal loads on the cantilever saddle introduce a fulcrum line on the nearest abutment tooth with a “direct\nrest seat.”\nRetention\nA RDP will be retentive if clasps or other retentive elements are placed at either end of the\nsupporting area, like a four-legged table with two of its legs nailed to the floor (Fig 3). This\nalso applies to RDPs with a fulcrum line, such as in Kennedy class I, II, or IV. Where a fulcrum\nline exists, clasps at the corresponding site of an indirect retainer (rest seat) on the opposite\nside of the fulcrum line should be avoided (Budtz-Jørgensen 1999). Such clasps would quickly\nexhibit material fatigue and finally fracture. This could cause additional wear on enamel of the\nabutment teeth or on the restoration.\nBasic principle: The line connecting the retention elements (the retention diagonal)\nshould run across the RDP and ideally divide the surface of the supporting area into two\nequal parts (Fig 4)."
  },
  {
    "page": 166,
    "content": "A favorable distribution of abutment teeth on both sides of the dental arch is therefore a\nprerequisite for good denture retention. In a severely reduced dentition, where the abutment\nteeth are only located on one side, no supporting area can be defined, and therefore the\nretention diagonal will not be very effective.\nFig 3 Two clasps provide sufficient retention for an elderly patient’s RPD, provided that the diagonal of retention\ncrosses the area of support. The example illustrates that the table cannot be moved once two table legs have been\nsecured in place.\nBasic principle: In RDPs with mixed tooth/mucosa support, the retention diagonal should\nbe closer to the cantilever saddle than the fulcrum line (Fig 5).\nThis principle is called “fail-safe” (Budtz-Jørgensen 1999) and is meant to protect the\nabutment tooth from extrusion and to minimize clasp fatigue from loads on the denture saddle.\nAt the same time, the “fail-safe” principle ensures that the clasp protects the denture from\ndisplacing forces.\nFig 4 Basic principle: The retention diagonal (blue) should divide the supporting area into two. Two clasps are\nsufficient to retain a partial denture for an elderly patient."
  },
  {
    "page": 167,
    "content": "Fig 5 Basic principle: An ideal retention line runs distally to the fulcrum line (closer to the cantilever saddle) to protect\nthe abutment tooth from extrusion forces during loading. However, for esthetic reasons, the clasp may also be placed in\nthe mesiovestibular undercut. As long as the tip of the clasp stays distally of the fulcrum line, the basic rule is not\nviolated.\nFig 6 Basic principle: As soon as one corner of the supporting polygon (blue) is missing, a cantilever saddle is created,\nwhich will compress when loaded. The two direct rest seats (16 and 23) will create a rotational axis (red). The length of\nthe load arm (green) should be opposed by a lever arm (yellow) which is at least as long as the load arm or longer. The\nlever arm is created by placing an indirect rest seat on the canine (13) and provides indirect retention of the denture\nsaddle is displaced, for example when chewing sticky food.\nFig 7 Basic principle: Indirect retention. The retention of a RDP with a cantilever saddle can be improved by placing\nindirect rest seats at the opposite side of the fulcrum line. The longer lever renders the clasp more effective against pull-\noff forces during mastication.\nApplying this basic principle to a Kennedy class I or II situation, the clasp connector would\nideally cross the interproximal area mesial to the abutment tooth as the clasp travels to\nretention in the distobuccal undercut. Obviously, a visible clasp often means poor esthetics,\nwhich can, however, be improved without violating the basic “fail-safe” principle by"
  },
  {
    "page": 168,
    "content": "designing the clasp retention to be located in the mesiobuccal undercut, but still distally to the\nfulcrum line (Fig 5). Ideally, the fail-safe principle requires a reciprocal plate, which may\nunintentionally provide direct support when placed above the prosthetic equator. Hence, the\nfail-safe principle is impossible to apply to canines and incisors due to their morphology.\nIn the severely depleted dentition, if the distribution of the remaining abutment teeth is such that\nthere is only a supporting line rather than a supporting area (e.g., with abutment teeth on only\none side of the jaw), the retention elements should be placed on the palatal/lingual side of the\nabutment tooth.\nBasic principle: If the retention diagonal cannot cross the supporting area, the retentive\npart of a clasp should be placed as close as possible to the “center” of the RDP.\nThis type of clasp performs so poorly in a clinical context that most clinicians would opt for\nother types of retention elements, such as telescopic crowns or implants. Only when the\ngeneral health of the patient, functional or cognitive decline, reduced motivation, or financial\naspects preclude the preparation of abutment teeth or the placement of implants, this type of\nclasp may be a “last resort” for partial-denture retention. In maxillofacial-surgery patients who\nhave undergone mandibular hemisection and radiotherapy, unilateral palatal/lingual clasps may\nbe used temporarily until the patient’s general health has improved.\nIndirect retention\nThe retention of a RDP with a cantilever saddle can be improved by placing indirect retainers\n(rest seats) at the opposite side of the fulcrum line. Ideally, the force arm created by the\ncantilever saddle should be opposed by a lever arm, defined as the perpendicular distance of\nthe most distant “indirect rest seat” to the fulcrum line.\nBasic principle: In partial dentures with a fulcrum line (Kennedy class I, II, or IV), the\nlever arm should be as long as or longer than the force arm (Fig 6).\nThe lever arm renders the clasp more effective against displacing forces (Fig 7). Indirect rest\nseats provide retention to the denture when the retention of the cantilever saddle is challenged,\nfor example when chewing sticky food such as bread or chewing gum. The longer the lever\narm, the more effective it will be from a mechanical point of view. As mentioned before,\nindirect retainers should not be combined with a retentive clasp.\nEnlarging the supporting area with implants\nIn terms of denture kinetics, dental implants must be considered additional abutments that\nenlarge the supporting area of a RDP and can significantly improve the kinetics of dentures on\nocclusal loading. Consequently, these implants will change the RDP’s Kennedy class (Kennedy"
  },
  {
    "page": 169,
    "content": "1928). It has been suggested to add the number and exact location of the implants to the\noriginal Kennedy class and its modifications and call this the “implant-corrected Kennedy”\n(ICK) classification (Al-Johany and Andres 2008).\nHowever, given that implants and abutment teeth behave similarly in terms of denture kinetics,\nfor the purposes of this chapter we prefer to treat the supporting implants as abutment teeth and\nstay with the original Kennedy classification and its modifications, in order to facilitate\nimmediate identification of the denture kinetics. For example, by placing two distal implants, a\nKennedy class I can be converted to a class III or VI (Fig 8). These distal implants may serve\nas rest seats, but they may at the same time serve as attachments and provide retention, as in the\nclinical example shown in Figures 8 and 9a-b. A three-year multicenter study indicated\nimproved patient satisfaction and denture stability as well as masticatory performance after\nplacing distal support implants with ball attachments to support cantilever saddles in Kennedy\nclass I cases (Wismeijer and coworkers 2013). Furthermore, the mechanical stimulation of the\nbone may also lead to increased bone mineral density (El Mekawy and coworkers 2012).\nWhen planning distal implants for an RDP with a Kennedy class I or II, the mandibular\ndeformation during chewing or wide opening has to be borne in mind. In those rare cases\nwhere such distal attachments cause discomfort, the posterior implants may serve as simple\nrest seats without retention (Mitrani and coworkers 2003; Fig 10). Bench experiments and\nfinite element analyses have confirmed lower stress concentrations and mucosal loads when\ndistal implant support is provided for class Kennedy I RDPs (Maeda and coworkers 2005b;\nOhkubo and coworkers 2007; Xiao and coworkers 2014). Long-term clinical studies are\nscarce and usually limited to case reports or small patient cohorts. However, they confirm\nclinical success, increased bite forces, comfort, and patient satisfaction (Bortolini and\ncoworkers 2011; El Mekawy and coworkers 2012; Ohkubo and coworkers 2008).\nFig 8 Implants can be used to extend the supporting polygon to meet the basic principle that the denture should be\n“framed” by tooth/implant support. In this example, a Kennedy class I is converted to a class V, and the initial fulcrum\nline no longer exists."
  },
  {
    "page": 170,
    "content": "Figs 9a-b The distal supporting implants were provided with Locator attachments. Although the RDP splinted large\nsections of the mandible, the patient did not perceive discomfort.\nFig 10 The concept of full tooth/implant support for a RPD with residual anterior teeth seems attractive, but mandibular\ndeformation during chewing or wide opening may cause discomfort in some patients. In those (rare) cases, the\nposterior implants may serve as rest seats without retention."
  },
  {
    "page": 171,
    "content": "Figs 11a-c A curvilinear interdental edentulous space can be supported by an implant, eradicating the fulcrum line.\nFig 12 Support can also be increased with implants in long tooth-bound edentulous spaces when one of the abutment\nteeth has an unfavorable shape for a direct rest seat: for example incisors.\nIn the presence of a curvilinear edentulous space, implants may also be helpful in providing\nsupport, ideally at the most distant site relative to the fulcrum line (Fig 11). Even partial\ndentures for long edentulous spaces could benefit from a supporting implant, especially in a"
  },
  {
    "page": 172,
    "content": "Kennedy class V situations where one of the abutment teeth is not suitable for a rest seat (Fig\n12). However, in these situations a fixed dental prosthesis may also be a suitable restoration.\nAbutment implants may even be beneficial for improving denture support and kinetics when a\nconversion to a more favorable Kennedy class or a fixed reconstruction cannot be achieved.\nBy shortening the force arm and lengthening the lever arm, the RDP may still have a fulcrum\nline, but with a larger supporting area (Fig 13a). Several implants may even avoid the fulcrum\nline completely (Fig 13b). This would improve denture stability, and in the present case, the\nimplant would eliminate the need for a visible clasp on the lateral incisor. Ideally, such\nimplant abutments should be placed where the newly created fulcrum provides a force arm of\nless or equal length than the lever arm. The rest seat on the distal abutment (here, the lateral\nincisor) will therefore be an indirect retainer.\nExceptions from this rule may become necessary when the anatomical condition would require\na major surgical intervention such as bone augmentation or a sinus lift in order to place the\nimplant in the ideal position. The invasiveness of such intervention would largely outweigh the\nmechanical advantage for the RDP. In the mandible, for example, it often seems preferable to\nplace implants distally to the distalmost abutment tooth by at least one premolar width to\nobtain a larger supporting area and indirect retention via a longer lever arm. However, this\nconcept is often impractical in the mandible where the implant has to be placed mesial to the\nmental foramen. Thus, both the retention polygon and the lever arm remain very small (Figs 14\nand 15a-c). In RDP cases with mandibular anterior natural teeth, the RPD often has an only\nslightly more distal fulcrum line when implants are placed. Their main advantage in this\nsituation is the possibility of avoiding visible clasps.\nFig 13a Implant 14 replaces the clasp on tooth 12, which was esthetically poor and provided little retention. The\nimplant was not placed adjacent to abutment tooth 12 but at site 14 to extend the supporting polygon and distalize the\nfulcrum line (II) so that the force arm for the cantilever saddle is shorter and the rest seat on tooth 12 can provide\nindirect retention via lever arm II. This design more closely follows the basic principle of the force arm and the lever\narm ideally being of the same length."
  },
  {
    "page": 173,
    "content": "Fig 13b If, in the same situation, two implants could be placed, there would no longer be a fulcrum line, and this\nKennedy class II would be converted to a class V.\nFig 14 In the mandible, the concept of distalizing the implant by at least one premolar width to create a larger\nsupporting area and indirect retention via a longer lever arm is not applicable if the implant has to be placed anterior\nto the mental foramen. Thus, both the retention polygon and the lever arm remain very small. The RPD still has a\nfulcrum line, but it is just slightly more distal and hence more favorable for the kinetics of the denture."
  },
  {
    "page": 174,
    "content": "Figs 15a-c Although implants 34 and 44 provide support, a rest seat is placed on both canines to provide indirect\nretention.\nFigs 16a-b Denture kinetics can be improved greatly even with one single implant if the residual abutment teeth are\nlocated only on one side of the arch."
  },
  {
    "page": 175,
    "content": "Figs 17a-c In a severely depleted dentition, implants can serve as additional abutments and substantially improve\ndenture kinetics. In this example, the linear unilateral fulcrum line was replaced by a bilateral one, and a supporting\narea was created.\nImproving denture retention with implants\nIn elderly patients, denture retention is a critical issue. Partial denture retention is rarely\nperceived by old patients as being too low; a retention that is felt to be too strong precludes\nautonomous denture insertion and removal of the prosthesis for cleaning purposes. Even a\nsmall number of natural abutment teeth can provide sufficient retention for a partial denture,\nespecially if these are distributed bilaterally. Adding retention to a partial removable dental\nprosthesis by means of implants may therefore be most useful in cases where only few\nabutment teeth are left or these are unfavorably distributed. The selection of the attachment\nsystem is critical, as the retentive forces of all available natural and implant abutments is\ncumulative. An eight-year retrospective study evaluated distal extension RDPs with retention\nbut no support from distal implants (Bortolini and coworkers 2011). The study found a\nsignificant increase in patient satisfaction in a cohort of 29 consecutive patients with unilateral\nor bilateral distal edentulism."
  },
  {
    "page": 176,
    "content": "The severely depleted dentition\nThe greatest improvement of denture kinetics through implants can be expected in partial\ndentures supplementing a severely depleted residual dentition. If the remaining abutment teeth\nare unfavorably distributed, implants may significantly improve denture stability and\nmasticatory efficiency (Figs 16a-b), as conventional clasps rarely perform well when the\nabutment teeth are located unilaterally. Implants may effectively improve such partial dentures\nby creating an area of support and denture retention. Implants can also be combined with\ntelescopic crowns on natural teeth (Figs 17a-c).\nFigs 18a-b The implant replaced the visible clasp on the central incisor, whose shape was unfavorable for providing\nretention. This treatment provided a pleasing and esthetic outcome at moderate biological and financial cost.\nEsthetic considerations\nBesides the mechanical advantages, the use of implants in RDP design may help avoid visible\nclasps. An improved appearance may promote the patient’s self-confidence and well-being in\na social context. Additionally, when placed at least one premolar width distally of the adjacent\nnatural abutment tooth, such an implant may serve as direct rest seat and further improve\ndenture kinetics (Figs 18a-b). In the case shown in Figures 19a-c, the clasps of the lower RDP\nwere not only highly visible but also rather ineffective, as the morphology of the lower lateral\nincisors did not provide much undercut. The existing denture was not renewed for economic\nreasons. After implant placement, the clasps were removed and the Locator housings were\nplaced indirectly.\nChoosing attachments\nWhen combining natural teeth and implant abutments, it seems intuitive that retentive and\nfrictional mechanisms should not be combined. However, clinical experience confirms that\nball attachments or Locators can be combined with telescopic crowns or milled bars, as long\nas the two types of abutments are not immediately adjacent. This is of particular relevance if a\nnatural tooth with a telescopic crown has to be extracted. In this case, the natural tooth can be\nreplaced by an implant with a ball attachment, while the female part can by polymerized into\nthe remaining secondary part of the telescopic crown."
  },
  {
    "page": 177,
    "content": "Figs 19a-c The lateral incisors were not suitable as abutment teeth. Implants were placed in both canine regions and\nreplaced the ineffective and unesthetic clasps on the lateral incisors. The RPD was not renewed.\nPreventive aspects\nAny removable partial cast-chromium framework denture is the “natural enemy” of periodontal\nhealth. RDPs must therefore be designed to stay clear of the gingival tissues wherever\npossible. Large connectors should be located at a minimum distance of 5 mm from the gingival\nmargin. RDPs also present a caries risk as they cover large enamel surfaces (Budtz-Jørgensen\nand Isidor 1990). RDPs should therefore receive a “bikini design,” covering as little as\npossible of the natural tooth structures. Access for saliva will assist in keeping the tooth and\nthe periodontal tissues healthy; it may even help remineralize incipient demineralized spots.\nClasps and their reciprocating arms, rest seats, and connectors create voids and change the\nnatural “self-cleaning” tooth morphology, fostering the adhesion of biofilm. Consequently,\nimplants may not only provide better RDP stability and retention, but may also play a major\nrole in the prevention of caries and periodontal disease by reducing the need for such elements.\nNo natural tooth substance will be sacrificed for preparing rest seats; no metal will cover the"
  },
  {
    "page": 178,
    "content": "enamel. Hence, the prognosis of the abutment teeth may be enhanced if the residual natural\ndentition is not relegated to the task of assuring denture retention and support."
  },
  {
    "page": 179,
    "content": "8\nImplant-supported Overdentures for the\nEdentulous Patient\n \nF. Müller"
  },
  {
    "page": 180,
    "content": "Although the percentage of completely edentulous patients in the working population is in steep\ndecline, there is still a significant rate of edentulism in the elderly population, whether living\nindependently or institutionalized.\nOf all the indications for dental implants, edentulous patients probably show the most\nfavorable ratio between effort/cost and benefit in terms of oral functional and psychosocial\nimprovements. Tooth loss and removable prostheses are often associated with aging,\nmorbidity, and finally death. Removable prostheses may present a handicap in a social context,\nespecially when denture retention is limited to the effect of suction, muscular control, and\nocclusion. Edentulous persons in their third age who still live an independent and active social\nlife will therefore often opt for fixed implant-supported restorations.\nHowever, medical or anatomical risk factors may limit these options, and financial issues may\nplay a role as well. In a study of edentulous patients who had worn both fixed and removable\nimplant-supported prostheses for a period of two months each in random order, half the\npatients preferred to keep the removable reconstruction, while the other half opted for the fixed\nprosthesis (Feine and coworkers 1994).\nIn this study, removable prostheses were associated with easier cleansability and esthetic\nadvantages. Indeed, replacing teeth with a removable prosthesis presents esthetic benefits, as\nanterior bone lost from the alveolar ridges can easily be replaced by the denture flange, which\nalso allows the restoration of the former lip support of the patient. For fourth-age patients\nlosing their autonomy and receiving help for the activities of daily living at home, or who live\nin an institution, a removable implant-supported prosthesis seems more favorable, as\ncaretakers rarely have the time or the skills to clean fixed “high-tech” reconstructions\nadequately. Removable implant-supported prostheses also provide a greater degree of\nflexibility in denture design and retention mechanism, which is very helpful in case of a future\nfunctional decline and reduced neuroplasticity.\nNumber and position of implants in mandibular implant-supported overdentures\nEven a careful and systematic evaluation of the literature in the field does not permit the\nrecommendation of an ideal number of implants for mandibular implant-supported\noverdentures (Klemetti 2008). A carefully conducted longitudinal RCT by Meijer and his\ngroup investigated treatment concepts using bar-supported mandibular overdentures in\nedentulous patients (Meijer and coworkers 2009). Sixty patients of similar age were\nrandomized into two groups. After receiving two or four implants, they were followed for 10\nyears. No difference was found in radiological and clinical parameters, patient satisfaction, or\nmaintenance needs. However, an analysis of posterior bone loss indicated significantly more\npronounced atrophy when only two implants had been placed (de Jong and coworkers 2010).\nAs this seemed independent of any peri-implant bone loss, it may be related to the settling of\nthe posterior denture saddle under occlusal load."
  },
  {
    "page": 181,
    "content": "A similar pattern of posterior bone atrophy was confirmed in a retrospective study from Bern\non overdenture wearers with two interforaminal implants, where posterior bone resorption\nincreased with the distance from the fulcrum line (Kremer and coworkers 2014). In third-age\nedentulous patients, where masticatory-muscle atrophy is not yet clinically relevant, or in\npatients with a strong antagonistic dentition, it therefore seems preferable to create a larger\nsupporting area by placing four implants in the canine and second premolar regions. Distal\ncantilever extensions are advisable to enlarge the supporting area even further, but often the\ndenture height is not sufficient to accommodate the corresponding superstructure. Frequent\nfractures of these extensions may be avoided using recent CAD/CAM technologies for milled\ntitanium bars (Katsoulis and coworkers 2015).\nThe higher occlusal loads made possible by implant-supported overdentures might also affect\nmaxillary ridge atrophy. In two- or four-implant mandibular overdentures, maxillary anterior\nbone resorption was significantly higher over a 10-year period, than in a control group with\ncomplete denture-wearers (Tymstra and coworkers 2011). Therefore, when implants are\nplaced in the mandible, it seems advisable to closely monitor the dentures for any need of\nrelining in order to avoid anteriorization of the occlusion (Kreisler and coworker 2003).\nIn four-implant mandibular overdentures, implants should be limited to the interforaminal area.\nAlthough this provides a limited supporting area, the favorable amount of available bone as\nwell as easier avoidance of the mandibular nerve appear to be a major advantage of this\nconcept. Furthermore, the mandible is a flexible bone that deforms under masticatory load and\nduring wide mouth opening, especially in the brachyfacial morphotype (Law and coworkers\n2012; Prasad and coworkers 2013).\nExperiences from the era of full-arch one-piece fixed dental prostheses has shown that some\npatients suffer from a “locked-in” feeling from large-span splinted reconstructions. Nowadays,\nsegmenting fixed reconstructions is an acknowledged paradigm in restorative dentistry.\nAlthough further research is needed on the clinical impact of mandibular flexure, placing the\nimplants for a mandibular overdenture in the interforaminal area seems to be a sensible\napproach, given that a large supporting area can still be achieved by means of distal\ncantilevers. For this concept, the distribution of the four implants should ideally be in positions\n5—3—3—5. However, depending to the shape of the alveolar ridge, the available bone, and\nthe location of the mandibular foramen, a 4—2—2—4 constellation may become necessary\n(Figs 1a-b).\nBasic principle: The distribution of four interforaminal implants should assure the\ndistalmost position mesial of the mental foramen, and the lateralmost anterior position.\nSuch a distribution would optimize the supporting area, stay clear of the mandibular nerve, and\navoid bulky superstructures where a natural denture morphology is important from a functional"
  },
  {
    "page": 182,
    "content": "point of view. Care should be taken not to place the implants too close to each other, as this\nmight lead to increased peri-implant bone resorption (Fig 1c).\nFig 1a A mandibular four-implant overdenture should place the distal implants as distally as possible, yet still mesial to\nthe mental foramen, and the anterior implants as laterally as possible. This concept stays clear of the alveolar nerve\nand avoids bulky superstructures in the sensitive anterior area. The ideal constellation is. 5—3—3—5.\nFig 1b The ideal constellation in Fig 1a could be modified to 4—2—2—4 if the shape of the ridge is rather “pointy”\nthan “rounded.”\nFig 1c Under no circumstances should the implants be placed too close to each other."
  },
  {
    "page": 183,
    "content": "Figs 2a-b Buccal (a) and frontal (b) view of a distally inclined occlusal plane in patient with Kelly’s syndrome caused\nby a lower residual dentition.\nFig 2c Kelly’s syndrome with barely visible upper incisors.\nThree implants have also been proposed as support for a mandibular denture, but this concept\nonly makes sense if the anterior alveolar ridge is shaped in a pronounced curve, so that using\nthe canine position for the most anterolateral support would result in a cantilevered position of\nthe lower incisors. In this case, an additional anterior abutment could be useful as indirect\nretainer. In this configuration, it is recommended not to add a retentive attachment, as—\nequivalent to the partial-RDP design—this is likely to fatigue and finally fracture when the\ndistal cantilever is loaded during chewing. Splinting the implants by means of a bar could be\nan alternative concept.\nThe two-implant overdenture with linear support will always create a rotational axis, which\nleads to a distal compression of the tissues when the free end saddle of the denture is loaded\nduring mastication. Correspondingly, accelerated posterior bone resorption may occur (de\nJong and coworkers 2010; Kremer and coworkers 2014). Care should be taken to avoid\nexcessive anterior occlusal contact, as the increased load on the maxillary anterior ridge risks\ncreating Kelly’s (combination) syndrome with flabby ridges and a distally inclined occlusal\nplane (Figs 2a-c).\nAs mentioned before, frequent remounting and possibly relining of the denture are required to\navoid this phenomenon. As for the position of the implants for a two-implant overdenture, the\ncanine region would again be preferable for mechanical and morphological reasons. Only in a\nstrongly curvilinear anterior ridge should implants be placed in the area of the lateral incisor,\nto avoid rocking of the denture on the fulcrum line (Figs 3a-b)."
  },
  {
    "page": 184,
    "content": "Given the limited resources of the public health systems, the question arises as to whether one\nsingle implant in the mandibular midline might be sufficient to satisfy the needs of the\nedentulous patient. Indeed, one randomized controlled trial with edentulous participants\nsupplied with either one or two mandibular implants for an overdenture showed a significant\nincrease in patient satisfaction in both groups (Walton and coworkers 2009). Surprisingly, at\nthe 12-month follow-up, 5 of the 42 patients in the one-implant group had already shifted from\nthe positive half of the visual analog scale to the negative half (Walton and coworkers 2002).\nHowever, the difference in satisfaction between the one-implant and two-implant overdentures\ngroups was not significant until the 5-year follow-up (Bryant and coworkers 2015). Implant\nsurvival seems excellent with this treatment concept although long-term observations are still\nscarce (AlSabeeha and coworkers 2009; Bryant and coworkers 2015; Passia and coworkers\n2014). Frequent denture fractures have been reported in some studies (Bryant and coworkers\n2015; Passia and coworkers 2014), while others did not confirm this (Kronstrom and\ncoworkers 2014). In a systematic review with a meta-analysis, it was confirmed that current\nevidence does not favor one or two implants in terms of implant survival (Srinivasan and\ncoworkers 2016). The midline suture of the mandible often presents a lingual canal containing\nblood vessels and nerves, which requires consideration during implant placement (Oettle and\ncoworkers 2015).\nFig 3a If minimally invasive treatment is required, the two-implant overdenture is the first choice. Implants should be\nplaced in the farthest anterior and lateral position. Depending on the shape of the ridge, this will most often be the\ncanine region. Implants placed too far distally may cause a rocking movement of the overdenture shortly after insertion.\nFig 3b Implant positions may vary depending on the shape of the ridge."
  },
  {
    "page": 185,
    "content": "Finally, none of the published or ongoing studies on single-implant overdentures investigates\nthe degree of posterior bone resorption. Even a minor premature contact in a complete denture\nwill lead to denture rotation on the ridge during the last few micrometers before maximum\nintercuspation. The additional degree of freedom in a single implant overdenture would\nprobably not preclude this movement. This kind of microrotation may accelerate resorption of\nthe lateral parts of the alveolar ridge. Implant survival and peri-implant bone loss are\nimportant, but not the only success criteria for clinical decisions. Before recommending a\nsingle-implant concept, further research including patient-centered outcome measures,\nprosthodontic parameters, and functional aspects would be needed.\nNumber and position of implants in maxillary implant-supported overdentures\nThe mucosa covering the hard palate has a considerably greater resilience than that covering\nthe mandibular alveolar ridge. The placement of only two implants to support a maxillary\nimplant-supported overdenture must be approached with caution, as the overdenture might\nbegin rocking on the inevitable fulcrum line soon after delivery. Although early short-term\nexperience with maxillary two-implant overdentures indicated patient satisfaction,\nprosthodontic and functional outcome measures are still missing (Zembic and Wismeijer\n2014b). As a rule, a minimum of four implants is therefore recommended, with or without\npalatal coverage, with the anterior implants placed in the canine region and the posterior\nimplants as close as possible to the chewing center. If the distal implants cannot be placed in\nthe chewing center due to a lack of bone, the implant may instead be inserted immediately\nanteriorly to the maxillary sinus, as the functional benefit in terms of overdenture stability\nwould not justify an intervention such as a sinus lift in a geriatric patient (Fig 4).\nFig 4 For a maxillary implant-supported overdenture, implants are ideally placed in the canine region and in the area\nof the chewing center (left side). Where the floor of the sinus precludes such position (right side), a more anterior\nposition could be adopted instead (left side).\nIn younger patients, the mechanical advantage of a larger supporting area may outweigh the\nrisks of such an intervention, and the clinical decision largely depends on the anatomical\nsituation and the patient’s functional state. The four-implant concept keeps the phonetic zone\nclear of bulky superstructures and encourages a more natural morphology of the palatal\ncoverage, which in turn provides greater comfort and more natural speech. A shallow 0.5-mm-\ndeep post-dam helps avoid food impaction under the prosthesis if a horseshoe-shaped palatal\nplate is used. The transition from the palatal coverage to the natural hard palate should be part"
  },
  {
    "page": 186,
    "content": "of the cast chromium framework. Unlike a posterior palatal band for a partial denture, which is\nconveniently located in Donder’s space, this transition is situated in a zone of the palate where\nthe tongue is in constant contact, making it particularly important to assure a smooth transition\nfrom the artificial to the natural palate.\nSome authors recommend placing implants in the maxillary tuberosities, as this provides the\nmaximum possible supporting area. Unlike the mandible, the maxillary alveolar ridge does not\nflex during mastication, but the tuberosities should still not be considered the most favorable\nimplant sites for other reasons. Firstly, access for clinical procedures such as connection of\nabutments or impression copings may be difficult, as elderly patients cannot easily be inclined\nbackwards during treatment. Furthermore, there is a high prevalence of dysphagia amongst\nelderly persons. Dental instruments such as screwdrivers can be secured with dental floss, but\nsmall screws or abutments cannot (Deliberador and coworkers 2011), and there is a risk of\naspiration. Finally, in the unlikely event of implant loss, the patient may be left with a poorer\nvolume of tuberosity, creating a difficult situation for conventional denture retention.\nThe fourth-age patient\nWith age, there is less need for a large supporting area for an implant-supported overdenture,\nas the maximum bite force diminishes along with age-related muscle atrophy (sarcopenia)\n(Newton and coworkers 1993). Consequently, very old and fragile patients are less likely to\npresent accelerated posterior bone resorption or the development of Kelly’s syndrome, as\ndescribed previously for a two-implant mandibular overdenture (Kremer and coworkers\n2014). Given their fragile constitution, a two-implant overdenture according to the McGill and\nYork consensus statements seems the first choice (Feine and coworkers 2002; Thomason and\ncoworkers 2009). The advantages of a two-implant overdenture—rather than a four-implant\noverdenture—for geriatric patients include a minimally invasive intervention, reasonable cost,\nand, most importantly, the possibility of the patient autonomously managing the overdenture. An\noverly retentive denture may cause panic if the patient cannot manage to place or remove the\ndenture, which may cause profound distrust and disrupt their confidence in the dentist.\nIn fourth-age patients, it is also preferable for the occlusion, the vertical dimension, the shape\nof the denture body, and the dental arch to be changed as little as possible. This facilitates\nadaptation to the new prosthesis and avoids unnecessary challenges to the patient’s\nneuroplasticity. Converting an existing complete denture into an implant-supported overdenture\nis an adequate therapy for fourth age patients, as long as the existing denture is reasonably\nfunctional and well tolerated. The low number of clinical treatment sessions required for such\nan intervention facilitates logistics in terms of patient attendance and meets the needs of the\npatient’s increasingly fragile constitution. Conversion of a complete denture to an implant-\nsupported overdenture could be done on the same day as abutment connection when no cast\nchromium framework is planned. In a dental arch in a suboptimal position, it may become\nnecessary to add provisional autopolymerizing resin at chairside to provide sufficient support\nfor the impression coping (Fig 5a).\nAs this is just a temporary support for the impression material, polishing could be performed"
  },
  {
    "page": 187,
    "content": "later, together with the reline, in the dental laboratory. After creating sufficient space for the\nimplant components and checking that there is no contact between the impression copings and\nthe denture, for example by means of boxing wax or silicone, adhesive can be added to the\ndenture base and a reline impression is taken (Figs 5b-d). Once the preferred retention insert\nhas been chosen, the denture can be returned to the patient the same day (Figs 5e-i).\nPatients will recognize the features of familiar prostheses to which they are already well\nadapted yet still appreciate the increased denture retention. Another way to avoid adaptation\nproblems is to use a duplication technique. By copying the existing denture, features such as\nRC, OVD, and occlusal plane, as well as the position of the dental arch, can be incorporated\ninto the new prosthesis. It is particularly important not to change the available tongue space,\neven if the posterior teeth of the existing denture are not mounted ideally. A lingual position of\nthe dental arch may result in painful injury from accidental bites, as geriatric patients are less\nable to adjust their habitual movement patterns than younger patients.\nFig 5a Conversion of an existing, suboptimal mandibular complete denture to an implant-supported overdenture. If the\nimplants are placed “outside” the dental arch, the denture body needs to be provisionally extended with\nautopolymerizing resin to provide support for the relining material.\nFig 5b The impression copings are placed on the Locator abutments; it is also possible to use the female part of the\nLocator directly for the reline impression."
  },
  {
    "page": 188,
    "content": "Fig 5c Boxing wax or a wash silicone impression to check if the denture base touches the impression copings.\nFig 5d A reline impression with impression copings is taken.\nFig 5e The vestibular denture flange needed to be slightly prolonged to accommodate the female part of the Locator\nattachment."
  },
  {
    "page": 189,
    "content": "Fig 5f The blue insert is chosen in situations where “medium”-strength retention is required.\nFig 5g The denture base with the female parts of the Locator attachments\nFig 5h Within one day, the patient had his well-adapted, yet suboptimal denture returned as a two-implant supported\noverdenture. The vestibular denture flange had to be slightly extended, as incisors were mounted rather lingual on the\ndenture."
  },
  {
    "page": 190,
    "content": "Fig 5i OVD and RC are not changed and the patient “recognizes” his old, familiar denture.\nHowever, copy techniques and the use of existing dentures are not widely used in dentistry.\nOne explanation may be that the resulting prostheses are not pleasing to the dentists’ eyes and\nmay offend their professional pride in terms of appearance and function. However, in geriatric\ndentistry it is crucial to consider the patient’s function and well-being as the first priority. The\nsmile of a happy geriatric patient “recognizing” a prosthesis compensates for the missed\nopportunity to deliver a state-ofthe-art denture design. The patient is the one wearing the\ndenture—not the dentist!\nImpressions for two-implant overdentures\nDistal settling of a two-implant overdenture often creates a void between the denture base and\nthe alveolar ridge in the anterior part of the denture, sometimes even shortly after delivery.\nThis initial settling of the denture is physiological, as the denture-bearing tissues adapt to the\nposterior pressure under the denture saddles. Denture settling is a phenomenon well known in\ncomplete dentures, where a remount in the articulator is usually performed 10 to 14 days after\ninsertion to correct the resulting occlusal discrepancies. In two-implant overdentures, this\nsettling process is even more visible, as it occurs only in localized areas supported by the\nmucosa rather than the implants.\nAn anterior void under the denture where no such settling occurs due to implant support may\nlead to the accumulation of food debris, which may be disturbing to the patient. An efficient\nway of avoiding anterior voids during the settling period is to simulate this process during\nimpression-taking by forcing a slight compression of the denture-bearing mucosa. For this\ntechnique, the impression tray is prepared in contact with the denture-bearing tissues and an\nanterior dome of 3 to 4 layers of wax for the implant components. In the first step, the borders\nof the tray are adjusted and functional border molding is executed with a thermoplastic\nimpression compound (e.g., Impression Compound, red sticks; Kerr, Orange, CA, USA) while\nthe patient is performing functional movements. In a second step, a partial impression is taken\nof the edentulous mucosa using zinc oxide paste without exerting pressure and in the absence of\nfunctional movements (Fig 6a)."
  },
  {
    "page": 191,
    "content": "Fig 6a ZnO pastes are used for the impression of the edentulous mucosa (e.g., Zinc Oxide & Eugenol Impression Paste;\nSS White, Lakewood, NJ, USA).\nFig 6b Sprue holes are added to the impression tray in the area of the domes.\nFig 6c The domes are coated from inside with a silicone or polyether adhesive."
  },
  {
    "page": 192,
    "content": "Fig 6d Silicone or polyether materials to add the remaining implant areas to the impression.\nThis first partial impression captures the edentulous mucosa in an unloaded state, with a tight\ninner seal. Care should be taken that no parts of the impression tray show through the initial\nimpression, as these zones are likely to create painful sore spots once the denture is processed\nand inserted. In a third step, sprue holes are created in the impression tray in the area of the\ndomes (Fig 6b) and the latter are coated from the inside with a silicone or polyether adhesive\n(Fig 6c). Then silicone or polyether materials are used to add the remaining implant areas to\nthe impression (Fig 6d). This third part of the impression is performed under moderate\npressure, anticipating the settling of the denture into the denture-bearing tissues. Careful\ninspection of the impression is necessary to verify a smooth transition of the silicone/polyether\nmaterial to the zinc oxide paste (Fig 6e). A thin layer may be found on the zinc oxide paste; it\ncan either be left on or peeled off before pouring the impression for the master cast.\nFig 6e Careful inspection of the impression to verify a smooth transition of the silicone/polyether material to the ZnO\npastes."
  },
  {
    "page": 193,
    "content": "Figs 7a-f After border molding while the patient is performing functional movements, a static impression without\npressure is taken of the edentulous parts."
  },
  {
    "page": 194,
    "content": "Figs 7g-j The implants are added to the impression by means of polyether material as moderate pressure, imitating the\ndenture setting, is applied to the impression tray.\nThe question arises as to why such compression cannot be achieved in a one-step impression\ntechnique. The answer is that applying moderate pressure to a single-step silicone/polyether\nimpression would result in multiple zones where the impression tray shows through. These\npressure peaks will compromise denture comfort once the prosthesis is polymerized and\ninserted. With the twostep impression technique, the pressure will be more evenly distributed\nwithout causing discomfort. The same technique can be used for a reline (Figs 7a-j).\nFig 8 A two-implant bar provides very good retention for the overdenture, but may be difficult to clean for an elderly\npatient (courtesy of Martin Schimmel, Bern, Switzerland)."
  },
  {
    "page": 195,
    "content": "Fig 9 A two-implant overdenture with unsplinted attachments can be considered the “standard” type of mandibular\noverdenture for very old and fragile patients\nFigs 10a-b Telescopic crowns are a suitable geriatric attachment system that provides retention via friction on parallel\nsurfaces. The system provides maximum flexibility and requires very little maintenance (courtesy of Siegfried Heckmann,\nErlangen, Germany).\nAttachment systems\nAn endless range of attachment systems is available in the market, and it would exceed the\nscope of this chapter to describe them all. The following section will therefore focus on\ncommonly used attachment systems, even if the more recent ones are not well documented in\nthe literature. The basic requirements of an attachment system for a geriatric overdenture are:\nAttachment design and mechanical features\n•\nLow volume to avoid bulky superstructures.\n•\nWear resistance to avoid maintenance and replacement.\n•\nPossibility to compensate for axial divergences between implants.\n•\nSmooth shape, to avoid injury when the denture is not worn (e.g., during the night).\nClinical requirements\n•\nAdjustable retentive force (increase or decrease).\n•\nPossibility of chairside repair and placement of the female part.\n•\nEase of handling and cleaning, even by a geriatric patient with reduced vision and dexterity.\n•\nLow maintenance."
  },
  {
    "page": 196,
    "content": "•\nEasy attachment removal, for a “back-off” strategy in the event of a functional decline.\nAgain, the literature does not conclusively recommend one ideal attachment system for the\nimplant-supported overdenture. However, a recent review on attachment systems summarized\nthe advantages and inconveniences of some commonly used systems (Andreiotelli and\ncoworkers 2010). Whereas bar attachments require substantial vertical space and have high\ninitial manufacturing costs, they provide good retention and require little maintenance (Fig 8).\nIn contrast, ball attachments have a lower volume but require more adjustments due to\nincreased wear (Fig 9). Only very few studies have been published on telescopic crowns and\nmilled bars for implant-supported overdentures. Despite their high cost, they seem to satisfy\nthe patient and require very little maintenance (Heckmann and coworkers 2004; Visser and\ncoworkers 2009) (Figs 10a-b). Magnets, however, seem to provide the lowest retentive force\n(Andreiotelli and coworkers 2010; Fig 11).\nFig 11 Magnets are attachments with low denture retention and particularly suited for patients with a weak hand force\nor requiring palliative care (courtesy of Martin Schimmel, Bern, Switzerland).\nFig 12a Locator attachments are widely used for a large range of indications."
  },
  {
    "page": 197,
    "content": "Fig 12b Locator attachments provide three degrees of retention from inserts with or without a central pin, respectively.\nFig 13a The CM LOC has the same volume and shape as the Locator, but no central hole that could trap food debris.\nFig 13b Female parts of the CM LOC.\nLittle long-term evidence exists on the use of Locator attachments (Zest Anchors, Escondido,\nCA, USA). In-vitro experiments indicate a high variability of the retentive force and an earlier\nloss of retention than with ball attachments or bars (Kobayashi and coworkers 2014; Figs 12a-\nb). The range of available attachment systems was recently complemented by the CM LOC\n(Cendres+Métaux, Biel, Switzerland), a titanium attachment with dimensions and shape similar\nto the Locator, but without the central hole (Fig 13a). In a newer version, the CM LOC Flex,\nthe axis of the attachment can be aligned on a dome and subsequently fixed with resin cement.\nThe female part consists either of a PAEK (polyaryletherketone) polymer (Pekkton;\nCendres+Métaux) insert, which comes in four different retention strengths, from extra-low to\nstrong, or a gold alloy (Fig 13b). The female part of the latter allows adjustment of the"
  },
  {
    "page": 198,
    "content": "retentive force in two steps by turning the insert in its housing with a special instrument.\nFig 14a For a four-implant overdenture, unsplinted attachment systems include the Locator, CM LOCs, or telescopic\ncrowns, whereas ball attachments are little suited for this indication.\nFig 14b Four-implant overdentures can also be used with prefabricated or milled straight bars with or without\nextensions.\nFig 14c Four-implant overdentures also allow for the use of individually milled bars that follow the contours of the\nalveolar mucosa.\nWith a larger area of support, a four-implant overdenture does not have a rotational axis and\ntherefore allows a larger choice of splinted or unsplinted attachment systems (Figs 14a-c).\nTelescopic crowns, Locator attachments, or CM LOCs are only some of the numerous\npossibilities amongst the unsplinted attachment systems. Ball attachments are less suitable for\nfour-implant overdentures. Bars come with many different cross-sections, mostly round or"
  },
  {
    "page": 199,
    "content": "ovoid, or parallel-shaped, the latter providing friction via intimate contact of the parallel\nsurfaces of the bar and the corresponding female part. Milled bars may also follow the\nalveolar mucosa to maximize the parallel surface area without increasing the height.\nAs with the two-implant overdenture, there are splinted and unsplinted attachment systems\n(Figs 15a-c).\nFig 15a For a two-implant overdenture, unsplinted attachment systems can be used.\nFig 15b For a two-implant overdenture, splinted attachments can be also used. Prefabricated Dolder bars in various\nshapes are available and can be used without cantilever extensions.\nFig 15c Prefabricated Dolder bars with cantilever extensions can be used as well. This concept features a larger\nsupporting area and, consequently, no rotational axis."
  },
  {
    "page": 200,
    "content": "Fig 16 Ball attachments are robust, reliable, and inexpensive attachments for a two-implant overdenture and fairly\nforgiving if not cleaned perfectly; patients appreciate the distinct “click” when the denture is placed.\nFor geriatric patients, ball attachments have to be considered the basic attachment of implant\ndentistry. They are robust, reliable, and inexpensive (Fig 16).\nThey require little space, come with a huge choice of female parts, and have a very favorable\ncost-benefit ratio. Worldwide, they are the most commonly used attachment system for\noverdentures. Ball attachments provide a distinct “click” sound when the denture is seated,\nwhich is often perceived as reassuring. Patients used to a clicking retention mechanism will be\nprofoundly disturbed if the click is missing, even if the denture is still retentive. Although ball\nattachments require regular maintenance, any repairs during these visits can be performed\nchairside and are generally associated with low cost. Service kits are available to deal with a\nloss of retention (Figs 17a-b).\nFig 17a A repair set (Cendres+Métaux, Biel, Switzerland) exists to facilitate the management of retention loss\noverdentures with ball attachments. An original ball attachment is used to check whether the attachment or the female\npart is worn."
  },
  {
    "page": 201,
    "content": "Fig 17b The lamella insert of the Dalbo Plus attachment can be activated or replaced with a screwdriver.\nFig 18a The central hole of a Locator is difficult to clean and may trap food debris.\nFig 18b A temporary filling avoids food trapping, but limits the choice of inserts to those without the central pin.\nFirst, such kits contain a gauge with an original ball attachment, which can be used to establish\nwhether it is the female part in the removable denture or the ball attachment itself that is worn.\nSecondly, there is a special screwdriver in the set, to turn the insert of the Dalbo Plus female\npart clockwise (Cendres+Métaux, Biel, Switzerland) in order to regain retention. Each one-\neighth of a turn represents 125 g of added retention. If this is not sufficient to regain\nsatisfactory retention, the lamella insert of the Dalbo Plus can be exchanged for a “soft-tuning”\nor “tuning” insert, which can be activated several times with the screwdriver.\nAlthough adjustments and repairs for two-implant-overdentures with unsplinted attachments\nare frequent, these must not necessarily be seen as negative. The little turn of the female part to"
  },
  {
    "page": 202,
    "content": "reactivate the retention takes only a minute or two, and the visit can be used to screen for oral\ncarcinomas or other lesions, which are still frequent in old age (Ryan Camilon and coworkers\n2014). At the same time, we can get an impression of patients’ well-being and cognitive\nperformance, and refer them for further examination if necessary.\nFor fourth-age geriatric patients, most attachment systems other than the ball attachment and the\nmagnet will be too retentive and too difficult to clean. Especially the lingual side of a bar is\noften covered with substantial biofilm and calculus. As for the Locator attachments, the central\nhole may present issues, as it may fill with food debris and interfere with denture insertion.\nThe prophylactic placement of a temporary composite filling can prevent this, but this limits\nthe choice of inserts to those without the central pin (Figs 18a-b).\nShort and reduced-diameter implants\nProgress in implant surfaces, materials, and shapes has introduced a trend towards short and\nnarrow implants. This minimally invasive treatment approach is very suitable for geriatric\ndentistry, because the surgical intervention presents one of the major barriers for accepting\nimplant therapy in elderly adults, so simplification of the surgery may put the benefits of this\ntherapy within reach of more patients. Furthermore, these novel implants extend the indication\nspectrum; even patients with anatomically challenging situations may benefit from the option of\nan implant treatment.\nShort and narrow implants may also help avoid accessory interventions such as bone grafting;\nthe operation will be shorter and less traumatic. Titanium-zirconium alloys (Roxolid;\nStraumann, Basel, Switzerland) alloys are an example of newly developed materials with\nenhanced mechanical properties. In a recent center study with eight European centers, the\nsafety of 3.3-mm Roxolid implants and Locator attachments was confirmed for the edentulous\nmandible (Müller and coworkers 2015). Other small-diameter implants suitable for the\nedentulous mandible in geriatric patients are mini-implants, manufactured as one-piece or two-\npiece implants. Two-piece implants with a diameter of 2.5 mm have been documented in a\nprospective study on mandibular two-implant overdentures to provide a satisfactory survival\nrate of 95.5% after 6 years (Morneburg and Pröschel 2008). One-piece mini-implants are less\nwell documented, and long-term survival data from prospective studies are still missing (Bidra\nand Almas 2013)."
  },
  {
    "page": 203,
    "content": "Fig 19a Where alveolar ridge atrophy causes a vertical pressure of the denture base on the mental nerve, support from\nan implant may alleviate “electric” pain from the bolus.\nFig 19b Panoramic radiograph of the patient showing the atrophic ridge.\nOne-piece mini-implants do not provide prosthetic support, as the female part is not seated on\nthe ball attachment of the implant. They solely provide retention, by means of a rubber O-ring\nplaced in the female part. Their function is profoundly different from all other implant systems.\nThird-age patients appreciate such mini-implants, as they are designed for flapless placement\nand are relatively inexpensive. In fourth-age patients with largely atrophied ridges, these mini-\nimplants may often be too long. With functional decline and reduced dexterity, the handling of\nthe denture may also become difficult, as the heads of the implants are very small and the\ndenture has to be placed with great precision. Removing a one-piece mini-implant when it is\nno longer useful can best be performed by simply cutting off the fragile head of the implant\nwith a diamond bur. However, this approach may be difficult in a domiciliary setting.\nIn addition to reduced-diameter implants, short implants may be particularly suitable for\nelderly patients with severely atrophied mandibular ridges (Figs 19a-b).\nThese clinical situations present a problem in terms of denture retention and exposure of the\nmental foramen on top of the alveolar ridge. Loading a denture that exerts pressure on the\nmental nerve may cause significant pain and severe discomfort to the patient. Here,\ninterforaminal implants may provide support for the denture base along with relief for the\nmental nerve. In these patients, implants are placed in the mandibular basal bone rather than in\nthe (lost) alveolar ridge. The width of these implants is therefore not a limiting factor, and\nstandard-diameter implants or even wide-platform implants may be used."
  },
  {
    "page": 204,
    "content": "9\nSurgical Considerations in the Aging Patient\n \nS. Barter"
  },
  {
    "page": 205,
    "content": "Fig 1 Treatment planning in the elderly patient (adapted from Bergendal and coworkers 2008).\nThe previous chapters of this Treatment Guide have shown that implant therapy can be\nsuccessful in elderly patients and that it can provide measurable improvements in terms of their\nsubjective and objective quality of life. Such improvements include functional benefits,\nperhaps most importantly the maintenance of adequate nutrition through better chewing comfort\nand efficiency, as well as the positive impact on esthetics and self-esteem. However, many\nfactors must be considered when treating or managing elderly patients who are to be provided\nwith or who already have implants. All treatment modalities have advantages and\ndisadvantages; the surgical aspects of treatment require special consideration. It has been\nsuggested that treatment planning for the geriatric patient can be seen as a sequence of four\nsteps (Bergendal and coworkers 2008; Fig 1):\n• The “academic” (ideal) treatment plan.\n• The “clinical” treatment plan, relating to the general health, cognitive ability, and autonomy\nof patients in handling and caring for their dental restorations.\n• The “practical” treatment plan, governed by subjective treatment expectations and the\nwillingness to undergo specific procedures, as well as by financial and family constraints.\n• The “modified” but realistic treatment plan that allows for adaptation due to changes in\ncompliance or general/oral health that may occur as the patient ages.\nThe ideal—strategic—implant positions may be in regions that are affected by bone\nresorption. This implies a careful consideration of the required positions of the prosthetic tooth\nor teeth, the required implant positions, and the availability of bone in that region for implant"
  },
  {
    "page": 206,
    "content": "placement—a process known as restoration-driven treatment planning. While this may lead to\nthe conclusion that the ideal plan is not practical, perhaps due to the need for adjunctive\nsurgery such as bone grafting, the same approach must be used for the modified implant\ntreatment plan. It is no longer acceptable to merely place implants in the available bone\nvolume and decide later how best to use them. The resulting prosthesis will often be\ninadequate in terms of function, phonetics, access for maintenance, and appearance. In the\nelderly patient with reduced capacity for adaptation and less ability to perform the necessary\n(perhaps complex) oral hygiene procedures, it may cause further difficulty, handicap, or\ndisease.\nThe intended restorative outcome must allow for the individual patients’ resilience and manual\ndexterity, their degree of autonomy, and their need for caregiver assistance. However, technical\nand biological complications are an almost inevitable consequence of all dental restorations; it\nis just a matter of time-to-failure. In the old person, the management of such complications\nneeds to be anticipated and made a “designed-in” feature of the restoration. This will be\ndiscussed further in Chapter 12.\nAs surgeons, our first duty is to “do no harm”; surgery in itself is harmful, and the success of\nsurgery has to be measured in terms of avoiding iatrogenic damage, adequate healing without\navoidable disability, and achieving the planned outcomes.\nThe aim of this chapter is therefore to consider some surgical issues of particular importance\nin elderly patients. It is of course impossible to cover every eventuality; successful surgery is\ndependent on multiple site- and patient-specific factors, and a thorough and complete\npreoperative assessment and planning of all related factors is required in each individual.\nAge-related changes in bone morphology and structure With improving overall oral health,\nit can no longer be assumed that elderly patients will be edentulous; many adults retain a\nsignificant number of teeth throughout their lives, and implant therapy may be required for tooth\nreplacement limited to single or multiple individual teeth, or small bridges. Neither can it be\nassumed that the elective edentulization of an aging individual to replace teeth with implants,\nas a “better or safer” option, is a valid treatment. Implants are not a tooth replacement; they are\nmerely an option for the replacement of missing teeth (Donos and coworkers 2012). The\nmaintenance of natural teeth should always be the primary choice where possible, in order to\npreserve proprioceptive feedback and simpler, less costly treatment.\nHowever, many elderly patients will present with complete edentulism, with a previously\nheavily restored and failing dentition, or simply with individual failing teeth. When the\nremaining natural teeth are beyond further conventional restorative treatment, the replacement\nof teeth with fixed or removable implant supported prostheses, rather than conventional partial\nor complete dentures, may avoid the need for an old person to adapt to a radically different\nsituation. As described in Chapter 5, the capacity of the elderly to adapt to such changes is\nreduced."
  },
  {
    "page": 207,
    "content": "Histological changes\nIn the classical concept by Lekholm and Zarb (1985), there are four subtypes of bone quality\n(Fig 2).\nSeveral other classifications of bone quality have since been suggested, but there is no\nuniversally accepted standard method.\nHowever, bone quality depends on more than the relative density of bone in terms of the\ncortical and cancellous compartments. Bone quality in orthopedic medicine is a combination of\nfactors that make bone fracture-resistant, such as the quality of the collagen content, mineral\ncrystal size, the degree of vascularity and cellular vitality, accumulated microscopic damage,\nand the rate of turnover. All these can vary in elderly patients, especially given the prevalence\nof polymorbidity and polypharmacy prevalent in this age group, as discussed in earlier\nchapters.\nThese factors also have a potential impact on successful implant osseointegration; dense bone\nis not always stronger, and low bone density is not always related to osteoporosis. However, it\nhas been shown that at any level of bone density (T score), aged bone is weaker and more\nliable to fracture than young bone (Hui and coworkers 1988). “Poor bone quality” has been\nassociated with a higher implant failure rate (Goiato and coworkers 2014; Alsaadi and\ncoworkers 2007). However, the presence of osteoporosis does not appear to be related to\nhigher rates of implant failure (Bornstein and coworkers 2009; Slagter and coworkers 2008).\nHigher rates of implant failure have in fact been reported in dense mandibular bone, where\nperhaps the reduced trabeculation results in lower vascularity and decreased oxygen tension in\nthe bone, with a consequent effect on bone healing and osseointegration. Bone with reduced\noxygen tension and decreased numbers of vital osteocytes has been associated with a higher\nrisk of osseointegration failure (Van Steenberghe and coworkers 2003). However, there are\npublications that show little difference in the survival of implants placed in “poor-quality” or\n“good-quality” bone, particularly when using implants with a microroughened surface\n(Stanford 2010).\nFig 2 Grading system for bone-quality assessment (Lekholm and Zarb 1985).\nOverheating of the bone due to poor surgical technique, inadequate irrigation, or the use of"
  },
  {
    "page": 208,
    "content": "blunted rotary instruments can all contribute to bony necrosis at the osteotomy site. The\nconcept of compression necrosis of bone has been described in the orthopedic field, with\nexcessive insertion torques beyond the physiologic capacity of the bone causing plastic\ndeformation, micro-fractures, and vascular ischemia (Winwood and coworkers 2006). It has\nbeen suggested that similar mechanisms may occur with implant placement, with concomitant\nresorption and loosening of the implant (Bashutski and coworkers 2009; Haider and coworkers\n1991).\nThe highly atrophic mandible will often be primarily composed of cortical bone with little\ncancellous space, and the risk of thermal injury or excessive insertion torque is consequently\ngreater, as is the risk of mandibular fracture (Chrcanovic and Custódio 2009), which is further\ndiscussed below. For a comprehensive overview of age-related changes in the histology and\nphysiology of the bone, see Boskey and Coleman (2010). The impact of histological age-\nrelated changes in bone on the success of osseointegration of implants in the elderly is unclear.\nOne could theorize that histological and anatomical changes, such as age-related deterioration\nof the inferior alveolar artery in the edentulous mandible, present a risk of poor bony healing\n(Bradley 1975; Bradley 1981). However, multiple studies have not shown any tendency to\nincreased failure rates of implants with age (de Baat 2000; Op Heij 2003).\nThe many factors involved in the treatment of any one individual site or patient make\nmeaningful assessment difficult. They include systemic and local site factors, but surgical\ntechnique and operator experience are often the most significant. Carefully performed surgery\nin a patient with appropriate disease control should result in a successful outcome, but as ever,\nsurgery does not come with any guarantees, and patients or their representatives have to be\nappraised of this when considering implant treatment.\nMorphological changes and surgical considerations\nBone resorption following tooth loss has long been a challenge for surgeons and\nprosthodontists in terms of obtaining satisfactory denture stability. It has a critical influence on\nthe placement of implants in appropriate positions. Bone loss in the alveolar process following\ntooth loss is part of normal wound healing (Araújo and Lindhe 2005; Cardaropoli and\ncoworkers 2003). The rate and degree of bone loss differs between patients and between sites\nwithin the same patient. This is further complicated by ongoing bone remodeling and\nresorption in the denture-bearing areas (Tallgren 1972). The long-term edentulous site or jaw\nmay present with severely resorbed bone at the desired site of implant placement, particularly\nin long-term complete-denture wearers or in patients who lost some teeth at an earlier age but\nmanaged well with fewer functioning teeth or fixed or removable partial dentures.\nThe loss of one or more supporting teeth for the prosthesis may preclude successful\nrehabilitation without implants. However, anatomical changes in the edentulous ridge bring\nspecial considerations in terms of implant placement. Following tooth loss, the alveolar ridge\nresorbs in an apicolingual direction (Lekholm and Zarb 1985; Cawood and Howell 1988).\nImportant anatomical structures become more superficial, and the relative distance between the\noriginal (and therefore necessary) tooth positions changes."
  },
  {
    "page": 209,
    "content": "Another claimed benefit of implant placement is the prevention of ongoing bone resorption. It\nhas been suggested that implants may play a role in preventing progressive bone loss by\nstimulating the bone under load in a more favorable way than with complete dentures,\npreventing disuse atrophy. However, many studies also show implants as a potential cause of\nbone loss, due to crestal bone stress or peri-implant disease. Like any therapy, implants have a\npotentially favorable and a possibly harmful effect.\nThe immediate placement of implants into extraction sockets to prevent alveolar-bone\nremodeling has been suggested (Werbitt and Goldberg 1992). However, other authors consider\nthis theory to be unsupported by conclusive evidence, and opinions remain divided (O’Neill\nand Yeung 2011; Schropp and Isidor 2008).\nMandible. In the mandible, the reduction in bone height results in muscular attachments\nbecoming more superficial. The genial tubercles and mylohyoid ridge are less deeply\npositioned in the floor of the mouth. This results in a shallower lingual vestibulum and in\nmuscle activity being more likely to cause denture displacement. The bony prominences may\nalso cause painful pressure points below a denture.\nLoss of bone height also results in the inferior alveolar nerve (IAN) becoming relatively more\nsuperficial. This will reduce the height of available bone for the placement of implants with an\nadequate safety margin without risk of damage to the IAN. Such damage can present a\nsignificant disability in any individual, not just “numbness or tingling.”\nThere can be variations in the anatomy of the mandibular canal, including a posterior\nintraosseous division giving rise to a bifid canal, multiple branches (Carter and Keen 1971),\nor the presence of multiple mental foramina (Naitoh and coworkers 2009). The need for\naccurate and appropriate imaging in the resorbed mandible combined with a careful clinical\nexamination cannot be overstated; the handicap produced by irreversibly altered sensation and\nneuropathic pain can be considerable, with reduced quality of life and psychological impact\n(Lam and coworkers 2003).\nWith progressive mandibular resorption, the mental foramina may eventually become situated\non the crest of the ridge. In severe resorption, the main trunk of the IAN can become dehiscent\nand lie in a groove in the crest of the ridge for some distance. In either case, compression of\nthe nerve by a denture base may cause pain. The advantage in terms of improved comfort of an\nimplant-supported prosthesis can be dramatic for the patient. However, considerable care will\nbe required in the placement of incisions and reflection of flaps to avoid nerve damage.\nPeripheral nerve damage can be classified into neurapraxia, axonotmesis, or neurotmesis\n(Seddon 1942). Neurapraxia is the least severe form of injury and produces, according to\nSeddon, transient paresthesia or anesthesia with no conduction across the region of injury, but\nintact conduction in the proximal and distal segments. Recovery usually occurs within hours,\ndays, or weeks, depending on severity."
  },
  {
    "page": 210,
    "content": "Axonotmesis is a loss of axonal and myelin sheath continuity but with preservation of the\nconnective-tissue framework (the epi- and perineurium). It results in conduction deficits distal\nto the site of injury, due to further degeneration of distal neural tissue, known as Wallerian\ndegeneration. Axonal regeneration may occur, producing a degree of recovery.\nNeurotmesis is a transection or disruption of the entire nerve fiber and may be partial or\ncomplete. Wallerian degeneration occurs and the sensory deficit is severe, with no spontaneous\nrepair.\nNerve damage may produce a sensation of tingling (paresthesia), numbness (anesthesia), or\nreduced function (hypoesthesia), altered sensation (dysesthesia), the sensation of pain from a\nstimulus that would not normally result in pain (allodynia), or an abnormal increase in\nsensitivity (hyperesthesia).\nNerve damage can occur even without penetration of the canal; neurapraxia may arise from\ncompression of the roof of the mandibular canal by the tip of an implant. It can also arise from\nthe administration of an inferior alveolar block anesthetic.\nThe classical signs of nerve injury described by Seddon may be modified by the fact that the\ninferior alveolar nerve is contained within a bony canal. Edema within the confines of the\ncanal may result in additional nerve compression and compromised vascular supply to the\nneural tissue. Bleeding into canal may have the same effect; in addition, hemoglobin is\nneurotoxic (Regan and Rogers 2003). Pain not responding to simple painkillers such as\nibuprofen or acetaminophen may be neuropathic in origin and require special management\n(Renton and Yilmaz 2012).\nThe submandibular and submental spaces also become more superficial with progressive\nmandibular atrophy. In a radiological study, lingual concavities with a depth of 6 mm were\nreported in 2.4% of assessed cases (Quirynen and coworkers 2003). There is a greater risk of\nperforation of the lingual cortical plate causing damage to the vessels in the floor of the mouth,\nwith a risk of hemorrhage.\nCross-sectional imaging studies have demonstrated that the sublingual and submental arteries\nmay not only pass close to the lingual cortical plate in the mandibular midline but that branches\nof these arteries may enter accessory foramina along the lingual cortex (Hofschneider and\ncoworkers 1999). Numerous studies have reported the formation of sublingual hematomas\nrelated to implant surgery, possibly even several hours after treatment (Dubois and coworkers\n2010; Isaacson 2004). In some cases, this bleeding may be severe and cause an acute airway\nobstruction (Niamtu 2001). Although very rare, this is potentially more likely with implant\nplacement in the mandibular first premolar position, a common site of implant placement for\noverdentures (Givol and coworkers 2000; Kalpidis and Setayesh 2004).\nIt is of course important to consider the risk of mandibular fracture when implant surgery is\nperformed in the atrophic mandible. Fractures may occur during or after implant placement"
  },
  {
    "page": 211,
    "content": "(Goodacre and coworkers 1999) and may result in further complications after fracture repair.\nThe incidence reported is variable, but is commonly quoted at around 0.2% (Rothman and\ncoworkers 1995). Peri-implant bone loss associated with implants in an atrophic mandible\nappears to be an important risk factor for mandibular fracture; it has been suggested that\nimplants be removed before 50% of the peri-implant bone are lost. However, the same authors\nalso wisely highlight the risk of mandibular fracture during the removal of an implant, should\nthis become necessary (Raghoebar and coworkers 2000).\nGiven that the removal of bone to place implants will inevitably weaken the structural integrity\nof the mandible, preserving an adequate bone volume and not violating the buccal and lingual\ncortical plates—and in particular the inferior border—is vital. Cross-sectional imaging of the\natrophic mandible is recommended to assess the degree of hard-tissue reduction required to\nremove prominences and achieve a flat bed for implant placement. In addition, the greater the\nnumber or length of implants placed, the higher the risk of fracture. A stress fracture of the\nedentulous mandible should be considered as part of the differential diagnosis of persistent\npain associated with implants (Rothman and coworkers 1995).\nFig 3a The required arch form is determined by the “neutral zone” between the lips and tongue, providing the correct\nocclusion, phonetics, and extraoral soft-tissue support.\nA = Anteroposterior arch length\nB = Posterior extent of dental arch\nFig 3b The occlusal/incisal tip position (blue) has to remain constant; soft tissue (green) and alveolar crest (orange)\nresorb in an apicolingual direction, away from the required tooth position."
  },
  {
    "page": 212,
    "content": "Fig 3c Consider a reconstruction needing 6 implants in the first molar, first premolar and lateral incisor positions: tooth\nposition and screw access holes are needed at position x, occlusal level. As the degree of ridge resorption increases, the\nradius of the available bony ridge decreases. This is more pronounced in the anterior maxilla.\nx = Desired tooth position (normal arch radius)\ny = Moderately resorbed ridge\nz = Severely resorbed ridge\nIt has been suggested that proper informed consent for implant placement in the atrophic\nmandible should include warnings related to this infrequently reported but significant risk\n(Soehardi and coworkers 2010). Many authors have observed that there is an age-related\ndegeneration in the vascular supply to the mandible from the inferior alveolar artery (IAA)\n(Bradley 1975) and that this may be linked to mandibular alveolar atrophy (Eiseman and\ncoworkers 2005). However, there is a considerable collateral supply from vessels in the\nadjacent muscles (masseter, mentalis, and medial pterygoid) that penetrate the periosteum and\nfrom the vessels in the floor of the mouth (sublingual, submental, and mylohyoid arteries). The\ndegeneration of the vascular supply from the IAA has been linked to localized alveolitis (“dry\nsocket”) (Chiapasco and coworkers 1993), poor socket infill, and poor outcomes of guided\nbone regeneration (Ersanli and coworkers 2004) as well as to a higher incidence of\nosteoradionecrosis of the posterior mandible (Bras and coworkers 1990). Careful flap design\nand management is necessary to preserve this blood supply in elderly patients where the\ncentral mandibular blood vessels may be less efficient.\nMaxilla. The pattern of bone resorption in the maxilla generally also runs in an apicolingual\ndirection, as described by the various classifications for the resorbed jaw (Lekholm and Zarb\n1985). Reduction in maxillary height as a consequence of bone resorption also results in\nchanges in the geometry of the arch and the relationship between implant and tooth position that\ncan cause issues in the surgical planning of a full-arch reconstruction, whether with an\noverdenture or a fixed reconstruction. The radius of the dental arch at the occlusal level will\nneed to remain relatively constant to ensure that the prosthesis is in the “neutral zone,”\nproviding adequate extraoral soft-tissue support while not impinging on the tongue space.\nHowever, the bony ridge will resorb in an apicolingual direction, and in doing so will become\nreduced in radius. This requires placing the implants at a more proclined angle; if the implants\nare on a narrower radius, they may be placed too close to one another. The difference in radius\nchange is more pronounced in the anterior maxilla (Figs 3a-c).\nThe progressive resorption of the maxilla also results in the remaining bony crest approaching"
  },
  {
    "page": 213,
    "content": "the air spaces of the maxillary antra and the nasal cavity. This will frequently preclude implant\nplacement without augmentation.\nAugmentation in the posterior maxilla can be achieved with subantral augmentation using the\n“sinus lift” procedure, which is safe and predictable in the hands of a skilled and experienced\nsurgeon. However, the question is whether patients can tolerate the procedure and are willing\nto accept both the risks and the extra time required, as the graft must mature before implants\ncan be placed. That some biomaterials may offer as reliable a grafting outcome as autogenous\nbone, previously considered the gold standard, removes the need for harvesting bone and\navoids the associated morbidity (Kim and coworkers 2009; Handschel and coworkers 2009).\nThe risk of hemorrhage in a sinus lift will need to be appropriately considered in aged\npatients, particularly those more at risk for medical reasons (as discussed in Chapter 5). The\nincidence of sinusitis following grafting is largely related to perforation of the Schneiderian\nmembrane and escape of graft materials into the sinus, which causes inflammation and may\ncause a loss of patency of the ostium (van den Bergh and coworkers 2000; Doud Galli and\ncoworkers 2001). Sinus lifts of course do not replace the lost alveolar bone; they provide a\nvolume of bone to facilitate the placement of implants, but the positions of these implants will\nnot necessarily be closely related to the positions of the missing teeth. Some authors have\nobserved that implant placement in the correct position for a fixed reconstruction also requires\nlateral augmentation. Bone grafting will not always be practical here: reconstruction of the\nvertical component of bone loss will not be simple, and in elderly patients, the complexity of\nthe surgery required will rarely be desirable or justifiable.\nOther authors suggest that a “simplified” approach to sinus augmentation is offered by placing\ngraft material into a subantral space created via the implant osteotomy: the osteotome\ntechnique, first described by Summers (1998) and further modified in many different ways.\nHowever, it is the opinion of this author that this technique is ineffective for several reasons\nand, given the associated risks, is largely obsolete for the following reasons:\n•\nThe evidence base surrounding the osteotome technique has a significant degree of\nheterogeneity; drawing meaningful conclusions is difficult (Tan and coworkers 2008).\n•\nMany of the studies showing success rates comparable to the survival rates for short implant\nplacement in the posterior maxilla employed the osteotome technique where the residual\nbone height would have allowed the use of short implants without grafting; further,\nsometimes no graft was placed due to a suspected perforation—and the implant outcome\nwas the same. There is no impact on the health of the sinus when penetrated by a fixed\nobject (Brånemark and coworkers 1984; Stamberger 1991); while there may be no\nadvantage in terms of implant penetration beyond the floor of the antrum, there is no harm,\neither.\n•\nIt is known that displacement of graft particles into the sinus can result in acute or chronic\nsinusitis (Wiltfang and coworkers 2000); membrane perforations cannot be detected\nreliably using this procedure, and the rate of membrane perforations increases with reduced\nresidual alveolar height (Ardekian and coworkers 2006)."
  },
  {
    "page": 214,
    "content": "•\nIt is known that significant remodeling of the graft placed in this manner occurs and that the\nbone gain is limited to small amounts on the walls of the implant, with little bone at the apex\n(Brägger and coworkers 2004; Leblebicioglu and coworkers 2005).\n•\nThe primary determinant of implant success is the height of the remaining residual ridge\n(Toffler 2004).\n•\nIt is further known that such bone is unlikely to add significantly to biomechanical load\ntransfer; this load is primarily borne in the posterior maxilla, by the cortical plates, and then\ndissipated to the palatal and zygomatic bones (Yacoub and coworkers 2002; Gross and\ncoworkers 2001a; Gross and Nissan 2001b). Unless the packing of graft matter into the\nsinus is complete to the walls of the antral space, small amounts of additional bone are\nrelatively useless (Tepper and coworkers 2002).\nAs there appears to be more variability in implant survival in the grafted sinus than in the\nunaugmented posterior maxilla (Graziani and coworkers 2004), the use of shorter implants,\nwhere possible, may be the preferred option to reduce surgical morbidity in elderly patients\nwith sufficient residual alveolar height.\nGiven the lack of a clear advantage of the osteotome technique, the additional risks associated\nwith the technique can be considered more significant than the potential limited advantage. The\nrisk of implant displacement into the sinus becomes greater as the residual alveolar height\ndiminishes (Chiapasco and coworkers 2009); displacement can still occur after many years in\nfunction (Iida and coworkers 2000; Ueda and Kaneda 1992).\nThere have been several reports of benign paroxysmal positional vertigo (BPPV) with the\nosteotome technique, attributed to the dislodgement of otoliths in the semicircular canals\ncaused by the malleting employed in this procedure (Chiarella and coworkers 2008). This can\nbe a significant disability in patients of any age, but in elderly patients with a decline in\nbalance and proprioception, BPPV could result in a considerable change in their quality of\nlife. The incidence may well be underreported, as the symptoms often do not manifest for days\nor weeks afterwards and may not be associated with the procedure (Vernamonte and\ncoworkers 2011; Kim and coworkers 2010; Peñarrocha-Diago and coworkers 2008; Di\nGirolamo and coworkers 2005; Kaplan and coworkers 2003).\nAttempting to simplify surgery and avoid sinus lifts by placing implants only in the anterior\nmaxilla, where sufficient bone volume remains, may increase the risk of implant failure. A\ngood anteroposterior spread of implants is needed (Lambert and coworkers 2009).\nConsequently, some clinicians advocate protocols utilizing a combination of longer, angled\nimplants to avoid the need for sinus elevation. The stated rationale that this “simplifies” the\nprocedure is questionable, as the protocol often requires a significant vertical reduction in\nheight to provide the necessary space for prosthetic components. The extensive flap elevation\nand bone removal required do not appear less invasive than the sinus lift procedure.\nFurthermore, in the event of implant failure or complications, the bone removal required for\nthe procedure may leave a situation that is impossible to restore even with a conventional"
  },
  {
    "page": 215,
    "content": "complete denture, leaving the patient with significant disability and disfigurement.\nThe use of other sites in the maxilla for implant placement with special protocols, such as the\nzygomatic or pterygomaxillary region, requires complex surgery and difficult prosthetic\nprocedures. There is again an increased risk of morbidity, and peri-implant mucosal\ninflammation is often a problem because of restricted access (Aparicio and coworkers 2006).\nSuch procedures are unlikely to be suitable in the elderly patient.\nGiven that it is not possible, even with considerable augmentation, to reconstruct significantly\nresorbed sites to their full pre-disease contour, fixed implant rehabilitations may require the\nmissing tissue to be made up for in the prosthesis itself. Full-arch fixed prostheses in resorbed\njaws commonly require flanges or volumes of pink-colored material to provide the necessary\nextraoral tissue support or the desired esthetic appearance of the teeth, or to prevent air escape\nfrom affecting phonetics. This will increase the difficulty of effective plaque control and\nincrease the risk of peri-implant disease and bone or implant loss.\nStrategies for simplifying surgical procedures in elderly patients\nAny complication may assume greater significance in the elderly patient as a result of its\nimpact on patients’ quality of life and on the practicality of the treatment required to treat those\ncomplications. The importance of planning for implant placement relative to the intended\nprosthesis is well documented. In addition, we must plan for maintenance, replacement of\nprostheses, adaptation of prostheses to future implant loss, or possible changes in the type or\ndesign of prosthesis as patients becomes less able to care for or manage the reconstruction. In\nshort, we have to plan for the contingency of reverting a potentially problematic situation to\none than can continue to benefit the patient—or at least not cause inconvenience or disability.\nFrom a surgical viewpoint, such strategic planning will include implants in key positions and a\nchoice of surgical approach that is the least invasive but still offers a predictable outcome with\nthe lowest risk. To a certain extent, this will also depend on operator experience.\nThe loss of the vertical component of alveolar ridge height may result in proximity of the IAN\nor maxillary air spaces at the desired implant location, as described above. Vertical ridge\naugmentation is challenging and shows considerable variation in clinical outcome, with limited\ndata available (Rocchietta and coworkers 2008). Like all augmentation procedures, there is\nincreased morbidity and a greater risk of complications. In situations of limited bone height in\nthe maxilla or mandible, the use of shorter implants can be considered a reasonable treatment\noption."
  },
  {
    "page": 216,
    "content": "Fig 4a-b One-piece mini-implant has fractured the buccal plate and is displaced into the vestibular tissue.\nShort implants appear to perform just as well as longer implants in bone of similar density\n(Renouard and Nisand 2006). Even shorter implants (4 mm) have been used with some\nsuccess, although the dense cortex of mandibular bone appears to be affected more by implant\ndiameter and stress peaks than implant length (Slotte and coworkers 2012). It has been\nsuggested that the reverse may be true in the maxilla (Baggi and coworkers 2008). As the most\ncoronal 2 to 3 mm of the implant transfers most of the functional load to bone (Pierrisnard and\ncoworkers 2003), and given the higher incidence of lower bone density and the lack of cortical\nplate in the posterior maxilla, this may present a case for considering appropriate sinus\naugmentation, depending on patient suitability in terms of risk-to-benefit and cost-to-benefit\nratios. The same consideration may be applied to lateral ridge augmentation in situations of\nreduced alveolar width. While perhaps more predictable in outcome than vertical\naugmentation, there is still increased cost, morbidity, and risk.\nThe use of reduced-diameter implants may to some extent offer an alternative solution in\nnarrow edentulous ridges. However, we have to consider the load-bearing capacity of the\nimplant and of the narrow bony ridge. The risk of fracture increases as implant diameter\nreduces, even with one-piece implants with integrated abutments made of titanium alloys such\nas Ti-Al-V (Allum and coworkers 2008), and these materials have been demonstrated to be\nless biocompatible than commercially pure titanium in cell cultures and animal experiments\n(Han and coworkers 1998). The clinical significance in implants for human use remains a topic\nof critical discussion, but other more biocompatible alloys of titanium-zirconium used in\nimplants 3.3 mm in diameter have been successful for fixed and removable prostheses (Barter\nand coworkers 2012; Chiapasco and coworkers 2012; Al-Nawas and coworkers 2012), if only\nin relatively short-term studies. The use of implants less than 3 mm in diameter is not well\ndocumented, being largely related to their use in the edentulous arch and in single tooth non-\nloadbearing sites, with few data on success rates (Klein and coworkers 2014). It is also\nreported that stress values in crestal cortical bone increase as implant diameter decreases,\nincreasing the risk of peri-implant crestal bone resorption (Baggi and coworkers 2008; Ding\nand coworkers 2009). In an already resorbed jaw, the effect could be significant. Age-related\nreduction in cortical bone thickness and elasticity occur in the jaws as in other bones and in\nparticular seem to affect the mandible (Sarajlic and coworkers 2009). When the cortical plate\nis thin or there is peri-implant bone loss, it is possible for the implant to break through the\nbuccal plate under load (Figs 4a-b)"
  },
  {
    "page": 217,
    "content": "Finally, solid implants with integrated abutments, typical of some mini-implant designs, may\npresent problems as they are less adaptable to changes in patient compliance. A patient\nsuffering from cognitive decline may be intolerant of a previously successful implant\noverdenture and refuse or be unable to wear it. Conventional two-piece implant designs may\nallow for the relatively simple removal of the abutment, which may otherwise cause trauma to\nthe intraoral tissues, resulting in pain and a reduced ability or inclination to eat. This is not\npossible with a one-piece implant design, and removing or modifying the implant in such a\npatient may not be so simple. This will be discussed further in Chapter 11.\nFlapless surgery has been advocated as simplifying the placement of implants. Avoiding\nperiosteal stripping with flap elevation undoubtedly reduces postoperative morbidity, but\n“blind” implant placement carries a risk of inaccurate placement, inadequate bone thickness\naround the implant, perforation of the cortical plate, or violation of adjacent anatomical\nstructures. Computer-guided surgical templates are not a new technique, and flapless\nplacement with such templates has been shown to reduce postoperative morbidity.\nHowever, the accuracy of placement has been questioned in systematic reviews of the\npublished literature. Computer-guided surgery is a promising development that may facilitate\nless invasive surgery, reduce surgical risk, and improve access to implant treatment for\nmedically compromised patients. However, as with all new techniques, it is important to\nunderstand the considerable technical details and inherent limitations (Tahmaseb and\ncoworkers 2014).\nGeneral surgical considerations in the older patient\nThe reduced physiological reserves of the elderly patient and their declining capacity to\ntolerate stress have been discussed in Chapter 5 on medical considerations. The elderly patient\nmay be less able to cope well with long and difficult procedures, and this will need to be taken\ninto account when deciding on what treatment option is best suited to the patient. The skill and\nexperience of the operator will largely determine how quickly a surgical procedure can be\ncompleted safely and accurately, and referral to a specialist surgeon may be advisable in many\ncases.\nTreatment under local anesthetics is generally preferred in geriatric patients, where\nphysiologic changes affect drug absorption, metabolism, and excretion. The only local\nanesthetic that has been extensively investigated in elderly patients is lidocaine (Oertel and\ncoworkers 1999). However, amide local anesthetics such as lidocaine are primarily\nmetabolized by the liver, and there is an age-related decrease in this capacity. Furthermore,\npatients with decreased hepatic blood flow (e.g. congestive heart failure) or reduced liver\nfunction may metabolize local anesthetics at a significantly slower rate, resulting in increased\nplasma drug levels and a greater risk of toxicity (Malamed 1997). The metabolites of lidocaine\nare also potentially toxic, with a potential impact on patients with impaired renal function.\nHowever, articaine, while an amide local anesthetic, is primarily metabolized in the\nbloodstream and has a significantly shorter half-life than lidocaine. The metabolites are non-"
  },
  {
    "page": 218,
    "content": "toxic. There were no significant differences in plasma concentrations and the half-life of\narticaine between young and old healthy individuals (Oertel 1999). It should be remembered\nthat articaine is highly bound to serum proteins, and this binding capacity does change in the\nelderly patient, particular in the chronically ill who may have low serum albumin levels.\nThe time that the operation may take will need to be considered within the constraints of the\namount of local anesthetic required—prolongation of the procedure as a result of reduced\ncapacity of the patient, with “topping up” of local anesthetic, may give rise to insidious\noverdose in the elderly patient. As discussed in Chapter 5 on medical considerations, the\nincidence of complications with local anesthetic solutions is greater in debilitated elderly\npatients, particularly in polymorbid individuals where interactions may occur with prescribed\nmedications. Further advice can be found in Chapter 5.\nPatient age, as well as the duration and complexity of the surgical procedure, have been linked\nto the degree of postoperative morbidity experienced with third-molar surgery (Jerjes and\ncoworkers 2010; Bello and coworkers 2011). It seems reasonable to expect that similar effects\nmay be observed with more protracted and complex procedures related to implant surgery.\nThere are other considerations related to complex or lengthy procedures in elderly patients.\nCertain conditions such as arthritis or gastric reflux may result in an inability to remain\ncomfortable in the chair for long appointments and can contribute to stress during the\nprocedure—both for the patient and the operator—threatening the successful completion of the\ntreatment. Other conditions such as diabetes, dementia, and osteoarthritis may affect the\nscheduling of the treatment during the day. Arthritic changes in the spine may make optimal\npositioning of the patient in the chair impossible, with a consequent impact on access, lighting,\nand visibility of the operative site. These may contribute both to the time taken to complete the\nprocedure and to the stress on both patient and operator. Even the practicality of certain\nimaging techniques may be affected: it may not be possible to position a patient with kyphosis\ncorrectly for a CBCT or panoramic investigation. For example, a patient with Parkinson’s\ndisease may not be able to remain still during the exposure.\nAll of these factors will have to be considered in treatment planning and appointment\nscheduling; more and shorter procedures may be advisable. However, the overall appointment\ntime at each visit may need to be proportionally longer so as not to rush the patient, which may\ncause them additional stress. More time may be needed for the patient to rest occasionally;\nsarcopenia and masticatory-muscle fatigue may affect the ability of patients to keep their\nmouths open for long periods without a tremor of the jaw. Anxiety regarding the nature of the\ntreatment may also be a significant stressor. Oral and inhalational sedation can normally be\nsafely tolerated in elderly individuals, and intravenous sedation may be considered—with\nadjustments for increased benzodiazepine sensitivity in older patients. However, some\ntechniques may not be suitable for medically compromised elderly patients in an outpatient\nenvironment, and a general anesthetic in an inpatient setting may be more appropriate, despite\nthe increased risks associated with age and some medical conditions."
  },
  {
    "page": 219,
    "content": "Swift, calm, smooth, and comfortable delivery of the operative treatment by a skilled and\nexperienced practitioner is of course essential. However, treatment is nothing without care; the\npastoral care element and consideration for the different needs of each individual elderly\npatient are of equal importance. This continues into the postoperative phase, throughout\ntreatment and into ongoing maintenance care.\nPostoperative period and healing\nThe provision of postoperative instructions in a clear and understandable fashion is important\nin all patients. Hearing difficulty, anxiety, or memory or cognitive impairment may all result in\na lack of proper understanding of important aspects of postoperative home care and could\nadversely affect the treatment outcome. Giving verbal postoperative instructions may not be\nadequate for any patient, especially at the time of surgery. Written postoperative instructions\nshould be provided in large enough print; instructions provided a week or two before the\nprocedure can also be very helpful. This allows the patient and any family member or\ncaregiver the opportunity not only to ask relevant questions in good time, but also to make any\nnecessary preparations, particularly with regard to maintaining adequate food and fluid intake.\nThe elderly patient may take longer to recover in the period immediately after completion of\neven relatively simple procedures; muscular stiffness, orthostatic hypotension, and fatigue can\nall increase the risk of falls, and so they should be permitted adequate time before leaving the\ndental chair to accommodate and be escorted/supported on discharge as required.\nWhile there appears to be no general increase in the risk of infection in patients over 65 years\nof age, this age group in general has a higher incidence of conditions or prescription\nmedications that that may predispose them to infections, or present a risk of adverse drug\nevents (ADEs) with prescribed postoperative antibiotics. As discussed in Chapter 5,\ninfections in the elderly patient may tend to begin earlier, develop more quickly, and be more\ndifficult to resolve, so prompt action is required.\nAdequate postoperative pain control is of course essential. Pain has many components in\naddition to the sensory mechanisms, including emotional and behavioral elements. The\nexperience of pain is influenced by biological, psychological, and cultural factors. The basic\nprinciple of pain control is the preemptive administration of analgesics, which may help\nprevent the potentiation of noxious stimuli (Scully 2014).\nSome of the many factors influencing analgesic use in the elderly patient have been discussed\nin Chapter 5. NSAIDs should be used with caution, especially in patients with gastric\nproblems or renal disease and in those taking ACE inhibitors or beta-blockers for\nhypertension, or anticoagulants. Centrally acting painkillers such as opioids carry a higher risk\nof confusion, drowsiness, or falls in elderly patients. Older patients are more at risk of poor\ncompliance with medication regimes, especially new additions to extensive drug regimes.\nWritten instructions should always be given along with careful oral explanations, particularly\nin relation to the timing of medication and whether the drug should be taken as prescribed, or\nas required. Small drug labels or manufacturers’ instruction sheets may be impossible to read"
  },
  {
    "page": 220,
    "content": "for visually impaired patients and it is useful to have information sheets that can be printed at\nvarying font sizes for commonly used medications.\nMany authors have observed age-dependent differences in wound healing. The response to\ninjury can be divided into four main phases: hemostasis, inflammation, proliferation, and tissue\nremodeling or resolution (Gosain and DiPietro 2004). As discussed, the inflammatory\nresponse decreases with age (Swift and coworkers 2001), and this will affect healing, as will\nthe age-related reduction in cellular migration and proliferation. Changes in collagen structures\nwith age will have an effect on remodeling. However, it appears that while healing may be\ndelayed in older adults, the overall process and results are not otherwise affected (Guo and\nDiPietro 2010). Most of the studies on wound healing in elderly patients relate to skin healing.\nIt is clear that there are histomorphological changes in the skin with aging; there are reductions\nin collagen and elastin volume and quality, vascularity, and the production of granulation\ntissue. Some of these changes are due to extrinsic factors such as solar UV light exposure\n(Thomas 2001), which will of course not apply to intraoral wounds, making this environment a\npotentially better predictor of the impact of age on wound healing. However, there are few\nstudies relating to this, and where they exist, the effect of polymorbidity and polypharmacy\nfactors in the elderly is frequently not assessed. Medical factors affecting tissue perfusion and\noxygenation such as cardiovascular disease, COPD, and smoking are all implicated in\nimpaired wound healing, as are conditions such as diabetes and medications such as\ncorticosteroids. Wound closure in older individuals was clearly delayed even when\neliminating potential age-related factors, indicating that aging does slow mucosal wound\nhealing, and the typical finding of a greater impact in males was reversed, with a greater\nincidence of delay in females. It was hypothesized that wound healing might be modulated by\ndifferent mechanisms, depending on tissue type (Engeland and coworkers 2006).\nBone healing is also slower in old age. It has been postulated that this is related to decreased\nlevels of the cyclooxygenase 2 (COX 2) enzyme, which plays an essential role in bone repair\n(Naik and coworkers 2009).\nWhile many studies indicate that increasing age has little effect on osseointegration in\notherwise healthy individuals, no comparable studies exist relating to guided bone\nregeneration in the elderly patient. Animal studies have indicated a delayed bone-healing\nresponse in guided tissue regeneration models; given the previously discussed changes in bone\nhealing with age, this would appear to be relevant to the older patient.\nFortunately, serious complications associated with dental implant placement are uncommon.\nHowever, the risk of complications may increase with the complexity of the procedure and\nwith multiple patient related risk factors. Proper surgical training should be acquired before\nattempting such procedures. Complications will inevitably occur despite our best efforts to\nprevent adverse events. It is therefore important to assess the risks not only in terms of\nprevention, but also in terms of what treatment may arise should such a risk actually occur.\nAbove all, accurate placement in carefully planned positions to achieve the equally carefully\nplanned prosthetic outcome is mandatory; the practicality of retrieving an unfavorable outcome"
  },
  {
    "page": 221,
    "content": "by means of revision surgery is difficult in all patients and may be impossible in an elderly\nindividual."
  },
  {
    "page": 222,
    "content": "10\nOral Hygiene in Geriatric Implant Patients\n \nF. Müller"
  },
  {
    "page": 223,
    "content": "Fig 1 Oral hygiene is not always a priority in old age. Reduced vision, tactile sensitivity, and manual dexterity render\noral hygiene difficult.\nMaintaining effective oral hygiene becomes increasingly difficult as manual dexterity\ndeteriorates. It seems generally acknowledged that oral hygiene in elderly patients is poor (Fig\n1), especially if they live in care homes or other institutional environments (Peltola and\ncoworkers 2004). In frail elderly patients with reduced masticatory efficiency and poor\ncoordination of the masticatory and facial muscles, retention of food debris is common; the\n“self-cleaning” effect that occurs with effective chewing and bolus formation is reduced.\nAccordingly, tongue coating with accompanying halitosis is a common finding in elderly\nadults.\nOral and general hygiene may no longer be a priority, as along with a withdrawal from the\nwork environment and social life, the need for a “proper” appearance may be felt as less\nimportant. Priorities also change with degrading general health; it seems logical that an elderly\nperson is more preoccupied with the more vital needs arising from chronic diseases and\ndisabilities.\nImplant-supported reconstructions of any type may impede the removal of biofilm. Implant-\nsupported prostheses or partially dentulous jaws with prosthetic restorations are distinctly\ndifferent in morphology from the natural dentition, which affects the self-cleaning effect during\nmastication.\nPoor oral hygiene was found in 23 out of 35 edentulous long-term care residents with—mostly\nfixed—implant-supported dental prostheses. However, only 18 subjects displayed moderate to\nsevere soft-tissue inflammation (Isaksson and coworkers 2009). While the objectives of\neffective oral hygiene remain the same in geriatric patients, methods and techniques have to be\nadapted to the individual’s functional decline and handicap.\nPeri-implantitis in old age\nIn younger patients, peri-implantitis seems likely to be associated with inadequate oral\nhygiene. However, little is known about the reaction of the periodontal tissues to bacterial load\nin geriatric patients, and even less about the reaction of their peri-implant tissues. In a split-"
  },
  {
    "page": 224,
    "content": "mouth study involving 15 volunteers, experimental gingivitis was compared to experimental\nperi-implantitis caused by a 3-week period of undisturbed plaque accumulation (Salvi and\ncoworkers 2012). During the experimental period, the implant sites developed more\ninflammation than the natural teeth (p < 0.04), although the natural teeth presented a higher\nplaque index (p < 0.02). However, these patients could hardly be described as geriatric,\nhaving an average age of 58.7 ± 10.9 years. Another study reported that the levels of P.\ngingivalis, T. forsythia, F. nucleatum, and T. denticola in the saliva of 89 “geriatric” patients\nwere related to the severity of the periodontal disease, but again, the average age of the cohort\nwas below 70 years (Shet and coworkers 2013).\nIt has also been demonstrated that the absence of preventive maintenance in patients with pre-\nexisting peri-implant mucositis is associated with a higher incidence of peri-implantitis after 5\nyears (Costa and coworkers 2012). Immunosenescence generally increases the susceptibility to\ninfection and impaired wound healing and elderly individuals do not respond as robustly to\nimmune challenges as the young do.\nA Swedish cross-sectional study screened 3,041 patients aged 65 years or older who had at\nleast one dental implant and who were identified by a Swedish municipality as being eligible\nfor subsidized care. In the final cohort of 26 participants, the authors reported less\ninflammation around the dental implants than around the corresponding natural teeth. Clinical\nexperience often shows abundant plaque accumulation on implant abutments; removing the\nplaque then reveals healthy peri-implant tissues (Figs 3a-b), a finding confirmed in this study,\nwhere 38% of the patients had high plaque scores but no correlation was found between\nplaque scores or bleeding index (Olerud and coworkers 2012).\nA different study found significantly more soft-tissue inflammation as well as cheek and lip\nbiting in edentulous patients over 80 years of age who were provided with fixed dental implant\nprostheses, compared to a younger control group with similar prostheses (p < 0.05), although\nthe implant survival rates were similar in both groups. Here it has to be borne in mind that\ncleaning fixed dental prostheses is extremely difficult for geriatric patients (Engfors and\ncoworkers 2004; Fig 2).\nPending more and stronger evidence, it is recommended that the prevention and treatment of\nperi-implantitis in geriatric patients are approached with the same protocols as in younger\nadults but with appropriate allowance being made for age and setting.\nGeneral setting for oral hygiene\nOral hygiene must remain part of the routine of daily personal hygiene. Sufficient time should\nbe planned for cleaning the teeth, mucosa and, if present, removable prostheses. Elderly\npersons unable to stand for long periods may appreciate a chair in front of the sink. Reading\nglasses or even a magnifying loupe should be used to enhance visibility (Fig 4). Good lighting\nis also helpful. Removable dentures may sometimes be slippery when covered with saliva, so\nfilling the sink with water or a towel may prevent fractures if the denture is accidentally\ndropped during cleaning (Fig 5)."
  },
  {
    "page": 225,
    "content": "Fig 2 Fixed implant-supported dental prostheses are particularly difficult to clean for elderly patients with reduced\ndexterity and impaired vision.\nFigs 3a-b The peri-implant tissues in elderly persons often show no signs of inflammation, despite abundant plaque.\nLocator attachments may fill with food debris, preventing the denture from being seated (a). A central filling with\ntemporary composite material may prevent this, but it requires the use of inserts without a central pin (b).\nFig 4 Most elderly patients require reading glasses for performing meticulous oral hygiene. Glasses may also be useful\nduring the dental consultation when oral findings are shown and explained to the patient. Do not hesitate to ask\npatients if they use glasses, as they may be too shy to admit that they cannot see very well."
  },
  {
    "page": 226,
    "content": "Fig 5 Filling the sink with water or a towel helps prevent denture fractures in case the denture is accidentally dropped.\nFigs 6a-b Prefabricated thick handles facilitate “safe” and efficient handling of a toothbrush by geriatric patients. The\nplug-on handles are dishwasher-safe and can be re-used with a new toothbrush. (a) Inava System toothbrush\n(Cocooncenter, Châlons-en-Champagne, France). (b) Extra Grip (TePe, Malmö, Sweden).\nFig 7 A tennis ball can also be used to adapt a toothbrush handle to an elderly person’s reduced manual strength."
  },
  {
    "page": 227,
    "content": "Fig 8 Power toothbrushes have a conveniently thick handle and offer good cleaning efficiency. However, they\nsometimes require substantial force and dexterity to switch on.\nChoice of appropriate oral-hygiene tools\nThe altered perception and dexterity of geriatric patients requires individually selected and\nadapted oral hygiene tools to match the patient’s intraoral status, visual acuity, and manual\nskills.\nFor example, in patients with osteoarthritis or sarcopenia, a larger-handled tool provides a\nmore effective grip. With the growing elderly population, manufacturers are now providing\nprefabricated tooth and denture brushes with thicker handles. Plug-on handles are also\navailable, which are dishwasher-safe and can be re-used (Figs 6a-b). A tennis ball or a\nbicycle handlebar grip may similarly be used to assist in holding a toothbrush firmly (Fig 7).\nFor patients with severe osteoarthritis, handles can also be individually shaped using silicone\nimpression putty, which can subsequently be converted to a more durable resin.\nMost electric toothbrushes have a thick and easy-to-hold handle that contains the battery (Fig\n8). Although their cleaning efficiency is excellent, their noise and vibration may not be\nappreciated by elderly persons, especially in the case of ultrasonic brushes. Furthermore, these\nbrushes are sometimes difficult to turn on, especially if the power button is protected by a\nwaterproof rubber layer. It would be preferable to have a model where the power can be\nturned on by pushing the brush on the table with both hands. Sometimes three-headed brushes\nare recommended that brush the lingual, vestibular, and occlusal surfaces at the same time.\nThese brushes are efficient, but when a loss of periodontal attachment has resulted in\nlengthening of the clinical crowns, the lateral bristles risk not reaching the gingival margin due\nto the occlusal stop. Other than that, any toothbrush will do, provided it is used regularly and\nefficiently. Most geriatric patients prefer their reliable old friend—the traditional manual\ntoothbrush."
  },
  {
    "page": 228,
    "content": "Fig 9 The central cavity of Locator attachments quickly accumulates biofilm and food debris. Special bristle brushes\nmay help to keep them clean (TePe Implant Care; TePe Malmö, Sweden).\nFigs 10a-b For ball attachments, a special brush with bent bristles is available that facilitates cleaning the undercut of\nthe ball. This brush may also be used for cleaning implant-supported bars (Access Oral Care; 3M ESPE, Seefeld,\nGermany).\nImplant superstructure hygiene\nImplant-supported prostheses sometimes present shapes that require special cleaning tools.\nCleaning implant-supported restorations is therefore more complex than cleaning natural teeth.\nIn the above-mentioned Swedish study, the 26 geriatric implant patients rated the ease of\ncleaning of their implants an average 5 on a scale from 0 to 10 (Olerud and coworkers 2012).\nGiven that most patients tend to give rather positive answers in interviews, this score indicates\nat least some difficulties.\nThe Locator attachment, for example, has a cavity on the occlusal aspect to accommodate a\ncentral pin of the retention insert. This cavity quickly fills up with biofilm and food debris,\nwhich may ultimately preclude denture insertion. Special rigid bristle brushes may help keep\nthese cavities clean (Fig 9). Alternatively, the cavity can be filled with a composite filling\n(Figs 3a-b). The latter should be provisional so that the abutment driver can still be used if\nrequired, and temporary composite materials such as those used for filling screw access canals\nhave proved to be successful.\nFor ball attachments, a special brush with bent bristles is available that facilitates cleaning the\nundercut of the ball (Figs 10a-b). This brush can also be used with bars or all other low-\nprofile attachments with undercuts. Bars are often less easy to clean on the lingual aspect and\nrequire special attention."
  },
  {
    "page": 229,
    "content": "Fig 11 Interdental brushes, also available in larger sizes, are effective in cleaning the mesial and distal surfaces of the\nimplant abutments, but fail to clean the lingual side (CPS soft implant; Curaden, Kriens, Switzerland).\nFig 12 Dental floss may be effective in cleaning below the bar and around the abutments, including the lingual surface,\nwhen passed around the abutments.\nFigs 13a-b Curved brushes with small heads may be an alternative for cleaning the lingual side of bars and for\nimplant-supported fixed dental prostheses. (a) Reverse and Focus Tip Brush (Erskine Oral Care, Macksville, NSW,\nAustralia). (b) TePe Implant Care (TePe, Malmö, Sweden).\nInterdental brushes are effective in cleaning the mesial and distal surfaces of the implant\nabutments, but despite being available in larger sizes, these fail to clean the lingual side (Fig\n11). Dental floss may be effective in cleaning below the bar and around the abutments,\nincluding the lingual surface, when passed around the abutments (Fig 12), but may be difficult\nto thread in place for an elderly person with reduced dexterity or visual acuity. Bent small-\nheaded brushes may be an alternative in cleaning the lingual side of bars and for implant-\nsupported fixed prostheses (Fig 13a-b). The latter should also be unscrewed in the dental\noffice for professional cleaning of the implants and the superstructure, at intervals adapted to"
  },
  {
    "page": 230,
    "content": "the patient’s own ability to keep the restoration clean. Again from a hygiene point of view, the\nmost critical areas are located between the prosthesis and the mucosa of the alveolar ridge as\non the lingual side of the implant abutments. Beyond the tools mentioned above, there is an\nexhaustive variety of oral-hygiene instruments designed for cleaning implant-supported\nprostheses, with new products appearing on the market almost every month.\nDenture hygiene\nIt seems trivial but needs to be explicitly mentioned to a patient receiving an implant-\nsupported removable prosthesis: the denture needs to be taken out for cleaning!\nPatients also need to understand that not only the denture teeth need cleaning; the intaglio\nsurface of the denture also requires a through brushing at least once a day. Special denture\nbrushes are available that reach all regions of the denture base (Fig 14), even where small\nedentulous ridges render the cleaning of the denture’s intaglio surface with a conventional\ntoothbrush impossible.\nAcrylic dentures can be cleaned exactly like household tableware; most patients understand\nthat mechanical brushing is mandatory when it comes to doing the dishes and that the same\nprinciple applies to their dentures. No expensive fluoride toothpastes are required—cheap\ndishwashing liquid or hand soap will do. The latter has the added advantage to have a\ndistinctly unpleasant taste, which may encourage better cleaning—if only to avoid the terrible\ntaste.\nAlthough the use of ultrasound baths or denture cleansers may help loosen stains or debris and\nperhaps provide a feeling of freshness in the mouth, they are not mandatory for keeping a\ndenture clean. A recent Cochrane review on interventions for cleaning dentures in adults\nrevealed that despite a lack of comparative studies, both mechanical and chemical cleaning\nseem superior to placebo (de Souza and coworkers 2009).\nOccasional professional cleaning at the dental office or laboratory is useful if stains and\ndeposits are not removed by the daily routines. Various methods are available, including\ncleaning in a vinegar-based cleansing bath with mechanical cleaning performed by swirling\nstainless-steel needles in a magnetic field (C2S, Lyon, France or Renfert, Hilzingen, Germany)\n(Figs 15a-c)."
  },
  {
    "page": 231,
    "content": "Fig 14 Denture brushes are large and rigid and have one side shaped to reach the narrow ridge parts of the denture\nbase.\nIf professional cleaning is required too often, a layer of clear acrylic can be added to cover\nany surface details or retention niches and make the surface of the prosthesis smoother.\nFigs 15a-c In-office denture cleaning may be performed in a vinegar-based cleansing bath (C2S, Lyon, France).\nFig 16 Biofilm may cause denture stomatitis."
  },
  {
    "page": 232,
    "content": "Fig 17 Microfiber glove to wipe down and massage the oral mucosa and edentulous ridges (Dr Hahn’s Ibrush; Tootec,\nTübingen, Germany).\nDenture storage during the night\nTo wear or not to wear the denture at night—that is a question often heard from patients.\nSeveral aspects have to be considered. When anterior teeth are replaced and removing the\ndenture is esthetically disfiguring, patients may prefer wearing their denture during the night for\ntheir self-esteem. They may also want to maintain their “prosthetic privacy” and keep their\ndental status a secret (Müller 2014). Meticulous hygiene is of even greater importance with\nnocturnal denture wearing, as the oral mucosa is never left uncovered for a prolonged period.\nUnder these conditions, the oral mucosa presents the same changes as the skin under a wide\nfinger ring. Additional mechanical load and prolonged biofilm exposure may cause denture\nstomatitis, which in its most common form is characterized by redness and swelling of the\nmucosa, corresponding to the shape of the denture base (Fig 16). Leaving the denture out\nduring the night seems therefore preferable, if the patient is willing. A recent cohort study in\n524 randomly selected seniors confirmed a 2.3-fold risk for developing aspiration pneumonia\nwhen a denture is worn during the night (Iinuma and coworkers 2015). Storing the denture\novernight under dry conditions is recommended to challenge the survival of bacteria and fungi\nin the biofilm. The slight distortion of the prosthesis caused by dehydration in dry storage may\nbe reversed by soaking the denture in clear water before inserting it the next morning.\nEdentulous ridges and tongue\nAlthough plaque adheres well to hard objects such as teeth and dentures in the mouth, a\nsubstantial bacterial load may also accumulate on the edentulous mucosa and on the tongue. As\nmentioned before, less vigorous chewing in elderly persons diminishes the self-cleaning effect\nduring eating. Deposits on the tongue appear clinically as a yellowish or brownish tongue\ncoating. The latter has even been identified as a risk factor for pneumonia in edentulous elderly\npatients (Abe and coworkers 2008)."
  },
  {
    "page": 233,
    "content": "Figs 18a-b Tongue scrapers exist in various forms and shapes.\nMicrofiber gloves are available to wipe and massage the oral mucosa and edentulous ridges\n(Fig 17). Although a toothbrush may also be used for gently massaging the tissues, some\nelderly patients, especially those with cognitive impairment, refuse to allow a toothbrush in\ntheir mouth. For these patients, the microfiber gloves are a more gentle way of scrubbing at\nleast some of the biofilm off. These microfiber gloves also allow a vestibular wipe in special-\ncare patients (or in children who refuse to open their mouth for more conventional oral\nhygiene).\nTongue scrapers exist in various forms and shapes (Figs 18a-b). Tongue scraping reduces the\nbacterial load in the oral cavity and helps reduce halitosis (Van der Sleen and coworkers\n2010). An initial gagging reflex may be perceived as unpleasant, but this is often less marked\nin the evening.\nOral hygiene in an institutionalized setting\nAlong with the loss of autonomy, oral hygiene becomes more and more the responsibility of the\ncaregiver staff. In geriatric nursing, maintaining the patient’s autonomy is one of the priorities\nof care; consequently, patients are expected to perform oral hygiene themselves for as long as\npossible. Gradually, patients will first require supervision and motivation, then assistance.\nWith further functional decline, the procedures have to be performed entirely by the nursing\nstaff. Occupational therapy may help to maintain autonomy, especially in residents with a mild\ncognitive impairment (Bellomo and coworkers 2005). At this stage, implant-supported\ndentures may become problematic, as knowledge regarding such “high-tech” prostheses is\nscarce amongst caregivers. The threshold for not wearing a denture becomes lower as patients\ntend to become less demanding with age, frailty, and multimorbidity.\nGeneral recommendations for oral hygiene in patients with mild functional impairment include:\nMild dependency\n•\nSupervise and motivate oral hygiene.\n•\nEmploy occupational therapy to maintain autonomy for as long as possible.\n•\nChoose tools adapted to the individual functional capability of the patient.\nBrushing technique for bedbound patients"
  },
  {
    "page": 234,
    "content": "• Sit the patient upright in bed (lower risk of aspiration).\n• Hold a kidney dish under the chin.\n• Place yourself behind the patient.\nFig 19 In bedbound patients, the caregiver should be behind the patient and keep the mouth open with the left hand.\nThis allows the right hand to perform the usual cleaning movements.\n• Support the patient’s head with one hand.\n• Brush teeth with the other hand using your “own” technique.\n• Remove the denture twice a day for thorough cleaning and rinse after each meal.\nComforting measures\nFor patients who are unconscious, ventilated, or have problems spitting or swallowing,\ncomforting measures may be indicated:\n• Wipe oral cavity with gauze soaked with tea or rinsing solution.\n• Apply ointment on the lips.\n• Cool the mucosa with pineapple lozenges.\n• If oral infections are present: wipe with 0.1% chlorhexidine.\n• If xerostomia is present: use sprays of artificial saliva or humidifying gel on the tongue.\n• If dentures are present: preferably leave them out and store them in a safe and dry place.\n• Assure oral comfort by removing sharp edges from restorations or implant superstructures.\nIn a clinical setting, the proposed measures may be combined or modified according to the\npatient’s individual oral status and health. If natural teeth are still present, the increased risk of\ncoronal and root caries may require prevention by intense fluoridation with gels, varnishes, or\ntoothpaste (Pretty and coworkers 2014; Srinivasan and coworkers 2014b). As xerostomia\nexacerbates the risk of caries and mucosal inflammation, symptomatic relief of xerostomia\nshould be included in any preventive scheme for geriatric patients."
  },
  {
    "page": 235,
    "content": "11\nThe Ailing Patient\n \nF. Müller"
  },
  {
    "page": 236,
    "content": "Introduction\nIn the fourth stage of life, when dependency sets in and physical, mental, or social frailty\ndominate life, dental care and preventive needs become distinctly different (Pretty and\ncoworkers 2014; Fig 1). Access to oral health care may be limited by multiple barriers such as\npoor mobility, unavailability of mobile dental services, or simply cost (Nitschke and\ncoworkers 2005). Patients with a cognitive impairment may find it difficult to express a\ntreatment need. Even in ailing patients who are able to explain their need for treatment, a\nstriking modesty concerning their needs and expectations can often be noted (Vigild 1993), and\nthey may understate the difficulties they are experiencing. Routine checkup visits are not\nmandatory for long-term care residents, and ailing patients maintain their right to self-\ndetermination concerning their health care, unless allocated a legal guardian. Access to dental\nservices for ailing patients who receive domiciliary care is even more restricted, as it may be\ndifficult obtain support from health professionals in organizing a visit at, or by, a dentist. Yet\nailing patients should, as far as possible, expect to receive the same high-level comprehensive\noral health care, whether living at home or a LTC facility.\nTreatment planning for ailing patients\nTreatment planning has to take into consideration the patient’s physical and mental handicaps\nas well as the possibility of declining autonomy in managing fixed or removable prostheses\nand essential oral hygiene. As mentioned, the ailing patient might not be interested in long and\ninvasive treatment procedures, such as implant placement or bone augmentation. Chronic\ndiseases and the effects of their treatment may also limit the range of possible surgical\ninterventions. A lack of saliva, perhaps caused by polypharmacy, increases the risk of caries\nand renders the oral mucosa more delicate. Muscle coordination is likely to be impaired, and\nswallowing disorders can occur. Furthermore, psychological afflictions such as depression\nhave a high prevalence in ailing and elderly patients, which may affect the prosthodontic\ntreatment outcome and recall compliance. Treatment planning also has to take into account the\npatient’s life expectancy and the cost/benefit ratio of the planned intervention.\nOften the most limiting factor in treatment planning can be the patients’ resistance or resilience\nto any dental intervention. For how long will they be able to sit in the dental chair? Can they\nopen the mouth and remain still? What will my working conditions be in terms of visibility and\naccessibility, will patients be able to tolerate a supine position in the dental chair (Fig 2)?\nHow will they react to an impression tray? Will they be frightened by radiographic apparatus?\nHow can we manage bed-bound patients in a domiciliary setting? And lastly, will the patient\nbe able and sufficiently compliant to follow simple instructions? All these issues need to be\nclarified before commencing a treatment that, once started, must be finished. Even with many\nyears of clinical experience, this is one of the most difficult decisions in geriatric treatment\nplanning. Some patients have a “day form”—they appear fit and compliant one day, while the\nnext day they may be disoriented, fatigued, or absent-minded."
  },
  {
    "page": 237,
    "content": "It is essential to evaluate ailing patients’ capability to undergo dental treatment in a\npreparatory treatment phase to avoid failure and premature abandonment of a restorative\ntreatment.\nFig 1 In the fourth stage of life, dental needs become distinctly different.\nFig 2 Transferring the ailing patient to the dental chair may be difficult.\nAiling is not a linear process, and general health may deteriorate at any time. The medical\nhistory must be updated regularly and the treatment plan adapted if necessary. However, the\npracticality of maintaining complex or even simple implant-supported restorations that were\nprovided when the patient was more able physically and mentally should not be\nunderestimated. Even simple treatments for minor technical complications may be very\nchallenging; the meticulous procedures required for the treatment of peri-implant disease will\noften be so difficult as to be beyond consideration, and this should be anticipated in planning\nthe treatment for elderly patients before they become too frail.\nEthical considerations\nAiling patients are considered a vulnerable patient group, and dentists, as part of the patient’s\nsocial network, have a responsibility to detect and react to elder abuse. Elder abuse may be\ndefined as violating a vulnerable older person’s human and civil rights. Psychiatric illness and\nphysical frailty, sensory impairment, social isolation, and physical dependency are important\ncauses of vulnerability to abuse (Cooper and Livingston 2014). Maltreatment of elderly, very"
  },
  {
    "page": 238,
    "content": "old, and dependent persons is more common than generally assumed, and violence against\nelders has a reported prevalence of up to 10%. Psychological maltreatment may comprise\nvilification, belittlement, infringement of rights, or ignorance of vulnerable seniors. In addition\nto physical violence, the withdrawal of food, clean clothes, or economic means are all forms\nof abuse. Dentists should be mindful of assessing whether or not any accompanying caregiver\nor guardian is trustworthy and whether they should be present during the consultation and\ndecision-making process. Ailing patients’ decisions for or against a suggested treatment should\nalways be respected. The dentist’s role is to provide the professional knowledge required for\nadequately informed consent, without influencing or manipulating the patients’ decisions.\nAssessing the capacity to consent to treatment is not always easy; in case of doubt, a referral to\na memory clinic for an in-depth examination may be indicated.\nOur care for ailing elders should adopt a humanitarian and holistic approach (Fig 3),\nespecially as medicine has become high-tech and machine-driven. Ailing, elderly patients may\nbe intimidated, for example, by a 3D tomography unit, and the negative psychological impact\non the treatment or the patient’s trust in the dentist may outweigh most of the diagnostic value of\nsuch an intervention. Respect and recognition of the patient’s values and lifetime achievements\nshould feature in the doctor-patient relationship, as this will in turn engender the patient’s trust\nin and respect for the dental professional. Shuman and Bebeau (1996) summarized some basic\nethical principles of the treatment of vulnerable elders as follows:\nFig 3 Caring for ailing elders should adopt a humanitarian and holistic approach.\nAutonomy\nRight to self-determination\nNon-maleficence\nDuty to do no harm\nDuty to prevent harm to others\nDuty to remove harm from others\nBeneficence\nObligation to do good for the benefit of others\nJustice\nObligation to treat others fairly, not discriminate, distribute\nresources fairly"
  },
  {
    "page": 239,
    "content": "Truth-telling\nDuty to tell the truth\nFidelity\nObligation to keep promises\nDentists would do well to remember the age-old maxim:\n“Patients do not care how much you know, until they know how much you care.”\nImplants in the ailing patient\nWhen considering implants in the treatment of ailing patients, two distinctly different scenarios\nhave to be distinguished:\nThe first scenario is the placement of new implants, which is critical, given that the ailing\npatient may increasingly lose the capability to manage implant-supported prostheses and\nperform adequate oral hygiene. The widespread assumption that patients request “tight” and\nfirmly fitting dentures does not apply to all elderly adults. Some patients openly admit that their\noral comfort dominates their prosthodontic treatment choices. However, considering the\nabovementioned ethical aspects, it seems unreasonable to withhold the means of modern\ndentistry to an ailing patient if they request implants for a justified indication. Also, there are\nmany different varieties of “ailing,” and recommendations therefore cannot be generalized.\nHowever, when opting for implants, the circumstances should be as close to ideal as possible.\nAnimal experiments showed a lower rate of implant-to-bone contact if a low-protein diet was\nprovided during osseointegration (Dayer and coworkers 2007; Fig 4). Food supplements\nshould therefore be considered during the healing phase, particularly when masticatory\nperformance is inevitably impaired.\nFig 4 Defective implant osseointegration under protein undernutrition in animal experiments (reprint with permission\nfrom Dayer and coworkers 2010)."
  },
  {
    "page": 240,
    "content": "Fig 5 Muscle weakness and reduced dexterity in frail elders may preclude the autonomous management of a\nsophisticated implant-supported prosthesis.\nThe second scenario applies to functionally declining patients who had implants placed while\nthey were still fit and the surgical intervention was no barrier. Ideally, these patients can\nbenefit from their implants for the rest of their lives if maintenance of their implant-supported\nprosthesis is assured. There is a need for an active and strict follow-up program, with\nappropriately adapted recall intervals, so as not miss the point for “backing off” to a\ntechnically less sophisticated prosthodontic solution (Fig 5).\nMonitoring the use and handling of fixed and removable implant-supported prostheses in\nailing patients seems mandatory. When functional decline and frailty preclude denture\nmanagement, “backing off” to a less sophisticated and simplified restoration with or\nwithout the implants may become necessary.\nIn practical terms, this back-off strategy could imply the replacement of a fixed reconstruction\nby a removable prosthesis, which is easier to manage and clean for the patient or the caregiver.\nGreat care should be taken to duplicate as many features as possible from an old fixed\nreconstruction to which the patient has become well adapted, to facilitate adaptation to the new\nprosthesis by avoiding unnecessary challenges to neuroplasticity.\nTechnically, in a few years’ time, an existing fixed implant dental prosthesis might be scanned\nintraorally and an identical dental arch milled or 3D-printed as a removable prosthesis.\nBacking off could also mean the gradual simplification of the current overdenture attachment\nsystem. For example, bar, Locator, or CM LOC attachments seem more difficult to manage than\nball or magnetic attachments."
  },
  {
    "page": 241,
    "content": "Fig 6a The edentulous patient had two interforaminal implants to support her mandibular overdenture.\nFig 6b Her dentures had been stored in the bathroom cabinet for months as she became too weak to seat the denture\nwith the famous “click.”\nFigures 6a-e depict a geriatric patient for whom the optimum time for a backing-off strategy\nwas missed. Her dentures had been stored in the bathroom cabinet for months as she became\ntoo weak to seat the denture with the famous “click.” The nursing staff accepted this situation\nas inevitable and the patient did not ask for a dental visit, although she was on a recall program\nand did have the contact details. At a first glance, when she opened her mouth, considerable\nfood debris was seen, with just a glimpse of the heads of the two ball attachments. The peri-\nimplant mucosa had grown over large parts of the implant, precluding denture insertion. The\nprocess of frailty had progressed rapidly, and transporting the patient to the dental office even\nfor a minor excision of the gingiva was disproportionate, given her condition. It was decided\nto unscrew the ball attachments and replace them with healing caps. A localized reline with a\ntissue conditioner filled the female part of the ball attachments. The patient re-used her\ndentures during the days and for meals, although she relied on denture adhesives until she\npassed away around 2 years later."
  },
  {
    "page": 242,
    "content": "Fig 6c Large morsels of food debris; only the heads of the two ball attachments are visible.\nFig 6d Peri-implant mucosa overgrowing the implants, precluding denture insertion.\nFig 6e The back-off strategy meant unscrewing the ball attachments and replacing them with healing caps."
  },
  {
    "page": 243,
    "content": "Fig 7 With progressing dementia, patients become less compliant for dental interventions. The extraction socket puzzles\nthe patient, who explores the wound with her fingers.\nSuch a situation demonstrates the advantage of two-piece implant systems over one-piece\n“mini-implants” where it is impossible simply to unscrew the abutment. The sectioning of a\none-piece implant to remove the intraoral part, causing soft-tissue trauma with potential\nconcomitant infection and pain, would not be a simple back-off procedure. Furthermore, a\nhigh-speed rotary instrument to render the implant comfortable may not be available in a\ndomiciliary setting, and the procedure could also be impossible in terms of patient compliance\nwithout recourse to sedation or general anesthesia, with the associated risks and serious\nimplications for the patients’ medical condition.\nThe cognitively impaired patient\nThe prevalence of cognitive impairments increases with age, with more than half of the\npopulation suffering from dementia at the age of 90 years or over (Graves and coworkers\n1996). Several types of dementia exist, with Alzheimer’s type being the most prevalent.\nClinical symptoms vary greatly and include a progressive loss of memory accompanied by\ndiminishing language skills, dyspraxia, impaired cognition, and a decline in executive\nfunctions, as well as a loss of social competence (American Psychiatric Association 1994).\nThe disease progresses slowly but although treatment may alleviate the symptoms, a cure does\nnot yet exist. Impaired motor coordination is one of the clinical symptoms; in the final stages of\nthe disease, even chewing movements may become “de-programmed.”\nPersons with dementia generally have poorer oral health and fewer teeth than healthy controls\n(Syrjälä and coworkers 2012). Effective motor control of complete dentures is also affected.\nWeight gain seems to reduce the morbidity of the condition; hence, improving the chewing\nefficiency by prosthodontic means seems intuitively beneficial (Faxen-Irving and coworkers\n2005; White 1998). In the final stages of the disease, dentures are rarely used, and implants\nmay cause injury, infection, discomfort, and pain (Taji and coworkers 2005). Dental treatment\nbecomes increasingly difficult when access to the mouth is violently refused by demented\npatients (Fig 7). Conscious sedation or even general anesthesia may become necessary.\nExisting implants should be “put to sleep” in good time by connecting gingiva-level healing\ncaps. When necessary, adhesive pastes may be prescribed for denture use when necessary.\nPalliative dentistry"
  },
  {
    "page": 244,
    "content": "Terminally ill patients for whom a cure is not possible will receive palliative care, which no\nlonger focuses on curing the disease but aims to alleviate discomfort and pain. It is an\napproach that improves the quality of life of patients and their families, facing the problems\nassociated with life-threatening illness, through the prevention and relief of suffering by\ntreatment of pain and other problems, be they physical, psychosocial or spiritual (WHO 1990).\nPalliative dentistry deals with the specific oral symptoms patients experience from either their\ndisease or its treatment that have a direct impact on their oral health related quality of life\n(Wiseman 2006). Most often, these are side effects of chemotherapy, which renders the oral\nmucosa sensitive to the point where this precludes denture wearing or adequate oral hygiene\n(Fig 8). Radiotherapy may additionally affect the salivary glands and cause xerostomia (Fig 9).\nAt the same time, the patient may need some unrelated dental treatment, for example the repair\nof a fractured filling or a denture reline. These conventional treatments also have to be planned\nin view of the patient’s life expectancy and quality of life. A need for dental treatments in a\npalliative-care setting is not rare, and it would be desirable to have a dentist and a hygienist in\neach palliative care team (Fig 10). Most treatment demands for a dental visit are related to\npain or denture maintenance, but esthetic repairs are also common (Schimmel and coworkers\n2008).\nWhen removable prostheses are not worn, implants may be problematic if they cause injury or\ninfection. If this is the case, the dental treatment should be limited to the elimination of sharp\nand disturbing elements from the oral cavity, which in some cases means unscrewing the\nattachments and putting the implants to sleep. Local chlorhexidine gel and mouth rinses may\nhelp control infection and thus alleviate pain. In palliative dentistry, it is even more important\nto respond to the patient’s requests, as this vulnerable group does not have many available\noptions in terms of treatment.\nFig 8 Radiotherapy renders the oral mucosa sensitive, and dental restorations or prostheses may cause pain and injury\n(after MacEntee and coworkers 2010)."
  },
  {
    "page": 245,
    "content": "Fig 9 Artificial saliva alleviates the symptoms of hyposalivation.\nFig 10 The patient- and family-centered care team should ideally comprise a dentist and a dental hygienist."
  },
  {
    "page": 246,
    "content": "12\nManagement of Technical and Biological\nComplications\n \nS. Barter"
  },
  {
    "page": 247,
    "content": "A great proportion of the literature relating to implants in the elderly patient focuses on the\nprovision of implants and related prostheses. It is clear that chronological age alone is not a\nbarrier to successful implant integration; the substantial benefits to oral health, function, and\nquality of life that can be provided are shown in other chapters of this book. However, we\nmust consider not only the provision of such treatment, but also the inevitable ongoing\nmaintenance requirements.\nIn elderly patients, planning a simple prosthesis designed for their current and likely future\nneeds should be relatively predictable. However, as a result of an aging population, we will\nface an increasing number of patients who were provided with implant-borne prostheses at a\ntime in their lives when they were younger, fitter, and more able. At the time of provision, it\nwas relatively easy for them to seek and receive preventive or interceptive treatment for their\nimplant-retained prostheses. The need for such treatment will not decline as the patient ages; in\nfact, it may be more necessary even as it becomes less practical.\nMuch as we would like to think our treatment will be perfect and that the prostheses we make\nwill last forever, this is unlikely to be the case. Biological and technical complications will\noccur in many patients, and the risk is only likely to increase with the time the restoration has\nbeen in place. This may have implications on the oral health and well-being of the patient, can\ninfluence the possibility of continuing with an implant-retained prosthesis, and will inevitably\nbring further cost. Patients need to be advised of both the inevitability of the required\nmaintenance and of the nature of the complications that may arise, not only from the surgical\nprocedures involved but also in terms of technical complications with the prosthesis and the\nrisk of peri-implant disease.\nThere are well-known criteria that are accepted as defining success, rather than the survival of\nan individual implant, but not all studies report the data necessary to determine whether these\ncriteria were met. In general, studies looking at survival rates consider whether the prostheses\nunder review have remained in service for the duration of the study. However, considerable\nnumbers of “surviving” prostheses have suffered technical complications, whose prevalence\nmay be greater than indicated in the literature due to underreporting—most studies report\nexperiences in hospitals or specialist centers and may not reflect the wider primary-care\nsituation.\nThe etiology of biological complications is patient-related and multifactorial: genetic\nsusceptibility to periodontal disease, medical factors such as diabetes, poor oral hygiene, etc.\nHowever, biological complications may also arise from iatrogenic factors such as poor\nsurgical technique, poor prosthesis design, excess cement, or similar operator-related faults. It\nis one thing to reduce the risk of peri-implant disease by increasing patient compliance, but\nquite another to ensure that patients can actually manage what is required. For older patients\nwith conditions that may preclude adequate compliance, their caregiver will need to be able to\ndo what is necessary. Risk management begins with the planning of the most suitable"
  },
  {
    "page": 248,
    "content": "prosthesis, not with its delivery.\nSimilar considerations apply to technical complications, which are largely related to\nprosthetic design and to the nature of the materials used. Recent systematic reviews suggest a\nminor improvement in our ability to avoid esthetic, and some technical, complications when\ncomparing data in the last decade or so with older data, although the incidence of biological\ncomplications has remained relatively unchanged and the rate of all such complications is still\nhigh (Pjetursson and coworkers 2014).\nThe validity of such findings has to be considered against the weaknesses in the data and,\ntherefore, the conclusions that we may draw. In general, most studies are uncontrolled,\nretrospective, and have low power in terms of the number of patients included. Many\nsystematic reviews fail to assess the reliability of the included studies and may not detail any\ncontrol group. When complications are reported, it is necessary to consider the level we use to\nmeasure success—it is not valid to use an individual implant as a success marker. If several\nimplants in the same “favorable” patient are used as individual units for analysis, this may not\nresult in valid statistics if, in that individual, it is the patient-related factors that have the\ngreatest influence on the outcome (Chuang and coworkers 2002).\nStudies reporting the rate and nature of complications may be interesting and valuable if they\ncan be used to guide the clinician in choosing the best treatment plan for an individual patient.\nHowever, the patient is the one who will ultimately tell us whether they share our view of\nsuccess. Patient-centered outcomes are equally important measurements and are not always\nreported.\nWhen considering the success of our treatment overall, we need to consider different factors\n(Papaspyridakos and coworkers 2012a; Chung and coworkers 2009):\n•\nHave we achieved the intended rehabilitation as planned and agreed with the patient?\n•\nHave we satisfied the desired patient centered outcomes?\n•\nOver time, is the rate of technical complications low and only requires simple intervention?\n•\nIs hygienic maintenance achievable and maintains peri-implant tissue health?\n•\nIs the longevity of the prosthesis adequate such that the original and on-going costs of\ntreatment and maintenance produce good health economics?\nThere is little data on whether the rate of complications increases in the elderly patient.\nStudies indicate that osseointegration is unaffected by age alone. Is this relevant? Is the failure\nof an implant to integrate a greater problem than a significant peri-implant bone defect with\nsoft-tissue inflammation and suppuration? Or, for that matter, healthy implants supporting an\nimplant-retained overdenture that is now intolerable to a patient suffering from a\nneurodegenerative disease who refuses to wear the denture but suffers severe oral ulceration\nfrom the intraoral components? How easily will such conditions be treated in an elderly\npatient of increasing frailty?"
  },
  {
    "page": 249,
    "content": "Technical complications\n•\nImplant fracture\n•\nAbutment loosening/fracture\n•\nScrew loosening or fracture\nFixed prosthesis\n•\nMisfit\n•\nLoss of screw hole seal\n•\nLoss of cement\n•\nDamage to veneering material\nRemovable prosthesis\n•\nWear or loss of retaining components\n•\nDamage to or loss of prosthesis\nMechanical complications with implant-retained prostheses are common and almost inevitable\nas a result of functional wear. It is difficult to evaluate accurately the true incidence of\ntechnical complications. In one study, the authors observed that four large systematic reviews\n(Lulic and coworkers 2007; Pjetursson and coworkers 2007; Aglietta and coworkers 2009;\nTan and coworkers 2004) provided data from less than 100 reconstructions on cumulative\ncomplications at five and ten years. Concluding their own study, they highlighted the fact that\nthe literature alone cannot be used to choose between different treatment options for a\nparticular patient (Brägger and coworkers 2011).\nImplant fractures are rare (Fig 1a), but more commonly associated with reduced-diameter\nimplants (Allum and coworkers 2008). However, a fractured retaining screw inside an implant\nmay be impossible to retrieve (Fig 1b), which not only renders the implant useless but also\nhinders the placement of a new implant in a suitable nearby location (Fig 2).\nFig 1a A mandibular overdenture with reduced-diameter implants that have fractured as a consequence of poor\nprosthetic design."
  },
  {
    "page": 250,
    "content": "Fig 1b A fractured abutment-retaining screw—difficult to retrieve in a patient with Parkinson’s disease.\nFig 2 The fractured implant is impossible to retrieve and precludes further implant placement in this position.\nIn fixed prostheses, problems with component fit are associated with biological problems such\nas mucosal inflammation and marginal bone loss due to bacterial accumulation, or increased\nwear and consequent risk of loosening or fracture of components (de Torres and coworkers\n2011).\nFig 3 Hyperplasia and ulceration associated with an overdenture.\nA discrepancy of 150 µm may be acceptable (Jemt and Book 1996). However, discrepancies\nof up to 500 µm may be difficult to detect clinically, especially when the margins are\nsubgingival. Periapical radiographs are recommended, but non-parallelism of the primary\nbeam can cause misdiagnosis (Kan and coworkers 1999; Sharkey and coworkers 2011).\nTechnical complication rates for full-arch fixed implant prostheses have been estimated at"
  },
  {
    "page": 251,
    "content": "24.6% per 100 restoration-years; in more recognizable terms, two-thirds of prostheses in this\nstudy had suffered some form of complication at five years, and at ten years, this figure was\nover 90% (Papaspyridakos and coworkers 2012b). These numbers are consistent with other\nstudies on the same topic.\nScrew loosening remains one of the most frequently reported complications in implant-\nsupported single crowns; in fixed and removable prostheses, the most common events appear\nto be fracture of the veneering materials or dentures, or loss of overdenture retention\n(Papaspyridakos and coworkers 2012b; Pjetursson and coworkers 2012; Bozini and\ncoworkers 2011).\nIn overdenture patients, the most common complication is loss of retention, normally due to\nwear and tear of the retaining elements. As would be expected, this will be time-related, but it\nis also related to other factors such as the nature of the opposing dentition, prosthesis design,\nand parafunction (Payne and Solomons 2000). Overdentures often have a higher rate of\ncomplications in the immediate post-insertion period relating to comfort and have a need for\nmore frequent maintenance, with associated costs (Zitzmann and coworkers 2005).\nBiological complications\n•\nTraumatic ulceration of soft tissues\n•\nSoft-tissue hyperplasia/hypertrophy\n•\nMucosal recession\n•\nPeri-implant disease\n•\nImplant loss or removal\n•\nCombination syndrome\nAge-related changes in the resilience of the oral mucosa are more commonly seen after the age\nof 70. Histological changes in mucosal structure and vascularity cause a loss of resilience,\nwhile increased susceptibility to mechanical and chemical trauma causes ulceration\n(Nedelman and Bernick 1978). The mucosa is more atrophic, and inflammatory changes last\nlonger, even where clinical symptoms are less intense. Oral mucosal conditions are more\nprevalent in elderly populations and are more frequent in denture-wearers (Jainkittivong and\ncoworkers 2002; Fig 3).\nMechanical irritation from ill-fitting dentures may cause hypertrophic conditions such as\ndenture stomatitis, even when then prosthesis is implant-supported. Multiple risk factors may\nalso be implicated, for example candidiasis and systemic factors such as diabetes. Hyperplasia\nof tissues under a bar or a fixed bridge may also occur due to inflammatory changes and may\nnot only cause discomfort; access for effective oral hygiene may be more difficult, further\nworsening the condition (Figs 4 to 6)."
  },
  {
    "page": 252,
    "content": "The increased friability of the oral mucosa may lead to recession around implants, particularly\nin the presence of a thin tissue biotype. While some elderly patients may not be concerned\nabout any degradation in the esthetic appearance, the exposure of the textured implant surface\nwill lead to increased rates of plaque formation, again potentially worsening the peri-implant\ntissue health and leading to peri-implantitis.\nThe periodontitis-susceptible patient is at greater risk of peri-implant disease (Ong and\ncoworkers 2008; Heitz-Mayfield 2008). While there are established protocols for the\ntreatment of periodontal disease that are effective in preserving teeth, there are no accepted\nprotocols that have been shown to be superior in treating peri-implant disease (Claffey and\ncoworkers 2008).\nIt is consequently invalid to anticipate that long-term implant success in the periodontitis-\nsusceptible patient can be achieved using the same principles of periodontal treatment, for\nestablished peri-implant disease.\nBiological complications are possibly as underreported as technical complications; peri-\nimplant tissue conditions are often reported in different ways or may not be reported at all in\nsome studies (Berglundh and coworkers 2002). The reporting of peri-implant marginal bone\nloss by means of radiographic evaluation may not always be reliable. An accurate evaluation\nrequires reproducibility of the exposure and positioning of the film/sensor. Panoramic imaging,\nused in many studies, is rarely valid as a technique for such evaluation; it is only possible to\nvisualize the proximal bone levels, which gives limited information.\nThe relevance of detection and reporting of biological peri-implant conditions is illustrated in\na study of mandibular fixed full arch reconstructions (Gallucci and coworkers 2009a). While\nmost of the implants had survived after five years, peri-implant health parameters showed a\nstatistically significant difference over this time, which was attributed to “oral hygiene being\nmore challenging.” When the peri-implant health parameters were considered, the true implant\nsuccess rate was significantly worse. Oral hygiene may be difficult with greater amounts of\n“pink prosthetics,” or, worse still, may be impossible when the prosthesis has a flange (Figs 7\nand 8), perhaps to achieve adequate esthetics or to prevent escaping air from causing phonetic\ndifficulties."
  },
  {
    "page": 253,
    "content": "Figs 4 to 6 These images show soft-tissue hyperplasia under a maxillary bar; cleaning was difficult and therefore\nneglected, leading to advanced peri-implant bone loss.\nFigs 7 and 8 The design of this fixed reconstruction, with both upright and angled implants, made access for adequate\noral hygiene impossible, leading to severe mucositis and peri-implant marginal bone loss."
  },
  {
    "page": 254,
    "content": "Figs 9 and 10 This prosthesis was ultimately retained by one screw (the others having been lost or fractured) and many\nyears’ worth of accumulated calculus. The patient’s caregivers and relatives were completely unaware that the patient\ndid not have natural lower teeth.\nPeri-implant crestal bone loss exceeding 2 mm has been reported as a common biological\ncomplication in fixed prostheses, with an incidence of approximately 20% over five years and\n40% over ten years. Peri-implant mucositis showed a similar increase over time, rising from\napproximately 10% at five years to 20% at ten years (Papaspyridakos and coworkers 2012b).\nA similar doubling of incidence was observed with soft-tissue hyperplasia, which will also\nmake peri-implant cleaning more difficult.\nAge-related changes in collagen turnover, immunosenescence, the effect of medications, the\nimpact of a lifetime of smoking, medical conditions, and psychosocial factors including stress\nor depression are all examples of factors that may affect the control or progression of\nperiodontal disease in elderly patients—factors that are not yet fully understood. To date, there\nare no studies investigating the relationship between advanced age and the progression of peri-\nimplant disease.\nSome studies have shown that plaque accumulation in the older patient is more rapid than in\nthe younger individual (Brecx and coworkers 1985; Holm-Pedersen and coworkers 1980).\nOther studies have suggested that the composition of plaque may vary with age and that the role\nof different bacteria in plaque may change with advancing age. However, there is no evidence\nto suggest that there is any association between advancing age and peri-implant plaque\ncomposition in either healthy or diseased sites (Mombelli 1998). There are many other factors\nof potential greater significance in the progression of peri-implant disease, such as medical\nconditions and most importantly the ability of the elderly patient to perform home care\neffectively. The cumulative increase in the microbial burden is likely to have an adverse effect\non stagnation areas that are inaccessible for daily home care.\nWhen it is more difficult for the patient to clean their prosthesis or access professional care,\nthere may be a greater likelihood of peri-implant disease. In a small study examining fixed\nprostheses on implants, it was found that nearly 40% of implants described by patients as\n“difficult to clean” were affected by peri-implantitis (Schuldt Filho and coworkers 2014; Figs\n9 and 10).\nThe treatment of peri-implant disease in a geriatric patient may become progressively less"
  },
  {
    "page": 255,
    "content": "practical; even non-surgical therapy that does not require the removal of a fixed prosthesis can\nbe difficult to provide and may be impossible in an institutional setting, or for a patient with\nneurodegenerative conditions. The progression of the disease may lead to more severe\ninfection with a need for surgical intervention in a hospital setting, which is likely to be\nundesirable for all patients.\nThere are no studies investigating age-related differences in the outcome of regenerative\nsurgery in either periodontal or peri-implant defects. However, given the variability in\noutcome of such procedures in the age groups commonly studied, the additional difficulty in\nperforming these procedures and the potential reduced healing capacity associated with\ncommon medical conditions in the geriatric patient may render the consideration of this\ntreatment unlikely.\nThe effect of multiple factors\nThere will always be multiple site- and patient-specific factors that influence the outcome of\ntreatment with implants in terms of benefits and risks. Such factors may have complex\ninteractions, which may not be immediately apparent to the unwary clinician who is planning\ntreatment on a purely technical or mechanistic level.\nFor example, in a denture patient with xerostomia, the provision of an overdenture may\nprovide significant help with the relief of mucosal irritation. However, if the xerostomia is a\nresult of Sjögren’s syndrome associated with rheumatoid arthritis (RA), there can be a higher\nincidence of peri-implant crestal bone loss in patients with connective-tissue diseases (CTD)\nsuch as scleroderma and RA, possibly as a result of reduced mucosal vascularization resulting\nin impaired bone nutrition. There may also be higher peri-implant bleeding indices attributed\nto the vascular immunological component (Kovács and coworkers 2000b; Mosca and\ncoworkers 2009).\nThere could also be pharmacological implications, as patients may be taking corticosteroids or\nimmunosuppressants, potentially requiring management of adrenal insufficiency and impaired\nhealing. The same patient may be taking non-steroidal anti-inflammatory drugs and have a\nhigher bleeding tendency.\nImpaired manual dexterity may make the insertion and removal of the denture more difficult.\nProblems with the accurate placement or removal of the denture can also cause increased wear\non the retentive elements of the denture, or increase the risk of fracture. Patients may not\nremove the denture as often as recommended for cleaning; oral hygiene may also be affected by\nimpaired dexterity, and a specific plan with aids such as adaptation of toothbrush handles may\nbe indicated.\nProfessional hygienic intervention may therefore be required more frequently, with increased\ncost and implications for the patient in terms of accessing the necessary care.\nA further factor may be the effect of a well-retained implant-supported lower overdenture on a"
  },
  {
    "page": 256,
    "content": "previously successful conventional complete upper denture. A moderately stable and retentive\ncomplete upper denture may not in itself present problems when the lower denture is not stable\nand retentive, as this situation precludes high masticatory forces. However, the dramatic\nincrease in lower-denture stability provided by implants may render a previously successful\ncomplete upper denture less stable; the patient now displaces the upper denture more readily.\nImplant placement in the upper arch may be impractical or undesirable, and the situation may\nworsen over time as a result of combination syndrome.\nCombination syndrome was first described by Kelly (1972) as a group of specific changes\nseen in patients with complete maxillary dentures opposed by a mandibular Kennedy Class I\nremovable partial denture. The existence of the “syndrome” has been questioned because of the\nquality of published evidence (Palmqvist and coworkers 2003); nevertheless, multiple authors\nhave reported one or more of the clinical features, which undoubtedly have a very real impact\non patients.\nCombination syndrome is characterized by the following features:\n•\nLoss of bone in the anterior maxilla.\n•\nOvergrowth of the maxillary tuberosities.\n•\nPapillary hyperplasia of the palatal mucosa.\n•\nOvereruption of the anterior maxillary teeth.\n•\nVertical bone loss of the posterior mandibular edentulous ridges.\nThese changes result in decreased vertical dimension, a reversal of the curve of Spee, an\nanterior mandibular rotation, and poor denture fit and stability. It has been theorized that the\ncause may partly be the natural tendency of patients to favor chewing on remaining anterior\nteeth, as this allows generation of maximal force.\nMandibular overdentures are generally supported by implants in the anterior region with good\nbone quality and sparse innervation. A similar situation occurs where maximal function is\ngenerated anteriorly, and given the lack of periodontal proprioceptive feedback, the forces may\nbe even higher, again resulting in combination syndrome, possibly in as short a period as two\nyears (Thiel and coworkers 1996). Surgical correction is frequently required to address soft-\ntissue problems, and this may be impractical in an aging patient.\nIt can be seen that the provision of even “simple” treatment, here in terms of placing two\nimplants and an overdenture, is only part of the equation; the associated overall care\nconsiderations can become paramount.\nPrevention and management\nIt is perhaps logical to presume that the rate of both biological and technical complications\nincreases with the age of the prosthesis or the implants. However, the practicality of dealing\nwith these complications may decrease with increasing patient frailty."
  },
  {
    "page": 257,
    "content": "When considering the topic of implant therapy in the elderly patient, there are two generic\nsituations:\n•\nThe provision of an implant-retained prosthesis in an elderly patient.\n•\nThe maintenance of such treatment that was provided when the patient was less impaired.\nWhen considering what treatment to provide in an aged patient, we should be mindful of the\nfact that previously edentulous patients may have to re-learn old skills or learn new ones to\nmaintain peri-implant health. These two situations are fundamentally different:\n•\nIn the former, we have the opportunity to more readily assess existing and possible later\nfunctional or cognitive decline; we can design a simple treatment that is easy to care for, has\nlow maintenance requirements and a high degree of reversibility—we can design into our\ntreatment the possibility of adaptation to future needs or the simple resolution of problems\narising from technical or biological complications.\n•\nIn the latter, there is no possibility of this if the patient already has a complex prosthesis. In\na scenario of failing physical or mental health, surgical or prosthetic treatment to address a\nfailing implant or prosthesis could be complex and beyond practicality (Engfors and\ncoworkers 2004).\nRemoving an integrated implant is not easy, even in a situation of peri-implant bone loss.\nWhile instrumentation has been developed to use reverse torque to unscrew an implant, this is\nnot always successful and surgical intervention may be required, with a need for bone removal\nand consequent morbidity. Such procedures also cause psychological distress, and the loss of a\npreviously comfortable and functional prosthesis as a result of implant loss can affect the\nquality of life. The ability of elderly patients with declining neuroplasticity to adapt to changes\nwill be compromised; it is quite possible that they simply will not be able to adapt and that this\nwill have consequences for nutrition, self-esteem, and multiple other quality-of-life\nmeasurements.\nWhile the provision of implants may be helpful in avoiding a need to adapt to a significantly\ndifferent situation—for example in providing an implant-retained restoration in the newly\nedentulous patient, avoiding a denture—we have to think ahead. The management of even\nsimple complications such as retorquing a retaining screw or replacing the resin seal of a\nscrew-retained prosthesis may present difficulty in a geriatric patient. Such procedures may be\nmore difficult in an institutional setting or even impossible, for example in a patient with\ndementia.\nWhat is considered “simple” treatment may not always be so, particularly if the future\nmaintenance is likely to be more involved. For example, the increasing use of protocols\nproviding a full-arch fixed reconstruction on two short upright implants and two long angled\nimplants has raised interesting questions about how many implants are needed to provide a\nfixed prosthesis. This technique is often promoted as a “simplified” approach with no need for"
  },
  {
    "page": 258,
    "content": "grafting, and a reduction in cost as fewer implants are used. The implants are loaded\nimmediately, reducing treatment time and giving patients fixed teeth in one appointment, with a\nresult that may be as reliable as any other protocol. Such claims may be very attractive to\npatients and, consequently, to dentists.\nHowever, careful interpretation of the supporting evidence is required, as there may be a\nsignificant potential for technical and biological complications. There are few long-term high-\nquality data. Some of the supporting evidence is in the form of finite-element analyses, whose\napplicability to normal clinical conditions is questionable: the uniformity of modelled cortical-\nbone thickness is inappropriate, as the protocol calls for a significant reduction in crestal\nalveolar bone, reducing or removing the cortex. In the clinical situation, bone density varies\nconsiderably at different locations and no studies model the effect of loosening of one\nabutment. Effective monitoring of peri-implant parameters is not possible if there is a\nsignificant volume of pink prosthetics and a consequent lack of access for probing, and\ntherefore is often not reported.\nGiven that most of the load on an implant is transferred to the cortical bone in the first 2 mm or\nso of the implant and that there is abundant evidence that short implants work well (Pierrisnard\nand coworkers 2003), do we need long implants at all? Removal of such an implant if affected\nby peri-implant disease may require considerable further surgery.\nThe reduction in ridge height needed to create space for prosthetic components in this protocol\nis questionable on several points. Firstly, the major flap elevation involved in degloving a jaw\nis not a simple surgical procedure. Secondly, the required significant alveolectomy may be a\nmajor surgical procedure, particularly in an elderly patient. If such a reduction is required,\nmight there be sufficient bone available for a conventional denture, which is of course very\nsuccessful in many patients (de Albuquerque Júnior and coworkers 2000; Heydecke and\ncoworkers 2003b)? Also, if implants are lost and the ridge has been surgically removed, there\nmay be no possibility of placing more implants or delivering a conventional denture, as the\njaw will have been “iatrogenically resorbed.”\nBiological complications are more likely to arise in a situation when there is little access for\ncleaning, as described above (Gallucci and coworkers 2009a). The regular removal of such\nprostheses for proper access to the implants for cleaning is of questionable value, given that\nthis is often only prescribed on an annual basis. In an elderly patient with limited access to\ncare, poor health, or mental decline, maintenance of proper oral health may be impossible.\nThe same may apply to the management of technical complications, such as fracture of the\nprosthesis or loosening of components. In large full-arch reconstructions, even a small fracture\nof veneering material, causing mucosal ulceration, may require removal of the entire prosthesis\nfor repair or replacement. Many authors have recommended a modular approach, such as\nreplacing every three teeth with a three-unit FPD on two implants (Stanford 2007). This\nsegmented approach allows a simpler, less costly, partial intervention in event of any failure\n(Gallucci and coworkers 2005)."
  },
  {
    "page": 259,
    "content": "It has also been suggested that because of the clinical and laboratory complexity and costs\nassociated with these types of prostheses, a maxillary overdenture on four to six implants,\ntypically connected with a rigid barand-clip attachment system, may be an alternative solution\n(Mericske-Stern and coworkers 2002).\nBy contrast, although implant-retained overdentures may be associated with a more frequent\nneed to adjust or replace the retentive elements inside, this maintenance is considerably\nsimpler. The need for maintenance will clearly be related to the age of the prosthesis, although\npost-placement adjustments appear to be more frequent in the first year (Payne and coworkers\n2000), possibly as a result of adaptation on the part of the patient.\nHowever, even the provision of a simpler prosthesis such as an overdenture may give rise to\nlater problems if there is no possibility to remove intraoral components appropriately and\neasily. One-piece implants with integral prostheses (such as “mini-implants” used for\noverdenture retention) are useful in providing lower-overdenture stability with minimal\nsurgical intervention and at reduced cost. When functioning well, there can be significant\nimprovements in oral health-related quality of life (OHRQoL) outcomes. However, in a patient\nwith dementia who cannot or will not wear the accompanying denture, the intraoral element\ncan cause significant ulceration and discomfort.\nIn some situations, patients may well be incapable of telling caregivers that there is a problem;\nthe caregivers themselves frequently fail to recognize that implants are in place, or even that\nthe denture was not a conventional denture. The problem may manifest itself in a reluctance of\nthe patient to take food and drink, due to oral pain and discomfort, which in itself may be\nmisdiagnosed as a difficult behavior resulting from dementia. In a two-piece implant system,\nremoval of the intraoral components is at least possible, even if challenging, and this may\nresolve the problem as mucosa grows over the implant. Sectioning a one-piece implant for\nsuch a patient, even in the clinical setting, may be so impractical as to require sedation.\nAs patients get older, visual impairment may have an impact on their ability to perform\neffective oral hygiene; insertion or removal of a denture, identification of cracks or\ndeterioration in the prosthesis and recognition of the need to seek advice may also be affected.\nReduced strength and manual dexterity may also have an effect on how well they can unclip a\nremovable prosthesis. Systems that allow for changes in the method or degree of retention\nallows us to adapt the prosthesis to their needs.\nAll maintenance and repair requires access to the dentist and implies additional cost, so it is\nimportant to design into both the surgical and prosthetic aspects features that allow for\nadequate plaque control and reversibility. In addition, and when appropriate, a timely\nconversion of a complex prosthesis to a prosthesis with these features while patients are still\nable to seek treatment may prevent later difficulties.\nThere are many key elements to planning implant therapy, and it is impossible to list them all.\nHowever, examples of simple considerations that may help reduce biological and technical"
  },
  {
    "page": 260,
    "content": "complications include:\nPlanning for hygienic maintenance\n• Ensuring adequate interimplant distances to allow access for cleaning with interdental\nbrushes.\n• Designing the prosthesis with readily identifiable access points for interdental brushes of a\nprescribed size; such brushes can be adapted to compensate for reduced grip strength,\nmanual dexterity, or to facilitate use by a caregiver if the patient is unable to use them. Floss\nis not likely to be used effectively or at all in such circumstances.\n• Creating convex mucosal surfaces on fixed prostheses, with clearance to prevent soft tissue\ntrauma when cleaning.\n• Structured professional aftercare programs are necessary, and oral health education of\ncaregivers will be required as well.\nPlanning for overdenture patients\n• Ensuring maximal anteroposterior spread of implants; this gives better stability, reduces the\npossibility of combination syndrome, and increases the opportunity for replacement of a\nfailed implant while maintaining adequate implant spacing.\n• Using milled bars with distal extensions also reduces the chance of combination syndrome;\nmilled bars are more rigid and are less likely to fracture.\n• Considering maxillary implant placement to reduce chance of combination syndrome.\n• Designing dentures with appropriate occlusion at the correct vertical dimension and with\nadequate extensions. Implants do not make a bad denture into a good denture.\n• Regular recalls for occlusal adjustment and relining.\n• Labeling of denture with patient identifiers.\n• Use of two-piece implant systems with a range of retentive components that allow for\nadjustment of the retentive force; also that allows for removal of abutment and\n“submergence” of the implant if necessary.\nPlanning for fixed prostheses\n• Plan the treatment according to the patient’s capacity to accommodate the necessary\nprocedures—if treatment is difficult, will this affect the fit? Misfit and screw-loosening\nincrease the risk of complications due to component wear as well as microbial\naccumulation.\n• Consider the need for later adaptation. Plan implant positions strategically with a view to\nsubsequent conversion to an overdenture.\nConclusions\nThe provision of implants in older patients, where we can choose a simple approach that can"
  },
  {
    "page": 261,
    "content": "be planned with aging issues in mind, may not necessarily be a problem. The bigger challenge\nmay be how to deal with problems arising with previously successful implants and prostheses\nin patients who are less fit and able than they were when that treatment was provided. With an\nincreasingly older population and a larger number of very old people, we will more frequently\nsee patients treated with implants that are ailing and prostheses that can no longer be\nmaintained either by the patient (or caregiver) or by the dental professional due to access\nissues. In addition, there may be medical and psychosocial issues, whose impact is not yet\nwell documented and may be hard to quantify, given the difficulties in performing a\nmultivariate analysis.\nComplications will occur; we have a responsibility to try and ensure that they have the least\npossible impact on the well-being of our patients and that they be, as far as possible, relatively\neasy to treat."
  },
  {
    "page": 262,
    "content": "13\nClinical Case Presentations"
  },
  {
    "page": 263,
    "content": "13.1\nImproving an Existing Implant-supported Denture\nin an Alzheimer Patient with Bipolar Affective\nDisorder with Moderate Depression and Dementia\n \nU. Webersberger\nFig 1 Panoramic radiograph after placement of the two mandibular implants.\nAn 83-year-old man presented together with his caregiver at the dental department of the\nMedical University of Innsbruck, Austria with complaints of swelling in the right maxillary\ncanine area and loss of retention of his 5-years-old mandibular denture.\nThe patient had a significant medical history (20 years) of bipolar affective disorder with\nmoderate depression (F 31.3) and dementia in Alzheimer’s disease (F 00.2).\nThe patient had been in ambulant psychiatric therapy for his depressive illness for the past 20\nyears. He lived alone and had no children; his sister assisted with daily living. She reported\nthat the patient exhibited compulsive hoarding behavior. In the previous two months, she had\nnoted increasing disorientation and vertigo in the patient. She therefore accompanied him for a\nmedical consultation at the Department of Psychiatry and Psychotherapy of the Medical\nUniversity of Innsbruck. He was released home after a 6-week inpatient stay. A care allowance\nwas applied and a daily caregiver was organized to help him with his activities of daily living.\nThe patient’s dental history included placement of two Straumann Tissue Level implants\n(Standard, diameter 4.1, length 10 mm; Institut Straumann AG, Basel, Switzerland) in the\ninterforaminal area 5½ years previously, because the patient experienced eating difficulties\ndue to his ill-fitting lower denture (Fig 1)."
  },
  {
    "page": 264,
    "content": "After a healing period of 4 months, the mandible received two Straumann Locator attachments\nand an implant-supported overdenture. Composite fillings were provided in the maxilla. The\nexisting partial denture was left in place because the patient felt comfortable with it.\nDuring this time, the patient showed signs of depression, but was well oriented. With the new\nmandibular overdenture, he had no more problems eating, swallowing, or speaking. His oral\nhygiene at the time of insertion was sufficient. After 2 years, Locator replacement males were\ninserted after a loss of retention in the mandibular denture. After this period, multiple signs of\ndeterioration occurred. Supervision to prevent plaque formation was performed, but daily oral\nself-care became problematic. The patient became increasingly dependent on assistance. He\ncould not come to a regular dental appointment anymore.\nAfter oral examination and radiographic investigation (Fig 2), the following diagnosis was\nmade:\n•\nDental abscess resulting from a destroyed maxillary canine.\n•\nNon-salvageable residual dentition.\n•\nRetention loss of the implant-supported mandibular denture because of food impaction in\nthe Locator abutments (Figs 3 to 5).\nThe patient felt very uncomfortable with the retention loss of his mandibular denture. Given his\npoor oral hygiene with food impaction around and in the Locator attachments and in the pink\nretention element of the denture, the patient could no longer insert his denture properly. He was\nunable to clean the Locator abutments. One reason was that he had lost part of his vision in\nboth eyes and could not see the impacted food. Other reasons included his loss of manual\ndexterity and his self-consciousness; he felt insecure and was afraid to damage the denture.\nAfter careful evaluation and discussions with the patient and his caregiver, the following\ntreatment plan was proposed:\n•\nExtraction of all remaining teeth.\n•\nProvisional extension of the maxillary partial denture, resulting in a complete denture.\n•\nModification of the implant-supported mandibular denture with an easy-to handling\nabutment while maintaining tooth positions."
  },
  {
    "page": 265,
    "content": "Fig 2 Panoramic radiograph 5 years later.\nFig 3 Base of the mandibular denture.\nFig 4 Locator male (in the pink retention element of the denture) with food impaction.\nFig 5 Very poor oral hygiene. Food impaction around and in the Locator attachments."
  },
  {
    "page": 266,
    "content": "Fig 6 Panoramic radiograph after extraction of the remaining teeth in the maxilla.\nThe extraction of the remaining teeth in the maxilla (Fig 6) and the insertion of the extended\ndenture proceeded without complications. In the mandible, we decided to keep the denture and\nmerely replace the abutment to keep the changes to a minimum and to spare the patient from\nhaving to adapt to a completely new denture. We choose the Straumann Titanmagnetics (Institut\nStraumann AG, Basel, Switzerland) insert as the new overdenture abutment.\nAfter removing the Locator attachments, the Straumann Titanmagnetics inserts were carefully\nhand-tightened with the Titanmagnetics insert applicator. The abutments were torqued to 20\nNcm using the Straumann ratchet with torque-control device. Figure 7 shows the Straumann\nTitanmagnetics inserts placed on the Tissue Level implants.\nThe maximum torque for tightening the Straumann Titanmagnetics inserts is 15 to 20 Ncm,\nunlike Locator abutment, for which the torque is 35 Ncm.\nAfter insertion, the positioning cuffs were placed on the Titanmagnetics inserts (Fig 8). They\nprotected the margin of the gingiva and the functional surfaces during polymerization of the\nTitanmagnetics denture magnet and ensured a resilience of 0.3 mm.\nThe denture magnets were set into the flat cavity of the positioning cuffs (Fig 9). The\nmandibular denture was relieved above the magnets. A hollow space was created to let the\nTitanmagnetics magnets fit correctly under the denture. The fit of the denture was checked in\nthe mouth (Fig 10).\nFig 7 Straumann Titanmagnetics inserts placed on the Tissue Level implants."
  },
  {
    "page": 267,
    "content": "Fig 8 Positioning cuffs on top of the Titanmagnetics inserts.\nFig 9 Denture magnets in the flat cavity of the positioning cuffs.\nFig 10 Existing mandibular denture was relieved above the magnets.\nThe denture magnets were polymerized into the previously created cavities with\nautopolymerizing methyl methacrylate (Aesthetic Autopolymerisat; Candulor, Wangen,\nSwitzerland). The cold-curing polymer was placed in the cavities on the intaglio side of the\ndenture and placed in the mouth. The patient had to bite hard for about 15 minutes until the\npolymer had set.\nThe polymerized magnets in the mandibular denture created a smooth surface, which made it\neasier to clean for the caregiver and patient using a brush or just running water (Fig 11). The\nabutments had an even surface, making impaction impossible. Plaque, however, would\nassemble around the implants and would have to be removed by the caregiver, who had been\ninstructed accordingly."
  },
  {
    "page": 268,
    "content": "The patient felt very comfortable wearing the modified denture. Cleaning the Titanmagnetics\nabutments was no problem for the caregiver. Unfortunately, after a short while the patient\nbecame bedridden and could not come to the dental clinic for a check-up. A phone call with the\ncaretaker revealed that the patient still ate with his maxillary denture and helped clean it.\nThe patient and caretaker were informed that in case of magnetic resonance imaging (MRI) of\nthe head and neck, it was recommended to remove the denture with the magnets. Additionally,\nthe magnetic abutments have to be unscrewed from the implants before an MRI examination of\nthe region (Laurell KA and coworkers 1989; Gegauff and coworkers 1990).\nThe patient and his caretaker were handed an implant pass to inform the clinic about the type of\nimplant system used and the type of magnets inserted in the event that an MRI was needed.\nFig 11 Polymerized magnets in the mandibular denture."
  },
  {
    "page": 269,
    "content": "13.2\nMaxillary Complete Denture and Mandibular\nOverdenture on Two Implants with Universal Design\n \nR. Leesungbok\nA 78-year-old female patient was referred by the Department of Neurosurgery to the\nDepartment of Biomaterials and Prosthodontics of Kyung Hee University Dental Hospital,\nGangdong, Seoul, South Korea. The patient was suffering from facial nerve palsy due to an\nischemic stroke that had left parts of her eye, chin, lip, tongue, and extremity paralyzed. She\nhad been wearing maxillary and mandibular complete dentures for 10 years, but after the stroke\nthey were not suitable anymore as her mandibular denture became dislodged during function\n(Figs 1 and 2).\nIn our aging society, dentures for the disabled and elderly are crucial in terms of patient\nsatisfaction and health-related quality of life. Patients suffer from chronic and severe\ndisorders, and elderly/disabled patients need special dental care. The provision of dentures\nusing a minimally invasive treatment approach and a universal design are important issues\n(Leesungbok 2004).\nRules for minimally invasive treatment for the disabled and elderly\n• Minimize pain during treatment.\n• Minimize the total treatment time.\n• Minimize swelling and pain after treatment.\n• Minimize the number of implants.\n• Load immediately with universal design to achieve immediate oral function.\n• Consider fixed prostheses rather than removable prostheses; a fixed prosthesis is the best\nuniversal design."
  },
  {
    "page": 270,
    "content": "Fig 1 Baseline situation. 78-year-old woman wearing her old maxillary and mandibular complete dentures.\nFig 2 The same patient without the old dentures. Severely atrophied ridges in both jaws.\nUniversal design strategies for occlusal rehabilitation of the disabled and elderly\n•\nStrategy 1: Fixed restorations on six to eight maxillary and/or four to eight mandibular\nimplants (Fig 3).\n•\nStrategy 2: Overdentures on four maxillary and/or two to four mandibular implants (Fig 4).\n•\nStrategy 3: Maxillary complete denture and mandibular one-piece fixed restoration on four\nimplants (Fig 5).\n•\nStrategies 4a and b: Maxillary complete denture and mandibular overdenture on two\nimplants (Figs 6 and 7).\nFig 3 Strategy 1: Fixed restorations on six to eight maxillary and/or four to eight mandibular implants."
  },
  {
    "page": 271,
    "content": "Fig 4 Strategy 2: Overdentures on four maxillary and/or two to four mandibular implants.\nFig 5 Strategy 3: Maxillary complete denture and mandibular one-piece fixed restoration on four implants.\nFig 6 Strategy 4a: Maxillary complete denture and mandibular overdenture on two implants with single abutments."
  },
  {
    "page": 272,
    "content": "Fig 7 Strategy 4b: Maxillary complete denture and mandibular overdenture on two implants connected with a bar in a\nseverely atrophied mandible.\nFig 8 Occlusal view before surgery. Vertically and horizontally atrophied ridge, especially in the mandible.\nFig 9 Two implants (Straumann Tissue Level, SLA) were placed on the site of canines after raising a full-thickness flap.\nOne keeper abutment (IP; Aichi Steel, Tokai, Japan) connected to the right implant.\nAt baseline, the patient presented with severely atrophied ridges, with reduced vertical height\nand horizontal width in both jaws. According to strategy 4a (Fig 6), in the case of severely\natrophied edentulous maxillary and mandibular jaws, a complete maxillary denture and a\nmandibular overdenture on two implants are recommended as a minimally invasive treatment\noption, especially for elderly disabled patients (Fig 8).\nSurgical and prosthodontic procedure\n•\nTop-down treatment planning—selecting a strategic option for elderly-disabled patient\n•\nMinimally invasive surgery"
  },
  {
    "page": 273,
    "content": "•\nImmediate loading with universal design to achieve immediate oral function\n•\nPeriodic recalls\nIn a U-shaped mandibular arch, if two implants are to be placed on the ridge, the sites of\ncanines or first premolars are recommended as implant sites (Fig 9). Two Tissue Level SLA\nimplants (RN, diameter 4.1 mm, length 10 mm; Straumann, Basel, Switzerland) were placed at\nthe canine sites after raising a full-thickness flap. The insertion torque was more than 35 Ncm\nfor both implants. Immediate loading by a removable overdenture is possible with this torque\nvalue. One magnetic so-called keeper abutment (IP; Aichi Steel, Tokai, Japan) was connected\nto the right implant at a torque of with 25 Ncm (Fig 10). The other keeper abutment (also IP)\nwas connected on the left implant at a torque of 25 Ncm. The flap was sutured completely (Fig\n11).\nFig 10 Two implants (Straumann Tissue Level, SLA, RN, diameter 4.1 mm, length 10 mm) were placed on the site of\ncanines after raising a full-thickness flap. One keeper abutment (IP; Aichi Steel, Tokai, Japan) connected to the right\nimplant.\nFig 11 The other keeper abutment (also IP) connected on the left implant. Sutured flap.\nFigure 12 shows a flexible and self-adjusting magnetic attachment (Magfit-SX 800; Aichi\nSteel). Rubber dam was placed over the keeper abutment to block out the undercut area and as\na separator. Magfit-SX 800 attachments with spacers were placed on the keeper abutments\n(Fig 13).\nPink acrylic resin was poured into the voids of the prepared overdenture (Fig 14). The"
  },
  {
    "page": 274,
    "content": "overdenture was positioned exactly and held in place until the resin has set completely (Fig\n15). After the resin had fully set, the overdenture was removed from the mouth. The metal 0.4-\nmm spacer was removed from the magnetic attachment surface (Fig 16).\nThe spacers were removed from the attachment, and the mucosal surface was finished as\nneeded (Figs 17 and 18).\nFigure 19 shows the situation after insertion of the maxillary complete denture and mandibular\nmagnetic overdenture as a typical example of a universal design for elderly and disabled\npatients (Fig 19). The patient had suffered from facial paralysis for more than five years (Fig\n20). Functional movements, including chewing and wide opening, were tested. The maxillary\ncomplete denture and mandibular magnetic overdenture worked very well and were easily\nhandled by the patient, who was highly satisfied with the universal design (Fig 21).\nFig 12 Flexible self-adjusting magnetic attachment (Magfit-SX 800; Aichi Steel).\nFig 13 Rubber dam around and Magfit-SX 800 attachments with spacers on the keeper abutments."
  },
  {
    "page": 275,
    "content": "Fig 14 Voids of the prepared overdenture before pouring pink acrylics.\nFig 15 The resin has set completely.\nFig 16 Tissue side of the overdenture before removal of the rubber dam and spacers.\nFig 17 Tissue side of the definite overdenture with rubber dam and spacers removed."
  },
  {
    "page": 276,
    "content": "Fig 18 Occlusal view of the definite overdenture after completed finishing and polishing.\nFig 19 Inserted maxillary complete denture and mandibular magnetic overdenture.\nFig 20 The patient had been suffering from a facial paralysis for 10 years."
  },
  {
    "page": 277,
    "content": "Fig 21 Maxillary complete denture and mandibular magnetic overdenture in situ.\nFigure 22 is a panoramic radiograph taken directly after the placement of the two implants in\nthe mandible. There were no complications at the six-year follow-up (Figs 23 and 24).\nDiscussion\nPrevalence of complete or partial edentulousness. Fully edentulous patients are becoming\nless frequent thanks to advancements in dental health and dental care. According to the\nNational Oral Health Survey released in South Korea in 2000, 26.8% of patients aged 65 to 74\nyears presented with a fully edentulous maxilla, 19.63% with a fully edentulous mandible). In\n2006, the corresponding figures had decreased to 21.6% in the maxilla and 14.3% in the\nmandible—a drop of more than five percentage points in just 6 years.\nAs dental implants become increasingly popular, implant overdentures in fully edentulous\ncases have been shown to give greater patient satisfaction and better function than conventional\ncomplete dentures. The number of fully edentulous patients has been steadily declining, while\nthe number of partially edentulous patients has been rising and the period of partial edentulism\nhas been prolonged—and the treatment paradigm for partial edentulism is changing.\nFig 22 Panoramic radiograph taken directly after the placement of the two implants in the mandible."
  },
  {
    "page": 278,
    "content": "Fig 23 Follow-up panoramic radiograph after 6 years of wearing the mandibular magnetic overdenture supported by\nthe two implants.\nFig 24 Six-year follow-up. Keeper abutments for the mandibular magnetic overdenture as a universal design.\nFig 25 Dentures for the disabled and elderly play a crucial part in patient satisfaction and oral health-related quality\nof life."
  },
  {
    "page": 279,
    "content": "Fig 26 An 82-year-old elderly disabled patient had worn this implant-supported maxillary overdenture made at a local\ndental clinic 2 years previously.\nFig 27 Dental care and denture treatment with a universal design should be considered especially for elderly or\ndisabled people.\nFig 28 This overdenture had originally contained 5 Locator retentions. Only one retentive device remained because the\npatient mishandled the denture during insertion/removal due to her manual handicap.\nUniversal design. The philosophy of universal design refers to the design that can be used for\neveryone. Devices, facilities, and equipment designed barrier-free can be readily used by non-\ndisabled people (nurses, assistants, family members, friends, etc.) as well as by disabled\npeople. Universal design makes dental appliances accessible to everyone without difficulty,\nregardless of possible disabilities (North Carolina State University 1997; Harpur 2013; Figs\n25 to 28).\nThe seven principles of universal design are:"
  },
  {
    "page": 280,
    "content": "1\nEquitable use\n2\nFlexibility in use\n3\nSimple and intuitive\n4\nPerceptible information\n5\nTolerance for error\n6\nLow physical effort\n7\nSize and space for approach and use\nMagnet-retained overdentures for the disabled and elderly. The production quality and the\nphysical properties of the materials generally depend greatly the skill and precision levels of\nthe manufacturer. Great skill and expertise are required to manufacture friction-type\nmechanical retainers. And while the friction between the metal and the elasticity of the\nmetal/plastic retainer components may initially show high performance level, these retainers\nwear out after many insertion/removal procedures or exhibit damage or deformation due to\nphysical fatigue. Some components are highly durable, but this cannot conceal the fact that\nthere will be a functional decline. Moreover, they can be especially difficult to use by elderly\nor disabled patients (Riley and coworkers 2001). The author has used many types of the\nmagnetic attachments clinically during the past 20 years and defines magnetic attachments as\n“retentive devices on prostheses using magnetic attractive force formed between the magnet\n(magnetic assembly) and the stainless-steel keeper.”\nThere are three different types of devices that use magnetism clinically for retention in\ndentistry (Fig 29):\n1\nDevices that use repulsion between same-name magnetic poles with an open magnetic\ncircuit.\n2\nDevices that use attraction between different-name magnetic poles with an open magnetic\ncircuit (Fig 29a).\n3\nDevices that use a stainless-steel keeper that attaches to the magnet with a closed magnetic\ncircuit (Figs 29b-c)."
  },
  {
    "page": 281,
    "content": "Fig 29 One type 2 device and two type 3 devices. (a) Magnet and magnet, using attraction between different-name\nmagnetic poles, open magnetic circuit. (b) Magnet and keeper, open magnetic circuit. (c) Magnet and keeper, closed\nmagnetic circuit.\nThe repulsion method (type 1) is infrequently used in orthodontics at this point. Type 2 has\nbeen tested widely by researchers—but a pair of magnets requires much space that is\nunnecessary clinically, raises the issue of protecting the main magnet, and does not necessarily\ndouble the attractive force when the two magnets are attached physically (Fig 30). Therefore,\nas in type 3, one side of the magnet should be used with a keeper. The keeper itself is not a\nmagnet, but when placed in a magnetic field it is magnetized, with the two components\nattracting each other; this design minimizes the vertical height. When the keeper is removed\nfrom the magnetic field, it becomes an ordinary bit of stainless steel again, rather than acting as\na magnet (Maeda and coworkers 2005a; Hasegawa and coworkers 2011; Figs 31 to 33).\nFig 30 A pair of magnets (Steco, Hamburg, Germany) used as in type 2 requires unnecessarily much space. A =\nmagnetic abutment; B = magnetic cap."
  },
  {
    "page": 282,
    "content": "Fig 31 In type 3, one side of the magnet (Magfit, Aichi Steel) is used with stainless-steel keeper. A = stainless-steel\nkeeper abutment; B = magnetic assembly (magnet encapsulated by stainless steel); C = stainless-steel keeper ring.\nFig 32 Mucosal surface of a typical universal-design overdenture with magnetic attachments for the patient in Figure\n31.\nFig 33 No complications at the 8-year follow-up. Facial view of the same universal-design overdenture as in Figure 32.\nFor many years, aluminum-nickel-cobalt magnets with open magnetic fields have been used in\ndentistry as retentive devices, but success had been limited because these magnets were\nsusceptible to corrosion by saliva and because their retentive force is weaker than the initial\nretention offered by mechanical attachments.\nIn recent years, magnets made from alloys of the rare-earth elements samarium and neodymium\nhave gained in popularity, since they provide a stronger magnetic force per unit size and can be\nhermetically encapsulated by stainless-steel housings to resist corrosion and tarnishing in the\nintraoral environment. Due to the greater attractive force (8–10 N), despite their smaller"
  },
  {
    "page": 283,
    "content": "volume and because they are free of corrosion, magnetic attachments have the potential for\nincreased durability and have been shown to be superior to other popular mechanical retentive\ndevices (ball and socket, bar and clip attachments) for removable prostheses on implants\n(Akin and coworkers 2011).\nDouble crowns, highly functional as retainers, also require a high level of technical skills to\nmake. Technicians encounter challenges such as having to ensure a careful balance or perform\ndelicate soldering on most precision attachment systems. The magnetic attachment used as a\ndenture retainer is not only a good substitute for the mechanical-frictional retainers, but also\noffers other practical advantages based on the specification of the magnet presented here:\n•\nIt does not show damage or abrasion as mechanical retainers do and can thus be used for\nprolonged periods without a decrease in retention.\n•\nIt is flexible in denture design and manufacturing, since the direction of force is not strictly\nfixed.\n•\nIt has an esthetic appearance, since it is embedded into the denture.\n•\nIt is easy to handle and to keep clean, especially for elderly or handicapped patients, as the\ndenture design is not complex.\n•\nBecause the attractive force weakens rapidly when the magnetic assembly and keeper create\na gap on the attached surface as the range of normal oral function is exceeded, the risk of\nharmful stress to the tooth or implant can be reduced effectively compared to other\nmechanical retainers.\n•\nIt is easy to repair damaged components of the magnetic attachment by simply exchanging\nthem.\nConclusion\nSince dental implants were first used as artificial roots to support restorations in edentulous\nsites, treatment planning for prostheses has changed significantly. Where there used to be no\nalternative but to employ removable dentures on the distal-extension side of a partially\nedentulism jaw, dental implants have created a revolutionary tooth-replacement option for\nthose patients. Dental implants in a partially or completely edentulous alveolar ridge have\nrevolutionized our treatment options for removable dentures and evolved into a new treatment\nparadigm where natural teeth and implants coexist in the same mouth.\nIn a case study at the Department of Biomaterials and Prosthodontics of Kyung Hee University\nDental Hospital, Heki and Gangdong, Seoul, South Korea, the universal design resulted in\ngreater patient satisfaction than conventional dentures or overdentures with frictional-type\nretainers."
  },
  {
    "page": 284,
    "content": "13.3\nImproving a Centenarian’s Quality of Life\n \nM. Schimmel\nIn 2007, a 97-year-old patient presented for treatment at the Geneva Dental School. His dentist\nhad retired. Like many elderly patients, he was left without regular dental care. He lived on a\ngeriatric ward, as he was partly dependent on help with most of the activities of daily living\n(ADL), such as getting dressed, washing, taking a shower, or climbing stairs. However, he was\nable to go to the bathroom and get up from bed on his own (ADL score 80, min. 18, max. 126; a\nlow score signifies a high degree of dependency) (Lawton and Brody 1969). He was not bound\nto a wheelchair, but used a walker. Moreover, he was socially highly active—his family\nvisited on a regular basis and he often went to the restaurant with his friend, who was some 20\nyears younger. His cognitive function did not seem to be impaired in a normal conversation,\nalthough his MMSE score was only 21/30 at that time (Folstein and coworkers 1975). The\npatient was a retired pharmacist, and his latest passion was astronomy.\nHis medical history revealed a myocardial infarction 15 years before the first visit; he\nreceived dilatation of the coronal vessels in 1992 and 1996. In 2002, he suffered from\ntransitional stroke symptoms, which at the time were attributed to a sclerosis of the right\ncarotid artery. Consequently, the affected artery was dilated and a stent placed. He also\nsuffered from bilateral glaucoma and cataract. These medical conditions resulted in a long list\nof daily medications: paracetamol (1,500 mg/day), spironolactone (a diuretic), clopidogrel (a\nplatelet-aggregation inhibitor), molsidomin (a coronary vasodilator), acetazolamide (a\ntreatment for glaucoma), macrogol (a laxative), omeprazole (a treatment for gastroesophageal\nreflux disease), pravastatin (a statin), torasemide (a loop diuretic), carteolol (a glaucoma\ntreatment and non-selective beta blocker), nitroglycerin (a coronary vasodilator), and a\ncarbamide ointment.\nThe patient was very happy about the prospect of improving his unsatisfying dental situation.\nHe took pleasure in his frequent visits to the Dental School, as this interrupted his daily routine\non the ward.\nHis dental history revealed the extraction of his last mandibular tooth and insertion of a\ncomplete conventional denture two years before. The removable partial prosthesis (RPP) in\nthe maxilla had been made 5 years before the first consultation.\nThe patient’s oral health-related quality of life (OHRQoL) was moderately reduced, with an"
  },
  {
    "page": 285,
    "content": "OHIP-EDENT score of 25/60 (where a high score means a low OHRQoL) (Allen and Locker\n2002). Regarding his satisfaction with his dental prostheses, he claimed that they were easy to\nclean and that he liked their esthetics. He stated in the Denture Satisfaction Questionnaires\n(Rashid and coworkers 2011) that he was moderately satisfied with them overall but had\ndifficulties speaking, eating white bread, hard cheese, raw carrots, dried sausages, apples, and\nsteak—primarily because of the unstable lower denture. He would mostly swallow those food\nitems unchewed.\nThe intraoral examination revealed a cantilever bridge in the maxilla, a ball attachment on the\nroot of tooth 23, and a residual root of tooth 25 (Fig 1). The mandible was edentulous, but with\na healthy mucosa. Denture hygiene was improvable, with a score of 9 out of 15 for the\nmaxillary prosthesis; as he never wore his mandibular denture, no denture plaque index was\nrecorded here. The saliva flow rate (SFR) after a 2-minute collection period was low at 2 ml\nstimulated and 1 ml unstimulated.\nFig 1 Baseline panoramic radiograph. Two hopeless teeth (15 and 22) and two other teeth that could support an\noverdenture. The interforaminal bone height was sufficient to accommodate two implants.\nFig 2 Two short implants were placed and left to heal transmucosally."
  },
  {
    "page": 286,
    "content": "Fig 3 Implant 33 had not osseointegrated, probably due to premature loading. A replacement implant was placed\nslightly mesially of the original surgical site.\nTaking the radiological findings into account, it was decided to transform the remaining\nmaxillary RPD into a root-supported overdenture on roots 23 and 25. The maxillary denture\nwas to be relined conventionally.\nIn October 2007, teeth 15 and 22 were extracted. The remaining two roots in the maxilla were\ndecapitated and covered with a hybrid composite resin. The RPP was transformed into a root-\nsupported overdenture by adding the missing teeth and relining the denture with polymethyl\nmethacrylate using an indirect technique. The same procedure was applied to reline the\nmandibular complete denture (CD) in a second stage.\nOne year after this treatment, the patient did not feel he had seen the improvement he had hoped\nfor. He desired to receive implants to stabilize his mandibular prosthesis.\nThe surgical procedure (standard protocol for transgingival healing) was performed in mid-\nDecember 2009. Two interforaminal implants were placed at sites 33 and 43 (Straumann SLA,\nRN, diameter 4.1 mm, length 8 mm; Institut Straumann AG; Fig 2) according to the standard\nprotocol (Payne and coworkers 2010).\nSeven days after the surgery, the sutures were removed and the mandibular prosthesis modified\nto avoid mechanical interference with the healing abutments. The patient was advised not to\nwear his mandibular denture during this initial healing period. It was agreed to load the\nimplants and connect the abutments after a 6- to 8-week period (Gallucci and coworkers\n2014).\nIn February 2009, the patient presented for the agreed procedure. He reported that he had not\nworn his dentures during the entire healing period (7 weeks). He had enjoyed a four-week\nholiday in a Hotel in the Swiss Mountains and, therefore, wanted to rule out any complications\nwith the implants. But when loading implant 33, it became obvious that osseointegration had\nnot taken place and, therefore, the implant was removed. During the same visit, another 8-mm\nStraumann implant (SLA, 4.1 mm RN) was inserted slightly mesially of the original site (Fig\n3). The patient was instructed not to wear his mandibular complete denture for two weeks. The\nsutures were removed after 7 days."
  },
  {
    "page": 287,
    "content": "Fig 4 The implants were loaded using Locator attachments.\nFig 5 Even the insert with the lowest retentive force of the Locator system was too strong for the patient to handle.\nTherefore, the patient was discharged with the laboratory inserts, which have an acceptably low retention but cannot\nwithstand the intraoral environment for long.\nAt the end of March 2009, the patient was seen for implant loading. This time, both implants\nwere osseointegrated and the mandibular complete denture was transformed into an implant-\nsupported overdenture (IOD) using Locator attachments (Zest Anchors, Escondido, CA, USA;\nFigs 4 to 6). Again, the patient had not worn his dentures for 6 weeks to avoid complications.\nAfter stabilization of the mandibular prosthesis by two Straumann implants and Locator\nabutments, the patient was extremely pleased with his oral appearance and function. The\nOHIP-EDENT score dropped to 1/60, indicating a highly improved OHRQoL. In the Denture\nSatisfaction Questionnaire, he indicated maximum satisfaction with the IOD. He had no more\nproblems speaking and stated that he would even eat hard cheese or dried sausages without any\ndifficulty; his capacity to eat white bread, steak, apples, and salad had improved. The patient\nfelt that he now chewed his food properly before swallowing. However, the three-month\ncontrol revealed insufficient implant hygiene, and instructions were given to ameliorate the\noral-hygiene situation. His SFR had improved and was stable at 3 ml stimulated and 1.5 ml\nunstimulated. At the one-year control, the denture hygiene was quite good, with scores of 4/15\nand 2/15 for the maxillary and mandibular prosthesis, respectively."
  },
  {
    "page": 288,
    "content": "Figs 6a-b The converted prosthesis was old and worn, but the patient was well adapted to functioning with it. In very\nold patients, compromises often have to be accepted in terms of denture design, as adaptive capacity decreases with\nage.\nFig 7 There was always plaque around the attachments and in the central retentive hole. The inflammatory signs were\nsurprisingly weak.\nFig 8 Central hole obturated to prevent food impaction. Despite high plaque scores, there were no clinical signs of peri-\nimplantitis.\nPlaque was always present, but the plaque score was remarkably low when taking into account\nhis dependency for ADLs (Fig 7). Still, the implant probing depths never exceeded 2 mm at\nany site, even after 4 years of the IOD in situ.\nThe low inflammatory response corresponded to the stable peri-implant bone, as noted in the\nradiographs.\nAt the one-year appointment, it was evident that residual food remained in the central holes of"
  },
  {
    "page": 289,
    "content": "the Locator-abutments. Thus, the hole was obturated with temporary inlay material (Telio;\nIvoclar Vivadent, Schaan, Liechtenstein; Fig 8). The red Locator inserts without a central pin\nwere provided to retain the prosthesis.\nFigures 9a-d show the follow-up radiographs taken 2009 through 2012.\nFigs 9a-d Stable peri-implant bone conditions and no signs of peri-implantitis around sites 43 and 33 on these follow-\nup radiographs taken 2009 (a), 2010 (b), 2011 (c), and 2012 (d).\nThe patient was last seen at the dental clinic at age 101 (Fig 10). His cognitive functions had\nfurther declined, and he had a MMSE score of 18/27. He was almost blind by that time and\nhighly dependent in his ADLs. However, he was still eating by himself and had remained\nsocially active. His OHIP score was still low at 13/60, and he reported being very satisfied\nwith his denture. He enjoyed hard cheese but would still not eat carrots, apples, steak, or\nsalad.\nThe patient passed away at the age of 103. He had benefited from implant therapy for over five\nyears and never regretted the decision.\nDisclosure\nThe patient had participated in an ITI-funded RCT on the stabilization of complete dentures in\ndependently living older adults (Müller and coworkers 2013). The effect of denture abstention\non masseter muscle thickness has been published as a case report (Schimmel and coworkers\n2010)."
  },
  {
    "page": 290,
    "content": "Fig 10 The patient at age 101."
  },
  {
    "page": 291,
    "content": "13.4\nOral Rehabilitation of an Elderly Edentulous\nPatient with Osteoarthritis Using an Implant-\nsupported Mandibular Prosthesis with Locator\nAbutments\n \nG. McKenna\nA 78-year-old man was referred to the dental hospital by his general dental practitioner. He\nwas a non-smoker but was taking a number of medications as prescribed by his general\nmedical practitioner, including atorvastatin-calcium for high cholesterol, lisinopril and\nhydrochlorothiazide for hypertension, warfarin as an anticoagulant, and metformin for the\nmanagement of type 2 diabetes. The patient also suffered from osteoarthritis in both hands (Fig\n1). The patient was edentulous in the maxilla and partially dentate in the mandible. A\nmandibular acrylic partial lower denture had been recently delivered but was poorly tolerated.\nOn presentation, an extraoral examination revealed nothing adverse. Intraorally, the soft tissues\nwere healthy, with little evidence of oral dryness. The remaining mandibular dentition\nconsisted of teeth 34–44 and the retained roots of teeth 45 and 48. The teeth were heavily\nrestored, and teeth 34–31 all showed grade 2 mobility. A panoramic radiograph was taken (Fig\n2). An initial treatment plan called for extracting the teeth with a hopeless prognosis and\nconstructing a well-fitting mandibular partial denture after a suitable period of healing.\nFig 1 Patient’s hand."
  },
  {
    "page": 292,
    "content": "Fig 2 Panoramic radiograph at the initial presentation.\nTwelve months after this treatment, the patient returned, reporting difficulties in wearing his\nmandibular partial denture. A clinical examination and a panoramic radiograph revealed that\ntooth 44 had decoronated and that recurrent caries was present in teeth 41 and 42. The\nremaining mandibular incisors now showed grade 2 mobility (Fig 3), and their prognosis was\nvery poor.\nThe hopeless prognosis for the remaining teeth was discussed with the patient and a revised\ntreatment plan developed. This included:\n• Extraction of the remaining teeth and provision of a mandibular complete immediate\ndenture.\n• After 6 months of healing, placement of two implants at sites 33 and 43 under intravenous\nsedation with midazolam.\n• Provision of an implant-retained maxillary overdenture on Locator abutments (Straumann,\nBasel, Switzerland).\n• Provision of a new maxillary complete conventional denture.\nEight weeks later, the maxillary denture was completed and delivered. The remaining natural\nteeth in the mandible were extracted atraumatically under local anesthesia. Healing of the\nextraction sockets was unremarkable (Fig 4).\nUnder intravenous sedation, a full-thickness mucoperiosteal flap was raised with relieving\nincisions. Two tissue-level implants (Straumann Regular Neck, SLActive, diameter 4.1 mm,\nlength 12 mm; Institut Straumann AG, Basel, Switzerland) were placed at sites 33 and 43 in\naccordance with the treatment plan. Localized guided bone regeneration (GBR) was used to\ncover the exposed implant threads on the buccal side with autologous bone chips harvested\nusing a bone scraper (HuFriedy, Chicago, Illinois, USA) supplemented with DBBM bone\nsubstitute (Bio-Oss; Geistlich Pharma, Wolhusen, Switzerland). The augmentation site was\ncovered with a non-crosslinked, porcine-derived, resorbable collagen membrane (Bio-Gide;\nGeistlich Pharma). As significant primary stability was achieved at the time of implant\nplacement, transmucosal healing abutments were placed. A panoramic radiograph was taken to\nconfirm the positioning of the two implants (Fig 5)."
  },
  {
    "page": 293,
    "content": "Fig 3 Panoramic radiograph 12 months after the initial referral.\nFig 4 Lower edentulous ridge 6 months after the extractions.\nFig 5 Panoramic radiograph to confirm optimal placement of implants 33 and 43.\nFig 6 Mandibular complete denture modified to accommodate implants."
  },
  {
    "page": 294,
    "content": "Fig 7 Modified dentures in situ.\nFigs 8a-b Copy impression for the maxillary complete denture.\nFig 9 Fixture-level impression of the mandibular implants in a custom tray.\nIn order to accommodate the transmucosal healing abutments, the fitting surface of the patient’s\nexisting mandibular complete denture was modified to prevent loading of the implants (Figs 6\nand 7).\nConstruction of the definitive prostheses began 3 months after implant placement. As the\npatient was very pleased with the appearance and esthetics of the existing maxillary denture, a\ncopy denture was constructed by taking an impression of the existing prosthesis in silicone\nputty (Aquasil Putty; Dentsply, Surrey, UK) (Fig 8). A mandibular conventional denture was\nprescribed and a fixture-level impression was taken in polyvinylsiloxane (Aquasil Putty and\nUltra; Dentsply) in a custom tray with impression copings (Straumann RN impression copings)\n(Fig 9)."
  },
  {
    "page": 295,
    "content": "Fig 10 Mandibular working model with Locator abutments (height 4.0 mm) in situ.\nFig 11 Maxillary bite record.\nFigs 12a-b Denture try-in on semi-adjustable articulator.\nFig 13 Maxillary and mandibular prostheses at try-in."
  },
  {
    "page": 296,
    "content": "Fig 14 Right-side occlusion of the definitive prostheses.\nFigs 15a-b Mandibular implant-supported overdenture with pink male Locator inserts.\nA working model was constructed from the impression and Locator abutments placed to retain\nthe mandibular denture (Fig 10) due to the patient’s medical condition (osteoarthritis in both\nhands). A mandibular bite record was constructed and the jaw registered (Fig 11).\nThe jaw registration facilitated construction of the definitive prostheses on a semi-adjustable\narticulator (Denar Anamark Plus; Whip Mix Europe, Dortmund, Germany) (Fig 12). The\nmandibular prosthesis was provided with a bilateral buccal crossbite to add to the available\ntongue space and improve patient comfort.\nThe definitive prostheses were inserted and instructions provided on the insertion and removal\nof the implant-supported mandibular overdenture (Figs 13 and 14). To facilitate\naccommodation of the new mandibular prosthesis, pink inserts were provided (Locator male,\nlight retention, 1.36 kg) (Figs 15a-b).\nThe patient was recalled at 6-monthly intervals during the 18 months since the treatment.\nMinimal maintenance was required; the Locator inserts were changed on one occasion. The\npatient was very pleased with the result, as was his wife (Fig 16). He noted a significant\nimprovement in chewing, speech and self-confidence and reported that he had “returned to\nplaying bridge with his wife and her friends.” He was placed on a yearly recall, with\nmaintenance also provided by a dental hygienist working with his general dental practitioner.\nA repeat panoramic radiograph was taken 24 months after implant placement, which shows\napproximately 2 mm of horizontal bone loss associated with the left implant (Fig 17).\nHowever, no clinical signs of inflammation were observed."
  },
  {
    "page": 297,
    "content": "Fig 16 The patient wearing his maxillary complete denture and mandibular implant-supported overdenture at the 12-\nmonth review.\nFig 17 Panoramic radiograph 24 months after implant placement (Locator inserts in place)."
  },
  {
    "page": 298,
    "content": "13.5\nMaxillary Implant-supported Full-arch Removable\nDental Prostheses for a Geriatric Patient:\nSequencing the Treatment for an Optimal Outcome\n \nA. Dickinson\nA 90-year-old, essentially healthy woman requested assistance following what she determined\nwas the loss of a dental restoration from a maxillary anterior tooth. She also complained of\npain associated with tooth 11.\nThe patient was assessed as relatively fit and healthy. She took medications for mild\nhypertension and to prevent angina attacks (atenolol and diltiazem). She had a form of arthritic\njoint degeneration affecting several joints; especially in her hands and fingers. When required\nshe used an NSAID (meloxicam) for pain management.\nShe reported living alone in a care facility that allows for independent living, with domestic\nsupport when and if necessary and primary medical triage when required.\nThe initial clinical examination (Figs 1 to 6) and evaluation revealed the following:\n•\nGrade 3 mobility and pain in tooth 11 with labial swelling and involvement of the sinus\ntract associated with the apical area of this tooth.\n•\nFractured crown of tooth 13.\n•\nUnsatisfactory upper RPD with cast-metal base (not shown).\n•\nReduced occlusal vertical dimension.\n•\nHeavily restored remaining maxillary anterior teeth.\n•\nPeriodontally hopeless remaining two maxillary molars (teeth 18 and 28).\n•\nReduced mandibular dentition (teeth 35 to 45 only).\n•\nMandibular teeth periodontally and functionally stable."
  },
  {
    "page": 299,
    "content": "Fig 1 Preoperative smile demonstrating tooth display.\nFig 2 Preoperative facial view in intercuspal position. Reduced vertical dimension of occlusion and labial pathology\nassociated with tooth 11.\nFig 3 Right-side view with the jaw in maximum intercuspation."
  },
  {
    "page": 300,
    "content": "Fig 4 Occlusal view of the maxillary arch.\nFig 5 Preoperative occlusal view of the remaining maxillary anterior teeth.\nFig 6 Panoramic radiograph taken after the initial presentation.\nCase analysis and preoperative planning\nMounted casts were prepared. The desired increase in vertical dimension and the planned\ntooth positions were diagnostically evaluated. A CBCT (Figs 7a-d) was taken without a\nradiographic template, as the desired implant positions were unlikely to be in question.\nA broad discussion was undertaken with the patient and her immediate family. Various\ntherapeutic options were considered and the advantages and disadvantages of each discussed.\nEmphasis was placed on eliminating of the existing disease and on a solution to the several\nstructural and functional problems identified by the patient, as well as those brought to the\npatient’s attention."
  },
  {
    "page": 301,
    "content": "The goal was to provide an outcome that would be broadly based on the therapeutic objectives\ndescribed by Chen and Buser (2008).\nPrimary objectives\n•\nSuccessful esthetic and functional outcome.\n•\nEsthetic outcome with long-term stability.\n•\nLow risk of complications during healing and function.\nSecondary objectives\n•\nThe least number of surgical interventions.\n•\nThe least possible pain and morbidity.\n•\nShort healing and overall treatment time.\n•\nA cost-effective treatment.\nWith specific reference to this patient, and because of her age, greater emphasis was placed on\nthe reduction of pain and morbidity in combination with a cost-effective therapeutic outcome,\nin preference to focusing on reducing the number of surgical interventions and the overall\nlength of the treatment."
  },
  {
    "page": 302,
    "content": "Figs 7a-d CBCT sections. (a-b) First quadrant, pages 1 and 2. (c-d) Second quadrant, pages 1 and 2.\nFigs 8a-c Placement of implant 16. Flapless procedure utilizing a punch incision and placement of a tissue-level\nSLActive implant providing for a placement that closely paralleled the previously placed implant 26 (courtesy of Dr.\nStephen Chen).\nThe treatment sequence is of great importance in geriatric patients. Emphasis had to be placed\non the elimination of disease and the restitution of a healthy and functional oral status, while\nintroducing changes in a manageable time frame and aiming to reduce the need for a"
  },
  {
    "page": 303,
    "content": "transitional prosthesis that may require significant adaptation by the patient.\nThe therapeutic goal was to transition the patient, in manageable stages, from her debilitated\nresidual maxillary dentition to a complete maxillary prosthesis retained via single retentive\nelements attached to four dental implants. A surgical and prosthetic treatment sequence was\nselected that would achieve the desired outcome, but reduce the patient’s adaptive\nrequirements.\nTreatment plan\nThe surgical and prosthetic treatment was undertaken using a staged protocol (sequence). This\nwould provide for the early elimination of disease while maintaining function and acceptable\nesthetics and with the expectation of achieving a reduction in the physiological and\npsychological adjustments required of the patient.\nInitial treatment steps\n•\nExtraction of teeth 13 (root), 23 and 11 (pain).\n•\nTransitional acrylic RDP with anterior palatal coverage to allow for an immediate increase\nin the vertical dimension of occlusion.\n•\nPlacement of two implants:\nImplant 16: Straumann RN S SLActive, length 12 mm (Figs 8a-c)\nImplant 26: Straumann RN S SLActive, length 10 mm (Figs 9a-e)\n(both Institute Straumann AG, Basel, Switzerland)\n•\nRetention of the periodontally hopeless teeth 18 and 28 to allow for continued retention of\nthe transitional RDP.\nFigs 9a-e Placement of implant 26. Flapless procedure using a punch incision and placement of a tissue-level RN\nSLActive implant (courtesy of Dr. Stephen Chen)."
  },
  {
    "page": 304,
    "content": "Figs 10a-b Extraction of teeth 13, 11, and 23 at the time of implant placement in the posterior maxilla (courtesy of Dr.\nStephen Chen).\nThe implant sites were managed with a flapless approach utilizing a punch entry through the\nalveolar mucosa to prepare the osteotomy site based on the CBCT findings. Both implant sites\nwere prepared to allow for a near-parallel placement of the tissue-level implants (RN).\nThe extraction of teeth 13, 11, and 23 (Figs 10a-b) was completed at the time of implant\nplacement in the posterior maxilla (Figs 11a-c). This allowed for the definitive management of\nthe infected tooth root of tooth 11, which had a hopeless prognosis, as well as the fractured\nroot of tooth 13 and the intact tooth 23. The latter two extraction sites were identified for\nsubsequent placement of implants in a type 2 surgical protocol.\nThe transitional acrylic RDP was modified to facilitate its immediate postsurgical delivery.\nThe patient stabilized and the initial healing of the implants in the 16 and 26 sites was\ncompleted.\nFigs 11a-c Implants 16 and 26 and extraction of teeth 13, 11, and 23, teeth 18 and 28 still being retained at this point."
  },
  {
    "page": 305,
    "content": "Figs 12a-b Having placed the Locator abutments on the previously inserted tissue-level RN implants 16 and 26 and\nmodified the transitional acrylic denture, the two remaining molars 18 and 28 were extracted (courtesy of Dr. Stephen\nChen).\nIntermediate treatment steps\n•\nLocator attachments placed on posterior implants (Figs 12a-b).\n•\nExtraction of teeth 18 and 28 (Figs 12a-b).\n•\nModification of the transitional acrylic RDP incorporating direct pick-up of the female\nhousing and retentive element within the denture.\n•\nPlacement of two further implants (type 2 protocol): Implant 13: Straumann RN S SLActive,\nlength\n10 mm (Figs 13a-c)\nImplant 23: Straumann RN S SLActive, length 10 mm (Figs 13a-c)\n(both Institute Straumann AG, Basel, Switzerland)\nFigs 13a-c Eight weeks later: implants 13 and 23 and Locator attachments.\nFollowing an adequate period of healing and successful integration of implants 13 and 23, the\nfinal prosthetic steps were undertaken.\nFinal treatment steps\n•\nPlacement of the additional two Locator attachments."
  },
  {
    "page": 306,
    "content": "•\nFabrication of the metal-reinforced maxillary complete implant-supported RDP (Figs 14a-b\nand 15a-b).\n•\nExtraction of the remaining three teeth (12, 21, and 22; Figs 16a-b).\n•\nImmediate placement of the definitive prosthesis.\n•\nRelining of the appliance following three months of post-extraction healing and function.\nThe definitive maxillary implant-supported complete RDP included a cast Co-Cr framework\nfor improved rigidity. Because of the shape of the residual maxillary arch that provided\nadequate lateral resistance, full palatal coverage was not required.\nFigs 14a-b Cast Co-Cr framework for inclusion in the maxillary implant-supported complete RDP. No full palatal\ncoverage.\nFigs 15a-b The processed maxillary removable prosthesis.\nFigs 16a-b Six weeks after implant placement in the anterior maxilla. Locator attachments on tissue-level implants 13\nand 23 and extraction of teeth 12, 21, and 22 with immediate prosthetic delivery."
  },
  {
    "page": 307,
    "content": "Figs 17a-d Review two weeks after extraction.\nThe processed maxillary RDP (Figs 17a-d) incorporated no flange on the facial aspect in the\nanterior sextant. Only three black processing males were retained in the appliance at the time\nof insertion to allow for ease of placement and removal.\nThis protocol allows time for the patient to become accustomed to the correct insertion and\nremoval technique for the prosthesis after delivery. The commencement of the buccal flanges in\nthe cuspid areas also provides a point of reference for the patient to apply her fingers or a\nsmooth implement to dislodge the prosthesis.\nConclusion\nThe use of four dental implants to support an implant-supported removable dental prosthesis is\na clinically well-documented procedure (Gallucci and coworkers 2009b). In geriatric patients,\nemphasis is best directed to the sequencing of the therapeutic stages in the transition from an\nunstable and poorly functioning natural dentition or prosthesis to the desired outcome. Time\nshould be allowed for the required adaptation to the changing oral environment and function.\nConsideration must be given to the requirements for ongoing maintenance by patients\nthemselves and to the possibility of such maintenance becoming the responsibility of third-\nparty care providers."
  },
  {
    "page": 308,
    "content": "13.6\nMandibular Overdenture Supported by a\nCAD/CAM-milled Bar with Long Distal Extensions\non Two Conventionally Loaded Implants\n \nM. Srinivasan\nAn 87-year-old man was referred to our Division of Gerodontology and Removable\nProsthodontics at the University Clinics of Dental Medicine, Geneva, Switzerland for dental\nimplant therapy. He was retired and led a very active social life, keeping himself busy in the\ncompany of his many grandchildren and with frequent travels to Italy.\nThe patient’s past medical and drug histories revealed that he suffered from angina, asthma,\nand arthritis of the knee. He was allergic to penicillin. His regular prescription medications\nincluded anti-anginal and anti-asthmatic drugs, along with occasional non-steroidal anti-\ninflammatory drugs for joint pain. Otherwise, he was a healthy patient who occasionally\nconsumed alcohol on social occasions and did not smoke.\nA detailed dental history revealed that he had lost his teeth to chronic adult periodontal disease\n(Fig 1) and had had an edentulous maxilla for over 20 years.\nThe two remaining mandibular teeth (32 and 33) supported an overdenture (Fig 2), but were\nfailing. The patient was unhappy with his mandibular denture and its poor retention and\ninstability.\nA mandibular implant overdenture supported by two interforaminal implants was planned at\nthe Division of Stomatology of the University of Geneva. Two Straumann tissue-level implants\n(Straumann Standard Plus RN SLActive, Ti, diameter 4.1 mm, length 8 mm; Institut Straumann\nAG, Basel, Switzerland) were placed; the remaining two teeth were simultaneously extracted\n(Fig 3)."
  },
  {
    "page": 309,
    "content": "Fig 1 Baseline panoramic radiograph showing a failing dentition.\nFig 2 Panoramic radiograph. Two remaining teeth supporting a mandibular overdenture before implant therapy.\nFig 3 Immediate postoperative panoramic radiograph showing implants 43 and 34.\nFig 4a Periapical radiograph at 8 weeks showing the successful implant 43."
  },
  {
    "page": 310,
    "content": "Fig 4b Failing implant 34.\nFig 5a Implant 34 lost 15 weeks after placement.\nFig 5b New implant placed at the adjacent site 33."
  },
  {
    "page": 311,
    "content": "Figs 6a-b Periapical radiographs 12 weeks after placement of the new implant 33. Both implants integrated well and\nwere ready to be loaded.\nA conventional loading protocol was planned. During the healing phase, clinical examinations\nand radiographs revealed an uneventful integration of implant 43 (Fig 4a), whereas implant 34\nwas failing (Fig 4b). The reasons for this failure remained speculative, but there was no\nevidence in the literature that the patient’s age could have played a role. We therefore\nsuspected that the presence of the endodontically and periodontally compromised residual\nteeth in the direct vicinity of the implantation site might have been implicated (Listgarten and\ncoworkers 1991; Mombelli and coworkers 1987; Mombelli and coworkers 1988; Mombelli\nand Lang 1992; Rosenberg and coworkers 1991).\nThe adaptation of the overdenture during the healing phase was performed alio loco; the\npossibility could not be excluded that an insufficient relief of the overdenture at the implant\nsite might have resulted in premature loading of the implant. Implant 34 was ultimately lost\nbefore loading (Fig 5a) and a new implant was placed at the adjacent site 33 (Fig 5b). After\nallowing 12 weeks of healing for the second implant, the implants were ready to be loaded\n(Figs 6a-b). A mandibular implant-supported overdenture on two retentive anchors with\nDalbo-PLUS attachments (Cendres+Métaux SA, Biel, Switzerland) was finally delivered; the\nexisting maxillary conventional complete denture was relined. The patient had undergone this\ntreatment before being referred to us.\nFig 7 Intraoral view of the edentulous maxilla."
  },
  {
    "page": 312,
    "content": "Fig 8 Intraoral buccal view. Implants with existing retentive anchors. Implant shoulders at different levels.\nFig 9 Occlusal view. Mild axial discrepancy of the implants.\nFig 10 Old dentures with the lips completely retracted.\nAt the initial consultation at our clinic, the patient was still unhappy with his mandibular\ndenture (Figs 7 to 10). He complained that the mandibular implant-supported overdenture was\nnot retentive and unstable. He was also unhappy with the esthetics of the maxillary denture, as\nhis upper teeth were not visible when he smiled and that the “pink portions” of the maxillary\ndentures were too obvious. He consulted for an improvement but rejected any further surgery\nfor more implants or other invasive treatment options.\nDetailed intraoral and radiographic examinations revealed a severely resorbed maxilla and\nmandible. The available bone was Cawood class VI in the anterior and posterior maxilla,\nwhile in the anterior and posterior mandible it was Cawood class V and VI, respectively\n(Cawood and Howell 1988; Fig 11). The available bone height in the mandibular"
  },
  {
    "page": 313,
    "content": "interforaminal region was estimated at 17 mm.\nFig 11 Panoramic radiograph 15 months after loading. Severely resorbed maxilla and posterior mandible. The implants\nseem to have preserved the bone in the mandible.\nExtraoral examinations without the prostheses in situ revealed a concave profile and a need for\nsoft-tissue support (Figs 12 to 14). With the prostheses in situ, inadequate lip support, a\ndiscrepancy between the lip, and smile lines along with an inharmonious tooth display were\nobserved (Figs 15 to 18). The teeth in the existing prostheses were worn and their resin bases\nexhibited discoloration (Figs 19a-d).\nFig 12 Extraoral profile view, without the prostheses in situ. Concave profile suggesting a need for lip support.\nFig 13 Profile view of smile without the prostheses in situ."
  },
  {
    "page": 314,
    "content": "Fig 14 Frontal view of smile without the prostheses.\nFig 15 Extraoral profile view with the old prostheses in situ. Lack of adequate upper-lip support.\nFig 16 Profile view of the smile with the old prostheses in situ."
  },
  {
    "page": 315,
    "content": "Fig 17 Lip line with the existing dentures.\nFig 18 Frontal view of a full forced smile with the old dentures.\nFigs 19a-d Old prostheses with severely worn teeth and resin discoloration, warranting a remake.\nAn assessment of the complexity of the case using the SAC tool classified the case as advanced\nand complex in the surgical (Chen and coworkers 2009) and restorative (Dawson and"
  },
  {
    "page": 316,
    "content": "coworkers 2009) categories, respectively (Figs 20a-b).\nFigs 20a-b SAC assessment tool. The case was assessed as an advanced surgical case and a complex restorative case.\nFigs 21a-b Buccal and occlusal views of the implants after removing the retentive anchors and before the definitive\nimpressions.\nFig 22 synOcta impression posts mounted on the implants."
  },
  {
    "page": 317,
    "content": "Fig 23 Impression taken with a rigid elastomeric impression material (polyether).\nA minimally invasive treatment option was offered to the patient. The proposed treatment plan\ntook into account the various clinical and economic factors along with the patient’s desires and\nexpectations. The plan involved utilizing the existing implants and excluded placement of\nadditional implants or further surgery. The spherical anchors were to be replaced by a\nCAD/CAM-milled titanium bar with long distal extensions for the mandibular implant-\nsupported overdenture. The design of the bar, in particular the length of the extensions, went\nbeyond our usual protocol in geriatric dentistry and was part of a randomized clinical trial\nperformed at the Division of Gerodontology and Removable Prosthodontics.\nThe research protocol was approved by the local ethics committee, and the patient signed\ninformed consent forms on possible risks, as this treatment concept is novel and not yet\ndocumented by long-term evidence. The concept aims to prove the functional improvement of\nlong extensions on CAD/CAM bars for overdentures in terms of masticatory performance as\nwell as oral health-related quality of life (OHRQoL) and patient satisfaction. Further interest\nfocuses on posterior bone resorption in comparison to two-implant overdentures retained by\nball attachments, as the larger support area of this novel concept may have a protective effect\non the bony structures of the posterior alveolar ridge. For this patient, both maxillary and\nmandibular prostheses were to be remade.\nThe treatment phase began with preliminary alginate impressions to obtain custom resin trays.\nThe retentive anchors were removed and master impressions were taken (Figs 21a-b to 23)\nwith polyether impression material (Impregum; 3M ESPE, Seefeld, Germany) using screw-\nretained synOcta impression posts (Institut Straumann AG, Basel, Switzerland). Master casts\nwere poured and occlusal rims fabricated on acrylic bases.\nAll conventional clinical and laboratory procedures for the fabrication of complete dentures\nwere adhered to up to the clinical try-in of the tooth set-up stage."
  },
  {
    "page": 318,
    "content": "Fig 24 Scan of the mandibular master cast.\nFig 25 Scan of the tooth set-up.\nFig 26 Designing the CAD/CAM-milled bar with long distal extensions in the CARES software.\nFig 27 Verifying the bar design against the scan of the tooth set-up."
  },
  {
    "page": 319,
    "content": "After the clinical try-in, the mandibular model and the mandibular denture set-up were scanned\nwith an in-lab scanner (Straumann CARES Scan CS2; Institut Straumann AG) using the\ndedicated software (Straumann CARES Visual Design software; Institut Straumann AG). The\nCAD/CAM-milled bar with long distal extensions was then designed and fabricated using the\nvalidated digital workflow (Straumann CARES Visual 8.5 Validated Workflow; Institut\nStraumann AG; Figs 24 to 30a-b). The bar was then clinically verified for fit (Figs 31a-b).\nAfter the try-in, the dentures were definitively processed and delivered (Figs 32a-d).\nFig 28 Occlusal view showing the extensions of the designed bar.\nFigs 29a-b Cross-sectional views. Adequate space between the bar framework and the denture base.\nFigs 30a-b Buccal and occlusal views of the final design of the bar before the milling process."
  },
  {
    "page": 320,
    "content": "Figs 31a-b Try-in of the CAD/CAM-milled bar (buccal and occlusal views).\nFigs 32a-d Finished prostheses.\nAt delivery, the CAD/CAM-milled bar was first tightened on the implants to 35 Ncm using the\nStraumann ratchet and torque control device (Institut Straumann AG, Basel, Switzerland). The\nscrew access channels on the milled bar were plugged with a polytetrafluoroethylene tape\n(Teflon; DuPont, Wilmington, DE, USA) and then sealed using a light-curing provisional resin\ncement (Telio CS Inlay; Ivoclar Vivadent, Schaan, Liechtenstein) (Moraguez and Belser, 2010)\n(Figs 33 to 35). The finished maxillary and mandibular prostheses were verified for fit,\nretention, stability and esthetics at the time of insertion, and patient satisfaction was duly noted\n(Figs 36 to 38a-d)."
  },
  {
    "page": 321,
    "content": "Fig 33 CAD/CAM-milled bar with screws tightened to 35 Ncm.\nFigs 34a-d Teflon tape packed into the screw channels. Light-activated provisional resin cement is condensed and\npolymerized over the Teflon tape.\nFig 35 Occlusal view after sealing the screw channels.\nFig 36 Final prostheses in situ with the lips fully retracted."
  },
  {
    "page": 322,
    "content": "Fig 37 Frontal smile with the new prostheses in situ.\nFigs 38a-d Profile views with the new prostheses in situ showing better soft-tissue support and improved esthetics\nduring smiling. An overall pleasing result and a thoroughly satisfied patient.\nThe patient received detailed instructions on the care and hygiene maintenance for the bar and\nthe dentures (Figs 39a-b). The patient was thoroughly satisfied with the result of the treatment."
  },
  {
    "page": 323,
    "content": "Figs 39a-b Adequate space for easy maintenance beneath the bar with an interdental brush or dental floss.\nFig 40 One-year clinical follow-up (buccal view).\nFig 41 One-year clinical follow-up (occlusal view)\nFig 42 Panoramic radiograph at one year after insertion of the CAD/CAM-milled bar."
  },
  {
    "page": 324,
    "content": "Fig 43 Prostheses in situ with the lips fully retracted at the one-year recall visit.\nAt the one-year recall visit, the patient was extremely happy and content with the retention and\nstability of the mandibular prosthesis (Figs 40 to 43)."
  },
  {
    "page": 325,
    "content": "13.7\nFlapless Guided Surgery: Bar-supported\nOverdenture on Four Implants\n \nR. J. Renting\nGuided surgery has become a well-known implantological treatment strategy in recent years. A\nCBCT scan combined with surgical planning software allows the surgeon to plan the ideal\nposition of the implants before surgery in a digital and three-dimensional environment. With\nthis workflow, the surgeon can recognize and avoid important anatomical structures (Tahmaseb\nand coworkers 2014).\nGuided surgery has a number of advantages if the planning is correct, especially for the\nmedically compromised and geriatric patient, where major surgery should be avoided:\n1\nSurgery is flapless, so no disturbance of healing needs to be expected.\n2\nMajor augmentation procedures are avoided.\n3\nThe time needed for surgery is reduced to a minimum.\nAll of these factors are likely to help reduce the pain and discomfort in the postoperative\nperiod (Hultin and coworkers 2012) and should be taken into consideration when treating a\ngeriatric patient.\nA female patient, born in 1934, medically compromised (Renton and coworkers 2013) (ASA\nIII: history of CVAs, arrhythmia, high blood pressure, type 2 diabetes mellitus, hypothyroid,\narthroses, and hyperventilation) presented at our clinic. Her remaining maxillary dentition had\nhad to be extracted some years ago due to multiple periapical infections; since then, the patient\nhad been functioning with a conventional maxillary denture. This denture had been giving her\nproblems in terms of function, eating, and digesting food. She lived at a considerable distance\nfrom the clinic. Despite the pain while wearing and using the denture, she kept her spirits and\nhoped for a different solution. She wished for more comfort and better chewing ability; at the\ntime, she could not visit friends or have dinner in a restaurant with her conventional denture.\nIntraorally, the patient presented with a complete mandibular dentition without complaints and\nsufficient oral hygiene. The maxilla had a flattened aspect and a shallow palate and vestibulum\nthat compromised the retention of the denture (Figs 1a-d). The patient complained about pain\nwhen loading the denture. Because of the exerted-force discrepancy between the upper and"
  },
  {
    "page": 326,
    "content": "lower jaws and the difficult status in the maxilla, an implant-supported denture appeared to be\nthe treatment of choice.\nFig 1a Initial smile line with the maxillary denture.\nFig 1b Maxillary denture in maximum occlusion.\nFig 1c Initial clinical presentation of the edentulous maxilla."
  },
  {
    "page": 327,
    "content": "Fig 1d Initial clinical presentation (occlusal view).\nFig 2 Initial panoramic radiograph.\nThe panoramic radiograph showed a bilaterally pneumatic maxillary sinus (Fig 2).\nBecause of the patient’s medical condition and history, it was decided to perform the surgery\nas atraumatically as possible, the goal being to avoid a sinus-floor augmentation. This can be\nachieved with a flapless guided-surgery workflow.\nTo be able to perform prosthetically driven digital implant planning, analog information had to\nbe digitized. The first step was a set-up in wax (wax try-in) to analyze and optimize the\nesthetics and the available intermaxillary space (Figs 3a-b). When the set-up had been\napproved by the dentist and patient, it was converted to a radiographic template with barium\nteeth (Israelson and coworkers 2013; Fig 3c).\nThe analog set-up was now converted into a digital setup using two CBCT scans and implant-\nplanning software. Two CBCT scans were taken, one of the patient with the scan denture in\nsitu and one of just the scan denture. A lab scanner was used to scan a plaster cast of the\nmaxillary jaw. By superimposing the scans in the coDiagnostiX planning software (Dental\nWings, Chemnitz, Germany), a 3D model was created to facilitate prosthetically driven implant\nplanning (Fig 4).\nWhen the planning was completed, a guided surgical guide (drilling stent) was manufactured,\nin this case by 3D printing (Implantec, Amstetten, Germany). Even though the surgical guide\nwas mucosally supported, this production method still increased accuracy. The main difference"
  },
  {
    "page": 328,
    "content": "was in the positions of the sleeves, which were digitally planned and printed and the surgeon\nsimply clicked metal sleeves in place. This positioning formerly had to be done manually on\nthe plaster cast (Kuehl and coworkers 2015; Schneider and coworkers 2015).\nIn this case, four implants were planned in the premaxilla region, avoiding the left and right\nmaxillary sinus.\nBefore the surgery, the fit of the guide was assessed and checked for stability. It is very\nimportant to keep the surgical guide immobile while performing the osteotomies. A sufficient\nwidth of keratinized mucosa made it possible to perform flapless surgery. Osteotomies where\nmade according to manufacturer’s instructions and checked for fenestrations. Four implants\nwere placed (Figs 5a-e): at sites 14, 24 (Straumann SP SLActive Roxolid, diameter 4.1 mm,\nlength 8 mm; Institut Straumann AG, Basel, Switzerland) and 12 and 22 (Straumann SP\nSLActive Roxolid, diameter 3.3 mm, length 10 mm; Institut Straumann AG). The panoramic\nradiograph showed the implants in front of the medial sinus walls (Fig 6).\nFig 3a Diagnostic bite registration.\nFig 3b Diagnostic wax try-in."
  },
  {
    "page": 329,
    "content": "Fig 3c Radiographic template with barium teeth in situ.\nFig 4 Superimposition of the digitalized information, CBCT scan, and planning (coDiagnostiX; Dental Wings, Chemnitz,\nGermany).\nFig 5a Frontal view of the 3D-printed surgical guide (Implantec, Amstetten, Germany)."
  },
  {
    "page": 330,
    "content": "Fig 5b Occlusal view of the 3D-printed surgical guide complete with guide sleeves.\nFig 5c Frontal view of implant with pick-ups inserted through the guide (guided surgical system: Institut Straumann AG,\nBasel, Switzerland).\nFig 5d Occlusal view directly after implant placement."
  },
  {
    "page": 331,
    "content": "Fig 5e Occlusal view after placement of healing abutments.\nFig 6 Panoramic radiograph after implant placement.\nFig 7a-b Occlusal and frontal view of impression copings.\nFig 7c Impression (Impregum; 3M ESPE, Seefeld, Germany) with impression copings."
  },
  {
    "page": 332,
    "content": "Fig 8a-b Milled splinted bar on cast model and occlusal view.\nAfter the recommended healing period, the four implants were loaded. The previous set-up\nwas checked again and a conventional impression was taken (Figs 7a-c). A splinted bar on the\nfour implants was chosen to support an overdenture (Figs 8a-c).\nFig 8c Panoramic radiograph after placement of the bar on the implants.\nFig 9a-b Frontal view and smile at prosthetic delivery."
  },
  {
    "page": 333,
    "content": "Fig 10a-b Occlusal and frontal views at the 12-month follow-up.\nFig 11 The patient demonstrating her daily maintenance.\nThanks to the guided planning, the surgeon was able to avoid elaborate sinus augmentation\nsurgery and keep surgical entries, treatment time, and morbidity to a minimum. This also meant\nreduced postsurgical maintenance, resulting in fewer clinical visits. No adjustments had to be\nmade in the patient’s medication. No implants were placed in augmented bone, resulting in an\nosseointegration time of 3 instead of 6 months. All these factors are of great benefit to a\ngeriatric patient with this kind of medical status.\nAfter getting used to the new denture (Figs 9a-b), the patient felt much more confident in social\nevents; her chewing comfort improved, and she was able to eat solid food again. Figures 10 to\n14 shows the situation at the 12-month follow-up.\nFig 12a-b The occlusion and a view of denture at the 12-month follow-up."
  },
  {
    "page": 334,
    "content": "Fig 13 Panoramic radiograph at the 12-month follow-up.\nFig 14 Frontal view one year after prosthetic delivery.\nAcknowledgment\nThe author wishes to thank Dr. W. D. C. Derksen for his help with the planning software."
  },
  {
    "page": 335,
    "content": "13.8\nProsthodontic Solution for Two Angulated 6-mm\nImplants Supporting a Removable Partial Denture\nin a 74-year-old Patient\n \nU. Webersberger\nA 74-year-old woman was referred to the Department of Maxillofacial Surgery at the Medical\nUniversity of Innsbruck, Austria with retention loss of her upper and lower dentures and\nresulting pain from the flabby ridge in the maxilla.\nHer general medical history included common bradycardic arrhythmias (AV block, 1st degree),\nbronchial asthma, and type 2 diabetes. She was under the regular control of her general\npractitioner, who prescribed her a number of medications including: Amilostad (Stada, Bad\nVilbel, Germany) for hypertension, Singulair (MSD, Kenilworth, NJ, USA) and Symbicort\nturbohalers (Astra-Zeneca, London, UK) for bronchial asthma, metformin for the management\nof type 2 diabetes, and simvastatin for high cholesterol.\nHer dental history included a chin osteotomy 25 years previously. The wires of the chin\nosteotomy were still in place (Fig 1). To prevent bone resorption, the alveolar defect in the\nmolar area had been filled with bone-graft material during the chin osteotomy after extraction\nof the molars (Figs 1, 19, and 20). At that time, the patient also became edentate in the maxilla.\nShe was used to dentures, but had been suffering from her hurting flabby ridge in the maxilla\nfor 20 years.\nThe patient was well oriented. She was living with her husband, had two children and\ngrandchildren, and enjoyed a fulfilling life.\nAn immediate radiographic evaluation of the remaining alveolar bone height in the mandible\nwas performed without a study model and radiographic ball-bearing template. Instead, the\ndiagnostic X-ray measurement balls were directly incorporated in the existing removable\npartial denture (RPD) (Fig 2). The method is simple and enables the busy practitioner to obtain\nan immediate radiographic diagnosis and to inform the patient about the available alveolar\nbone height at the planned implant site at the first visit."
  },
  {
    "page": 336,
    "content": "Fig 1 Baseline panoramic radiograph. Wires from a previous chin osteotomy still in place.\nFig 2 Panoramic radiograph with measurement balls in the distal part of the existing removable partial denture.\nThe following dental diagnoses resulted after oral examination and radiographic investigation\n(Figs 1 and 2):\n•\nCompletely edentulous maxilla opposing a Kennedy class I partially edentulous mandible\n(bilaterally).\n•\nAdvanced atrophy in the anterior maxilla and posterior mandible.\n•\nLack of retention and stability of the complete maxillary denture resulting from the flabby\nridge.\n•\nThe remaining mandibular dentition was considered salvageable.\n•\nRetention loss of the mandibular partial denture.\nA staged treatment approach to maximize the esthetic and functional treatment outcome with\nsurgical hard-tissue augmentation in both jaws was discussed with the patient but was\ndeclined. She liked the esthetics of her maxillary denture, she just felt very uncomfortable with\nthe retention loss resulting from the painful flabby ridge. Discussions revealed that she had\nconcerns about extensive surgical procedures. She was aware that without additional distal\nimplant support, the retention and stability of the mandibular RPD could not be improved.\nAfter careful evaluation and discussions with the patient, the following treatment plan was\ndecided on:"
  },
  {
    "page": 337,
    "content": "•\nMaxillary vestibuloplasty.\n•\nProvisional relining of the maxillary denture.\n•\nInsertion of two angulated implants at sites 37 and 47.\n•\nRestoration of the remaining teeth with composite fillings.\n•\nAfter healing, definitive relining of the maxillary denture.\n•\nImplant-supported RPD with resilient implant attachments.\nOral hygiene and conservative treatment of the remaining mandibular teeth with composite\nfillings proceeded without complications. After maxillary vestibuloplasty surgery with a free\nmucosal flap harvested from the cheek, two 6-mm Tissue Level SLA implants (Institut\nStraumann AG, Basel, Switzerland) were placed at sites 37 and 47 (Fig 3).\nFig 3 Panoramic radiograph view after placement of two implants in the mandible.\nFig 4 Straumann open-tray impression posts on the Tissue Level implants.\nFig 5 Occlusal view of the open impression tray."
  },
  {
    "page": 338,
    "content": "Fig 6 Occlusal rim of the framework after determination of the jaw relationship.\nFig 7 Trial mandibular denture.\nFig 8 Occlusal view. Mandible with torqued SFI abutments.\nAfter the vestibuloplasty, the intaglio surface of the maxillary denture was relieved and relined\nwith a soft relining material (Coe-Comfort; GC Europe, Leuven, Belgium). Two months later,\nthe border of the existing complete denture was molded using impression compound\n(KerrHawe, Bioggio, Switzerland) to duplicate the contour and size of the vestibule. A\nfunctional impression was then taken using Permlastic polysulfide (KerrHawe). The new\ndenture base was reprocessed at the dental laboratory with heat-polymerizing acrylic resin.\nAnother two months later, two impression posts were inserted in the mandible (Fig 4), and an\nopen-tray impression was taken in silicone (Affinis; Coltene, Altstätten, Switzerland) with a\ncustom open acrylic-resin tray (Fig 5).\nFigures 4 and 5 demonstrate the mesial angulation of the implants in the molar area. The"
  },
  {
    "page": 339,
    "content": "available implant attachments allow restoring non-parallel implants diverging by up to 40°.\nHowever, even more compensation was needed here. This problem could not be resolved with\nthe originally planned Locator attachment. Because of the great divergence, we decided to use\nthe new SFI-Anchor D60 abutment (Institut Straumann AG, Basel, Switzerland), which\nprovides 50% more angulation compensation: implant divergences of up to 60° can be\ncompensated for. After the impression was taken, it was decided to produce the metal-\nframework RPD first and integrate the SFI-Anchors afterwards.\nAt the next appointment, the metal framework design was placed in occlusion using the\nocclusal rims to determine the jaw relationship (Fig 6).\nThe shade, material, and mold of the artificial teeth were specified. The next stage was a try-in\nof the trial denture (Fig 7). The wax was replaced by acrylic at the laboratory, and the denture\nwas delivered at the next visit.\nAfter 4 weeks, the healing caps were removed and the SFI-Anchor attachments were inserted\ninto the Tissue Level implants. The abutments were torqued to 35 Ncm with the SFI-Anchor\nscrewdriver and the Straumann ratchet with torque-control device.\nThe occlusal view of the mandible (Fig 8) demonstrates the modification of the Kennedy class\nI mandibular arch to a more favorable Kennedy class III arch with two implants and SFI-\nAnchor attachments.\nFig 9 SFI-Anchor aligner positioned on the SFI abutments.\nFig 10 Frontal view: SFI-Anchor aligner on the SFI abutments."
  },
  {
    "page": 340,
    "content": "Fig 11 Occlusal view. SFI-Anchor impression post on the SFI-Anchor abutment.\nFig 12 Impression with SFI-Anchor impression post.\nThe abutment aligners were placed on the Straumann SFI-Anchors (Figs 9 and 10). Self-\nadhesive dual-cure composite bonding cement (Multilink, Ivoclar Vivadent, Schaan,\nLiechtenstein) was inserted in the abutment aligner until excess cement came out of the vent\nholes. The two Straumann SFI-Anchor abutments were oriented with the help of the abutment\naligner to achieve parallelism. Once the cement had completely cured, the aligners were\nremoved.\nThe existing mandibular denture was relieved above the anchors. SFI-Anchor impression posts\nwere placed on the SFI-Anchor abutments (Fig 11), and an impression was taken in silicone\n(Affinis; Coltene, Altstätten, Switzerland) (Fig 12). The denture was sent to the dental\nlaboratory to polymerize the SFI-Anchor inserts into the relief areas of the denture.\nFour color-coded polymer Pekkton (Cendres+Métaux, Biel, Switzerland) retention inserts\n(extra-low, low, medium, and strong) and the Elitor (highest retention strength; Institut\nStraumann AG, Basel, Switzerland) for different retention strength needs are available for the\nSFI-Anchor system. In this case, we opted for the red Pekkton insert (045.048) with low\nretention strength for both SFI-Anchors (Figs 13 to 15).\nOnce the maxillary complete denture was relined, the patient had enough retention and\nstability. The maxillary mucosa healed well after a vestibuloplasty (Fig 16). The insertion of\nthe implant-supported metal-framework RPD proceeded uneventfully (Figs 17 and 18)."
  },
  {
    "page": 341,
    "content": "Fig 13 Removable metal-framework partial denture (RPD) with Pekkton inserts.\nFig 14 Polymerized five-star Pekkton insert in the mandibular denture (right side).\nFig 15 Polymerized five-star Pekkton insert in the mandibular denture (left side).\nFig 16 Occlusal view. Edentate maxilla 7 months after the vestibuloplasty."
  },
  {
    "page": 342,
    "content": "Fig 17 Occlusal view. Inserted implant-supported metal-framework RPD.\nFig 18 Frontal view after insertion of the denture.\nFig 19 SFI-Anchor after insertion (left side).\nFig 20 SFI-Anchor after insertion (right side)."
  },
  {
    "page": 343,
    "content": "The radiographs of the SFI-Anchors after insertion (Figs 19 and 20) impressively demonstrate\nthe compensated angle of the two abutments.\nThe prosthetic design changed the Kennedy classification of the partially edentulous mandible\nfrom class I to class III. Additionally, the bilateral distal single implants changed the\nmandibular RPD from tooth/tissue-supported to tooth/implant-supported. The patient felt very\ncomfortable wearing the new metal-framework RPD. After the initial assessment, the patient\nwas seen every 6 months for a 2-year period. There were no complications.\nAt the dental appointment 2 years after insertion (Fig 21), the patient was still satisfied with\nthe restoration, as she was able to perform routine oral functions and maintain good oral\nhygiene. A final panoramic radiograph was taken (Fig 22) that showed no change in crestal\nbone levels of the two distal mandibular implants after 2 years of loading.\nRemark\nWith this abutment type, the retention cannot be easily restored when it diminishes by replacing\na worn retentive five-star Pekkton insert, unlike the procedure when using Locator abutments.\nIn the author’s opinion, an intraoral pickup of the SFI-Anchor abutment will be necessary if the\ninsert has to be replaced.\nFig 21 Happy patient 2 years after delivery of her RPD.\nFig 22 Panoramic radiograph 2 years after delivery."
  },
  {
    "page": 344,
    "content": "13.9\nRehabilitation of a Mandibular Distal Extension\nSituation in a 89-year-old Patient with an Implant-\nsupported Fixed Dental Prosthesis\n \nD. Buser\nFig 1 Distal extension situations due to the loss of retention of a three-unit FDP. Extraction site 45 showed complete\nsoft-tissue healing, whereas the root of tooth 47 was still present. The ridge showed slight flattening at site 46.\nFig 2 3D CBCT rendering. Distal extension situation, root 47, socket 45, and the buccal flattening at site 46. Note the\nposition of the mental foramen."
  },
  {
    "page": 345,
    "content": "A 89-year-old female patient had been referred to the Department of Oral Surgery and\nStomatology at the University of Bern for consideration of implant therapy. A long-standing\nthree-unit fixed dental prosthesis (FDP) supported by teeth 45 and 47 showed a loss of\nretention due to deep secondary caries at tooth 45. The referring dentist removed this tooth\nprior to referral. At that time, the patient had already undergone implant therapy at our\ndepartment twice, at the age of 85, at which time hopeless maxillary premolars and molars had\nto be removed bilaterally. Implant-supported FDPs in both quadrants were provided by the\nreferring dentist following implant surgery at our department, since the patient could not adapt\nto a removable dental prosthesis in the maxilla.\nPreoperative examination\nThe preoperative examination clearly showed that the patient, despite her advanced age, was\nin very good physical shape and not mentally impaired at all; she reported taking Aspirin\nCardio (Bayer Switzerland, Zürich, Switzerland) as her only medication. The patient insisted\non an implant-supported FDP because she had been very pleased with the outcome of previous\nimplant treatment in the maxilla. However, she also asked us to examine the option of a\ntreatment without bone grafting.\nThe clinical examination showed a partially healed socket at site 45 and remnants of the roots\nof tooth 47 (Fig 1).\nOn palpation, the alveolar crest showed buccal flattening at site 46, where the former pontic\nhas been located. Due to the local borderline anatomy, it was decided to analyze potential\nimplant sites with a 3D radiographic examination using cone-beam computed tomography\n(CBCT). The 3D image—produced by a 3D Accuitomo 170 (Morita, Kyoto, Japan)—\nconfirmed the buccal flattening in the right posterior mandible (Fig 2). The CBCT also showed\nthat the bone height above the mandibular crest was sufficient for implant placement, even\nthough it did not exceed 10 mm (Fig 3).\nThe axial cut confirmed slight buccal flattening in the mesial aspect of site 46 (Fig 4).\nPerpendicular orofacial cuts were made at all potential implant sites. The cut in site 45 (Fig 5)\nshowed the extraction-socket defect with a typical reduction of the buccal bone wall. At this\nsite, implant placement would have required a simultaneous GBR procedure to reestablish an\nintact buccal bone wall. At sites 46 (Figs 6 and 7), the images demonstrated that the alveolar\ncrest was narrow at the top, but had a favorable shape with an increasing width in apical\ndirection. In addition, there was no lingual undercut present. A favorable ridge anatomy allows\nthe placement of a standard implant without bone grafting if the alveolar crest is reduced in\nheight to yield a sufficient crest width of 5 mm for reduced-diameter implants, or 6 mm for\nstandard-diameter implants. The sagittal cut on the mesial aspect of site 46 showed the need\nfor a reduction of roughly 2–3 mm to allow the placement of a diameter-reduced implant (Fig\n6). The bone height available following this crest reduction was more than 9 mm—sufficient\nfor an 8-mm implant. On the distal aspect of site 46, the crest width was more favorable,\nrequiring only minimal crest reduction for the placement of a standard-diameter 8-mm implant\n(Fig 7)."
  },
  {
    "page": 346,
    "content": "Fig 3 Panoramic cut of the CBCT. Root remnant 47, socket 45, and edentulous site 46. Bone height was limited by the\nmandibular canal and measures roughly 11 mm. 10-mm implants could not be utilized in this patient.\nFig 4 The axial cut confirms the buccal flattening of the crest on the mesial aspect of site 46.\nFig 5 Sagittal cut of extraction socket 45. Typical buccal bone defect that would require contour augmentation in case\nof implant placement."
  },
  {
    "page": 347,
    "content": "Fig 6 Sagittal cut at site 46 mesially. Narrow crest and a need for crest reduction to increase the crest width. The site\nwas suitable for an 8-mm reduced-diameter NNC implant.\nFig 7 Sagittal cut at site 46 distally. Wider crest, allowing the placement of an 8-mm standard-diameter implant.\nFig 8 Flap elevated without relieving incision and root 47 extracted. The crest at site 46 was slightly shortened. The two\nimplant sites were marked in the appropriate positions with a round bur."
  },
  {
    "page": 348,
    "content": "Fig 9 Intraoperative radiograph with two depth gauges in place following preparation with the first spiral drill. The\nmesial implant bed could be prepared 1 mm deeper without jeopardizing the alveolar nerve.\nBased on this preoperative analysis, two treatment options were considered:\nOption 1\n•\nImplant placement at sites 45 and 46 with simultaneous GBR\n•\nBoth implants would be standard-diameter Tissue Level (TL) implants\n•\nSubmerged healing for 8 weeks\n•\nImplant restoration with two single crowns\nOption 2\n•\nImplant placement at site 46 mesially with a reduced-diameter NNC (Narrow Neck\nCrossFit) implant\n•\nImplant placement at site 46 distally with a standard-diameter TL implant\n•\nImplant placement using a standard technique, no bone grafting\n•\nNon-submerged healing for 8 weeks\n•\nImplant restoration with two splinted single crowns and a mesial cantilever at site 45\nThe patient decided to go for option 2, since she wanted to avoid bone grafting.\nImplant therapy\nThe surgery was undertaken in local anesthesia using an articaine 4% solution combined with a\nvasoconstrictor (Ubistesin forte; 3M ESPE, Seefeld, Germany), without sedative\npremedication. The medication with Aspirin Cardio was not interrupted. The flap was raised\nwith a mid-crestal incision at sites 45 and 46 with the goal to obtain a band of keratinized\nmucosa on both flap margins. The incision was extended mesially into the distobuccal sulcus\nof tooth 44 without a releasing incision. Distally, the incision was extended through the sulcus\nof the root remnants 47, also without a releasing incision. The resulting full-thickness flap gave\nsufficient access to the alveolar crest.\nThe two root remnants of tooth 47 were removed. The crest was carefully flattened at site 46\nand mesially of socket 47 to increase the crest width. The two implant positions were marked\nwith a round bur: the first implant position roughly 10 mm distally of the contact point of tooth"
  },
  {
    "page": 349,
    "content": "44 and the second one 7 mm further distally (Fig 8).\nThe implant bed was prepared using a low-trauma technique and a protocol established more\nthan 20 years ago, with a drilling speed of 500 to 800 rpm and copious irrigation with chilled\nsterile saline (Buser and von Arx 2000). Following the initial preparation of the implant bed\nwith the first spiral drill, an intraoperative digital radiograph was taken with small depth\ngauges in place to examine the proximity to the mandibular canal. This first step of implant bed\npreparation often involves a reduced sink depth to eliminate the risk of nerve damage (Fig 9).\nIn this case, it was obvious that the implant bed at site 46 could be prepared 1 to 1.5 mm\ndeeper than planned. Implant-bed preparation continued for a reduced-diameter bed mesially\n(Figs 10 and 11) and for a standard-diameter implant bed distally, as outlined under option 2\n(Fig 12).\nFig 10 The preparation continued. It was decided to utilize a reduced-diameter NNC implant at the mesial site to\nmaintain an intact buccal bone wall of sufficient thickness (1 mm or more).\nFig 11 Implant bed prepared mesially, including the use of a profile drill for the NNC implant."
  },
  {
    "page": 350,
    "content": "Fig 12 NNC implant inserted. The second implant bed was prepared for a standard-diameter TL implant (S 4.1).\nFig 13 Both implants inserted. The border between the smooth and the SLA surface is located roughly 1 mm below the\ncrest.\nA sink depth of roughly 9 mm was chosen for both implant beds. It was important to maintain\nan intact lingual and buccal bone wall (1 mm or more) to avoid the need for bone grafting. The\ntwo 8-mm implants were inserted to a depth of roughly 8.5 to 9 mm. The mesial implant was a\nNNC Roxolid implant (Straumann, Basel, Switzerland), whereas the distal implant was a\nStandard Tissue Level (S 4.1) implant with a Regular Neck (RN) configuration (Straumann,\nBasel, Switzerland). With this insertion technique, the borderline between the machined\nsurface of the implant neck, and the hydrophilic microrough surface of the implant body\n(SLActive) was located roughly 1 mm below the crest (Fig 13). Prior to flap closure, the\nextraction socket in site 47 was degranulated, rinsed with sterile saline, and filled with a\ncollagen plug (TissueCone; Baxter AG, Volketswil, Switzerland) to stabilize the blood clot.\nThe bone defect in the former extraction socket 45 was grafted with Bio-Oss Collagen\n(Geistlich Biomaterials, Wolhusen, Switzerland)."
  },
  {
    "page": 351,
    "content": "Fig 14 3-mm healing caps inserted to facilitate easy adaptation of the wound margins for non-submerged healing.\nExtraction socket 47 is filled with a collagen plug.\nFig 15 Completed wound closure using 5-0 non-resorbable monofilament sutures.\nFig 16 Postsurgical panoramic radiograph. Correct position of both implants and a safe distance from the mandibular\ncanal."
  },
  {
    "page": 352,
    "content": "Fig 17 Eight weeks later: The peri-implant soft tissues are well healed. The width of keratinized mucosa is sufficient.\nPrior to flap closure, 3-mm healing caps were inserted (Fig 14), and a thin layer of fibrin\nsealant (Tisseel; Baxter AG, Volketswil, Switzerland) was applied to immediately initiate\nblood coagulation underneath the flap. Then, the wound margins were carefully adapted to both\nhealing caps and secured in place with interrupted single sutures utilizing 5-0 non-resorbable\nmonofilament suture material (Fig 15). This facilitated non-submerged healing without a need\nfor reopening. The postsurgical panoramic radiograph showed the two implants in their correct\npositions (Fig 16).\nFollowing an uneventful healing period of 8 weeks, both implants were clinically well\nintegrated. Both implants had a sufficient band of keratinized mucosa without visible signs of\ninflammation (Fig 17). The patient was referred back to the dentist. The two implants were\nrestored with a screw-retained FDP supported by both implants including a mesial cantilever\nunit.\nFig 18 At the 1-year follow-up. The implants were restored with a FDP including a mesial cantilever unit. The peri-\nimplant mucosa is healthy; the 90-year-old patient exercises good plaque control."
  },
  {
    "page": 353,
    "content": "Fig 19 Periapical radiograph. Both implants were well integrated in the bone. The typical signs of slight bone\nremodeling in the crestal area are visible. The fit of the restoration is excellent.\nFig 20 The two implant-supported FDP in the maxilla and mandible. Neighboring teeth show tooth-supported\nrestorations and composite fillings with compromised esthetics, as often seen in patients of that age.\nAt the 1-year examination, the clinical status showed the two implants restored with a FDP\nincluding two splinted single crowns with a mesial cantilever crown. The peri-implant mucosa\nwas clinically healthy and showed no signs of inflammation (Fig 18). The patient, now 90\nyears old, performed good oral hygiene, using interdental brushes every day. She was very\nsatisfied with her chewing comfort in the right mandible. The periapical radiograph\ndemonstrated some typical signs of bone remodeling at both implants (Fig 19). Overall, the\nradiograph showed two implants with direct bone apposition to the implant surface. The fit of\nthe FDP on the implant shoulders was very good.\nThe elderly patient now has implant-supported FDP in the posterior mandible and in the\nmaxilla, offering good chewing comfort (Fig 20). Neighboring teeth mesial to both FDPs show\nold composite fillings with compromised esthetics, as often seen in patients of that age\ncategory.\nDiscussion\nIn the present case, implant therapy had been performed in an 89-year-old patient. Such an age\nis not unusual today. Our department has witnessed an increase of the average age of our\nimplant patients over the past 15 years. In a three-year patient pool treated with dental implants\nbetween 2002 and 2004, the percentage of patients aged over 80 years was 1.0% (Bornstein\nand coworkers 2008). In a later three-year period (2008–2010), representation of this age"
  },
  {
    "page": 354,
    "content": "category had increased to 1.9% (Brügger and coworkers 2015). In 2014, another clear\nincrease to 5.2% was noted (unpublished data). In 2014, the age group over 70 years made up\n21.0% of all implant patients, which is quite remarkable. Of those 104 patients aged over 70\nyears, only 19 had been fully edentulous (18.2%), whereas the remaining patients were all\npartially edentulous (81.8%), presenting most often with distal extension situations, followed\nby single-tooth gaps and extended edentulous spaces. It is important to understand that patients\nof this age group in Switzerland are no longer dominated by edentulism, as was the case 20\nyears ago. However, in both categories of patients—if fully or partially edentulous—the main\nobjective of therapy is clearly to improve or maintain their chewing function. In the present\npatient, the alternative to implant therapy would have been a removable partial denture, which\nwas no option for the female patient due to a non-satisfactory experience with a similar\nsituation in the maxilla 4 years earlier.\nDuring treatment planning, it is our strategy in elderly patients (age over 80 years) to limit the\nmorbidity of therapy.\nThe most elegant treatment option is flapless implant placement, which requires an excellent\nbone volume and at least 7 mm of keratinized mucosa. This approach is very elegant in patients\nwith anticoagulation therapy, since it limits the risk for postsurgical bleeding. In the present\ncase, these conditions were not fulfilled due to the buccal flattening at site 46.\nThe second best treatment option is standard implant placement without the need for bone\ngrafting and extended flap elevation. This approach was feasible in the present case, although a\npost-extraction bone defect was present at site 45. It was decided to avoid an implant\nplacement in this area. The favorable shape of the mandible at site 46 allowed standard\nimplant placement without bone grafting, as desired by the patient. The available bone height\nand the rather narrow crest at the top of the alveolar ridge required the shortening of the crest\nby 2-3 mm to a sufficient width. This shortening to optimize the crest width has been routine at\nour department for more than 15 years (Buser and von Arx 2000). In addition, the border\nbetween the smooth and the microrough SLA implant surface was positioned roughly 1 mm\nbelow the bone crest.\nThe main purpose of this insertion technique is to achieve an intact buccal and lingual bone\nwall of at least 1 mm thickness following the initial bone-healing phase, which always\nincludes some physiologic bone remodeling caused by the surgical trauma. This helps avoid an\nexposed microrough SLA (sandblasted and acid-etched) surface in the supracrestal area. As\nconsequence of this surgical technique, implant crowns are slightly longer, but this is no\nproblem in the posterior segments of either jaw; the crown-to-implant ratio is slightly\nincreased. This was acceptable as it is not a risk factor for the long-term performance of dental\nimplants (Blanes and coworkers 2006; Schulte and coworkers 2007; Schneider and coworkers\n2012).\nConcerning the selection of implant types, Tissue Level implants with an SLA surface were\nutilized, since these implant types have shown excellent long-term results in our department"
  },
  {
    "page": 355,
    "content": "since their introduction in 1997. As demonstrated in a large study on partially edentulous\npatients with more than 500 implants, these implants offer a failure rate of less than 2% for a\n10-year period (Buser and coworkers 2012). This favorable long-term prognosis, however, is\nnot applicable for heavy smokers (more than 10 cigarettes per day). The distal implant was an\n8-mm standard-diameter implant (S 4.1) with a regular neck (RN) design and a machined\nsurface 2.8 mm in height. The mesial implant was diameter-reduced, since the crest was\nslightly reduced in width as demonstrated by the CBCTs. The implant was an 8-mm NNC\nimplant made of a titanium-zirconium alloy (Roxolid), which offers an increased mechanical\nstrength when compared with commercially pure titanium. This implant type was introduced in\nour department in 2012 and is primarily utilized in implant sites with borderline crest width.\nSo far, evidence for this implant is only short-term, but it has great potential for more\nwidespread use (Chiapasco and coworkers 2012).\nWith the two 8-mm implants, the rehabilitation was achieved following an 8-week healing\nperiod with two splinted crowns and a mesial cantilever unit. This prosthesis, delivered by the\nreferring dentist in private office, was screw-retained, as most of our implant restorations are\nthese days. A cantilever unit attached to an implant-supported crown has been the standard of\ncare at the University of Bern for roughly 15 years and has been documented by other groups as\na valid treatment option in special situations. In the present case, the utilization of only one\nimplant with a cantilever unit was no option, since the mesial implant had a reduced diameter\nand was only 8 mm long.\nIn summary, this 89-year-old woman could be treated with a low-morbidity approach using\nstandard implant placement and no simultaneous bone augmentation at either implants. At the\n1-year follow-up examination, the patient, now 90 years old, was highly satisfied with her\nimplant-supported FDP, since it offered her the excellent chewing comfort she had hoped for."
  },
  {
    "page": 356,
    "content": "13.10\nMinimally Invasive Treatment of a Patient in Her\nNineties After Removing Implants Affected by\nSevere Peri-implantitis\n \nM. Roccuzzo\nA 93-year-old female patient presented in September 2010 with an enlarged swelling on the\nlingual side of her lower incisors. At the time, she was essentially healthy, except for reduced\nvision due to bilateral age-related macular degeneration. She had been a heavy smoker (about\n30 cigarettes a day) for the past 20 years after becoming a widow. The patient lived at home by\nherself, with full-time domestic support.\nAn extraoral examination revealed nothing adverse. Intraoral plaque control was anything but\nideal, and a soft-tissue tumescence was visible around the lingual aspect of 41–42 (Fig 1).\nBecause the nature of the lesion was not clear, a biopsy was carried out that revealed the\ninflammatory nature of the lesion. The panoramic radiograph (Fig 2) showed six irregularly\ndistributed mandibular implants supporting a full-arch prosthesis, with various degrees of\ninterproximal peri-implant resorption. The periapical radiograph (Fig 3) revealed\ninterproximal bone resorption mesially and distally to implant 41.\nDifferent therapeutic options were presented to the patient and her immediate family,\nexplaining the risks and the benefits of each solution. Emphasis was placed on consulting her\nmedical doctor. Even though a minimally invasive treatment was proposed, the patient refused\nfurther treatment because of her “old age” and reported that she was still pleased with her\nchewing capabilities. She accepted only to be seen by the dental hygienist for a session of\n“light” scaling and cleaning."
  },
  {
    "page": 357,
    "content": "Fig 1 Soft-tissue tumescence lingually at site 41–42.\nFig 2 Panoramic radiograph. Six unevenly distributed mandibular implants supporting a full arch dental prosthesis.\nFig 3 Periapical radiograph. Interproximal bone resorption mesial and distal to the implant at site 41."
  },
  {
    "page": 358,
    "content": "Fig 4 Swelling due to abscess in the lower right mandibular area. Accumulation of soft deposits on the gingival margin\nand on the adjacent tooth surfaces. The patient had experienced pain and tenderness of the area for several weeks.\nFig 5 Probing at site 45 reveals deep pockets with severe inflammation of the gingival margin and abundant bleeding\non probing.\nFig 6 The minimally invasive treatment plan included segmentation of the existing full-arch reconstruction and removal\nof the two implants affected by peri-implantitis.\nSeven months later, in April 2011, the patient returned because of a major abscess in the lower\nright mandible (Fig 4). It seemed related to implant 45 and presented with pocket depths of 8–\n9 mm, severe inflammation of the gingival margin, and abundant bleeding on probing (Fig 5).\nSoft deposits on the gingival margin and the adjacent tooth surfaces were visible to the naked\neye.\nThe patient initially did not want to have the situation remedied, but she and her accompanying\nperson were informed that this could hazardous. They finally accepted the treatment on"
  },
  {
    "page": 359,
    "content": "condition that it be minimally invasive.\nIt was decided to segment the full-arch mandibular prosthesis, leaving the left half in situ (as\nthe tissue was judged sufficiently healthy) while removing the right half (Fig 6).\nFig 7 When the bridge was segmented, the implant at the incisor site came off spontaneously.\nFig 8 The removal of the implant is facilitated by piezosurgery.\nFig 9 Extraction of the compromised implant at the molar site."
  },
  {
    "page": 360,
    "content": "Fig 10 The mandibular left side immediately after implant removal.\nFig 11 The old restoration after removal of the two implants.\nWhen the bridge was cut between crowns 41 and 31 with a tungsten carbide bur, the implant at\nthe incisor site came off spontaneously (Fig 7). The implant at the molar position, which has\ncaused the abscess, was removed by piezosurgery (Figs 8 to 11).\nFig 12 Five weeks after implant placement. Uneventful soft-tissue healing. The cover screws had been removed to\nconnect the provisional fixed restoration."
  },
  {
    "page": 361,
    "content": "Fig 13 Panoramic radiograph at 4 months. Two new Tissue Level implants in the lower right mandible, with regular\nperi-implant bone levels. The two implants supported a provisional resin restoration with a double mesial cantilever.\nThe reconstructive procedure was based on the assumption that the primary objective was a\nfunctional outcome with a low risk of complications during healing, a minimum number of\nsurgical interventions, and minimum pain and morbidity. In May 2011, two chemically\nmodified titanium implants (Straumann SLActive, RN, diameter 4.1 mm, length 8 mm; Institut\nStraumann AG, Basel, Switzerland) were placed at sites 43 and 45. Interrupted Vicryl sutures\nwere put in place for non-submerged healing. An impression was taken for a screw-retained\nprovisional fixed restoration. As soon as the two implants could predictably support it (at 5\nweeks), a provisional five-unit fixed restoration with a double mesial cantilever, was screwed\nonto implants 43 and 45 (Fig 12).\nThe original idea had been to keep the provisional restoration for several weeks to allow for\nsufficient tissue maturation and to make sure the patient was satisfied with the results. The\npatient was not willing to come back for the final restoration, as she was able to use her right\nside for chewing. She did accept a panoramic radiograph to be taken in September 2011,\nwhich confirmed stable peri-implant bone levels around the two new implants (Fig 13).\nIn June 2012, the definitive six-unit fixed prosthesis screw-retained on two implants was\ndelivered and tightened to 35 Ncm (Figs 14a-b).\nFig 14a-b The definitive six-unit fixed prosthesis with ceramic crowns on two implants, ready for delivery. (a) Lateral\nview. (b) Occlusal view."
  },
  {
    "page": 362,
    "content": "Fig 15 Painful condition with swelling in the left maxilla.\nFig 16 Very poor plaque control.\nFig 17 Removed three-unit bridge 24–26 and its two supporting implants."
  },
  {
    "page": 363,
    "content": "Fig 18 Lower right quadrant. The screw-retained bridge was removed and cleaned by the dental hygienist. Implant\nshoulders and peri-implant soft tissue were cleaned and gently treated.\nFig 19 Scaling and root planning was performed on the natural dentition.\nFig 20 The fixed dental prosthesis was reconnected and the access holes were sealed with composite.\nIn June 2014, the patient came back reporting pain in the left maxilla (Fig 15), which exhibited\nvery poor plaque control (Fig 16).\nA three-unit bridge (24–26) and its two supporting implants were removed (Fig 17). After a\nfew days, the patient was treated by the dental hygienist. The screw-retained bridge was\nremoved and cleaned. The shoulders of the implants were carefully cleaned by the dental\nhygienist (Fig 18), and the peri-implant soft tissue was gently treated. Scaling and root\nplanning was performed on the natural dentition, to the extent possible (Fig 19). The bridge\nwas reconnected and the access holes were sealed with composite (Fig 20)."
  },
  {
    "page": 364,
    "content": "Fig 21 Panoramic radiographs of July 2014. Stable peri-implant bone levels around the two new implants.\nFig 22 Intraoral radiograph of the left mandible. Limited peri-implant bone resorption around the four older implants.\nFig 23 The last clinical view. Stable soft-tissue contours. No significant signs of inflammation and minimal soft-tissue\nrecession.\nThe panoramic and intraoral radiographs of July 2014, confirmed stable peri-implant bone\nlevels around the two newly placed implants and limited peri-implant bone resorption around\nthe four older implants in the left mandible (Figs 21 and 22).\nThe last clinical picture, taken in October 2014 when the patient was almost 97 years old,\nmore than 4 years after the first visit, revealed stable soft-tissue contours and no significant\nsigns of inflammation or recession (Fig 23).\nWith this patient’s history in mind, it is advisable to place implants with a long-term vision, so\nthat maintenance is easy for the patient and the dentist. Moreover, given that peri-implantitis"
  },
  {
    "page": 365,
    "content": "occurs not infrequently in partially and completely edentulous patients, the treatment plan\nshould take possible complications into consideration and anticipate ways to resolve them,\nespecially in older patients.\nAcknowledgments\nLaboratory Procedures\nFrancesco Cataldi – Master Dental Technician,\nTorino, Italy.\nPeriodontal Maintenance\nSilvia Gherlone – Registered Dental Hygienist, Torino, Italy."
  },
  {
    "page": 366,
    "content": "13.11\nImplant-retained Rehabilitation after Mandibular\nRim Resection\n \nS. Shahdad\nA 77-year-old woman was referred to our department by an oral and maxillofacial surgeon for\nrehabilitation of her dentition. She had been diagnosed with squamous cell carcinoma 6 months\nearlier and was treated surgically by right mandibular rim resection and local floor-ofmouth\nresection extending to tooth 33. No radiotherapy or chemotherapy had been considered\nnecessary.\nThe patient complained that she was unable to eat and that her face was disfigured due to a\nlack of lip support on the resection side.\nShe reported a history of well-controlled asthma and angina, in addition to cardiac arrhythmia\nand an allergy to penicillin. Her medication included acetylsalicylic acid and diltiazem.\nClinical examination revealed an edentulous maxilla and only teeth 33 and 34 remaining in the\nmandible. Multiple extractions in the mandible had been carried out at the time of the\nmandibular rim resection. Due to the extent of resection, the buccal and lingual sulci were\nlevel with the floor of the mouth, with a complete lack of attached, keratinized mucosa (Fig 1).\nThe mental foramen had been surgically relocated approximately to site 46. The patient\nreported reduced mental nerve sensation, which was confirmed during the clinical\nexamination.\nThe radiographs showed less than 25% alveolar bone loss at teeth 33 and 34 (Fig 2). The\ndistalized mental foramen was visible on the radiograph and showed the extent of the\nmandibular resection (Fig 3)."
  },
  {
    "page": 367,
    "content": "Fig 1 Initial mandibular clinical status after rim and floor-of-mouth resection on the right side. Completely absent\nsulcus, continuation of the lingual and buccal sulcus, and lack of keratinized mucosa.\nFig 2 Periapical radiograph of teeth 33 and 34. Less than 25% alveolar bone loss.\nFig 3 Panoramic radiograph. Mandibular rim resection and position of the relocated mental foramen (arrow)."
  },
  {
    "page": 368,
    "content": "Fig 4 Orthodontic wires of known dimensions attached to the denture with sticky wax for the radiographic template.\nFig 5 Panoramic radiograph with wire bits used for implant planning.\nTaking into consideration the patient’s medical history and the clinical and radiographic\nfindings, the following treatment options were discussed with the patient:\nOption 1\n• Maxillary removable conventional acrylic denture.\n• Mandibular removable conventional acrylic denture with retentive clasp and rest on teeth\n33 and 34.\nOption 2\n• Maxillary removable conventional acrylic denture.\n• Implant-retained fixed dental prosthesis (FDP) extending from site 32 to 45 or 46.\nThe patient requested option 1, as she was keen to avoid surgery and willing to try a\nremovable partial denture. The challenges of achieving adequate stability and retention in the\nlower denture were discussed, and the patient was warned about the anticipated poor\nprognosis. Nonetheless, even for the implant option, determining an idealized tooth position\nwas imperative, and at the least, the denture would be useful for finalizing the positions of the\nimplants.\nTreatment stage 1\nIn January 2006, treatment commenced with the fabrication of a maxillary conventional"
  },
  {
    "page": 369,
    "content": "complete denture and a mandibular removable partial denture. The dentures were delivered in\nApril 2006. The patient returned for denture adjustments on a couple of occasions. However,\nshe continued to report an inability to eat and an “electric shock”-like sensation while chewing\nwith the mandibular denture. Clinically, tenderness to palpation was present on the right side.\nDuring the following 18 months, repeated ulceration of the mandibular mucosa due to trauma\nfrom the denture prevented any effective functional benefit or improvement in the quality of life\nof the patient.\nTherefore, a decision was made in discussions with the patient to provide an implant-\nstabilized fixed dental prosthesis to replace the missing teeth based on the “shortened dental\narch” concept (Käyser 1981).\nImplant planning\nThe mandibular removable denture was used for radiographic planning (Fig. 4). Orthodontic\nwires in 8- and 10-mm lengths were used to localize the planned implants in relation to the\ninferior dental nerve and relocated mental foramen (Fig. 5).\nFig 6 Copied mandibular denture for use as a surgical guide.\nFig 7 Surgical guide modified and adapted for access to implant drills."
  },
  {
    "page": 370,
    "content": "Fig 8 Immediately after implant placement with transmucosal closure. Specially ordered 6-mm healing abutments to aid\nhealing and prevent submergence.\nFig 9 Calculus on healing abutments noted after 8 weeks of healing. Anterior implant 32 partially submerged.\nNo three-dimensional imaging was performed. At the time, no cone-beam CT scanning facility\nwas available at the hospital. Conventional CT scans taken for mandibular resection were used\nto evaluate the shape of the mandible in cross-sections.\nThe mandibular removable prosthesis was duplicated and a surgical guide fabricated (Figs 6\nand 7). The lingual flange was cut to aid the preparation of implant osteotomies.\nIn December 2007, three implants were placed:\n• 31: Straumann S SLActive, RN, diameter 4.8 mm, length 10 mm\n• 43: Straumann S SLActive, RN, diameter 4.8 mm, length 10 mm\n• 45: Straumann S SLActive, RN, diameter 4.8 mm, length 8 mm\n(all Institut Straumann AG, Basel, Switzerland)\nCustomized healing abutments 6 mm in height were placed for transmucosal closure (Fig 8).\nImplants were allowed to heal for 8 weeks before commencing prosthodontic treatment. The\npatient had a high propensity to accumulate calculus, as is evident on the healing abutments at\nthe impression appointment (Fig 9). The healing abutment on implant 32 was partially\nsubmerged despite having used the highest available healing abutment."
  },
  {
    "page": 371,
    "content": "Fig 10 Radiograph to confirm accurate seating of the impression copings.\nFig 11 Radiograph confirming complete seating of the gold superstructure on the implants.\nFig 12 Working cast with wax tooth set-up on gold superstructure.\nThe restorative plan was to use 1.5-mm synOcta abutments (Institut Straumann AG, Basel,\nSwitzerland) with a screw-retained gold/acrylic hybrid superstructure. A definitive implant\nimpression was taken after verifying the seating of the impression copings radiologically (Fig\n10).\nThe accuracy of the impression was confirmed using a verification jig made from temporary\nabutments joined together with Pattern Resin (GC Corporation, Tokyo, Japan). A cast-gold\nframework was fabricated and its fit verified in situ with a radiograph (Fig 11).\nThe teeth were set up in wax on the framework (Fig 12), and the set-up was tried in to confirm\nthe teeth’s position, shape, shade, and occlusion. The definitive prosthesis was delivered in"
  },
  {
    "page": 372,
    "content": "December 2008 (Fig 13). The synOcta abutments were torqued to 35 Ncm and the SCS\nocclusal screws to 15 Ncm. The screw-access holes were sealed with polytetrafluoroethylene\n(PTFE) tape followed by composite resin.\nA control radiograph was taken (Fig 14), and the patient was reexamined after one month. The\npatient was placed on an annual recall, and a 4- to 6-monthly professional maintenance\nprogram was initiated. Regular radiographs were taken to assess the peri-implant bone levels.\nFig 13 Intraoral try-in of the set-up.\nFig 14 Control radiograph after delivery of the definitive prosthesis.\nIn July 2012, during one of the follow-up appointments, peri-implant mucositis was noted,\nparticularly on the lingual aspect (Fig 15). It seemed the patient’s manual dexterity was\ndiminishing with age. She reported difficulty in effectively brushing the prosthesis and the\nperi-implant mucosa, especially lingually (Fig 16). She also found the peri-implant mucosa\nsensitive, which was affecting her ability to brush firmly. As a result, the decision was made to\nmodify the intaglio surface of the prosthesis to provide additional space and allow easier\naccess by interdental brushes (Figs 17a-b)."
  },
  {
    "page": 373,
    "content": "Fig 15 Peri-implant mucositis (arrows) on the lingual aspect.\nFig 16 Prosthesis returned to the laboratory for modification of the lingual and intaglio surfaces.\nFig 17a Before adjustment.\nFig 17b After adjustment and trimming of the surface. More space to aid in oral hygiene."
  },
  {
    "page": 374,
    "content": "Fig 18 Signs of peri-mucositis persist with edematous tissues and bleeding on probing.\nFig 19 Follow-up radiograph after six years. Stable bone levels compared to the control radiograph.\nFig 20 After seven years. Persistent peri-implant mucositis with calculus.\nFig 21 Lingual view. Deteriorated peri-implant mucosa and inability to maintain optimal oral hygiene."
  },
  {
    "page": 375,
    "content": "The hospital then lost contact with the patient until January 2014, when she requested an\nappointment. It transpired that she had moved into a care home facility. During this time, the\npatient had not seen a dentist or a hygienist. Despite the previous adjustments to the prosthesis,\nthe clinical examination showed persistent mucositis (Fig 18) with bleeding on probing and an\nedematous peri-implant mucosa, but with probing depths under 5 mm and stable bone levels\n(Fig 19).\nThe patient requested future implant maintenance to be carried out by a dentist nearer to her\ncare home, as she was now finding it difficult and expensive to travel for her hospital\nappointments.\nHowever, due to difficulty in accessing appropriate expertise for implant maintenance, the\npatient returned for help in March 2015. A local general dentist, instead of providing implant\nmaintenance, had advised and persuaded her to reline the maxillary denture. The intervention\nhas resulted in a complete loss of retention, incorrect occlusion, and a very bulky denture. A\nnew maxillary denture was now indicated. Clinical examination again showed bleeding on\nprobing, and supra- and submucosal calculus (Fig 20) on three implants and on the lingual and\nintaglio surfaces of the prosthesis (Fig 21). Nonetheless, after seven years, peri-implant bone\nlevels remained stable despite persistent mucositis (Fig 22). Figures 23a-b show frontal and\nlateral views of the patient.\nDiscussion\nThis case demonstrates a multitude of challenges encountered by clinicians when rehabilitating\na patient with mandibular rim and floor-of-mouth resection who has difficulty in tolerating a\nconventional removable denture, with implants in an unfavorable soft- and hard-tissue\nenvironment and persistent peri-implant mucositis due to the patient’s inability to maintain\nadequate oral hygiene in old age.\nThe resective surgery resulted in the removal of the alveolus and part of the floor of mouth\nwith a subsequent lack of sulcus depth. As the mental foramen had been distalized, the\nmandibular bone height was sufficient to accommodate implants in the basal bone. However,\nthere was a complete lack of keratinized mucosa, and the peri-implant tissue comprising of the\nlining mucosa was sensitive in that area, with patient-reported pain and discomfort during\nbrushing. The hyperesthesia could be attributed to the lining mucosa, or more plausibly to an\ninferior dental nerve injured during the resection. As a result, the patient struggled to maintain\na clean peri-implant mucosal cuff.\nThere seems to be no conclusive evidence that the lack of adequate keratinized mucosa impairs\noral hygiene, although pain and discomfort during brushing at sites with a bordering lining\nmucosa may hamper adequate cleaning (Wennström and Derks 2012).\nThere was a persistent insult to the peri-implant mucosa for more than seven years due to\nplaque and calculus accumulation with resultant peri-implant mucositis. Nonetheless, until\nmost recent examination, there was no radiographic evidence of progression to peri-"
  },
  {
    "page": 376,
    "content": "implantitis. While animal experiments have demonstrated a link and a progression of peri-\nmucositis to peri-implantitis (Lang and coworkers 2011b; Berglundh and coworkers 2011),\nlongitudinal studies in humans have failed to corroborate the progression (Lang and Berglundh\n2011a). Animal experiments also failed to demonstrate any significant difference in peri-\nimplant bone loss around implants with keratinized or non-keratinized mucosa, although more\npronounced recession was noted in the latter group (Warrer and coworkers 1995).\nDespite a modified prosthesis, oral hygiene further deteriorated with the age of the patient,\nwhich demonstrates the challenges in maintaining implant-supported prostheses in geriatric\npatients as they experience diminishing manual dexterity. The patient now resides in a care\nhome further away from access to specialist care. This raises further concerns about her ability\nto maintain an optimal level of oral hygiene in the coming years, with a detrimental effect on\nthe implants.\nFig 22 Panoramic radiograph after seven years. Stable bone levels despite persistent peri-implant mucositis.\nFigs 23a-b The patient’s facial and dental esthetics were restored once the replacement maxillary conventional denture\nwas delivered."
  },
  {
    "page": 377,
    "content": "13.12\nFour Immediately Loaded Mini-implants\nSupporting a Mandibular Overdenture\n \nS. Esfandiari\nFig 1 Preoperative radiograph showing favorable vertical bone height in the interforaminal region.\nFig 2 Approximate height measurement using a dental caliper.\nA 74-year-old male patient, a non-smoker, who had been wearing complete dentures for more\nthan 30 years, presented to our clinic complaining about discomfort in connection with his\nlower denture. The patient suffered from asthma and had a history of cardiac disease and blood\npressure disorders. All conditions were medically controlled and stable.\nThe clinical inspection of the oral cavity revealed an ill-fitting complete mandibular denture.\nThe patient expressed the wish for his lower denture to “stop moving when chewing,\nswallowing, and speaking.” He reported having heard about dental implants and asked whether\nthese could help in “fixing” his lower denture, but also requested non-invasive treatment. The"
  },
  {
    "page": 378,
    "content": "mucosa presented healthy and was free of defects such as pressure sores. An band of\nkeratinized mucosa approximately 2 mm wide was visible. The patient’s mucosal biotype was\nmedium thick to thin.\nThe panoramic radiograph (Fig 1) exhibited no anatomical abnormality that would have\nprecluded implant placement. The height of the anterior mandibular region was screened by\nmeans of dental calipers (Fig 2), from the tip of the edentulous ridge to the outer lower part of\nthe chin. A minimum height of approximate 27 mm is needed for the placement of a 10-mm\nimplant. Any desired variations in implant length can be calculated based on this minimum\nrequired height.\nDue to the reduced alveolar bone width and to respond to the patient’s wish for a treatment\napproach that is as minimally invasive as possible, the placement of mini-implants was\nconsidered. The patient was asked if he would be willing to participate in a clinical trial at\nMcGill University, whose treatment schedule called for the placement of four mini-implants in\nthe edentulous anterior mandibular ridge, which he agreed to.\nThe study setup and treatment approach as defined in the clinical trial’s protocol (flapless\nplacement of four mini-implants (DMD; 3M ESPE, MN, USA) in the interforaminal region of\nthe mandible and immediate loading with a transitional complete mandibular denture) were\ndiscussed with the patient. This included the risk of perforation of the cortical plates during\nsurgery as a result of the flapless approach as outlined in the study protocol. The patient gave\nhis informed consent.\nSurgical procedure\nFollowing the screening, the patient was scheduled for implant placement. He first received a\nchlorhexidine digluconate 0.12% rinse. The juxtaposed distal point of the canines and the\nmandibular midline on the inside of the mandibular denture were marked with an indelible\nmarker (two equidistant points on each side of the midline and the canine line) (Fig 3).\nThe edentulous ridge was dried and the marked denture inserted, after which the marks were\ntransferred to the patient’s tissue—three lines and four points, each representing the future\nimplant sites. This step may have to be repeated until all points are clearly visible (Fig 4).\nThe anterior mandibular region was anesthetized, first applying the topical anesthetic followed\nby the buccal mucosa infiltration. Block anesthetics was not required. The crest of the\nmandibular ridge was perforated with a 15c blade at each of the indicated points, not to\nelevate a flap but simply to confirm the width of the ridge (Fig 5).\nFor the first implant (MDI Collared Standard O-Ball, diameter 2.1 mm, length 13 mm; 3M\nESPE), the pilot drill (1.1-mm Pilot Drill; 3M ESPE) was carefully placed on the initial entry\npoint and moved up and down ever so lightly at the recommended drill speed of 1,200 to 1,500\nrpm until the cortical plate was penetrated (Fig 6). Irrigation with sterile saline solution to\navoid overheating the bone was mandatory throughout the drilling process. The drill hole"
  },
  {
    "page": 379,
    "content": "created was as deep as one-third to one-half of the implant height.\nFig 3 Juxtaposed canine marks.\nFig 4 Equidistant implant positions.\nFig 5 Locating the crest of the ridge."
  },
  {
    "page": 380,
    "content": "Fig 6 Initial perforation.\nFig 7 Implant placement.\nFig 8 Verifying implant height and neck position.\nFig 9 Rubber spacer tubing in place."
  },
  {
    "page": 381,
    "content": "Fig 10 Metal housings in place.\nThe implant was then placed in the drill hole and the implant driver (Winged Thumb Wrench;\n3M ESPE) attached to the head of the implant. After inserting the implant into the prepared\nbed, it was rotated clockwise to allow it to self-tap while exerting downward pressure until\nthe wrench became more difficult to turn by hand, i.e. until noticeable resistance in the bone\nwas encountered (Fig 7).\nNext, the torque wrench (Adjustable Torque Wrench; 3M ESPE) was used to finalize the\ninsertion of the implant, which was placed such that the abutment head was allowed to\nprotrude from the gingival soft tissue at its full length but with no aspects of the neck or thread\nportions visible (Fig 8).\nA minimum of 15 Ncm of resistance upon final insertion was sufficient for immediate loading\nof 4 mini-implants. Excessive torque (> 45 Ncm) may fracture the body of narrow-diameter\nimplants (NDI).\nSubsequent implants (all of the same endosteal diameter and length) were introduced following\nthe same procedure. All implants axes should parallel to the maximum extent possible.\nProsthetic procedure\nProsthetic treatment was initially assisted by the patient’s existing conventional complete\ndentures.\nSegments of green rubber spacer tubing 2 to 2.5 mm in length (Blockout Shim; 3M ESPE) were\ncut and placed on each implant to block out undercuts (Fig 9), followed by the metal housings\nwith O-rings (Metal Housing; 3M ESPE) (Fig 10).\nNext, the existing mandibular denture was inserted in the mouth to inspect the locations of the\nimplants in relation to the denture. The tissue side of the denture was relieved with a round\nacrylic bur, making sure not to extend trimming beyond the premolar regions. Posterior soft-\ntissue support is needed to make sure that patient occludes in a correct and comfortable\nposition (Fig 11)."
  },
  {
    "page": 382,
    "content": "Fig 11 Relieved denture.\nFig 12 Polished overdenture with metal housings.\nThe denture was then returned to the patient’s mouth and checked for a passive fit over the\nimplants and housings, making sure the posterior region was in contact with the soft tissue. The\nrelief area was roughened with an acrylic bur, then cleaned and dried. Petroleum jelly was\napplied to all areas not coming in touch with the autopolymerizing material during the\nfollowing pick-up step, while a thin layer of adhesive was applied to the relief area of the\ndenture. The pick-up acrylic resin (Secure Hard Pick-Up; 3M ESPE) was then extruded\ndirectly onto the metal housings and into the relief area of the denture.\nHaving slowly and carefully returned the denture to the patient’s mouth, the patient was asked\nto close and apply normal bite pressure to confirm centric occlusion. The resin can take about\n5 to 8 minutes to set. Excess resin was removed and the denture trimmed; all rubber tubes were\nremoved, and the surfaces of the picked-up housings were polished (Fig 12).\nThe patient was instructed to keep the denture in place for the first 48 hours after placement to\nprevent tissue overgrowth and to stick to a soft diet for 2 weeks. He was prescribed\nchlorhexidine digluconate 0.12% for mouth rinses and ibuprofen 600 mg if needed for pain\nrelief; antibiotics are not required with this procedure.\nThe overall chairside time for this procedure was 100 minutes.\nFollow-up appointments were scheduled at 6, 12, and 24 months. The O-rings needed to be\nreplaced three times during the last 2 years as part of regular maintenance."
  },
  {
    "page": 383,
    "content": "The 2-year panoramic radiograph (Fig 13) showed stable implant and bone conditions. The\npatient was extremely satisfied with the outcome.\nConclusion\nReduced-diameter implants and mini dental implants are a good way to reduce the need for\naugmentation procedures prior to implant insertion. Implant treatment that is less invasive\nparticularly benefits elderly patients or patients with systemic risk factors.\nWith flapless approaches, as in the present case, there is always the risk that the sharp and thin\ndrills required might perforate the cortical plate of the mandible. These procedures should\ntherefore be performed only by experienced surgeons, and pre-treatment assessment should\ninclude CBCT scans.\nFig 13 Panoramic radiograph at 2 years showing stable bone levels."
  },
  {
    "page": 384,
    "content": "14\nConclusions\n \nS. Barter, F. Müller"
  },
  {
    "page": 385,
    "content": "A real-life anecdote:\nToday I was late for my first patient after lunch, who was due to have implant surgery. This\npatient was a fit and well 80-year-old lady who had only one missing tooth, the upper left\nsecond premolar (25). She did not want to wear a denture, feeling that she was “not old\nenough for that.” She had the demeanor and appearance of someone in her mid-sixties. The\nadjacent teeth were healthy and unprepared, and an implant was the ideal solution.\nWe placed a tissue-level implant and performed some guided bone regeneration in a very\nshort time, under local anesthesia, with no problems, and we had some cheerful\nconversation while the procedure was under way. The procedure was exactly as it would\nhave been had the patient been eighteen rather than eighty. She could understand the\npostoperative instructions perfectly and will undoubtedly comply with them.\nI was late because immediately before my lunch break, a 79-year-old patient, whom I had\nlast seen in 2004, turned up unannounced at the clinic. She had been fit and well at the time\nand had undergone complex bone-grafting procedures using bone from iliac crest under\ngeneral anesthesia. She had later had five maxillary and four mandibular implants placed,\nwhich had been restored with bar-retained overdentures. At that time, she had been\ndelighted and it had changed her life. She had moved away after a year or so, and we did\nnot see her again.\nToday, she was confused, disorientated, disheveled, and very alone. She appeared 99 years\nold, not 79. She thought that she had lost her lower denture approximately a year previously\nand had since been chewing on the upper denture with the lower bar. Not only did she have\nsignificant deposits of plaque and calculus on the remaining maxillary denture and the bars,\nshe also had rotting food in her mouth stuck under the denture and bars. Her clothes were\ndirty; she had obviously not washed properly in a long time, and she could not even\nremember how she got to us. In fact she was in such a state, I did not know how she had\nmanaged to get to us.\nShe claimed to live at home with her son, but when we made some enquiries, the address\nthat she had given was not one she had lived at for some time. She could barely stand\nbecause she was so weak, and although not obviously suffering from Alzheimer’s, she was\nclearly confused and disoriented, whether due to a form of dementia or possibly\nmalnutrition, dehydration, infection, or illness.\nWe had to contact Adult Social Care Services and arrange for her to be taken for\nappropriate medical care. They would also assess her home living conditions and wider\ncare needs. We then needed to liaise with her caregivers and medical attendants on\nappropriate dental care and on how it would be provided."
  },
  {
    "page": 386,
    "content": "The difference between these two patients was less than a year in age. The older patient had\na simple implant treatment, the other patient had had a more complex treatment carried out\nsome eleven years previously. She had probably not had any care for that complex\nreconstruction in the last three years.\nI found this experience very poignant and a perfect representation of the issues outlined in this\nvolume. We are all going to encounter such cases more frequently, and we must know how to\ndeal with them in the best interest of the patient.\nFor the first patient, an implant was the best option, being the simplest way to restore her\nappearance, self-esteem, and function. She spent less time in the chair than she might have for\nother restorative procedures, the economics were favorable, and that treatment option suited\nher personal circumstances.\nImplants are a safe and predictable treatment option in elderly people. This is not new\nknowledge. As always, success depends on appropriate diagnosis and meticulous treatment\nplanning. Nevertheless, failures and complications are inevitable, and now it seems we must\nalso be able to see into the future!\nFor the second patient, her initially life-changing implant treatment had exactly the same\nadvantages as for the first patient at the time the treatment was provided. However, it was now\nlife-changing for a second time, but in the opposite sense. She was in pain, with a loss of\nfunction and appearance, and now had peri-implant disease. Treatment planning will be\ndifficult, with issues of comprehension, consent, competence, access, affordability, and\nongoing oral healthcare. If we roll back the rehabilitation to simple dentures, will she cope,\nhaving been used to a very retentive and resilient set of prostheses? How will her increasing\ncognitive impairment affect the treatment plan? What medical diagnoses exist, and how will\nthese affect our decisions? What supporting services will she need? To whom can the dentist\nturn for advice and assistance?\nThere is clear evidence that we have an expanding aged population, with increasing rates of\ngeneral multimorbidity, polypharmacy, and mental-health problems. The goals of treatment\nfrom the patients’ perspective may progressively become more removed from the reality of the\nneeds of those patients as they age. The patients, or their caregivers, may need to be carefully\nguided to an understanding of both the present and future implications of treatment.\nMuch of the content of previous volumes in this Treatment Guide series deals with the\ntechnical aspects of providing dental implant treatment and in dealing with the inevitable\nbiological and technical complications that will occur. These excellent volumes have all\nhighlighted in their conclusions the need for individualized treatment plans and ongoing\nsupportive care programs. They have also stressed the importance of clinicians being aware of\ntheir own experience levels and skills.\nThere is a need for dental practitioners to have an increased level of knowledge regarding the"
  },
  {
    "page": 387,
    "content": "medical status of their patients, and particularly the effect of aging on that status. Along with\nthis knowledge, practitioners need to be prepared to accept the professional ethics of\nfollowing up of their patients and to assure that, once frail and dependent, they are not left\nalone with their implant-supported restorations, often without access to dental care and in a\ninstitutionalized context, with limited knowledge and strong apprehensions in those caring for\nthem. As a profession, we need to ensure that our patients receive lifelong oral health care and\nthat oral comfort, infection control, and quality of life are provided until the last moments of\nlife.\nThe term “team approach” is widely used when considering implant treatment – as you can\nsee, the “team” comprises more than just the dental experts. We have an important role to play\nin the wider health care team, including geriatricians, social workers, care-home workers, and\ngeneral medical practitioners.\nIt is not just about implants; it is about patients, about caring, and it is about you and me."
  },
  {
    "page": 388,
    "content": "15\nReferences"
  },
  {
    "page": 389,
    "content": "References have been listed in the order of (1) the first or only author’s last name and (2)\nthe year of publication. Identical short references are distinguished in the text by lowercase\nletters, which if used are given in parentheses at the end of the respective entry in this list of\nreferences.\nAAOS/ADA (American Academy of Orthopaedic Surgeons/American Dental Association).\nPrevention of orthopaedic implant infection in patients undergoing dental procedures. 2014.\nhttp://ebd.ada.org/~/media/EBD/Files/PUDP_guideline.ashx. Last accessed 20 December\n2014.\nAbate M, Vanni D, Pantalone A, Salini V. Cigarette smoking and musculoskeletal disorders.\nMuscles Ligaments Tendons J. 2013 Jul 9; 3(2): 63–69.\nAbduo J. Occlusal schemes for complete dentures: a systematic review. Int J Prosthodont.\n2013 Jan–Feb; 26(1): 26–33.\nAbe S, Ishihara K, Adachi M, Okuda K. Tongue-coating as risk indicator for aspiration\npneumonia in edentate elderly. Arch Gerontol Geriatr. 2008 Sep–Oct; 47(2): 267–275.\nAbete P, Della-Morte D, Gargiulo G, Basile C, Langellott A, Galizia G, Testa G, Vincenzo C,\nBonaduce D, Cacciatore F. Cognitive impairment and cardiovascular diseases in the elderly.\nA heart-brain continuum hypothesis. Ageing Res Rev. 2014 Nov; 18: 41–52.\nAdamson JW, Eschbach J, Finch CA. The kidney and erythropoiesis. Am J Med. 1968 May;\n44(5): 725–733.\nAghaloo TL, Felsenfeld AL, Tetradis S: Osteonecrosis of the jaw in a patient on denosumab. J\nOral Maxillofac Surg. 2010 May; 68(5): 959–963.\nAghaloo TL, Kang B, Sung EC, Shoff M, Ronconi M, Gotcher JE, Bezouglaia O, Dry SM,\nTetradis S. Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the\nrat. J Bone Miner Res. 2011 Aug; 26(8): 1871–1882.\nAglietta M, Siciliano VI, Zwahlen M, Brägger U, Pjetursson BE, Lang NP, Salvi GE. A\nsystematic review of the survival and complication rates of implant supported fixed dental\nprostheses with cantilever extensions after an observation period of at least 5 years. Clin\nOral Implants Res. 2009 May; 20(5): 441–451.\nAguirre JI, Akhter MP, Kimmel DB, Pingel JE, Williams A, Jorgensen M, Kesavalu L,\nWronski TJ. Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like\nlesions in rice rats (Oryzomys palustris) with periodontitis. J Bone Miner Res. 2012 Oct;\n27(10): 2130–2043."
  },
  {
    "page": 390,
    "content": "Agustí A. Systemic effects of chronic obstructive pulmonary disease: what we know and what\nwe don’t know (but should). Proc Am Thorac Soc. 2007 Oct 1; 4(7): 522–525.\nAhmed T, Haboubi N. Assessment and management of nutrition in older people and its\nimportance to health. Clin Interv Aging. 2010 Aug 9; 5: 207–216.\nAkin H, Coskun ME, Akin EG, Ozdemir AK. Evaluation of the attractive force of different\ntypes of new-generation magnetic attachment systems. J Prosthet Dent. 2011 Mar; 105(3):\n203–207.\nAlbrektsson T, Donos N, Working G. Implant survival and complications. The Third EAO\nConsensus Conference 2012. Clin Oral Implants Res. 2012 Oct; 23(Suppl 6): 63–65.\nAli A, Patton DW, El-Sharkawi AM, Davies J. Implant rehabilitation of irradiated jaws: a\npreliminary report. Int J Oral Maxillofac Implants. 1997 Jul–Aug; 12(4): 523–526.\nAli-Erdem M, Burak-Cankaya A, Cemil-Isler S, Demircan S, Soluk M, Kasapoglu C, Korhan-\nOral C. Extraction socket healing in rats treated with bisphosphonate: Animal model for\nbisphosphonate related osteonecrosis of jaws in multiple myeloma patients. Med Oral Patol\nOral Cir Bucal. 2011 Nov 1; 16(7): e879–e883.\nAl-Johany SS, Andres C. ICK classification system for partially edentulous arches. J\nProsthodont. 2008 Aug; 17(6): 502–507.\nAllen PF, McMillan AS, Walshaw D. A patient-based assessment of implant-stabilized and\nconventional complete dentures. J Prosthet Dent. 2001 Feb; 85(2): 141–147.\nAllen F, Locker D. A modified short version of the oral health impact profile for assessing\nhealth-related quality of life in edentulous adults. 2002 Sep–Oct; 15(5): 446–450.\nAllen PF, McMillan AS. A longitudinal study of quality of life outcomes in older adults\nrequesting implant prostheses and complete removable dentures. Clin Oral Implants Res.\n2003 Apr; 14(2): 173–179.\nAllum SR, Tomlinson RA, Joshi R. The impact of loads on standard diameter, small diameter\nand mini implants: a comparative laboratory study. Clin Oral Implants Res. 2008 Jun; 19(6):\n553–559.\nAlmirall J, Rofes L, Serra-Prat M, Icart R, Palomera E, Arreola V, Clavé P. Oropharyngeal\ndysphagia is a risk factor for community-acquired pneumonia in the elderly. Eur Respir J.\n2013 Apr; 41(4): 923–928.\nAlsaadi G, Quirynen M, Komárek A, van Steenberghe D. Impact of local and systemic factors\non the incidence of oral implant failures, up to abutment connection. J Clin Periodontol.\n2007 Jul; 34(7): 610–617."
  },
  {
    "page": 391,
    "content": "Alsaadi G, Quirynen M, Komárek A, van Steenberghe D. Impact of local and systemic factors\non the incidence of late oral implant loss. Clin Oral Implants Res. 2008 Jul; 19(7): 670–\n676.\nAlSabeeha N, Payne AG, De Silva RK, Swain MV. Mandibular single-implant overdentures: a\nreview with surgical and prosthodontic perspectives of a novel approach. Clin Oral\nImplants Res. 2009 Apr; 20(4): 356–365.\nAlzheimer’s Society. Dementia UK: Update. London: Alzheimer’s Society; 2014.\nAmam A, Rustom J. Assessment of mandibular alveolar bone density in osteoporotic adults in\nSyria. Open Journal of Dentistry and Oral Medicine. 2014; 2(2): 26–32.\nAndersohn F, Konzen C, Garbe E. Systematic review: agranulocytosis induced by\nnonchemotherapy drugs. Ann Intern Med. 2007 May 1; 146(9): 657–665.\nAndreiotelli M, Att W, Strub JR. Prosthodontic complications with implant overdentures: a\nsystematic literature review. Int J Prosthodont. 2010 May–Jun; 23(3): 195–203.\nAndres R, Bierman EL, Hazzard WR. Principles of geriatric medicine. New York: McGraw-\nHill; 1990.\nAmerican Psychiatric Association (APA). Diagnostic and statistical manual of mental\ndisorders 4th ed. Washington: APA Publishing; 1994.\nAparicio C, Ouazzani W, Garcia R, Arevalo X, Muela R, Fortes V. A prospective clinical\nstudy on titanium implants in the zygomatic arch for prosthetic rehabilitation of the atrophic\nedentulous maxilla with a follow-up of 6 months to 5 years. Clin Implant Dent Relat Res.\n2006; 8(3): 114–122.\nAraújo M, Lindhe J. Dimensional ridge alterations following tooth extraction. An\nexperimental study in the dog. J Clin Periodontol. 2005 Feb; 32(2): 212–218.\nArdekian L, Oved-Peleg E, Mactei EE, Peled M. The clinical significance of sinus membrane\nperforation during augmentation of the maxillary sinus. J Oral Maxillofac Surg. 2006 Feb;\n64(2): 277–282.\nAronow WS. Management of the older person with atrial fibrillation. J Gerontol A Biol Sci\nMed Sci. 2002 Jun; 57(6): M352-63.\nArora A, Arora M, Roffe C. Mystery of the missing denture: an unusual cause of respiratory\narrest in a nonagenarian. Age Ageing. 2002 Sep; 34(5): 519–520.\nASA (American Society of Anesthesiologists). ASA physical status classification system.\n2014. https://www.asahq.org/resources/clinical-information/asa-physical-status-"
  },
  {
    "page": 392,
    "content": "classification-system. Last accessed April 29, 2015.\nAslam M, Vaezi MF. Dysphagia in the elderly. Gastroenterol Hepatol. 2013 Dec; 9(12): 784–\n795.\nAtchison KA, Dolan TA. Development of the Geriatric Oral Health Assessment Index. J Dent\nEduc. 1990 Nov; 54(11): 680–687.\nAugust M, Chung K, Chang Y, Glowacki J. Influence of estrogen status on endosseous implant\nosseointegration. J Oral Maxillofac Surg. 2001 Nov; 59(11): 1285–1289; discussion 1290–\n1291.\nAwad MA, Lund JP, Dufresne E, Feine JS. Comparing the efficacy of mandibular implant-\nretained overdentures and conventional dentures among middle-aged edentulous patients:\nsatisfaction and functional assessment. Int J Prosthodont. 2003 Mar–Apr; 16(2): 117–122.\nAwad MA, Rashid F, Feine JS; Overdenture Effectiveness Study Team Consortium. The effect\nof mandibular 2-implant overdentures on oral health-related quality of life: an international\nmulticentre study. Clin Oral Implants Res. 2014 Jan; 25(1): 46–51.\nBacci C, Berengo M, Favero L, Zanon E. Safety of dental implant surgery in patients\nundergoing anticoagulation therapy: a prospective case-control study. Clin Oral Implants\nRes. 2011 Feb; 22(2): 151–156.\nBaggi L, Cappelloni I, Di Girolamo M, Maceri F, Vairo G. The influence of implant diameter\nand length on stress distribution of osseointegrated implants related to crestal bone\ngeometry: a three-dimensional finite element analysis. J Prosthet Dent. 2008 Dec; 100(6):\n422–431.\nBahat O. Brånemark system implants in the posterior maxilla: clinical study of 660 implants\nfollowed for 5 to 12 years. Int J Oral Maxillofac Implants. 2000 Sep–Oct; 15(5): 646–653.\nBaker MA. The management of leukaemia in the elderly. Baillieres Clin Haematol. 1987 Jun;\n1(2): 427–448.\nBaldwin JG: Hematopoietic function in the elderly. Arch Intern Med. 1988 Dec; 148(12):\n2544–2546.\nBarat I, Andreasen F, Damsgaard EM. Drug therapy in the elderly: what doctors believe and\npatients actually do. Br J Clin Pharmacol. 2001 Jun; 51(6): 615–622.\nBarnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med. 1995 Mar 30; 332(13): 868–\n875.\nBarnett KN, McMurdo ME, Ogston SA, Morris AD, Evans JM.. Mortality in people"
  },
  {
    "page": 393,
    "content": "diagnosed with type 2 diabetes at an older age: a systematic review. Age Ageing. 2006 Sep;\n35(5): 463–468.\nBarnett K, Mercer S W, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of\nmultimorbidity and implications for health care, research, and medical education: a cross-\nsectional study. The Lancet. 2012 Jul 7; 380(9836): 37–43.\nBarros SP, Suruki R, Loewy ZG, Beck JD, Offenbacher S. A cohort study of the impact of\ntooth loss and periodontal disease on respiratory events among COPD subjects: modulatory\nrole of systemic biomarkers of inflammation. PLoS One. 2013 Aug 8; 8(8): e68592.\nBarrowman RA, Wilson PR, Wiesenfeld D. Oral rehabilitation with dental implants after\ncancer treatment. Aust Dent J. 2011 May 30; 56(2): 160–165.\nBarter S, Stone P, Brägger U. A pilot study to evaluate the success and survival rate of\ntitanium-zirconium implants in partially edentulous patients: results after 24 months of\nfollow-up. Clin Oral Implants Res. 2012 Jul; 23(7): 873–881.\nBartlett JG, Gorbach SL. The triple threat of aspiration pneumonia. Chest. 1975 Oct; 68(4):\n560–566.\nBashutski JD, D’Silva NJ, Wang HL. Implant compression necrosis: current understanding and\ncase report. J Periodontol. 2009 Apr; 80(4): 700–7ß4.\nBasker RM, Watson CJ). Tongue control of upper complete dentures: a clinical hint. Br Dent\nK. 1991 Oct; 170(12): 449–450.\nBassett JH, Williams AJ, Murphy E, Boyde A, Howell PG, Swinhoe R, Archanco M, Flamant\nF, Samarut J, Costagliola S, Vassart G, Weiss RE, Refetoff S, Williams GR. A lack of\nthyroid hormones rather than excess thyrotropin causes abnormal skeletal development in\nhypothyroidism. Mol Endocrinol. 2008 Feb; 22(2): 501–512.\nBatty GM, Oborne CA, Swift CG, Jackson SH. The use of over-the-counter medication by\nelderly medical in-patients. Postgrad Med J. 1997 Nov; 73(865): 720–722.\nBauer KA, Weiss LM, Sparrow D, Vokonas PS, Rosenberg RD. Aging associated changes in\nindices of thrombin generation and protein C activation in humans: normative aging study. J\nClin Invest. 1987 Dec; 80(6): 1527–1534.\nBeers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for\ndetermining inappropriate medication use in nursing home residents. Arch Intern Med. 1991\nSep; 151(9): 1825–1832.\nBeijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-\nanalysis of observational studies. Pharm World Sci. 2002 Apr; 24(2): 46–54."
  },
  {
    "page": 394,
    "content": "Beikler T, Flemmig TF. Implants in the medically compromised patient. Crit Rev Oral Biol\nMed. 2003; 14(4): 305–316.\nBello SA, Adeyemo WL, Bamgbose BO, Obi EV, Adeyinka AA. Effect of age, impaction types\nand operative time on inflammatory tissue reactions following lower third molar surgery.\nHead Face Med. 2011 Apr 28; 7: 8.\nBellomo F, de Preux F, Chung JP, Julien N, Budtz-Jørgensen E, Müller F. The advantages of\noccupational therapy in oral hygiene measures for institutionalised elderly adults.\nGerodontology. 2005 Mar; 22(1): 24–31.\nBergendal B, Anderson JD, Müller F. Comprehensive treatment planning for the patient with\ncomplex treatment needs. In: Jokstad A (ed). Osseointegration and dental implants. 2008.\nJohn Wiley & Sons. 43–62.\nBerglundh T, Persson L, Klinge B. A systematic review of the incidence of biological and\ntechnical complications in implant dentistry reported in prospective longitudinal studies of\nat least 5 years. J Clin Periodontol. 2002; 29(Suppl. 3): 197–212.\nBerglundh T, Zitzmann NU, Donati M. Are peri-implantitis lesions different from periodontitis\nlesions? J Clin Periodontol. 2011 Mar; 38(Suppl 11): 188–202.\nBerr C, Wancata J, Ritchie K. Prevalence of dementia in the elderly in Europe. C384 Eur\nNeuropsychopharmacol. 2005 Aug; 15(4): 463–471.\nBethel MA, Sloan FA, Belsky D, Feinglos MN. Longitudinal incidence and prevalence of\nadverse outcomes of diabetes mellitus in elderly patients. Arch Intern Med. 2007 May 14;\n167(9): 921–927.\nBidra AS, Almas K. Mini implants for definitive prosthodontic treatment: a systematic review.\nJ Prosthet Dent. 2013 Mar; 109(3): 156–164.\nBilhan H, Mumcu E, Arat S. The comparison of marginal bone loss around mandibular\noverdenture-supporting implants with two different attachment types in a loading period of\n36 months. Gerodontology. 2011 Mar; 28(1): 49–57.\nBinon PP. Thirteen-year follow-up of a mandibular implant-supported fixed complete denture\nin a patient with Sjögren’s syndrome: a clinical report. J Prosthet Dent. 2005 Nov; 94(5):\n409–413.\nBlack DM, Reid IR, Boonen S, Bucci-Rechtweg C, Cauley JA, Cosman F, Cummings SR, Hue\nTF, Lippuner K, Lakatos P, Leung PC, Man Z, Martinez RL, Tan M, Ruzycky ME, Su G,\nEastell R. The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: A\nrandomized extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res."
  },
  {
    "page": 395,
    "content": "2012 Feb; 27(2): 243–254.\nBlanes RJ, Bernard JP, Blanes ZM, Belser UC. A 10-year prospective study of ITI dental\nimplants placed in the posterior region. II: Influence of the crown-toimplant ratio and\ndifferent prosthetic treatment modalities on crestal bone loss. Clin Oral Implants Res. 2007\nDec; 18(6): 707–714.\nBoerrigter EM, Stegenga B, Raghoebar GM, Boering G. Patient satisfaction and chewing\nability with implant-retained mandibular overdentures: a comparison with new complete\ndentures with or without preprosthetic surgery. J Oral Maxillofac Surg. 1995 Oct; 53(10):\n1167–1173. (a)\nBoerrigter EM, Geertman ME, Van Oort RP, Bouma J, Raghoebar GM, van Waas MA, van’t\nHof MA, Boering G, Kalk W: Patient satisfaction with implant-retained mandibular\noverdentures. A comparison with new complete dentures not retained by implants—a\nmulticentre randomized clinical trial. Br J Oral Maxillofac Surg. 1995 Oct; 33(5): 282–288.\n(b)\nBonewald L. The amazing osteocyte. J Bone Miner Res. 2011 Feb; 26(2): 229–238.\nBornstein MM, Halbritter S, Harnisch H, Weber HP, Buser D. A retrospective analysis of\npatients referred for implant placement to a specialty clinic: indications, surgical\nprocedures, and early failures. Int J Oral Maxillofac Implants. 2008 Nov-Dec; 23(6): 1109–\n1116.\nBornstein MM, Cionca N, Mombelli A. Systemic conditions and treatments as risks for\nimplant therapy. Int J Oral Maxillofac Implants. 2009; 24(Suppl): 12–27.\nBorromeo GL, Brand C, Clement JG, McCullough M, Crighton L, Hepworth G, Wark JD. A\nlarge case-control study reveals a positive association between bisphosphonate use and\ndelayed dental healing and osteonecrosis of the jaw. J Bone Miner Res. 2014 May 19;\n29(6): 1363–1368.\nBortolini S, Natali A, Franchi M, Coggiola A, Consolo U. Implant-retained removable partial\ndentures: an 8-year retrospective study. J Prosthodont. 2011 Apr; 20(3): 168–172.\nBoscolo-Rizzo P, Stellin M, Muzzi E, Mantovani M, Fuson R, Lupato V, Trabalzini F, Da\nMosto MC. Deep neck infections: a study of 365 cases highlighting recommendations for\nmanagement and treatment. Eur Arch Otorhinolaryngol. 2012 Sep 14; 269(4): 1241–1249.\nBoskey AL, Coleman R. Aging and bone. J Dent Res. 2010 Dec; 89(12): 1333–1448.\nBots CP, Poorterman JH, Brand HS, Kalsbeek H, van Amerongen BM, Veerman EC, Nieuw\nAmerongen AV. The oral health status of dentate patients with chronic renal failure"
  },
  {
    "page": 396,
    "content": "undergoing dialysis therapy. Oral Dis. 2006 Mar; 12(2): 176–180.\nBoult C, Green AF, Boult LB, Pacala JT, Snyder C, Leff B. Successful models of chronic care\nfor older adults with chronic conditions: evidence for the Institute of Medicine’s “Retooling\nfor an aging America” report. J Am Geriatr Soc. 2009 Dec; 57(12): 2328–2337.\nBoyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and\nquality of care for older patients with multiple comorbid diseases: implications for pay for\nperformance. JAMA. 2005 Aug 10; 294(6): 716–724.\nBoyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050\nburden of diabetes in the US adult population: dynamic modeling of incidence, mortality,\nand prediabetes prevalence. Popul Health Metr. 2010 Oct 22; 8: 29.\nBozini T, Petridis H, Tzanas K, Garefis P. A meta-analysis of prosthodontic complication rates\nof implant- supported fixed dental prostheses in edentulous patients after an observation\nperiod of at least 5 years. Int J Oral Maxillofac Implants. 2011; 26: 304–318.\nBradbury J, Thomason JM, Jepson NJ, Walls AW, Allen PF, Moynihan PJ. Nutrition\ncounseling increases fruit and vegetable intake in the edentulous. J Dent Res. 2006 May;\n85(5): 463–468.\nBradley JC. A radiological investigation into the age changes of the inferior dental artery. Br J\nOral Surg. 1975 Jul; 13(1): 82–90.\nBradley JC. The clinical significance of age changes in the vascular supply to the mandible. Int\nJ Oral Surg. 1981; 10(Suppl 1): 71–76.\nBrägger U, Gerber C, Joss A, Haenni S, Meier A, Hashorva E, Lang NP. Patterns of tissue\nremodelling after placement of ITI dental implants using an osteotome technique: a\nlongitudinal radiographic case cohort study. Clin Oral Implants Res. 2004 Apr; 15(2): 158–\n166.\nBrägger U, Karoussis I, Persson R, Pjetursson B, Salvi G, Lang N. Technical and biological\ncomplications/failures with single crowns and fixed partial dentures on implants: a 10-year\nprospective cohort study. Clin Oral Implants Res. 2005 Jun; 16(3): 326–334.\nBrägger U, Hirt-Steiner S, Schnell N, Schmidlin K, Salvi GE, Pjetursson B, Matuliene G,\nZwahlen M, Lang NP. Complication and failure rates of fixed dental prostheses in patients\ntreated for periodontal disease. Clin Oral Implants Res. 2011 Jan; 22(1): 70–77.\nBraman SS, Hanania NA. Asthma in older adults. Clin Chest Med. 2007 Dec; 28(4): 685–702.\nBrånemark PI, Adell R, Albrektsson T, Lekholm U, Lindström J, Rockler B. An experimental\nand clinical study of osseointegrated implants penetrating the nasal cavity and maxillary"
  },
  {
    "page": 397,
    "content": "sinus. J Oral Maxillofac Surg. 1984 Aug; 42(8): 497–505.\nBras J, de Jonge HK, van Merkesteyn JP. Osteoradionecrosis of the mandible: pathogenesis.\nAm J Otolaryngol. 1990 Jul–Aug; 11(4): 244–250.\nBrecx M, Holm-Pedersen P, Theilade J. Early plaque formation in young and elderly\nindividuals. Gerodontics. 1985 Feb; 1(1): 8–13.\nBrill N, Tryde G, Schübeler S. The role of exteroceptors in denture retention. J Prosthet Dent.\n1959; 9: 761–768.\nBrodeur JM, Laurin D, Vallee R, Lachapelle D. Nutrient intake and gastrointestinal disorders\nrelated to masticatory performance in the edentulous elderly. J Prosthet Dent. 1993 Nov;\n70(5): 468–473.\nBronskill SE, Gill SS, Paterson JM, Bell CM, Anderson GM, Rochon PA. Exploring variation\nin rates of polypharmacy across long term care homes. J Am Med Dir Assoc. 2012 Mar;\n13(3): 309\nBrook I, Frazier HE. Immune response to Fusobacterium nucleatum and Prevotella intermedia\nin the sputum of patients with acute exacerbations of chronic bronchitis. Chest. 2003 Sep;\n124(3): 832–833.\nBrown RS, Rhodus NL. Adrenaline and local anaesthesia revisited. Oral Surg Oral Med Oral\nPathol Oral Radiol Endod. 2005 Oct; 100(4): 401–408.\nBrügger OE, Bornstein MM, Kuchler U, Janner SF, Chappuis V, Buser D. Implant therapy in a\nsurgical specialty clinic: An analysis of patients, indications, surgical procedures, risk\nfactors and early failures. Int J Oral Maxillofac Implants. 2015 Jan–Feb; 30(1): 151–160\nBryant SR. The effects of age, jaw site, and bone condition on oral implant outcomes. Int J\nProsthodont. 1998 Sep–Oct; 11(5): 470–490.\nBryant SR, Zarb GA. Crestal bone loss proximal to oral implants in older and younger adults.\nJ Prosthet Dent. 2003 Jun; 89(6): 589–597.\nBryant SR, MacDonald-Jankowski D, Kim K. Does the type of implant prosthesis affect\noutcomes for the completely edentulous arch? Int J Oral Maxillofac Implants. 2007;\n22(Suppl): 117–139.\nBryant SR, Walton JN, MacEntee MI. A 5-year randomized trial to compare 1 or 2 implants\nfor implant overdentures. J Dent Res. 2015 Jan; 94(1): 36–43.\nBuckeridge D, Huang A, Hanley J, Kelome A, Reidel K, Verma A, Winslade N, Tamblyn R.\nRisk of injury associated with opioid use in older adults. J Am Geriatr Soc. 2010 Sep;"
  },
  {
    "page": 398,
    "content": "58(9): 1664–1670.\nBudtz-Jørgensen E, Isidor F. A 5-year longitudinal study of cantilevered fixed partial\ndentures compared with removable partial dentures in a geriatric population. J Prosthet\nDent. 1990 Jul; 64(1): 42–47.\nBudtz-Jørgensen E, Bochet G. Alternate framework designs for removable partial dentures. J\nProsthet Dent. 1998 Jul; 80(1): 58–66.\nBudtz-Jørgensen E. Prosthodontics for the elderly: diagnosis and treatment. Chicago:\nQuintessence. 1999.\nBuser D, Weber HP, Lang NP. Tissue integration of non-submerged implants. 1-year results of\na prospective study with 100 ITI hollow-cylinder and hollow-screw implants. Clin Oral\nImplants Res. 1990 Dec; 1(1): 33–40.\nBuser D, von Arx T. Surgical procedures in partially edentulous patients with ITI implants.\nClin Oral Implants Res. 2000; 11(Suppl 1): 83–100.\nBuser D, Janner SF, Wittneben JG, Brägger U, Ramseier CA, Salvi GE. 10-year survival and\nsuccess rates of 511 titanium implants with a sandblasted and acid-etched surface: a\nretrospective study in 303 partially edentulous patients. Clin Implant Dent Relat Res. 2012\nDec; 14(6): 839–851.\nCabre M, Serra-Prat M, Palomera E, Almirall J, Pallares R, Clavé P. Prevalence and\nprognostic implications of dysphagia in elderly patients with pneumonia. Age Ageing. 2010\nJan; 39(1): 39–45.\nCancer Research UK. 2014. http://www.cancerresearchuk.org/health-professional/cancer-\nstatistics/statistics-by-cancer-type/oral-cancer/incidence. Last accessed December 21,\n2014.\nCandel-Marti ME, Ata-Ali J, Peñarrocha-Oltra D, Peñarrocha-Diago M, Bagán JV. Dental\nimplants in patients with oral mucosal alterations: an update. Med Oral Patol Oral Cir\nBucal. 2011 Sep 1; 16(6): e787–793.\nCardaropoli G, Araújo M, Lindhe J. Dynamics of bone tissue formation in tooth extraction\nsites. An experimental study in dogs. J Clin Periodontol. 2003 Sep; 30(9): 809–818.\nCarter RB, Keen EN. The intramandibular course of the inferior alveolar nerve. J Anat. 1971;\n108(Pt 3): 433–440.\nCastle SC, Uyemura K, Rafi A, Akande O, Makinodan T. Comorbidity is a better predictor of\nimpaired immunity than chronological age in older adults. J Am Geriatr Soc. 2005 Sep;\n53(9): 1565–1569."
  },
  {
    "page": 399,
    "content": "Cawood JI, Howell RA. A classification of the edentulous jaws. Int J Oral Maxillofac Surg.\n1988 Aug; 17(4): 232–236.\nCawood JI, Howell RA. A classification of the edentulous jaws. Int J Oral Maxillofac Surg.\n1988 Aug; 17(4): 232–236.\nChallacombe SJ, Percival RS, Marsh PD. Age-related changes in immunoglobulin isotypes in\nwhole and parotid saliva and serum in healthy individuals. Oral Microbiol Immunol. 1995\nAug; 10(4): 202–207.\nChambrone L, Mandia J Jr, Shibli JA, Romito GA, Abrahao M. Dental implants installed in\nirradiated jaws: a systematic review. J Dent Res. 2013 Dec; 92(12 Suppl): 119S–130S.\nChamizo Carmona E, Gallego Flores A, Loza Santamaría E, Herrero Olea A, Rosario Lozano\nMP. Systematic literature review of bisphosphonates and osteonecrosis of the jaw in\npatients with osteoporosis. Reumatol Clin. 2012 May–Jun; 9(3); 172–177.\nChapuy MC, Durr F, Chapuy P. Age-related changes in parathyroid hormone and 25\nhydroxycholecalciferol levels. J Gerontol. 1983 Jan; 38(1): 19–22.\nCharlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic\ncomorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;\n40(5): 373–383.\nChen S, Buser D. Advantages and disadvantages of treatment options for implant placement in\npost-extraction sites. In: Buser D, Wismeijer D, Belser U (eds). ITI Treatment Guide, Vol 3:\nImplant placement in post-extraction sites. Berlin: Quintessence. 2008: 29–35.\nChen S, Buser D, Cordaro L. Classification of surgical cases. In: Dawson A, Chen S (eds).\nThe SAC classification in implant dentistry. Berlin: Quintessence. 2009: 27–81.\nChiapasco M, De Cicco L, Marrone G. Side effects and complications associated with third\nmolar surgery. Oral Surg Oral Med Oral Pathol. 1993 Oct; 76(4): 412–420.\nChiapasco M, Felisati G, Maccari A, Borloni R, Gatti F, Di Leo, F. The management of\ncomplications following displacement of oral implants in the paranasal sinuses: a\nmulticenter clinical report and proposed treatment protocols. Int J Oral Maxillofac Surg.\n2009 Dec; 38(12): 1273–1278.\nChiapasco M, Casentini P, Zaniboni M, Corsi E, Anello T. Titanium zirconium alloy narrow-\ndiameter implants (Straumann Roxolid) for the rehabilitation of horizontally deficient\nedentulous ridges: prospective study on 18 consecutive patients. Clin Oral Implants Res.\n2012 Oct; 23(10): 1136–1141.\nChiarella G, Leopardi G, De Fazio L, Chiarella R, Cassandro E. Benign paroxysmal"
  },
  {
    "page": 400,
    "content": "positional vertigo after dental surgery. Eur Arch Otorhinolaryngol. 2008 Jan; 265(1): 119–\n122.\nChou KL, Evatt M, Hinson V, Kompoliti K. Sialorrhea in Parkinson’s disease: a review. Mov\nDisord. 2007 Dec; 22(16): 2306–2313.\nChrcanovic BR, Custódio ALN. Mandibular fractures associated with endosteal implants.\nOral Maxillofac Surg. 2009 Dec; 13(4): 231–238.\nChrcanovic BR, Albrektsson T, Wennerberg A. Diabetes and oral implant failure: a systematic\nreview. J Dent Res. 2014 Sep; 93(9): 859–867.\nChuang SK, Wei LJ, Douglass CW, Dodson TB. Risk factors for dental implant failure: a\nstrategy for the analysis of clustered failure-time observations. J Dent Res. 2002 Aug; 81(8):\n572–577.\nChui MA, Stone JA, Martin BA, Croes KD, Thorpe JM. Safeguarding older adults from\ninappropriate over-the-counter medications: the role of community pharmacists.\nGerontologist. 2013 Nov 6; 54(6): 980–1000.\nChung WE, Rubenstein JE, Phillips KM, Raigrodski AJ. Outcomes assessment of patients\ntreated with osseointegrated dental implants at the University of Washington Graduate\nProsthodontic Program, 1988 to 2000. Int J Oral Maxillofac Implants. 2009 Sep-Oct; 24(5):\n927–935.\nCKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation,\nprevention, and treatment of Chronic Kidney Disease—Mineral and Bone Disorder (CKD-\nMBD). Kidney Int Suppl. 2009 Aug; (113): S1–S130.\nClaffey N, Clarke E, Polyzois I, Renvert S. Surgical treatment of peri-implantitis. J Clin\nPeriodontol. 2008 Sep; 35(Suppl. 8): 316–332.\nClaudy MP, Miguens SA Jr, Celeste RK, Camara Parente R, Hernandez PA, da Silva AN Jr.\nTime interval after radiotherapy and dental implant failure: systematic review of\nobservational studies and meta-analysis. Clin Implant Dent Relat Res. 2015 Apr; 17(2):\n401–411.\nClaxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose\nregimens and medication compliance. Clin Ther. 2001 Aug; 23(8): 1296–1310.\nCochran DL, Schou S, Heitz-Mayfield LJA, Bornstein MM, Salvi GE, Martin WC. Consensus\nstatements and recommended clinical procedures regarding risk factors in implant therapy.\nInt J Oral Maxillofac Implants. 2009; 24(Suppl): 86–89.\nColella G, Cannavale R, Pentenero M, Gandolfo S. Oral implants in radiated patients: A"
  },
  {
    "page": 401,
    "content": "systematic review. Int J Oral Maxillofac Implants. 2007 Jul–Aug; 22(4): 616–622.\nCooper C, Livingston G. Mental health/psychiatric issues in elder abuse and neglect. Clin\nGeriatr Med. 2014 Nov; 30(4): 839–850.\nCoresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS:\nPrevalence of chronic kidney disease in the United States. JAMA. 2007 Nov 7: 298(17):\n2038–2047.\nCosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R; National\nOsteoporosis Foundation. Clinician’s Guide to Prevention and Treatment of Osteoporosis.\nOsteoporos Int. 2014 Oct; 25(10): 2359–2381.\nCosta FO, Takenaka-Martinez S, Cota LO, Ferreira SD, Silva GL, Costa JE. Peri-implant\ndisease in subjects with and without preventive maintenance: a 5-year follow-up. J Clin\nPeriodontol. 2012 Feb; 39(2): 173–181.\nCzerninski R, Eliezer M, Wilensky A, Soskolne A. Oral lichen planus and dental implants—a\nretrospective study. Clin Implant Dent Relat Res. 2013 Apr; 15(2): 234–242.\nDaubländer M, Müller R, Lipp MD. The incidence of complications associated with local\nanesthesia in dentistry. Anesth Prog. 1997 Fall; 44(4): 132–141.\nDavid LA, Sandor GK, Evans AW, Brown DH. Hyperbaric oxygen therapy and mandibular\nosteoradionecrosis: a retrospective study and analysis of treatment outcomes. J Can Dent\nAssoc. 2001 Jul–Aug; 67(7): 384.\nDavidovich E, Schwarz Z, Davidovitch M, Eidelman E, Bimstein E. Oral findings and\nperiodontal status in children, adolescents and young adults suffering from renal failure. J\nClin Periodontol. 2005 Oct; 32(10): 1076–1082.\nDawson A, Martin W, Belser U. Classification of restorative cases. In: Dawson A, Chen S\n(eds). The SAC classification in implant dentistry. Berlin: Quintessence. 2009: 83–111.\nDayer R, Badoud I, Rizzoli R, Ammann P. Defective implant osseointegration under protein\nundernutrition: prevention by PTH or pamidronate. J Bone Miner Res. 2007 Oct; 22(10):\n1526–1533.\nde Albuquerque Júnior RF, Lund JP, Tang L, Larivée J, de Grandmont P, Gauthier G, Feine\nJS. Within-subject comparison of maxillary long-bar implant-retained prostheses with and\nwithout palatal coverage: patient-based outcomes. Clin Oral Implants Res. 2000 Dec; 11(6):\n555-565.\nde Baat C. Success of dental implants in elderly people—a literature review. Gerodontology.\n2000 Jul; 17(1): 45–48."
  },
  {
    "page": 402,
    "content": "de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity: a critical\nreview of available methods. J Clin Epidemiol. 2003 Mar; 56(3): 221–229.\nde Jong MH, Wright PS, Meijer HJ, Tymstra N. Posterior mandibular residual ridge\nresorption in patients with overdentures supported by two or four endosseous implants in a\n10-year prospective comparative study. Int J Oral Maxillofac Implants. 2010 Nov–Dec;\n25(6): 1168–1174.\nDe Rossi SS, Glick M. Dental considerations for the patient with renal disease receiving\nhemodialysis. J Am Dent Assoc. 1996 Feb; 127(2): 211–219.\nDe Rossi SS, Slaughter YA. Oral changes in older patients: a clinician’s guide. Quintessence\nInt. 2007 Oct; 38(9): 773–780.\nde Souza RF, de Freitas Oliveira Paranhos H, Lovato da Silva CH, Abu-Naba’a L,\nFedorowicz Z, Gurgan CA. Interventions for cleaning dentures in adults. Cochrane Database\nSyst Rev. 2009 Oct 7; (4): CD007395.\nde Torres EM, Barbosa GAS, Bernardes SR, de Mattos Mda G, Ribeiro RF. Correlation\nbetween vertical misfits and stresses transmitted to implants from metal frameworks. J\nBiomech. 2011 Jun 3; 44(9): 1735–1739.\nDegidi M, Piattelli A. Immediately loaded bar-connected implants with an anodized surface\ninserted in the anterior mandible in a patient treated with diphosphonates for osteoporosis: a\ncase report with a 12-month follow-up. Clin Implant Dent Relat Res. 2003; 5(4): 269–272.\nDel Fiol G, Weber AI, Brunker CP, Weir CR. Clinical questions raised by providers in the care\nof older adults: a prospective observational study. BMJ Open. 2014 Jul 4; 4(7): e005315.\nDeliberador TM, Marengo G, Scaratti R, Giovanni AF, Zielak JC, Baratto Filho F. Accidental\naspiration in a patient with Parkinson’s disease during implant-supported prosthesis\nconstruction: a case report. Special Care Dentist. 2011 Sep–Oct; 31(5): 156–161.\nDello Russo NM, Jeffcoat MK, Marx RE, Fugazzotto P. Osteonecrosis in the jaws of patients\nwho are using oral bisphosphonates to treat osteoporosis. Int J Oral Maxillofac Implants.\n2007 Jan–Feb; 22(1): 146–153.\nDepartment of Health, United Kingdom. Long term conditions compendium of information:\nThird edition. 2012 May 12.\nhttps://www.gov.uk/government/uploads/system/uploads/attachment_data/file/216528/dh_13\nLast accessed October 29, 2015.\nDevlin J. Patients with chronic obstructive pulmonary disease: management considerations for\nthe dental team. Br Dent J. 2014 Sep; 217(5): 235–237."
  },
  {
    "page": 403,
    "content": "Dhanuthai K, Rojanawatsirivej S, Somkotra T, Shin HI, Hong SP, Darling M, Ledderhof N,\nKhalili M, Thosaporn W, Rattana-Arpha P, Saku T. Geriatric oral lesions: A multicentric\nstudy. Geriatr Gerontol Int. 2016 Feb; 16(2): 237–243.\nDi Girolamo M, Napolitano B, Arullani CA, Bruno E, Di Girolamo S. Paroxysmal positional\nvertigo as a complication of osteotome sinus floor elevation. Eur Arch Ootorhinolaryngol.\n2005 Aug; 262(8): 631–633.\nDijakiewicz M, Wojtowicz A, Dijakiewicz J, Szycik V, Rutkowski P, Rutkowski B. Is\nimplanto-prosthodontic treatment available for haemodialysis patients? Nephrol Dial\nTransplant. 2007 Sep; 22(9): 2722–2724.\nDimopoulos MA, Kastritis E, Bamia C, Melakopoulos I, Gika D, Roussou M, Migkou M,\nEleftherakis-Papaiakovou E, Christoulas D, Terpos E, Bamias A. Reduction of\nosteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with\nmultiple myeloma treated with zoledronic acid. Ann Oncol. 2009 Jan; 20(1): 117–120.\nDing X, Zhu XH, Liao SH, Zhang XH, Chen H. Implant-bone interface stress distribution in\nimmediately loaded implants of different diameters: a three-dimensional finite element\nanalysis. J Prosthodont. 2009 Jul; 18(5): 393–402.\nDiz P, Scully C, Sanz M. Dental implants in the medically compromised patient. J Dent. 2013\nMar 1; 41(3): 195–206.\nDodd MJ, Facione NC, Dibble SL, MacPhail L. Comparison of methods to determine the\nprevalence and nature of oral mucositis. Cancer Pract. 1996 Nov–Dec; 4(6): 312–318.\nDonoff RB. Treatment of the irradiated patient with dental implants: The case against\nhyperbaric oxygen treatment. J Oral Maxillofac Surg. 2006 May; 64(5): 819–822.\nDonos N, Laurell L, Mardas N. Hierarchical decisions on teeth vs. implants in the\nperiodontitis-susceptible patient: the modern dilemma. Periodontol 2000. 2012 Jun; 59(1):\n89–110.\nDoud Galli SK, Lebowitz RA, Giacchi RJ, Glickman R, Jacobs JB. Chronic sinusitis\ncomplicating sinus lift surgery. Am J Rhinol. 2001 May–Jun; 15(3): 181–186.\nDouglass CW, Shih A, Ostry L. Will there be a need for complete dentures in the United States\nin 2020? J Prosthet Dent. 2002 Jan; 87(1): 5–8.\nDubois L, de Lange J, Baas E, Van Ingen J. Excessive bleeding in the floor of the mouth after\nendosseous implant placement: a report of two cases. Int J Oral Maxillofac Surg 2010; 39:\n412–415.\nDudley J. Implants for the ageing population. Aust Dent J. 2015 Mar; 60(Suppl 1): 28–43."
  },
  {
    "page": 404,
    "content": "Dvorak G, Arnhart C, Heuberer S, Huber CD, Watzek G, Gruber R. Peri-implantitis and late\nimplant failures in postmenopausal women: a cross-sectional study. J Clin Periodontol.\n2011 Oct; 38(10): 950–955.\nDwyer LL, Han B, Woodwell DA, Rechtsteiner EA. Polypharmacy in nursing home residents\nin the United States: results of the 2004 National Nursing Home Survey. Am J Geriatr\nPharmacother. 2010 Feb; 8(1): 63–72.\nEder A, Watzek G. Treatment of a patient with severe osteoporosis and chronic polyarthritis\nwith fixed implant-supported prosthesis: a case report. Int J Oral Maxillofac Implants. 1999\nJul–Aug; 14(4): 587–590.\nEdwards LL, Pfeiffer RF, Quigley EM, Hofmann R, Balluff M. Gastrointestinal symptoms in\nParkinson’s disease. Mov Disord. 1991; 6(2): 151–156.\nEiseman B, Johnson LR, Coll JR. Ultrasound measurement of mandibular arterial blood\nsupply: techniques for defining ischemia in the pathogenesis of alveolar ridge atrophy and\ntooth loss in the elderly. Oral Maxillofac Surg. 2005; 63: 28–35.\nEl Mekawy NH, El-Negoly SA, Grawish Mel A, El-Hawary YM. Intracoronal mandibular\nKennedy Class I implant-tooth supported removable partial overdenture: a 2-year\nmulticenter prospective study. Int J Oral Maxillofac Implants. 2012 May–Jun; 27(3): 677–\n683.\nEmami E, Heydecke G, Rompré PH, de Grandmont P, Feine JS. Impact of implant support for\nmandibular dentures on satisfaction, oral and general health-related quality of life: a meta-\nanalysis of randomized-controlled trials. Clin Oral Implants Res. 2009 Jun; 20(6): 533–544.\nEngeland CG, Bosch JA, Cacioppo JT, Marucha PT. Mucosal wound healing: the roles of age\nand sex. Arch Surg. 2006 Dec; 141(12): 1193–1187; discussion 1198.\nEngfors I, Ortorp Am Jemt T. Fixed implant-supported prostheses in elderly patients: a 5-year\nretrospective study of 133 edentulous patients older than 79 years. Clin Implant Dent Relat\nRes. 2004; 6(4): 190–198.\nEom CS, Park SM, Myung SK, Yun JM, Ahn JS. Use of acid-suppressive drugs and risk of\nfracture: a meta-analysis of observational studies. Ann Fam Med. 2011 May–Jun; 9(3): 257–\n267.\nEpstein JB, Lunn R, Le N, Stevenson-Moore P. Periodontal attachment loss in patients after\nhead and neck radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998\nDec; 86(6): 673–677.\nErsanli S, Olgac V, Leblebicioglu B. Histologic analysis of alveolar bone following guided"
  },
  {
    "page": 405,
    "content": "bone regeneration. J Periodontol. 2004 May; 75(5): 750–756.\nEsposito SJ, Camisa C, Morgan M. Implant retained overdentures for two patients with severe\nlichen planus: a clinical report. J Prosthet Dent. 2003 Jan; 89(1): 6–10.\nEsposito M, Worthington HV. Interventions for replacing missing teeth: hyperbaric oxygen\ntherapy for irradiated patients who require dental implants. Cochrane Database Syst Rev.\n2013 Sep 30; 9: CD003603.\nEsser E, Wagner W. Dental implants following radical oral cancer surgery and adjuvant\nradiotherapy. Int J Oral Maxillofac Implants. 1997 Jul–Aug; 12(4): 552–557.\nEttinger RL, Pinkham JR. Dental care for the homebound—assessment and hygiene. Aust Dent\nJ. 1977 Apr; 22(2): 77–82.\nEvans WJ. Exercise, nutrition and aging. Clin Geriatr Med. 1995 Nov; 11(4): 725–734.\nFadaei Fathabady F, Norouzian M, Azizi F. Effect of hypothyroidism on bone repair in mature\nfemale rats. Int J Endocrinol Metab. 2005; 1: 126–129.\nFaggion CM Jr. Critical appraisal of evidence supporting the placement of dental implants in\npatients with neurodegenerative diseases. Gerodontology. 2013 Dec 10. [Epub ahead of\nprint.]\nFarrell B, Shamji S, Monahan A, French Merkley V. Reducing polypharmacy in the elderly:\nCases to help you “rock the boat.” Can Pharm J (Ott). 2013 Sep; 146(5): 243–244.\nFaxen-Irving G, Basun H, Cederholm. Nutritional and cognitive relationships and long-term\nmortality in patients with various dementia disorders. Age Ageing. 2005 Mar; 34(2): 136–\n141.\nFDA (United States Food and Drug Administration). Background document for meeting of\nadvisory committee for reproductive health drugs and drug safety and risk management\nadvisory committee. 2011.\nhttp://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/drugs/Dr\nLast accessed February 10, 2014.\nFDA (United States Food and Drug Administration). Avastin (bevacizumab). Safety\ninformation. 2014. http://www.fda.gov/safety/medwatch/safetyinformation/ucm275758.htm.\nLast accessed December 7, 2014. (a)\nFDA (United States Food and Drug Administration). Sutent (sunitinib malate) capsules. Safety\ninformation. 2014. http://www.fda.gov/safety/medwatch/safetyinformation/ucm224050.htm.\nLast accessed December 7, 2014. (b)"
  },
  {
    "page": 406,
    "content": "Feine JS, de Grandmont P, Boudrias P, Brien N, LaMarche C, Taché R, Lund JP. Within-\nsubject comparisons of implant-supported mandibular prostheses: choice of prosthesis. J\nDent Res. 1994 May; 73(5): 1105–1111.\nFeine JS, Carlsson GE, Awad MA, Chehade A, Duncan WJ, Gizani S, Head T, Heydecke G,\nLund JP, MacEntee M, Mericske-Stern R, Mojon P, Morais JA, Naert I, Payne AG, Penrod\nJ, Stoker GT, Tawse-Smith A, Taylor TD, Thomason JM, Thomson WM, Wismeijer D. The\nMcGill consensus statement on overdentures. Mandibular two-implant overdentures as first\nchoice standard of care for edentulous patients. Gerodontology. 2002 Jul; 19(1): 3–4.\nFeitosa Dda S, Bezerra Bde B, Ambrosano GM, Nociti FH, Casati MZ, Sallum EA, de Toledo\nS. Thyroid hormones may influence cortical bone healing around titanium implants: a\nhistometric study in rats. J Periodontol. 2008 May; 79(5): 881–887.\nFelsenberg D, Hoffmeister B: Kiefernekrosen nach hoch dosierter Bisphosphonattherapie.\n[Necrosis of the jaw after high-dose bisphosphonate therapy.] Dtsch Ärztebl. 2006; 103(46):\nA-3078/B-2681/C-2572.\nFerguson DB. The Aging Mouth. (Frontiers of Oral Biology, Vol. 6.) Basel: Karger AG; 1987.\nFerreira SD, Silva GL, Cortelli JR, Costa JE, Costa FO. Prevalence and risk variables for\nperi-implant disease in Brazilian subjects. J Clin Periodontol. 2006 Dec; 33(12): 929–935.\nFialová D, Topinková E, Gambassi G, Finne-Soveri H, Jónsson PV, Carpenter I, Schroll M,\nOnder G, Sørbye LW, Wagner C, Reissigová J, Bernabei R; AdHOC Project Research\nGroup. Potentially inappropriate medication use among elderly home care patients in\nEurope. JAMA. 2005 Mar 16; 293(11): 1348–1358.\nFich A, Camilleri M, Phillips SF. Effect of age on human gastric and small bowel motility. J\nClin Gastroenterol. 1989 Aug; 11(4); 416–420.\nFick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers\ncriteria for potentially inappropriate medication use in older adults: results of a US\nconsensus panel of experts. Arch Intern Med. 2003 Dec 8–22; 63(22): 2716–2724.\nFillion M, Aubazac D, Bessadet M, Allegre M, Nicolas E. The impact of implant treatment on\noral health related quality of life in a private dental practice: a prospective cohort study.\nHealth Quality Life Outcomes. 2013 Nov; 11: 197.\nFindler M, Galili D, Meidan Z, Yakirevitch V, Garfunkel AA. Dental treatment in very high-\nrisk patients with active ischemic heart disease. Oral Surg Oral Med Oral Pathol. 1993 Sep;\n76(3): 298–300.\nFiorellini JP, Nevins M. Dental implant considerations in the diabetic patient. Periodontology"
  },
  {
    "page": 407,
    "content": "2000. 2000 Jun; 23, 73–77.\nFiske J, Frenkel H, Griffiths J, Jones V. Guidelines for the development of local standards of\noral health care for people with dementia. Gerodontology. 2006 Dec; 23 (Suppl 1): 5–32.\nFolstein MF, Folstein SE, McHugh PR. “Mini-mental state.” A practical method for grading\nthe cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov; 12(3): 189–198.\nFriberg B, Ekestubbe A, Mellström D, Sennerby L. Brånemark implants and osteoporosis: a\nclinical exploratory study. Clin Implant Dent Relat Res. 2001; 3(1): 50–56.\nFried LP, Guralnik JM. Disability in older adults: evidence regarding significance, etiology,\nand risk. J Am Geriatr Soc. 1997 Jan; 45(1): 92–100.\nFried LP, Walston J. Frailty and failure to thrive. In: Hazzard WR, Blass JP, EW (eds).\nPrinciples of geriatric medicine and gerontology. New York: McGraw Hill; 1998: 1387–\n1402.\nFried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R,\nKop WJ, Burke G, McBurnie MA; Cardiovascular Health Study Collaborative Research\nGroup. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci.\n2001 Mar; 56(3): M146–156.\nFried LP, Hadley EC, Walston JD, Newman AB, Guralnik JM, Studenski S, Harris TB, Ershler\nWB, Ferrucci L. From bedside to bench: research agenda for frailty. Sci Aging Knowl\nEnviron. 2005 Aug 3; 2005(31): pe24.\nFried TR, Tinetti ME, Iannone L. Primary care clinicians’ experiences with treatment decision\nmaking for older persons with multiple conditions. Arch Int Med. 2011 Jan 10; 171(1): 75–\n80. (a)\nFried TR, Tinetti ME, Iannone L, O’Leary JR, Towle V, Van Ness PH. Health outcome\nprioritization as a tool for decision making among older persons with multiple chronic\nconditions. Arch Intern Med. 2011 Nov 14; 171(20): 1854–1856. (b)\nFrith J, Jones D, Newton JL. Chronic liver disease in an ageing population. Age and Ageing.\n2008 Nov 13; 38(1): 11–8.\nFujimoto T, Niimi A, Nakai H, Ueda M. Osseointegrated implants in a patient with\nosteoporosis: a case report. Int J Oral Maxillofac Implants. 1996 Jul–Aug; 11(4): 539–542.\nGallo JJ, Bogner HR, Morales KH, Post EP, Ten Have T, Bruce ML. Depression,\ncardiovascular disease, diabetes, and two-year mortality among older, primary-care\npatients. Am J Geriatr Psychiatry. 2005 Sep; 13(9): 748–755."
  },
  {
    "page": 408,
    "content": "Gallucci GO, Bernard JP, Belser UC. Treatment of completely edentulous patients with fixed\nimplant-supported restorations: three consecutive cases of simultaneous immediate loading\nin both maxilla and mandible. Int J Periodontics Restorative Dent. 2005 Feb; 25(1): 27–37.\nGallucci GO, Doughtie CB, Hwang JW, Fiorellini JP, Weber HP. Five-year results of fixed\nimplant-supported rehabilitations with distal cantilevers for the edentulous mandible. Clin\nOral Implants Res. 2009 Jun; 20(6): 601–607. (a)\nGallucci GO, Morton D, Weber HP. Loading protocols for dental implants in edentulous\npatients. Int J Oral Maxillofac Implants. 2009; 24(Suppl): 132–146. (b)\nGallucci GO, Benic GI, Eckert SE, Papaspyridakos P, Schimmel M, Schrott A, Weber HP.\nConsensus statements and clinical recommendations for implant loading protocols. Int J Oral\nMaxillofac Implants. 2014; 29(Suppl): 287–290.\nGandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, Seger DL, Shu K,\nFederico F, Leape LL, Bates DW. Adverse drug events in ambulatory care. N Engl J Med.\n2003 Apr 17; 348(16): 1556–1564.\nGavalda C, Bagan JV, Scully C, Silvestre F, Milian M, Jimenez V. Renal hemodialysis\npatients: oral, salivary, dental and periodontal findings in 105 adult cases. Oral Dis. 1999\nOct; 5(4): 299–302.\nGegauff AG, Laurell KA, Thavendrarajah A, Rosenstiel SF. A potential MRI hazard: forces\non dental magnet keepers. J Oral Rehabil. 1990 Sep; 17(5): 403–410.\nGesing A, Lewiński A, Karbownik-Lewińska M. The thyroid gland and the process of ageing;\nwhat is new? Thyroid Res. 2012 Nov 24, 5(1): 16.\nGibson PG, McDonald VM, Marks GB. Asthma in older adults. Lancet. 2010 Sep 4;\n376(9743): 803–813.\nGisbert JP, Chaparro M. Systematic review with meta-analysis: inflammatory bowel disease\nin the elderly. Aliment Pharmacol Ther. 2014 Jan 9; 39(5): 459–477.\nGivol N, Chaushu G, Halamish-Shani T, Taicher S. Emergency tracheostomy following life-\nthreatening hemorrhage in the floor of the mouth during immediate implant placement in the\nmandibular canine region. J Periodontol. 2000 Dec; 71(12): 1893–1895.\nGlaser DL, Kaplan FS. Osteoporosis. Definition and clinical presentation. Spine. 1997 Dec\n15; 22(24 Suppl): 12S-16S.\nGleissner C, Willershausen B, Kaesser U, Bolten WW. The role of risk factors for periodontal\ndisease in patients with rheumatoid arthritis. Eur J Med Res. 1998 Aug 18; 3(8): 387–392."
  },
  {
    "page": 409,
    "content": "Goiato MC, dos Santos DM, Santiago JF Jr, Moreno A, Pellizzer EP. Longevity of dental\nimplants in type IV bone: a systematic review. Int J Oral Maxillofac Surg. 2014 Sep; 43(9):\n1108–1116.\nGoldman KE. Dental management of patients with bone marrow and solid organ\ntransplantation. Dent Clin North Am. 2006 Oct; 50(4): 659–676.\nGoodacre CJ, Kan JY, Rungcharassaeng K. Clinical complications of osseointegrated\nimplants. J Prosthet Dent. 1999 May; 81(5): 537–552.\nGosain A, DiPietro LA. Aging and wound healing. World J Surg. 2004 Mar; 28(3): 321–326.\nGotfredsen K, Holm B. Implant-supported mandibular overdentures retained with ball or bar\nattachments: a randomized prospective 5-year study. Int J Prosthodont. 2000 Mar–Apr;\n13(2): 125–130.\nGottrup F. Oxygen in wound healing and infection. World J Surg. 2004 Mar; 28(3): 312–315.\nGranström G, Jacobsson M, Tjellström A. Titanium implants in irradiated tissue: benefits\nfrom hyperbaric oxygen. Int J Oral Maxillofac Implants. 1992 Spring; 7(1): 15–24.\nGranström G, Tjellström A. Effects of irradiation on osseointegration before and after implant\nplacement: a report of three cases. Int J Oral Maxillofac Implants. 1997 Jul–Aug; 12(4):\n541–551.\nGranström G. Radiotherapy, osseointegration and hyperbaric oxygen therapy. Periodontol\n2000. 2003; 33: 145–162.\nGranström G. Osseointegration in irradiated cancer patients: An analysis with respect to\nimplant failures. J Oral Maxillofac Surg. 2005 May; 63(5): 579–585.\nGrant DJ, McMurdo ME, Mole PA, Paterson CR, Davies RR. Suppressed TSH levels\nsecondary to thyroxine replacement therapy are not associated with osteoporosis. Clin\nEndocrinol (Oxford). 1993 Nov; 39(5): 529–533.\nGrant BT, Amenedo C, Freeman K, Kraut RA. Outcomes of placing dental implants in patients\ntaking oral bisphosphonates: a review of 115 cases. J Oral Maxillofac Surg. 2008 Feb;\n66(2): 223–230.\nGravenstein S, Fillit HM, Ershler WB. Clinical immunology of aging. In: Tallis RC, Fillit\nHM (eds). Brocklehurst’s textbook of geriatric medicine and gerontology. 6th edition.\nChurchill Livingstone; 2003: 117–118.\nGraves AB, Larson EB, Edland SD, Bowen JD, McCormick WC, McCurry SM, Rice MM,\nWenzlow A, Uomoto JM. Prevalence of dementia and its subtypes in the Japanese American"
  },
  {
    "page": 410,
    "content": "population of King County, Washington state. The Kame Project. Am J Epidemiol. 1996 Oct;\n144(8): 760–771.\nGraziani F, Donos N, Needleman I, Gabriele M, Tonetti M. Comparison of implant survival\nfollowing sinus floor augmentation procedures with implants placed in pristine posterior\nmaxillary bone: a systematic review. Clin Oral Implants Res. 2004 Dec; 15(6): 677-682.\nGrbic JT, Landesberg R, Lin SQ, Mesenbrink P, Reid IR, Leung PC, Casas N, Recknor CP,\nHua Y, Delmas PD, Eriksen EF. Incidence of osteonecrosis of the jaw in women with\npostmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic\nacid once yearly pivotal fracture trial. J Am Dent Assoc. 2008 Jan; 139(1): 32–40.\nGrbic JT, Black DM, Lyles KW, Reid DM, Orwoll E, Mc-Clung M, Bucci-Rechtweg C, Su G.\nThe incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic\nacid: Data from the health outcomes and reduced incidence with zoledronic acid once yearly\nclinical trials program. J Am Dent Assoc. 2010 Nov; 141(11): 1365–1370.\nGross MD, Nissan J, Samuel R. Stress distribution around maxillary implants in anatomic\nphotoelastic models of varying geometry. Part I. J Prosthet Dent. 2001 May; 85(5): 442–\n449. (a)\nGross MD, Nissan J. Stress distribution around maxillary implants in anatomic photoelastic\nmodels of varying geometry. Part II. J Prosthet Dent. 2001 May; 85(5): 450–454. (b)\nGross CP, Mallory R, Heiat A, Krumholz HM. Reporting the recruitment process in clinical\ntrials: who are these patients and how did they get there? Ann Intern Med. 2002 Jul 2;\n137(1): 10–16.\nGrubbs V, Plantinga LC, Tuot DS, Powe NR. Chronic kidney disease and use of dental\nservices in a United States public healthcare system: a retrospective cohort study. BMC\nNephrol. 2012 Apr 2; 13(1): 16.\nGu L, Wang Q, Yu YC. Eleven dental implants placed in a liver transplantation patient: a case\nreport and 5-year clinical evaluation. Chin Med J (Engl). 2011 Feb; 124(3): 472–475.\nGu L, Yu YC. Clinical outcome of dental implants placed in liver transplant recipients after 3\nyears: a case series. Transplant Proc. 2011 Sep; 43(7): 2678–2682.\nGuarneri V, Miles D, Robert N, Diéras V, Glaspy J, Smith I, Thomssen C, Biganzoli L, Taran\nT, Conte P. Bevacizumab and osteonecrosis of the jaw: Incidence and association with\nbisphosphonate therapy in three large prospective trials in advanced breast cancer. Breast\nCancer Res Treat. 2010 Jul; 122(1): 181–188.\nGuigoz Y, Vellas B, Garry PJ. Mini nutritional assessment: a practical assessment tool for"
  },
  {
    "page": 411,
    "content": "grading the nutritional state of elderly patients. In: The mini nutritional assessment. Facts\nand research in gerontology (suppl I). Paris: Serdi; 1994.\nGuo S, DiPietro LA. Factors affecting wound healing. J Dent Res. 2010 Mar; 89(3): 219–229.\nGupta A, Pansari K, Shett H. Post-stroke depression. Int J Clin Pract. 2002 Sep; 56(7): 531–\n537.\nGuralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in\npersons 65 years and older in the United States: evidence for a high rate of unexplained\nanemia. Blood. 2004 Oct; 104(8): 2263–2268.\nGurwitz JH, Avorn J, Ross-Degnan D, Choodnovskiy I, Ansell J. Aging and the anticoagulant\nresponse to warfarin therapy. Ann Intern Med. 1992 Jun 1; 116(11): 901–904.\nGurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, Cadoret C, Fish LS,\nGarber L, Kelleher M, Bates DW. Incidence and preventability of adverse drug events\namong older persons in the ambulatory setting. JAMA. 2003 Mar; 289(9): 1107–1116.\nGuyatt GH, Sackett DL, Cook DJ. Users’ guides to the medical literature. II. How to use an\narticle about therapy or prevention. B. What were the results and will they help me in caring\nfor my patients? JAMA. 1994 Jan 5; 271(1): 59–63.\nHaider R, Watzek G, Plenk H Jr. Histomorphometric analysis of bone healing after insertion of\nIMZ-1 implants independent of bone structure and drilling method (in German). Z Stomatol.\n1991; 88: 507–521.\nHajjar ER, Hanlon JT, Sloane RJ, Lindblad CI, Pieper CF, Ruby CM, Branch LC, Schmader\nKE. Unnecessary drug use in frail older people at hospital discharge. J Am Geriatr Soc.\n2005 Sep; 53(9): 1518–1523.\nHajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr\nPharmacother. 2007 Dec; 5(4): 345–351.\nHakim FT, Gress RE. Immunosenescence: deficits in adaptive immunity in the elderly. Tissue\nantigens. 2007 Sep; 70(3): 179–189.\nHalbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of\nCOPD: systematic review and meta-analysis. Eur Respir J. 2006 Sep; 28(3): 523–532.\nHamdan NM, Gray-Donald K, Awad MA, Johnson-Down L, Wollin S, Feine JS. Do implant\noverdentures improve dietary intake? A randomized clinical trial. J Dent Res. 2013 Dec;\n92(12 Suppl): 146S-153S.\nHan CH, Johansson CB, Wennerberg A, Albrektsson T. Quantitative and qualitative"
  },
  {
    "page": 412,
    "content": "investigations of surface enlarged titanium and titanium alloy implants. Clin Oral Implants\nRes. 1998 Feb; 9(1): 1–10.\nHandschel J, Simonowska M, Naujoks C, Depprich RA, Ommerborn MA, Meyer U, Kübler\nNR. A histomorphometric meta-analysis of sinus elevation with various grafting materials.\nHead Face Med. 2009 Jun 11; 5: 12.\nHandschin AE, Trentz OA, Hoerstrup SP, Kock HJ, Wanner GA, Trentz O. Effect of low\nmolecular weight heparin (dalteparin) and fondaparinux (Arixtra) on human osteoblasts in\nvitro. Br J Surg. 2005 Feb; 92(2): 177–183.\nHanlon JT, Handler S, Maher R, Schmader KE. Geriatric Pharmacotherapy and Polypharmacy.\nIn: Fillit H, Rockwood K, Woodhouse K (eds). Brocklehurst’s textbook of geriatric\nmedicine and gerontology. 7th edition. Philadelphia: WB Saunders. 2010. 880–885.\nHanna LA, Hughes CM. Public’s views on making decisions about over-the-counter\nmedication and their attitudes towards evidence of effectiveness: a cross-sectional\nquestionnaire study. Patient Educ Couns. 2011 Jun; 83(3): 345–351.\nHansen J. Common cancers in the elderly. Drugs Aging. 1998 Dec; 13(6): 467–478.\nHarding SM, Guzzo MR, Richter JE. The prevalence of gastroesophageal reflux in asthma\npatients without reflux symptoms. Am J Respir Crit Care Med. 2000 Jul; 162(1): 34–39.\nHarpur P. From universal exclusion to universal equality: regulating ableism in a digital age.\n2013; Northern Kentucky Law Review 40(3): 529–565.\nHarris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM,\nByrd-Holt DD. Prevalence of diabetes, impaired fasting glucose, and impaired glucose\ntolerance in U.S. adults. The Third National Health and Nutrition Examination Survey,\n1988–1994. Diabetes Care. 1998 Apr; 21(4): 518–524.\nHarrison JS, Stratemann S, Redding SW. Dental implants for patients who have had radiation\ntreatment for head and neck cancer. Spec Care Dentist. 2003 Nov 1; 23(6): 223–229.\nHartmann R, Müller F. Clinical studies on the appearance of natural anterior teeth in young\nand old adults. Gerodontology. 2004 Aug; 21(1): 10–16.\nHasegawa M, Umekawa Y, Nagai E, Ishigami T. Retentive force and magnetic flux leakage of\nmagnetic attachment in various keeper and magnetic assembly combinations. J Prosthet Dent.\n2011 Apr; 105(4): 266–271.\nHaugeberg G. Focal and generalized bone loss in rheumatoid arthritis: Separate or similar\nconcepts? Nat Clin Pract Rheumatol. 2008 Aug; 4(8): 402–403."
  },
  {
    "page": 413,
    "content": "Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials on\ninterventions to assist patients to follow prescriptions for medications. Lancet. 1996 Aug\n10; 348(9024): 383–386. [Erratum: Lancet. 1997 Apr 19; 349(9059): 1180.]\nHeaney RP, Gallagher JC, Johnston CC, Neer R, Parfitt AM, Whedon GD. Calcium nutrition\nand bone health in the elderly. Am J Clin Nutr. 1982 Nov; 36(5 Suppl): 986–1013.\nHeath MR. The effect of maximum biting force and bone loss upon masticatory function and\ndietary selection of the elderly. Int Dent J. 1982 Dec; 32(4): 345–356.\nHebling E, Pereira AC. Oral health-related quality of life: a critical appraisal of assessment\ntools used in elderly people. Gerodontology. 2007 Sep; 24(3): 151–161.\nHeckmann SM, Heckmann JG, Weber HP. Clinical outcomes of three Parkinson’s disease\npatients treated with mandibular implant overdentures. Clin Oral Implants Res. 2000 Dec;\n11(6): 566–567.\nHeckmann SM, Heckmann JG, Linke JJ, Hohenberger W, Mombelli A. Implant therapy\nfollowing liver transplantation: clinical and microbiological results after 10 years. J\nPeriodontol 2004 Jun; 75 (6): 909–913.\nHeino TJ, Kurata K, Higaki H, Väänänen K. Evidence of the role of osteocytes in the initiation\nof targeted remodeling. Technol Health Care. 2009; 17(1): 49–56.\nHeitz-Mayfield LJ. Peri-implant diseases: diagnosis and risk indicators. J Clin Periodontol.\n2008 Sep; 35(8 Suppl): 292–304.\nHernández G, Lopez-Pintor RM, Arriba L, Torres J, de Vicente J C. Implant treatment in\npatients with oral lichen planus: a prospective-controlled study. Clin Oral Implants Res.\n2012 Jun; 23(6): 726–732.\nHeschl A, Payer M, Clar V, Stopper M, Wegscheider W, Lorenzoni M. Overdentures in the\nedentulous mandible supported by implants and retained by a Dolder bar: a 5-year\nprospective study. Clin Implant Dent Relat Res. 2013 Aug; 15(4): 589–599.\nHeydecke G, Klemetti E, Awad MA, Lund JP, Feine JS. Relationship between prosthodontic\nevaluation and patient ratings of mandibular conventional and implant prostheses. Int J\nProsthodont. 2003 May–Jun; 16(3): 307–312. (a)\nHeydecke G, Locker D, Awad MA, Lund JP, Feine JS. Oral and general health-related quality\nof life with conventional and implant dentures. Community Dent Oral Epidemiol. 2003 Jun;\n31(3): 161–168. (b)\nHeydecke G, Penrod JR, Takanashi Y, Lund JP, Feine JS, Thomason JM. Cost-effectiveness of\nmandibular two-implant overdentures and conventional dentures in the edentulous elderly. J"
  },
  {
    "page": 414,
    "content": "Dent Res. 2005 Sep; 84(9): 794–799.\nHoeksema AR, Visser A, Raghoebar GM, Vissink A, Meijer HJ. Influence of age on clinical\nperformance of mandibular two-implant overdentures: a 10-year prospective comparative\nstudy. Clinical implant dentistry and related research. 2015 Apr 29. [Epub ahead of print.]\nHoff AO, Toth BB, Altundag K, Johnson MM, Warneke CL, Hu M, Nooka A, Sayegh G,\nGuarneri V, Desrouleaux K, Cui J, Adamus A, Gagel RF, Hortobagyi GN. Frequency and\nrisk factors associated with osteonecrosis of the jaw in cancer patients treated with\nintravenous bisphosphonates. J Bone Miner Res. 2008 Jun; 23 (5): 826–836.\nHofmann M, Pröschel P. Funktionelle Wechselbeziehung zwischen perioraler. Muskulatur und\ntotaler Prothese. [Mandibular dynamics and the mastication pattern of complete denture\nwearers and of subjects with a full set of teeth]. Dtsch Zahnärztl Z. 1982 Sep; 37(9): 763–\n771.\nHofschneider U, Tepper G, Gahleitner A, Ulm C. Assessment of the blood supply to the\nmental region for reduction of bleeding complications during implant surgery in the\ninterforaminal region. Int J Oral Maxillofac Implants. 1999 May–Jun; 14(3): 379–383.\nHolm-Pedersen P, Folke LEA, Gawronski TH. Composition and metabolic activity of dental\nplaque from healthy young and elderly individuals. J Dent Res. 1980 May; 59 (5): 771–776.\nHoltzman JM, Akiyama H. Symptoms and the decision to seek professional care. Gerodontics.\n1985 Feb; 1(1): 44–49.\nHong CH, Napenas JJ, Brennan MT, Furney SL, Lockhart PB. Frequency of bleeding\nfollowing invasive dental procedures in patients on low-molecular-weight heparin therapy.\nJ Oral Maxillofac Surg. 2010 May; 68(5): 975–979.\nHorne BD, Anderson JL. Haptoglobin 2-2 genotyping for refining standard cardiovascular risk\nassessment: a promising proposition in need of validation. J Am Coll Cardiol. 2015 Oct 20;\n66(16): 1800–1802.\nHorner K, Devlin H, Alsop CW, Hodgkinson IM, Adams JE. Mandibular bone mineral density\nas a predictor of skeletal osteoporosis Br J Radiol. 1996 Nov; 69(827): 1019–1025.\nHubbard BM, Squier M. The physical aging of the neuromuscular system. In: Tallis J (ed). The\nclinical neurology of old age. London: John Wiley and Sons. 1989: 137–142.\nHui SL, Slemenda CW, Johnston CC Jr. Age and bone mass as predictors of fracture in a\nprospective study. J Clin Invest. 1988 Jun; 81(6): 1804–1809.\nHuja SS, Fernandez SA, Hill KJ, Li Y: Remodeling dynamics in the alveolar process in\nskeletally mature dogs. Anat Rec A Discov Mol Cell Evol Biol. 2006 Dec; 288(12): 1243–"
  },
  {
    "page": 415,
    "content": "1249.\nHultin M, Svensson KG, Trulsson M. Clinical advantages of computer-guided implant\nplacement: a systematic review. Clin Oral Implants Res. 2012 Oct; 23(Suppl 6): 124–135.\nHwang D, Wang HL. Medical contraindications to implant therapy: part I: absolute\ncontraindications. Implant Dent. 2006 Dec; 15(4): 353–360.\nIber FL, Nurohy PA, Connor ES. Age-related changes in the gastrointestinal system. Effects on\ndrug therapy. Drugs Aging. 1994 Jul; 5(1): 34–48.\nIida S, Tanaka N, Kogo M, Matsuya T. Migration of a dental implant into the maxillary sinus.\nA case report. Int J Oral Maxillofac Surg. 2000 Oct; 29(5): 358–359.\nIinuma T, Arai Y, Abe Y, Takayama M, Fukumoto M, Fukui Y, Iwase T, Takebayashi T, Hirose\nN, Gionhaku N, Komiyama K. Denture wearing during sleep doubles the risk of pneumonia\nin the very elderly. J Dent Res. 2015 Mar 94(3 Suppl): 28S-36S.\nIkebe K, Wada M, Kagawa R, Maeda Y. Is old age a risk factor for dental implants? Japanese\nDental Science Review. 2009; 4(1): 59–64.\nIkebe K, Hazeyama T, Ogawa T, Kagawa R, Matsuda K, Wada M, Gonda T, Maeda Y.\nSubjective values of different age groups in Japan regarding treatment for missing molars.\nGerodontology. 2011 Sep; 28(3): 192–196.\nIncel NA, Sezgin M, As I, Cimen OB, Sahin G. The geriatric hand: correlation of hand-muscle\nfunction and activity restriction in elderly. Int J Rehabil Res. 2009 Sep; 32(3): 213–218.\nInternational Diabetes Federation. IDF Diabetes Atlas. Sixth edition. 2014.\nhttp://www.idf.org/diabetesatlas. Last accessed December 29, 2014.\nIsaacson TJ. Sublingual hematoma formation during immediate placement of mandibular\nendosseous implants. J Am Dent Assoc. 2004 Feb; 135(2): 168–172.\nIsaksson R, Becktor JP, Brown A, Laurizohn C, Isaksson S. Oral health and oral implant status\nin edentulous patients with implant-supported dental prostheses who are receiving long-term\nnursing care. Gerodontology. 2009 Dec; 26(4): 245–249.\nIsidor F, Brøndum K, Hansen H J, Jensen J, Sindet-Pedersen S. Outcome of treatment with\nimplant-retained dental prostheses in patients with Sjögren syndrome. Int J Oral Maxillofac\nImplants. 1999 Sep–Okt; 14(5): 736–743.\nIsraelson H, Plemons JM, Watkins P, Sory C. Barium-coated surgical stents and computer-\nassisted tomography in the preoperative assessment of dental implant patients. Int J\nPeriodontics Restorative Dent. 1992; 12(1): 52–61."
  },
  {
    "page": 416,
    "content": "Jacobs R, Schotte A, van Steenberghe D, Quirynen M, Naert I. Posterior jaw bone resorption\nin osseointegrated implant-supported overdentures. Clin Oral Implants Res. 1992 Jun; 3(2):\n63–70.\nJacobs R, Ghyselen J, Koninckx P, van Steenberghe D. Long-term bone mass evaluation of\nmandible and lumbar spine in a group of women receiving hormone replacement therapy.\nEur J Oral Sci. 1996 Feb; 104(1): 10–16.\nJacobs JW, Bijlsma JW, van Laar JM. Glucocorticoids in early rheumatoid arthritis: are the\nbenefits of joint-sparing effects offset by the adverse effect of osteoporosis? The effects on\nbone in the utrecht study and the CAMERA-II study. Neuroimmunomodulation. 2015; 22(1–\n2): 66–71.\nJainkittivong A, Aneksuk V, Langlais RP. Oral mucosal conditions in elderly dental patients.\nOral Dis. 2002 Jul; 8(4): 218–223.\nJaved F, Almas K. Osseointegration of dental implants in patients undergoing bisphosphonate\ntreatment: a literature review. J Periodontol. 2010 Apr; 81(4): 479–484.\nJeffcoat MK. Safety of oral bisphosphonates: controlled studies on alveolar bone. Int J Oral\nMaxillofac Implants. 2006 May–Jun; 21(53): 349–353.\nJemt T, Chai J, Harnett J, Heath MR, Hutton JE, Johns RB, McKenna S, McNamara DC, van\nSteenberghe D, Taylor R, Watson RM, Herrmann I. A 5-year prospective multicenter\nfollow-up report on overdentures supported by osseointegrated implants. Int J Oral\nMaxillofac Implants. 1996 May–Jun; 11(3): 291–298. (a)\nJemt T, Book K. Prosthesis misfit and marginal bone loss in edentulous implant patients. Int J\nOral Maxillofac Implants. 1996 Sep–Oct; 11(5): 620–625. (b)\nJerjes W, Upile T, Nhembe F, Gudka D, Shah P, Abbas S, et al. Experience in third molar\nsurgery: an update. Br Dent J. 2010 Jul 10; 209(1): E1.\nJevon P. Emergency oxygen therapy in the dental practice: administration and management. Br\nDent J. 2014 Feb; 216(3): 113–115.\nJisander S, Grenthe B, Alberius P. Dental implant survival in the irradiated jaw: a preliminary\nreport. Int J Oral Maxillofac Implants. 1997 Sep–Oct; 12(5):643–648.\nJones R, Jones RO, McCowan C, Montgomery AA, Fahey T. The external validity of\npublished randomized controlled trials in primary care. BMC Fam Pract. 2009 Jan 19; 10:\n5.\nJoshi A, Douglass CW, Feldman H, Mitchell P, Jette A. Consequences of success: do more\nteeth translate into more disease and utilization? J Public Health Dent. 1996 Summer; 56(4):"
  },
  {
    "page": 417,
    "content": "190–197.\nJyrkkä J, Enlund H, Lavikainen P, Sulkava R, Hartikainen S. Association of polypharmacy\nwith nutritional status, functional ability and cognitive capacity over a three-year period in\nan elderly population. Pharmacoepidemiol Drug Saf. 2010 May; 20(5): 514–522.\nKale SS, Yende S. Effects of aging on inflammation and hemostasis through the continuum of\ncritical illness. Aging Dis. 2011 Dec; 2(6): 501–511.\nKalpidis CD, Setayesh RM. Hemorrhaging associated with endosseous implant placement in\nthe anterior mandible: a review of the literature. J Periodontol. 2004 May; 75(5): 631–645.\nKalpidis CD, Setayesh RM. Haemorrhaging associated with endosseous implant placement in\nthe anterior mandible: a review of the literature. J Periodontol. 2004 May; 75(5): 631–645.\nKan JY, Rungcharassaeng K, Bohsali K, Goodacre CJ, Lang BR. Clinical methods for\nevaluating implant framework fit. J Prosthet Dent. 1999 Jan; 81(1), 7–13.\nKang B, Cheong S, Chaichanasakul T, Bezouglaia O, Atti E, Dry SM, Pirih FQ, Aghaloo TL,\nTetradis S. Periapical disease and bisphosphonates induce osteonecrosis of the jaws in\nmice. J Bone Miner Res. 2013 Jul 28(7): 1631–1640.\nKaplan DM, Attal U, Kraus M. Bilateral benign paroxysmal positional vertigo following a\ntooth implantation. J Laryngol Otol. 2003 Apr; 117(4): 312–313.\nKapur K. Masticatory performance and efficiency in denture wearers. J Prosthet Dent. 1964;\n14: 687–694.\nKapur KK, Garrett NR, Hamada MO, Roumanas ED, Freymiller E, Han T, Diener RM, Levin\nS, Wong WK. Randomized clinical trial comparing the efficacy of mandibular implant-\nsupported overdentures and conventional dentures in diabetic patients. Part III: comparisons\nof patient satisfaction. J Prosthet Dent. 1999 Oct; 82(4): 416–427.\nKaton WJ, Lin EH, Von Korff M, Ciechanowski P, Ludman EJ, Young B, Peterson D, Rutter\nCM, McGregor M, McCulloch D. Collaborative care for patients with depression and\nchronic illnesses. N Engl J Med. 2010 Dec 10; 363(27): 2611–2620.\nKatsoulis J, Walchli J, Kobel S, Gholami H, Mericske-Stern R. Complications with computer-\naided designed/computer-assisted manufactured titanium and soldered gold bars for\nmandibular implant-overdentures: short-term observations. Clin Implant Dent Relat Res.\n2015 Jan; 17(Suppl 1): e75–e85.\nKaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of\nmedication use in the ambulatory adult population of the United States: the Slone survey.\nJAMA. 2002 Jan 16; 287(3): 337–344."
  },
  {
    "page": 418,
    "content": "Kay EJ, Nuttall NM, Knill-Jones R. Restorative treatment thresholds and agreement in\ntreatment decision-making. Community Dent Oral Epidemiol. 1992 Oct; 20(5): 265–268.\nKay EJ, Nuttall N. Clinical decision making—an art or a science? Part V: Patient preferences\nand their influence on decision making. Br Dent J. 1995 Mar; 178(6): 229–233.\nKäyser AF. Shortened dental arches and oral function. J Oral Rehabil. 1981 Sep; 8(5): 457–\n462.\nKeefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, Migliorati\nCA, McGuire DB, Hutchins RD, Peterson DE. Updated clinical practice guidelines for the\nprevention and treatment of mucositis. Cancer. 2007 Mar 1; 109(5): 820–831.\nKeller EE. Placement of dental implants in the irradiated mandible: A protocol without\nadjunctive hyperbaric oxygen. J Oral Maxillofac Surg. 1997 Sep; 55(9): 972–980.\nKelly E. Changes caused by a mandibular removable partial denture opposing a maxillary\ncomplete denture. J Prosthet Dent. 1972 Feb; 27(2): 140–150.\nKennedy E. Partial denture construction. Dent Items Interest. 1928; 1: 3–8.\nKhadivi V, Anderson J, Zarb GA. Cardiovascular disease and treatment outcomes with\nosseointegration surgery. J Prosthet Dent. 1999 May; 81(5): 533–536.\nKhan AA, et al. International consensus on diagnosis and management of osteonecrosis of the\njaw: a systematic review and international consensus. J Bone Miner Res. 2015 Jan; 30(1)\n3–23.\nKilmartin CM. Managing the medically compromised geriatric patient. J Prosthet Dent. 1994\nNov; 72(5): 492–499.\nKim YK, Yun PY, Kim SG, Lim SC. Analysis of the healing process in sinus bone grafting\nusing various grafting materials. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009\nFeb; 107(2): 204–211.\nKim MS, Lee JK, Chang BS, Um HS. Benign paroxysmal positional vertigo as a complication\nof sinus floor elevation. J Periodontol Implant Sci. 2010 Apr; 40(2): 86–89.\nKimura T, Wada M, Suganami T, Miwa S, Hagiwara Y, Maeda Y. Dental implant status of\npatients receiving long-term nursing care in Japan. Clin Implant Dent Relat Res. 2015 Jan;\n17(Suppl 1): e163-167.\nKlein MO, Schiegnitz E, Al-Nawas B. Systematic review on success of narrow-diameter\ndental implants. Int J Oral Maxillofac Implants. 2014; 29(Suppl): 43–54."
  },
  {
    "page": 419,
    "content": "Klemetti E. Is there a certain number of implants needed to retain an overdenture? J Oral\nRehabil. 2008 Jan; 35(Suppl 1): 80–84.\nKo YJ, Kim JY, Lee J, Song HJ, Kim JY, Choi NK, Park BJ. Levothyroxine dose and fracture\nrisk according to the osteoporosis status in elderly women. J Prev Med Public Health. 2014\nJan 29; 47(1): 36–46.\nKobayashi M, Srinivasan M, Ammann P, Perriard J, Ohkubo C, Müller F, Belser UC,\nSchimmel M. Effects of in vitro cyclic dislodging on retentive force and removal torque of\nthree overdenture attachment systems. Clin Oral Implants Res. 2014 Apr; 25(4): 426–434.\nKoch WM, Patel H, Brennan J, Boyle JO, Sidransky D. Squamous cell carcinoma of the head\nand neck in the elderly. Arch Otolaryngol Head Neck Surg. 1995 Mar; 121(3): 262–265.\nKoller MM. [Geriatric dentistry: medical problems as well as disease- and therapy-induced\noral disorders]. Schweiz Rundsch Med Prax. 1994 Mar 8; 83(10): 273–282.\nKotsovilis S, Karoussis IK, Fourmousis I. A comprehensive and critical review of dental\nimplant placement in diabetic animals and patients. Clin Oral Implants Res. 2006 Oct;\n17(5): 587–599.\nKovács AF. Clinical analysis of implant losses in oral tumor and defect patients. Clin Oral\nImplants Res. 2000 Oct; 11(5): 494–504. (a)\nKovács L, Török T, Bari F, Kéri Z, Kovács A, Makula E, Pokorny G. Impaired microvascular\nresponse to cholinergic stimuli in primary Sjögren’s syndrome. Ann Rheum Dis. 2000 Jan;\n59(1): 48–53. (b)\nKowar J, Eriksson A, Jemt. Fixed implant-supported prostheses in elderly patients: a 5-year\nretrospective comparison between partially and completely edentulous patients aged 80\nyears or older at implant surgery. Clin Implant Dent Relat Res. 2013 Feb; 15(1): 37–46.\nKreisler M, Behneke N, Behneke A, d’Hoedt B. Residual ridge resorption in the edentulous\nmaxilla in patients with implant-supported mandibular overdentures: an 8-year retrospective\nstudy. Int J Prosthodont. 2003 May–Jun; 16(3): 295–300.\nKremer U, Schindler S, Enkling N, Worni A, Katsoulis J, Mericske-Stern R. Bone resorption\nin different parts of the mandible in patients restored with an implant overdenture. A\nretrospective radiographic analysis. Clin Oral Implants Res. 2014 Nov 22. [Epub ahead of\nprint.]\nKrennmair G, Seemann R, Piehslinger E. Dental implants in patients with rheumatoid arthritis:\nclinical outcome and peri-implant findings. J Clin Periodontol. 2010 Oct; 37(19): 928–936.\nKripalani S, LeFevre F, Phillips CO, Williams MV, Basaviah P, Baker DW. Deficits in"
  },
  {
    "page": 420,
    "content": "communication and information transfer between hospital-based and primary care\nphysicians: implications for patient safety and continuity of care. JAMA. 2007 Feb 28;\n297(8): 831–841.\nKronstrom M, Davis B, Loney R, Gerrow J, Hollender L. A prospective randomized study on\nthe immediate loading of mandibular overdentures supported by one or two implants; a 3\nyear follow-up report. Clin Implant Dent Relat Res. 2014 Jun; 16(3): 323–329.\nKshirsagar AV, Craig RG, Moss KL, Beck JD, Offenbacher S, Kotanko P, Klemmer PJ,\nYoshino M, Levin NW, Yip JK, Almas K, Lupovici EM, Usvyat LA, Falk RJ. Periodontal\ndisease adversely affects the survival of patients with end-stage renal disease. Kidney Int.\n2009 Apr; 75(7): 746–751.\nKuehl S, Payer M, Zitzmann NU, Lambrecht JT, Filippi A. Technical accuracy of printed\nsurgical templates for guided implant surgery with the coDiagnostiX™ software. Clin\nImplant Dent Relat Res. 2015 Jan; 17(Suppl 1): e177–182.\nKuluski K, Gill A, Naganathan G, Upshur R, Jaakkimainen RL, Wodchis WP. A qualitative\ndescriptive study on the alignment of care goals between older persons with multi-\nmorbidities, their family physicians and informal caregivers. BMC Fam Pract. 2013 Sep 8;\n14: 133.\nKunchur R, Need A, Hughes T, Goss A. Clinical investigation of C-terminal cross-linking\ntelopeptide test in prevention and management of bisphosphonate-associated osteonecrosis\nof the jaws. J Oral Maxillofac Surg. 2009 Jun 1; 67(6): 1167–1173.\nKyrgidis A, Vahtsevanos K, Koloutsos G, Andreadis C, Boukovinas I, Teleioudis Z, Patrikidou\nA, Triaridis S. Bisphosphonate-related osteonecrosis of the jaws: a case-control study of\nrisk factors in breast cancer patients. J Clin Oncol. 2008 Oct 1; 26(28): 4634–4638.\nLam NP, Donoff RB, Kaban LB, Dodson TB. Patient satisfaction after trigeminal nerve repair.\nOral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 May; 95(5): 538–543.\nLambert FE, Weber HP, Susarla SM, Belser UC Gallucci GO. Descriptive analysis of implant\nand prosthodontic survival rates with fixed implant-supported rehabilitations in the\nedentulous maxilla. J Periodontol. 2009 Aug; 80(8): 1220–1230.\nLambrecht JT, Filippi A, Arrigoni J. Cardiovascular monitoring and its consequences in oral\nsurgery. Ann Maxillofac Surg. 2011 Jul; 1(2): 102–106.\nLandesberg R, Cozin M, Cremers S, Woo V, Kousteni S, Sinha S, Garrett-Sinha L, Raghavan\nS. Inhibition of oral mucosal cell wound healing by bisphosphonates. J Oral Maxillofac\nSurg. 2008 May; 66(5): 839–847."
  },
  {
    "page": 421,
    "content": "Lang PO, Michel JP, Zekry D. Frailty syndrome: a transitional state in a dynamic process.\nGerontology. 2009; 55(5): 539–549.\nLang NP, Berglundh T. Periimplant diseases: where are we now?—Consensus of the Seventh\nEuropean Workshop on Periodontology. J Clin Periodontol. 2011 Mar; 38(Suppl 11): 178–\n181. (a)\nLang NP, Bosshardt DD, Lulic M. Do mucositis lesions around implants differ from gingivitis\nlesions around teeth? J Clin Periodontol. 2011 Mar; 38(Suppl 11): 182–187. (b)\nLanza FL, Hunt RH, Thomson AB, Provenza JM, Blank MA. Endoscopic comparison of\nesophageal and gastroduodenal effects of risedronate and alendronate in post- menopausal\nwomen. Gastroenterology. 2000 Sep; 119 (3): 631–638.\nLarrazabal-Morón C, Boronat-López A, Peñarrocha-Diago M, Peñarrocha-Diago M. Oral\nrehabilitation with bone graft and simultaneous dental implants in a patient with\nepidermolysis bullosa: a clinical case report. J Oral Maxillofac Surg. 2009 Jul 1; 67(7):\n1499–1502.\nLarsen PE. Placement of dental implants in the irradiated mandible: a protocol involving\nadjunctive hyperbaric oxygen. J Oral Maxillofac Surg. 1997 Sep; 55(9): 967–971.\nLaurell KA, Gegauff AG, Rosenstiel SF. Magnetic resonance image degradation from\nprosthetic magnet keepers; J Prosthet Dent. 1989 Sep; 62(3): 344–348.\nLaw C, Bennani V, Lyons K, Swain M. Mandibular flexure and its significance on implant\nfixed prostheses: a review. J Prosthodont, 2012 Apr; 21(3): 219–224.\nLawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental\nactivities of daily living. Gerontologist. 1969 Autumn; 9(3): 179–186.\nLeblebicioglu B, Ersanli S, Karabuda C, Tosun T, Gokdeniz H. Radiographic evaluation of\ndental implants placed using an osteotome technique. J Periodontol. 2005 Mar; 76(3): 385–\n390.\nLecka-Czernik B. Bone loss in diabetes: use of antidiabetic thiazolidinediones and secondary\nosteoporosis. Curr Osteoporos Rep. 2010 Sep 1; 8(4): 178–184.\nLedermann PD, Schenk RK, Buser D. Long-lasting osseointegration of immediately loaded,\nbar-connected TPS screws after 12 years of function: a histologic case report of a 95-year-\nold patient. Int J Periodontics Restorative Dent. 1998 Dec; 18(6): 552–563.\nLee RH, Lyles KW, Colón-Emeric C. A review of the effect of anticonvulsant medications on\nbone mineral density and fracture risk. Am J Geriatr Pharmacother. 2010 Feb; 8(1): 34–46."
  },
  {
    "page": 422,
    "content": "Leesungbok R. Dr. Lee’s Top-Down Implant Dentistry [in Korean]. Myung-Moon Publishing;\n2004.\nLeiss W, Méan M, Limacher A, Righini M, Jaeger K, Beer HJ, Osterwalder J, Frauchiger B,\nMatter CM, Kucher N, Angelillo-Scherrer A, Cornuz J, Banyai M, Lämmle B, Husmann M,\nEgloff M, Aschwanden M, Rodondi N, Aujesky D. Polypharmacy is associated with an\nincreased risk of bleeding in elderly patients with venous thromboembolism. J Gen Intern\nMed. 2014 Jan 30; 30(1): 17–24.\nLekholm U, Zarb G. Patient selection and preparation. In: Brånemark PI, Zarb G, Albrektsson\nT (eds). Tissue-integrated prostheses. Chicago: Quintessence. 1985: 199–211.\nLim KO, Zipursky RB, Watts MC, Pfefferbaum A. Decreased gray matter in normal aging: an\nin vivo magnetic resonance study. J Gerontol. 1992 Jan; 47(1): B26–B30.\nLindhardsen J, Ahlehoff O, Gislason GH, Madsen OR, Olesen JB, Torp-Pedersen C, Hansen\nPR. The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish\nnationwide cohort study. Ann Rheum Dis. 2011 Jun; 70(6): 929–934.\nLindquist LW, Rockler B, Carlsson GE. Bone resorption around fixtures in edentulous patients\ntreated with mandibular fixed tissue-integrated prostheses. J Prosthet Dent. 1988 Jan; 59(1):\n59–63.\nLindquist LW, Carlsson GE, Jemt T. A prospective 15-year follow-up study of mandibular\nfixed prostheses supported by osseointegrated implants. Clinical results and marginal bone\nloss. Clin Oral Implants Res. 1996 Dec; 7(4): 329–336.\nLinsen SS, Martini M, Stark H. Long-term results of endosteal implants following radical oral\ncancer surgery with and without adjuvant radiation therapy. Clin Implant Dent Relat Res.\n2012 Apr; 14(2): 250–258.\nLipschitz DA, Mitchell CO, Thompson C: The anemia of senescence. Am J Hematol. 1981;\n11(1): 47–57.\nListgarten MA, Lang NP, Schroeder HE, Schroeder A. Periodontal tissues and their\ncounterparts around endosseous implants Clin Oral Implants Res. 1991 Jan–Mar; 2(3): 1–\n19.\nLittle JW, Miller CS, Henry RG, McIntosh BA. Antithrombotic agents: implications in\ndentistry. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 May; 93(5): 544–551.\nLo JC, O’Ryan FS, Gordon NP, Yang J, Hui RL, Martin D, Hutchinson M, Lathon PV, Sanchez\nG, Silver P, Chandra M, McCloskey CA, Staffa JA, Willy M, Selby JV, Go AS. Prevalence\nof osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac"
  },
  {
    "page": 423,
    "content": "Surg. 2010 Feb; 68(2): 243–253.\nLocker D, Jokovic A. Using subjective oral health status indicators to screen for dental care\nneeds in older adults. Community Dent Oral Epidemiol. 1996 Dec; 24(6): 398–402.\nLocker D. Dental status, xerostomia and the oral health-related quality of life of an elderly\ninstitutionalized population. Spec Care Dentist. 2003; 23(3): 86–93.\nLockhart PB, Gibson J, Pond SH, Leitch J. Dental management considerations for the patient\nwith an acquired coagulopathy. Part 2: Coagulopathies from drugs. Br Dent J. 2003 Nov 8;\n195(9): 405–501.\nLoftus MJ, Peterson LJ. Delayed healing of mandibular fracture in idiopathic myxedema. Oral\nSurg Oral Med Oral Pathol. 1979 Mar; 47(3): 233–237.\nLogemann JA. Evaluation and treatment of swallowing disorders. Austin: Pro-Ed. 1998.\nLoo WJ, Burrows NP. Management of autoimmune skin disorders in the elderly. Drugs Aging.\n2004; 21(12): 767–777.\nLópez-Jornet P, Camacho-Alonso F, Martínez-Canovas A, Molina-Miñano F, Gómez-García\nF, Vicente-Ortega V. Perioperative antibiotic regimen in rats treated with pamidronate plus\ndexamethasone and subjected to dental extraction: A study of the changes in the jaws. J Oral\nMaxillofac Surg. 2011 Oct; 69(10): 2488–2493.\nLugtenberg M, Burgers JS, Clancy C, Westert GP, Schneider EC. Current guidelines have\nlimited applicability to patients with comorbid conditions: a systematic analysis of\nevidence-based guidelines. PLoS One. 2011; 6(10): e25987.\nLulic M, Brägger U, Lang NP, Zwahlen M, Salvi, GE. Ante’s (1926) law revisited: a\nsystematic review on survival rates and complications of fixed dental prostheses (FDPs) on\nseverely reduced periodontal tissue support. Clin Oral Implants Res. 2007 Jun; 18(Suppl 3):\n63–72.\nMacEntee MI, Walton JN, Glick N. A clinical trial of patient satisfaction and prosthodontic\nneeds with ball and bar attachments for implant-retained complete overdentures: three-year\nresults. J Prosthet Dent. 2005 Jan; 93(1): 28–37.\nMacEntee MI, Müller F, Wayatt C (eds). Oral healthcare and the frail elder: a clinical\nperspective. Wiley-Blackwell. 2010.\nMadland G, Newton-John T, Feinmann C. Chronic idiopathic orofacial pain: I: What is the\nevidence base? Br Dent J. 2001 Jul 14; 191(1): 22–24.\nMadrid C, Sanz M. What impact do systemically administrated bisphosphonates have on oral"
  },
  {
    "page": 424,
    "content": "implant therapy? A systematic review. Clin Oral Implants Res. 2009 Sep; 20(Suppl 4): 87–\n95. (a)\nMadrid C, Sanz M. What influence do anticoagulants have on oral implant therapy? A\nsystematic review. Clin Oral Implants Res. 2009 Sep; 20(Suppl 4): 96–106. (b)\nMaeda Y, Walmsley DA (ed). Implant dentistry with new generation magnetic attachments.\nChicago: Quintessence. 2005. (a)\nMaeda Y, Sogo M, Tsutsumi S. Efficacy of a posterior implant support for extra shortened\ndental arches: a biomechanical model analysis. J Oral Rehabil. 2005 Sep; 32(9): 656–660.\n(b)\nMaher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert\nOpin Drug Saf. 2014 Jan; 13(1): 57–65.\nMahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J. 1965\nFeb; 14: 61–65.\nMalamed SF. Handbook of local anesthesia. 4th ed. St. Louis: Mosby; 1997.\nMalan J, Ettinger K, Naumann E, Beirne OR. The relationship of denosumab pharmacology\nand osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Dec;\n114(6): 671–676.\nMalden N, Lopes V: An epidemiological study of alendronate-related osteonecrosis of the\njaws. A case series from the south-east of Scotland with attention given to case definition\nand prevalence. J Bone Miner Metab. 2012 Mar; 30(2): 171–182\nMalmstrom K, Daniels S, Kotey P, Seidenberg BC, Desjardins PJ. Comparison of rofecoxib\nand celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: a randomized,\nplacebo- and active comparator-controlled clinical trial. Clin Ther. 1999 Oct; 21(10):\n1653–1663.\nMaloney WJ, Weinberg MA. Implementation of the American Society of Anesthesiologists\nphysical status classification system in periodontal practice. J Periodontol. 2008 Jul; 79(7):\n1124–1126.\nMancha de la Plata M, Gías LN, Díez PM, Muñoz-Guerra M, González-García R, Lee GY,\nCastrejón-Castrejón S, Rodríguez-Campo FJ. Osseointegrated implant rehabilitation of\nirradiated oral cancer patients. J Oral Maxillofac Surg. 2012 May; 70(5): 1052–1063.\nMangoni AA, Jackson SHD. Age-related changes in pharmacokinetics and\npharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004\nJan; 57(1): 6–14."
  },
  {
    "page": 425,
    "content": "Mannucci PM, Nobili A; REPOSI Investigators. Multimorbidity and polypharmacy in the\nelderly: lessons from REPOSI. Intern Emerg Med. 2014 Oct; 9(7): 723–734.\nMarengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, Meinow B,\nFratiglioni L. Aging with multimorbidity: a systematic review of the literature. Ageing Res\nRev. 2011 Sep 1; 10(4): 430–439.\nMarques MA, Dib LL: Periodontal changes in patients undergoing radiotherapy. J Periodontol.\n2004 Sep; 75(9): 1178–1187.\nMarx JJ: Normal iron absorption and decreased red cell iron uptake in the aged. Blood. 1979\nFeb; 53(2): 204–211.\nMarx RE, Johnson RP. Studies in the radiobiology of osteoradionecrosis and their clinical\nsignificance. Oral Surg Oral Med Oral Pathol. 1987 Oct; 64(4): 379–390.\nMarx RE. Bisphosphonate-induced osteonecrosis of the jaws: A challenge, a responsibility,\nand an opportunity. Int J Periodontics Restorative Dent. 2008 Feb; 28(1): 5–6.\nMasarachia P, Weinreb M, Balena R, Rodan GA: Comparison of the distribution of 3H-\nalendronate and 3H-etidronate in rat and mouse bones. Bone. 1996 Sep; 19(3): 281–290.\nMason ME, Triplett RG, Van Sickels JE, Parel SM. Mandibular fractures through endosseous\ncylinder implants: report of cases and review. J Oral Maxillofac Surg. 1990; 48: 311–317.\nMattheos N, Caldwell P, Petcu EB, Ivanovski S, Reher P. Dental implant placement with bone\naugmentation in a patient who received intravenous bisphosphonate treatment for\nosteoporosis. J Can Dent Assoc. 2013; 79: d2.\nMauri D, Valachis A, Polyzos IP, Polyzos NP, Kamposioras K, Pesce LL. Osteonecrosis of the\njaw and use of bisphosphonates in adjuvant breast cancer treatment: a meta-analysis. Breast\nCancer Res Treat. 2008 Aug; 116(3): 433–439.\nMavrokokki T, Cheng A, Stein B, Goss A. Nature and frequency of bisphosphonate-\nassociated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg. 2007 Mar; 65(3):\n415–423.\nMcComsey G, Kitch D, Daar E, et al. Bone mineral density and fractures in anti-retroviral-\nnaive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-\nemtricitabine along with efavirenz or atazanavir-ritonavir: AIDS clinical trials group\nA5224s, a substudy of ACTG A5202. J Infect Dis. 2011 Jun 15; 203(12): 1791–1801.\nMeijer HJ, Raghoebar GM, Van’t Hof MA, Geertman ME, Van Oort RP. Implant-retained\nmandibular overdentures compared with complete dentures; a 5-years’ follow-up study of\nclinical aspects and patient satisfaction. Clin Oral Implants Res. 1999 Jun; 10(3): 238–244."
  },
  {
    "page": 426,
    "content": "Meijer HJ, Raghoebar GM, Van ‘t Hof MA. Comparison of implant-retained mandibular\noverdentures and conventional complete dentures: a 10-year prospective study of clinical\naspects and patient satisfaction. Int J Oral Maxillofac Implants. 2003 Nov–Dec; 18(6): 879–\n885.\nMeijer HJ, Raghoebar GM, Van’t Hof MA, Visser A. A controlled clinical trial of implant-\nretained mandibular overdentures: 10 years’ results of clinical aspects and aftercare of IMZ\nimplants and Brånemark implants. Clin Oral Implants Res. 2004 Aug; 15(4): 421–427.\nMeijer HJ, Raghoebar GM, Batenburg RH, Visser A, Vissink A. Mandibular overdentures\nsupported by two or four endosseous implants: a 10-year clinical trial. Clin Oral Implants\nRes. 2009 Jul; 20(7): 722–728.\nMeraw SJ, Reeve CM. Dental considerations and treatment of the oncology patient receiving\nradiation therapy. J Am Dent Assoc. 1998 Feb; 129(2): 201–205.\nMericske-Stern R, Oetterli M, Kiener P, Mericske E. A follow-up study of maxillary implants\nsupporting an overdenture: clinical and radiographic results. Int J Oral Maxillofac Implants.\n2002 Sep–Oct; 17(5): 678–686.\nMerriam Webster. Medical Dictionary. 2015. http://www.merriam-\nwebster.com/dictionary/polypharmacy. Last accessed October 29, 2015.\nMersel A, Babayof I, Rosin A. Oral health needs of elderly short-term patients in a geriatric\ndepartment of a general hospital. Spec Care Dentist. 2000 Mar–Apr; 20(2): 72–74.\nMicheelis W, Schiffner U. Vierte Deutsche Mundgesundheitsstudie (DMS IV). Cologne:\nDeutscher Zahnärzte Verlag. 2006.\nMillwood J, Heath MR. Food choice by older people: the use of semi-structured interviews\nwith open and closed questions. Gerodontology. 2000 Jul; 17(1): 25–32.\nMinsk L, Polson AM. Dental implant outcomes in postmenopausal women undergoing\nhormone replacement. Compend Contin Educ Dent. 1998 Sep; 19(9): 859–864.\nMioche L, Bourdiol P, Monier S, Martin JF, Cormier D. Changes in jaw muscles activity with\nage: effects on food bolus properties. Physiol Behav. 2004 Sep 30; 82(4): 621–627.\nMitrani R, Brudvik JS, Phillips KM. Posterior implants for distal extension removable\nprostheses: a retrospective study. Int J Periodontics Restorative Dent. 2003 Aug; 23(4):\n353–359.\nMojon P, Budtz-Jørgensen E, Michel JP, Limeback H. Oral health and history of respiratory\ntract infection in frail institutionalised elders. Gerodontology. 1997 Jul; 14(1): 9–16."
  },
  {
    "page": 427,
    "content": "Mojon P. The world without teeth: demographic trends. In: Feine J, Carlsson GE (eds).\nImplant overdentures: the standard of care for edentulous patients. Chicago: Quintessence.\n2003: 3–14.\nMombelli A, van Oosten MA, Schurch E, Jr., Lang NP. The microbiota associated with\nsuccessful or failing osseointegrated titanium implants. Oral Microbiol Immunol. 1987 Dec;\n2(4): 145–151.\nMombelli A, Buser D, Lang NP. Colonization of osseointegrated titanium implants in\nedentulous patients. Early results. Oral Microbiol Immunol. 1988 Sep; 3(3): 113–120.\nMombelli A, Lang NP. Antimicrobial treatment of peri-implant infections. Clin Oral Implants\nRes. 1992 Dec; 3(4): 162–168.\nMombelli A. Aging and the periodontal and peri-implant microbiota. Periodontol 2000. 1998\nFeb; 16: 44–52.\nMombelli A, Cionca N. Systemic diseases affecting osseointegration therapy. Clin Oral\nImplants Res. 2006 Oct; 17(Suppl 2), 97–103.\nMontagnani A, Gonnelli S, Alessandri M, Nuti R. Osteoporosis and risk of fracture in patients\nwith diabetes: an update. Aging Clin Exp Res. 2011 Apr; 23(2): 84–90.\nMoore JG, Tweedy C, Christian PE, Datz FL. Effect of age on gastric emptying of liquid-solid\nmeals in man. Dig Dis Sci. 1983 Apr; 28(4); 340–344.\nMoore KL, Boscardin WJ, Steinman MA, Schwartz JB. Age and sex variation in prevalence of\nchronic medical conditions in older residents of U.S. nursing homes. J Am Geriatr Soc.\n2012 Apr; 60(4): 756–764.\nMoraguez OD, Belser UC. The use of polytetrafluoroethylene tape for the management of\nscrew access channels in implant-supported prostheses. J Prosthet Dent. 2011 Mar; 103(3):\n189–191.\nMorais JA, Heydecke G, Pawliuk J, Lund JP, Feine JS. The effects of mandibular two-implant\noverdentures on nutrition in elderly edentulous individuals. J Dent Res. 2003 Jan; 82(1):\n53–58.\nMorales MP, Carvallo AP, Espinosa KA, Murillo EE. A young man with myelosuppression\ncaused by clindamycin: a case report. J Med Case Rep. 2014 Jan 5; 8: 7.\nMorley JE. Anorexia in older persons: epidemiology and optimal treatment. Drugs Aging.\n1996 Feb; 8(2): 134–155.\nMorneburg TR, Pröschel PA. Success rates of microimplants in edentulous patients with"
  },
  {
    "page": 428,
    "content": "residual ridge resorption. Int J Oral Maxillofac Implants. 2008 Mar–Apr; 23(2): 270–276.\nMosca M, Virdis A, Tani C, Ghiadoni L, Versari D, Duranti E, d’Ascanio A, Salvetti A,\nTaddei S, Bombardieri S. Vascular reactivity in patients with undifferentiated connective\ntissue diseases. Atherosclerosis. 2009 Mar; 203(1): 185–191.\nMoussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases,\nand decrements in health: results from the World Health Surveys. Lancet. 2007; 370(9590):\n851–858.\nMoy PK, Medina D, Shetty V, Aghaloo TL. Dental implant failure rates and associated risk\nfactors. Int J Oral Maxillofac Implants. 2005 Jul–Aug; 20(4): 569–577.\nMoynihan PJ. The relationship between nutrition and systemic and oral well-being in older\npeople. J Am Dent Assoc. 2007 Apr; 138(4): 493–497.\nMozzati M, Arata V, Gallesio G: Tooth extraction in patients on zoledronic acid therapy. Oral\nOncol. 2012 Sep; 48(8): 817–821.\nMuir JM, Andrew M, Hirsh J, Weitz JI, Young E, Deschamps P, Shaughnessy SG.\nHistomorphometric analysis of the effects of standard heparin on trabecular bone in vivo.\nBlood. 1996 Aug 15; 88(4): 1314–1320.\nMuller JE, Tofler GH, Stone PH. Circadian variation and triggers of acute cardiovascular\ndisease. Circulation. 1989 Apr; 79(4): 733–743.\nMüller F, Hasse-Sander I. Experimental studies of adaptation to complete dentures related to\nageing. Gerodontology. 1993 Jul; 10(1): 23–27.\nMüller F, Link I, Fuhr K, Utz KH. Studies on adaptation to complete dentures. Part II: Oral\nstereognosis and tactile sensibility. J Oral Rehabil. 1995 Oct; 22(10): 759–767.\nMüller F, Heath MR, Ferman AM, Davis GR. Modulation of mastication during experimental\nloosening of complete dentures. Int J Prosthodont. 2002 Nov–Dec; 15(6): 553–558.\nMüller F, Naharro M, Carlsson GE. What are the prevalence and incidence of tooth loss in the\nadult and elderly population in Europe? Clin Oral Impl Res. 2007 Jun; 18(Suppl 3): 2–14.\nMüller F. Tooth loss and dental prostheses in the oldest old. Eur Geriatr Med. 2010; 1(4):\n239–243.\nMüller F, Bergendal B, Wahlmann U, Wagner W. Implant-supported fixed dental prostheses in\nan edentulous patient with dystrophic epidermolysis bullosa. Int J Prosthodont. 2010 Jan–\nFeb; 23(1): 42–48."
  },
  {
    "page": 429,
    "content": "Müller F, Salem K, Barbezat C, Herrmann FR, Schimmel M. Knowledge and attitude of\nelderly persons towards dental implants. Gerodontology. 2012 Jun; 29(2): e914–e923. (a)\nMüller F, Hernandez M, Grutter L, Aracil-Kessler L, Weingart D, Schimmel M. Masseter\nmuscle thickness, chewing efficiency and bite force in edentulous patients with fixed and\nremovable implant-supported prostheses: a cross-sectional multicenter study. Clin Oral\nImplants Res. 2012 Feb; 23(2): 144–150. (b)\nMüller F, Duvernay E, Loup A, Vazquez L, Herrmann FR, Schimmel M. Implant-supported\nmandibular overdentures in very old adults: a randomized controlled trial. J Dent Res. 2013\nDec; 92(12 Suppl): 154S–160S.\nMüller F. Interventions for edentate elders—what is the evidence? Gerodontology. 2014 Feb;\n31(Suppl 1): 44–51.\nMüller F, Al-Nawas B, Storelli S, Quirynen M, Hicklin S, Castro-Laza J, Bassetti R,\nSchimmel M; Roxolid Study Group. Small-diameter titanium grade IV and titanium-\nzirconium implants in edentulous mandibles: five-year results from a double-blind,\nrandomized controlled trial. BMC Oral Health. 2015 Oct; 15(1); 123.\nNabil S, Samman N: Incidence and prevention of osteoradionecrosis after dental extraction in\nirradiated patients: a systematic review. Int J Oral Maxillofac Surg. 2011 Mar; 40(3): 229–\n243.\nNaert I, Quirynen M, Theuniers G, van Steenberghe D. Prosthetic aspects of osseointegrated\nfixtures supporting overdentures. A 4-year report. J Prosthet Dent. 1991 May; 65(5): 671–\n680.\nNaert I, Alsaadi G, van Steenberghe D, Quirynen M. A 10-year randomized clinical trial on\nthe influence of splinted and unsplinted oral implants retaining mandibular overdentures:\nperi-implant outcome. Int J Oral Maxillofac Implants. 2004 Sep–Oct; 19(5): 695–702.\nNagaya M, Sumi Y. Reaction time in the submental muscles of normal older people. J Am\nGeriatr Soc. 2002 May; 50(5): 975–976.\nNaik AA, Xie C, Zuscik MJ, Kingsley P, Schwarz EM, Awad H, Guldberg R, Drissi H, Puzas\nJE, Boyce B, Zhang X, O’Keefe RJ. Reduced COX-2 expression in aged mice is associated\nwith reduced fracture healing. J Bone Miner Res. 2009 Feb; 24(2): 251–264.\nNaitoh M, Hiraiwa Y, Aimiya H, Gotoh K, Ariji E. Accessory mental foramen assessment\nusing cone-beam computed tomography. Oral Surg Oral Med Oral Pathol Oral Radiol\nEndod. 2009 Feb; 107(2): 289–294.\nNakayama H. Osteoporosis in the patients with rheumatoid arthritis (3): The efficacy and the"
  },
  {
    "page": 430,
    "content": "selection of the osteoporosis therapeutic drug [in Japanese]. Clin Calcium. 2007 Oct;\n17(10): 1607–1612.\nNapeñas JJ, Hong CH, Brennan MT, Furney SL, Fox PC, Lockhart PB. The frequency of\nbleeding complications after invasive dental treatment in patients receiving single and dual\nantiplatelet therapy. J Am Dent Assoc. 2009 Jun; 140(6): 690–695.\nNedelman CI, Bernick S. The significance of age changes in human alveolar mucosa and bone.\nJ Prosthet Dent. 1978 May; 39(5): 495–501.\nNelson K, Heberer S, Glatzer C. Survival analysis and clinical evaluation of implant-retained\nprostheses in oral cancer resection patients over a mean follow-up period of 10 years. J\nProsthet Dent. 2007 Nov; 98(5): 405–410.\nNewton JP, Abel EW, Robertson EM, Yemm R. Changes in human masseter and medial\npterygoid muscles with age: a study by computed tomography. Gerodontics. 1987 Aug; 3(4):\n151–154.\nNewton JP, Yemm R, Abel RW, Menhinick S. Changes in human jaw muscles with age and\ndental state. Gerodontology. 1993 Jul; 10(1): 16–22.\nNewton JP, McManus FC, Menhenick S. Jaw muscles in older overdenture patients.\nGerodontology. 2004 Mar; 21(1): 37–42.\nNey DM, Weiss JM, Kind AJ, Robbins J. Senescent swallowing: impact, strategies, and\ninterventions. Nutr Clin Pract. 2009 Jun–Jul; 24(3): 395–413.\nNiamtu J 3rd. Near-fatal airway obstruction after routine implant placement. Oral Surg Oral\nMed Oral Pathol Oral Radiol Endod. 2001 Dec; 92(6): 597–600.\nNICE (National Institute for Health and Care Excellence). Clinical Knowledge Summaries.\n2014. http://cks.nice.org.uk/osteoporosis-prevention-of-fragility-fractures#!topicsummary.\nLast accessed December 27, 2014.\nNICE (National Institute for Health and Care Excellence). Ensuring the safe and effective use\nof medicines. 2015 Mar. https://www.nice.org.uk/news/article/ensuring-the-safe-and-\neffective-use-of-medicines. Last accessed February 20, 2016.\nNitschke I, Ilgner A, Müller F. Barriers to provision of dental care in long-term care facilities:\nthe confrontation with ageing and death. Gerodontology. 2005 Sep; 22(3): 123–129.\nNiwa H, Sato Y, Matsuura H. Safety of dental treatment in patients with previously diagnosed\nacute myocardial infarction or unstable angina pectoris. Oral Surg Oral Med Oral Pathol\nOral Radiol Endod. 2000 Jan; 89(1): 35–41."
  },
  {
    "page": 431,
    "content": "Nobili A, Garattini S, Mannucci PM. Multiple diseases and polypharmacy in the elderly:\nchallenges for the internist of the third millennium. Journal of Comorbidity. 2011; 1(1): 28–\n44.\nNooh N. Dental implant survival in irradiated oral cancer patients: a systematic review of the\nliterature. Int J Oral Maxillofac Implants. 2013 Sep–Oct; 28(5): 1233–1242.\nNorth Carolina State University. The principles of universal design. 1997:\nhttps://www.ncsu.edu/ncsu/design/cud/about_ud/udprinciples.htm+D559\nNyomba BL, Verhaegue J, Tomaste M, Nyomba BL, Verhaeghe J, Thomasset M, Lissens W,\nBouillon R. Bone mineral homeostasis in spontaneously diabetic BB rats. I. Abnormal\nvitamin D metabolism and impaired active intestinal calcium absorption. Endocrinology.\n1989 Feb; 124(2): 565–572.\nO’Halloran M, Boyd N, Smith A. Denosumab and osteonecrosis of the jaws—the\npharmacology, pathogenesis and a report of two cases. Aust Dent J. 2014 Dec; 59(4): 516–\n519.\nO’Neill PA, Davies I, Fullerton KJ, Bennett D. Stress hormone and blood glucose response\nfollowing acute stroke in the elderly. Stroke. 1991 Jul; 22(7): 842–847.\nO’Neill JE, Yeung SC. Do dental implants preserve and maintain alveolar bone? J Investig\nClin Dent. 2011 Nov; 2(4): 229–235.\nOczakir C, Balmer S, Mericske-Stern R. Implant-prosthodontic treatment for special care\npatients: a case series study. Int J Prosthodont. 2005 Sep-Oct; 18(5), 383–389.\nOertel R, Ebert U, Rahn R, Kirch W. The effect of age on pharmacokinetics of the local\nanesthetic drug articaine. Reg Anesth Pain Med. 1999 Nov–Dec; 24(6): 524–528.\nOettle AC, Fourie J, Human-Baron R, van Zyl AW. The midline mandibular lingual canal:\nimportance in implant surgery. Clin Implant Dent Relat Res. 2015 Feb; 17(1): 93–101.\nOffice for National Statistics. Population trends. PT 118, table 1.4 (population age and sex).\nLondon: ONS. 2004.\nOghalai JS. Aspiration of a dental appliance in a patient with Alzheimer disease. JAMA. 2002\nNov; 288(20): 2543–2544.\nOhkubo C, Kurihara D, Shimpo H, Suzuki Y, Kokubo Y, Hosoi T. Effect of implant support on\ndistal extension removable partial dentures: in vitro assessment. J Oral Rehab. 2007 Jan;\n34(1): 52–56.\nOhkubo C, Kobayashi M, Suzuki Y, Hosoi T. Effect of implant support on distal-extension"
  },
  {
    "page": 432,
    "content": "removable partial dentures: in vivo assessment. Int J Oral Maxillofac Implants. 2008 Nov–\nDec; 23(6): 1095–1101.\nOlerud E, Hagman-Gustafsson ML, Gabre P. Oral status, oral hygiene, and patient satisfaction\nin the elderly with dental implants dependent on substantial needs of care for daily living.\nSpec Care Dentist. 2012 Mar; 32(2): 49–54.\nOlesen C, Harbig P, Barat I, Damsgaard EM. Absence of “over-the-counter” medicinal\nproducts in on-line prescription records: a risk factor of overlooking interactions in the\nelderly. Pharmacoepidemiol Drug Saf. 2013 Feb; 22(2): 145–150.\nOng CT, Ivanovski S, Needleman IG, Retzepi M, Moles DR, Tonetti MS, Donos N. Systematic\nreview of implant outcomes in treated periodontitis subjects. J Clin Periodontol. 2008 May;\n35(5): 438–462.\nOp Heij DG, Opdebeeck H, van Steenberghe D, Quirynen M. Age as compromising factor for\nimplant insertion. Periodontol 2000. 2003; 33: 172–184.\nOral Cancer Foundation. Oral cancer facts. Rates of occurrence in the United States. 2012.\nhttp://www.oralcancerfoundation.org/facts. Last accessed December 21, 2014.\nOsterberg T, Carlsson GE, Sundh V. Trends and prognoses of dental status in the Swedish\npopulation: analysis based on interviews in 1975 to 1997 by Statistics Sweden. Acta\nOdontol Scand. 2000 Aug; 58(4): 177–182.\nOsterberg T, Carlsson GE, Sundh V, Steen B. Number of teeth—a predictor of mortality in the\nelderly? A population study in three Nordic localities. Acta Odontol Scand. 2007 Nov;\n65(6): 335–340.\nOstuni E. Stroke and the dental patient. J Am Dent Assoc. 1994 June; 125(6): 721–727.\nOtt SM. Bone disease in CKD. Curr Opin Nephrol Hypertens. 2012 Jul; 21(4): 376–381.\nOyebode O. Cardiovascular disease. In: Craig R, Mindell J (eds). Health survey for England\n—2011. Vol 1: Health, social care and lifestyles. Leeds: Health and Social Care Information\nCentre. 2012: 21–62.\nPacker M, Nikitin V, Coward T, Davis DM, Fiske J. The potential benefits of dental implants\non the oral health quality of life of people with Parkinson’s disease. Gerodontology. 2009\nMar; 26(1): 11–18.\nPalmqvist S, Carlsson GE, Öwall B. The combination syndrome: a literature review. J\nProsthet Dent. 2003 Sep; 90(3): 270–275.\nPandya A, Gaziano TA, Weinstein MC, Cutler D. More Americans living longer with"
  },
  {
    "page": 433,
    "content": "cardiovascular disease will increase costs while lowering quality of life. Health Aff. 2013;\n32(10): 1706–1714.\nPapaspyridakos P, Chen CJ, Singh M, Weber HP, Gallucci GO. Success criteria in implant\ndentistry: a systematic review. J Dent Res. 2012 Mar; 91(3): 242–248.\nPapaspyridakos P, Chen CJ, Chuang SK, Weber HP, Gallucci GO. A systematic review of\nbiologic and technical complications with fixed implant rehabilitations for edentulous\npatients. Int J Oral Maxillofac Implants. 2012 Jan; 27(1): 102–110.\nParlesak A, Klein B, Schecher K, Bode JC, Bode C. Prevalence of small bowel bacterial\novergrowth and its association with nutrition intake in nonhospitalized older adults. J Am\nGeriatr Soc. 2003 Jun; 51(6); 768–773.\nPassia N, Wolfart S, Kern M. Six-year clinical outcome of single implant-retained mandibular\noverdentures—a pilot study. Clin Oral Implants Res. 2015 Oct; 16(19: 1191–1194.\nPatel KV. Epidemiology of anemia in older adults. Semin Hematol. 2008 Oct; 45(4): 210–217.\nPauly L, Stehle P, Volkert D. Nutritional situation of elderly nursing home residents. Z\nGerontol Geriatr. 2007 Feb; 40(1): 3–12.\nPawelec G, Solana R, Remarque E, Mariani E. Impact of aging on innate immunity. J Leukoc\nBiol. 1998 Dec; 64(8): 703–712.\nPayne AG, Lownie JF, Van Der Linden WJ. Implant-supported prostheses in patients with\nSjögren’s syndrome: a clinical report on three patients. Int J Oral Maxillofac Implants. 1997\nSep–Oct; 12(5): 679–685.\nPayne AGT, Solomons YF. The prosthodontic maintenance requirements of mandibular\nmucosa- and implant-supported overdentures: a review of the literature. Int J Prosthodont.\n2000 May–Jun; 13(3): 238–245.\nPayne AG, Tawse-Smith A, De Silva RK, Duncan WJ. Early loading of two implants in the\nmandible and final restauration with a retentive-anchor-supported RPD. In: Wismeijer D,\nBuser D, Belser U (eds). ITI Treatment Guide, Vol 2: Loading protocols in implant dentistry.\nBerlin: Quintessence Publishing Co (Ltd); 2010.\nPeltola P, Vehkalahti MM, Wuolijoki-Saaristo K. Oral health and treatment needs of the long-\nterm hospitalised elderly. Gerodontology. 2004 Jun; 21(2): 93–99.\nPeñarrocha-Diago M, Serrano C, Sanchis JM, Silvestre FJ, Bagán JV. Placement of\nendosseous implants in patients with oral epidermolysis bullosa. Oral Surg Oral Med Oral\nPathol Oral Radiol Endod. 2000 Nov; 90(5): 587–590."
  },
  {
    "page": 434,
    "content": "Peñarrocha M, Rambla J, Balaguer J, Serrano C, Silvestre J, Bagán JV. Complete fixed\nprostheses over implants in patients with oral epidermolysis bullosa. J Oral Maxillofac\nSurg. 2007 Jul; 65(7): 103–106. [Erratum: J Oral Maxillofac Surg. 2008 Oct; 66(10): 2195–\n2196.] (a)\nPeñarrocha M, Larrazábal C, Balaguer J, Serrano C, Silvestre J, Bagán JV. Restoration with\nimplants in patients with recessive dystrophic epidermolysis bullosa and patient satisfaction\nwith the implant-supported superstructure. Int J Oral Maxillofac Implants. 2007 Jul–Aug;\n22(4): 651–655. (b)\nPeñarrocha-Diago M, Rambla-Ferrer J, Perez V, Pérez-Garrigues H. Benign paroxysmal\nvertigo secondary to placement of maxillary implants using the alveolar expansion technique\nwith osteotomes: a study of 4 cases. Int J Oral Maxillofac Implants. 2008 Jan–Feb; 23(1):\n129–132.\nPercival RS, Challacombe SJ, Marsh PD. Flow rates of resting whole and stimulated parotid\nsaliva in relation to age and gender. J Dent Res. 1994 Aug; 73(8): 1416–1420.\nPetersen PE. The World Oral Health Report 2003: continuous improvement of oral health in\nthe 21st century—the approach of the WHO Global Oral Health Programme. Community\nDent Oral Epidemiol. 2003 Dec; 31(Suppl 1):3–23.\nPeyron MA, Blanc O, Lund JP, Woda A. Influence of age on adaptability of human mastication.\nJ Neurophysiol. 2004 Aug; 92(2): 773–779.\nPierrisnard L, Renouard F, Renault P, Barquins M. Influence of implant length and bicortical\nanchorage on implant stress distribution. Clin Implant Dent Relat Res. 2003; 5(4): 254–262.\nPinto A, Glick M. Management of patients with thyroid disease: oral health considerations. J\nAm Dent Assoc. 2002 Jul; 133(7): 849–858.\nPirih FQ, Zablotsky M, Cordell K, McCauley LK. Case report of implant placement in a\npatient with Paget’s disease on bisphosphonate therapy. J Mich Dent Assoc. 2009 May;\n91(5): 38–43.\nPjetursson BE, Brägger U, Lang NP, Zwahlen M. Comparison of survival and complication\nrates of tooth-supported fixed dental prostheses (FDPs) and implant-supported FDPs and\nsingle crowns (SCs). Clin Oral Implants Res. 2007; 18 (Suppl. 3): 97–113.\nPjetursson BE, Thoma D, Jung R, Zwahlen M, Zembic A. A systematic review of the survival\nand complication rates of implant-supported fixed dental prostheses (FDPs) after a mean\nobservation period of at least 5 years. Clin Oral Implants Res. 2012 Oct; 23(Suppl 6): 22–\n38."
  },
  {
    "page": 435,
    "content": "Pjetursson BE, Asgeirsson AG, Zwahlen M, Sailer I. Improvements in implant dentistry over\nthe last decade: comparison of survival and complication rates in older and newer\npublications. Int J Oral Maxillofac Implants. 2014; 29(Suppl): 308–324.\nPlun-Favreau H, Lewis PA, Hardy J, Martins LM, Wood NW. Cancer and neurodegeneration:\nbetween the devil and the deep blue sea. PLoS Genet. 2010 Dec 23; 6(12): e1001257.\nPorter SR, Scully C. Adverse drug reactions in the mouth. Clin Dermatol. 2000 Sep–Oct;\n18(5): 525–532.\nPrasad M, Hussain MZ, Shetty SK, Kumar TA, Khaur M, George SA, Dalwai S. Median\nmandibular flexure at different mouth opening and its relation to different facial types: A\nprospective clinical study. J Nat Sci Biol Med. 2013 Jul; 4(2): 426–430.\nPretty IA, Ellwood RP, Lo EC, MacEntee MI, Müller F, Rooney E, Murray Thomson W, Van\nder Putten GJ, Ghezzi EM, Walls A, Wolff MS. The Seattle Care Pathway for securing oral\nhealth in older patients. Gerodontology. 2014 Feb; 31(Suppl 1): 77–87.\nPrice EA. Aging and erythropoiesis: Current state of knowledge. Blood Cells Mol Dis. 2008\nSep–Oct; 41(2): 158–165.\nProctor R, Kumar N, Stein A, Moles D, Porter S. Oral and dental aspects of chronic renal\nfailure. J Dent Res. 2005 Mar; 84(3): 199–208.\nQato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST. Use of prescription\nand over-the-counter medications and dietary supplements among older adults in the United\nStates. JAMA. 2008 Dec 24; 300(24): 2867–2878.\nQi WX, Tang LN, He AN, Yao Y, Shen Z. Risk of osteonecrosis of the jaw in cancer patients\nreceiving denosumab: a meta-analysis of seven randomized controlled trials. Int J Clin\nOncol. 2014 Apr; 19(2): 403–410.\nQuagliarello V, Ginter S, Han L, Van Ness P, Allore H, Tinetti M. Modifiable risk factors for\nnursing home-acquired pneumonia. Clin Infec Dis. 2005 Jan; 40(1): 1–6.\nQuirynen M, Mraiwa N, van Steenberghe D, Jacobs R. Morphology and dimensions of the\nmandibular jaw bone in the interforaminal region in patients requiring implants in the distal\nareas. Clin Oral Implants Res. 2003 Jun; 14(3): 280–285.\nQuirynen M, Al-Nawas B, Meijer HJ, Razavi A, Reichert TE, Schimmel M, Storelli S,\nRomeo E; Roxolid Study Group. Small-diameter titanium Grade IV and titanium-zirconium\nimplants in edentulous mandibles: three-year results from a double-blind, randomized\ncontrolled trial. Clin Oral Implants Res. 2015 Jul; 26(7): 831–840.\nRabkin JM, Hunt TK. Infection and oxygen. In: Davis JC, Hunt TK (eds). Problem wounds: the"
  },
  {
    "page": 436,
    "content": "role of oxygen. New York: Elsevier. 1988: 1–16.\nRaghoebar GM, Stellingsma K, Batenburg RH, Vissink A. Etiology and management of\nmandibular fractures associated with endosteal implants in the atrophic mandible. Oral Surg\nOral Med Oral Pathol Oral Radiol Endod. 2000 May; 89(5): 553-559.\nRaj DV, Abuzar M, Borromeo GL. Bisphosphonates, healthcare professionals and oral health.\nGerodontology. 2014 Jul 15. [Epub ahead of print.]\nRajgopal R, Bear M, Butcher MK, Shaughnessy SG. The effects of heparin and low molecular\nweight heparins on bone. Thrombosis Research. 2008; 122(3): 293–298.\nRankin K, Jones DL (eds). Oral health in cancer therapy. A guide for health care\nprofessionals. Austin: Texas Cancer Council; 1999: 1–48.\nRashid F, Awad MA, Thomason JM, Piovano A, Spielberg GP, Scilingo E, Mojon P, Müller F,\nSpielberg M, Heydecke G, Stoker G, Wismeijer D, Allen F, Feine JS. The effectiveness of\n2-implant overdentures—a pragmatic international multicentre study. J Oral Rehabil. 2011\nMar; 38(3): 176–184.\nRasmussen JM, Hopfensperger ML. Placement and restoration of dental implants in a patient\nwith Paget’s disease in remission: literature review and clinical report. J Prosthodont. 2008\nJan; 17(1): 35–40.\nRegan RF, Rogers B. Delayed treatment of haemoglobin neurotoxicity. J Neurotrauma. 2003\nJan; 20(1): 111–120.\nReid IR, Bolland MJ, Grey AB: Is bisphosphonate-associated osteonecrosis of the jaw caused\nby soft tissue toxicity? Bone. 2007 Sep; 41(3): 318–320.\nRémond D, Machebeuf M, Yven C, Buffière C, Mioche L, Mosoni L, Patureau Mirand P.\nPostprandial wholebody protein metabolism after a meat meal is influenced by chewing\nefficiency in elderly subjects. Am J Clin Nutr. 2007 May; 85(5): 1286–1292.\nRenouard F, Nisand D. Impact of implant length and diameter on survival rates. Clin Oral\nImplants Res. 2006 Oct; 17(Suppl 2): 35-51.\nRenton T, Woolcombe S, Taylor T, Hills CM. Oral surgery: part 1. Introduction and the\nmanagement of the medically compromised patient. Br Dent J. 2013 Sep; 215(5): 213–223.\nRenton T, Yilmaz Z. Managing iatrogenic trigeminal nerve injury: a case series and review of\nthe literature. Int J Oral Maxillofac Surg. 2012 May; 41(5): 629–637.\nRibera-Casado JM. Ageing and the cardiovascular system. Z Gerontol Geriatr. 1999 Dec;\n32(6): 412–419."
  },
  {
    "page": 437,
    "content": "Riesen M, Chung JP, Pazos E, Budtz-Jorgensen E. Interventions bucco-dentaires chez les\npersonnes âgées. Rev Med Suisse. 2002; 2414: 2178–2188.\nRiley MA, Walmsley AD, Harris IR. Magnets in prosthetic dentistry. J Prosthet Dent. 2001\nAug; 86(2): 137–142.\nRipamonti CI, Maniezzo M, Campa T, Fagnoni E, Brunelli C, Saibene G, Bareggi C, Ascani L,\nCislaghi E. Decreased occurrence of osteonecrosis of the jaw after implementation of dental\npreventive measures in solid tumour patients with bone metastases treated with\nbisphosphonates. The experience of the National Cancer Institute of Milan. Ann Oncol. 2009\nJan; 20(1): 137–145.\nRistow O, Gerngroß C, Schwaiger M, Hohlweg-Majert B, Kehl V, Jansen H, Hahnefeld L,\nKoerdt S, Otto S, Pautke C. Effect of antiresorptive drugs on bony turnover in the jaw:\ndenosumab compared with bisphosphonates. Br J Oral Maxillofac Surg. 2014 Apr; 52(4):\n308–313.\nRobert Wood Johnson Foundation. 2010; http://www.rwjf.org/pr/product.jsp?id=50968.\nRoberts HW, Mitnitsky EF. Cardiac risk stratification for postmyocardial infarction dental\npatients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Jun; 91(6): 676–681.\nRocchietta I, Fontana F, Simion M. Clinical outcomes of vertical bone augmentation to enable\ndental implant placement: a systematic review. J Clin Periodontol. 2008 Sep; 35(Suppl):\n203–215.\nRoccuzzo M, Bonino F, Gaudioso L, Zwahlen M, Meijer HJ. What is the optimal number of\nimplants for removable reconstructions? A systematic review on implant-supported\noverdentures. Clin Oral Implants Res. 2012 Oct; 23(Suppl 6): 229–237.\nRofes L, Arreola V, Romea M, Palomera E, Almirall J, Cabré M, Serra-Prat M, Clavé P.\nPathophysiology of oropharyngeal dysphagia in the frail elderly. Neurogastroenterol Motil.\n2010 Aug; 22(8): 851–858.\nRohlin M, Mileman PA. Decision analysis in dentistry—the last 30 years. J Dent. 2000 Sep;\n28(7): 453–468.\nRomano MM, Soares MS, Pastore CA, Tornelli MJ, de Oliveira Guaré R, Adde CA. A study\nof effectiveness of midazolam sedation for prevention of myocardial arrhythmias in\nendosseous implant placement. Clin Oral Implants Res. 2012 Apr; 23(4): 489–495.\nRosenberg ES, Torosian JP, Slots J. Microbial differences in 2 clinically distinct types of\nfailures of osseointegrated implants. Clin Oral Implants Res. 1991 Jul–Sep; 2(3): 135–144.\nRossi MI, Young A, Maher R, Rodriguez KL, Appelt CJ, Perera S, Hajjar ER, Hanlon JT."
  },
  {
    "page": 438,
    "content": "Polypharmacy and health beliefs in older outpatients. Am J Geriatr Pharmacother. 2007 Dec;\n5(4): 317–323.\nRothman SLG, Schwarz MS, Chafetz NI. High-resolution computerized tomography and\nnuclear bone scanning in the diagnosis of postoperative stress fractures of the mandible: a\nclinical report. Int J Oral Maxillofac Implants. 1995 Nov–Dec; 10(6): 765–768.\nRoubenoff R. The pathophysiology of wasting in the elderly. J Nutr. 1999 Jan; 121(1S Suppl):\n256S–259S.\nRuggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B. American\nAssociation of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related\nosteonecrosis of the jaws—2009 update. J Oral Maxillofac Surg. 2009 May; 67 (5 Suppl):\n2–12.\nRuggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O’Ryan F.\nAmerican Association of Oral and Maxillofacial Surgeons position paper on medication-\nrelated osteonecrosis of the jaw—2014 update. J Oral Maxillofac Surg. 2014 Oct; 72(10):\n1938–1956.\nRuospo M, Palmer SC, Craig JC, Gentile G, Johnson DW, Ford PJ, Tonelli M, Petruzzi M, De\nBenedittis M, Strippoli GF. Prevalence and severity of oral disease in adults with chronic\nkidney disease: a systematic review of observational studies. Nephrology Dialysis\nTransplantation. 2014 Feb; 29(2): 364–375.\nRussell RG, Croucher PI, Rogers MJ. Bisphosphonates: pharmacology, mechanisms of action\nand clinical uses. Osteoporos Int. 1999; 9(Suppl 2): S66–S80.\nRyan Camilon P, Stokes WA, Nguyen SA, Lentsch EJ. The prognostic significance of age in\noropharyngeal squamous cell carcinoma. Oral oncol. 2014 May; 50(5): 431–436.\nSaad F, Brown JE, Van Poznak C, Ibrahim T, Stemmer SM, Stopeck AT, Diel IJ, Takahashi S,\nShore N, Henry DH, Barrios CH, Facon T, Senecal F, Fizazi K, Zhou L, Daniels A, Carrière\nP, Dansey R. Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated\nanalysis from three blinded active-controlled phase III trials in cancer patients with bone\nmetastases. Ann Oncol. 2012 May; 23(5): 1341–1347.\nSaarela RK, Lindroos E, Soini H, Hiltunen K, Muurinen S, Suominen MH, Pitkälä KH.\nDentition, nutritional status and adequacy of dietary intake among older residents in assisted\nliving facilities. Gerodontology. 2014 Aug 28.\nSakakura CE, Marcantonio Jr E, Wenzel A, Scaf G. Influence of cyclosporin A on quality of\nbone around integrated dental implants: a radiographic study in rabbits. Clin Oral Implants\nRes. 2007 Feb; 18(1): 34–39."
  },
  {
    "page": 439,
    "content": "Salvi GE, Aglietta M, Eick S, Sculean A, Lang NP, Ramseier CA. Reversibility of\nexperimental peri-implant mucositis compared with experimental gingivitis in humans. Clin\nOral Implants Res. 2012 Feb; 23(2): 182–190.\nSantana RB, Xu L, Chase HB, Amar S, Graves DT, Trackman PC. A role for advanced\nglycation end products in diminished bone healing in type 1 diabetes. Diabetes. 2003 Jun;\n52(6): 1502–1510.\nSantini D, Vincenzi B, Dicuonzo G, Avvisati G, Massacesi C, Battistoni F, Gavasci M, Rocci\nL, Tirindelli MC, Altomare V, Tocchini M, Bonsignori M, Tonini G. Zoledronic acid\ninduces significant and long-lasting modifications of circulating angiogenic factors in cancer\npatients. Clin Cancer Res. 2003 Aug 1; 9(8): 2893–2897.\nSarajlic N, Topic B, Brkic H, Alajbeg IZ. Aging quantification on alveolar bone loss. Coll\nAntropol. 2009 Dec; 33(4): 1165–1170.\nScannapieco FA, Stewart EM, Mylotte J. Colonization of dental plaque by respiratory\npathogens in medical intensive care patients. Crit Care Med. 1992 Jun; 20(6): 740–745.\nSchein OD, Hochberg MC, Muñoz B, Tielsch JM, Bandeen-Roche K, Provost T, Anhalt GJ,\nWest S. Dry eye and dry mouth in the elderly: a population- based assessment. Arch Intern\nMed. 1999 Jun 28; 159(12): 1359–1363.\nSchembri A, Fiske J. The implications of visual impairment in an elderly population in\nrecognizing oral disease and maintaining oral health. Spec Care Dentist. 2001 Nov–Dec;\n21(6): 222–226.\nSchilcher J, Koeppen V, Aspenberg P, Michaëlsson K. Risk of atypical femoral fracture during\nand after bisphosphonate use. N Engl J Med. 2014 Sep; 371(10): 974–976.\nSchimmel M, Schoeni P, Zulian GB, Müller F. Utilisation of dental services in a university\nhospital palliative and long-term care unit in Geneva. Gerodontology. 2008 Jun; 25(2): 107–\n112.\nSchimmel M, Loup A, Duvernay E, Gaydarov N, Müller F. The effect of lower denture\nabstention on masseter muscle thickness in a 97 year-old patient: a case report. Int J\nProsthodont. 2010 Sep–Oct; 23(5): 418–420.\nSchimmel M, Srinivasan M, Herrmann FR, Müller F. Loading protocols for implant-supported\noverdentures in the edentulous jaw: a systematic review and meta-analysis. Int J Oral\nMaxillofac Implants. 2014; 29(Suppl): 271–286.\nSchneider D, Witt L, Hämmerle CH. Influence of the crown-to-implant length ratio on the\nclinical performance of implants supporting single crown restorations: a cross-sectional"
  },
  {
    "page": 440,
    "content": "retrospective 5-year investigation. Clin Oral Implants Res. 2012 Feb; 23(2): 169–174\nSchneider D, Schober F, Grohmann P, Hämmerle CH, Jung RE. In-vitro evaluation of the\ntolerance of surgical instruments in templates for computer-assisted guided implantology\nproduced by 3-D printing. Clin Oral Implant Res. 2015 Mar; 26(3): 320–325.\nSchoen F. The heart. In: Kumar V (ed). Robbins and Cotran pathologic basis of disease. 7th\ned. St. Louis: Saunders. 2005: 584–586.\nSchropp L, Isidor F. Timing of implant placement relative to tooth extraction. J Oral Rehabil.\n2008 Jan; 35(Suppl. 1): 33–43.\nSchuldt Filho G, Dalago HR, Oliveira de Souza JG, Stanley K, Jovanovic S, Bianchini MA.\nPrevalence of peri-implantitis in patients with implant-supported fixed prostheses.\nQuintessence Int. 2014 Nov; 45(10): 861–868.\nSchulte J, Flores AM, Weed M. Crown-to-implant ratios of single tooth implant-supported\nrestorations. J Prosthet Dent. 2007 Jul; 98(1): 1–5.\nScott J, Valentine JA, St Hill CA, Balasooriya BA. A quantitative histological analysis of the\neffects of age and sex on human lingual epithelium. J Biol Buccale. 1983 Dec; 11(4): 303–\n315.\nScully C, Boyle P. Reliability of a self-administered questionnaire for screening for medical\nproblems in dentistry. Community Dent Oral Epidemiol. 1983 Apr; 11(2): 105–108.\nScully C: Scully’s medical problems in dentistry. 7th ed. Elsevier Health Sciences. 2014: 167–\n168.\nSeddon HJ. A classification of nerve injuries. Br Med J. 1942 Aug 29; 2(4260): 237–239.\nSedghizadeh PP, Kumar SK, Gorur A, Schaudinn C, Shuler CF, Costerton JW. Identification of\nmicrobial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy. J Oral\nMaxillofac Surg. 2008 Apr; 66(4): 767–775.\nSedghizadeh PP, Kumar SK, Gorur A, Schaudinn C, Shuler CF, Costerton JW. Microbial\nbiofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to\nbisphosphonate therapy. J Am Dent Assoc. 2009 Oct; 140(10): 1259–1265.\nSeitz HK, Stickel F. Alcoholic liver disease in the elderly. Clin Geriatr Med. 2007 Nov;\n23(4): 905–921.\nSeymour DG, Vaz FG. A prospective-study of elderly general surgical patients: II. Post-\noperative complications. Age Ageing. 1989 Sep; 18(5): 316–326."
  },
  {
    "page": 441,
    "content": "Sharkey S, Kelly A, Houston F, O’Sullivan M, Quinn F, O’Connell B. A radiographic analysis\nof implant component misfit. Int J Oral Maxillofac Implants. 2011 Jul–Aug; 26(4): 807–815.\nSharma L. Epidemiology of osteoarthritis. In: Moskovitz RW, Howell OS, Altman RD,\nBuckwater JA, Goldberg VM (eds). Osteoarthritis: Diagnosis and medical surgical\nmanagement. 3rd edition. Philadelphia: Saunders; 2001: 3–17.\nShaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and\n2030. Diabetes Res Clin Pract. 2010 Jan; 87(1): 4–14.\nShay K. Identifying the needs of the elderly dental patient. The geriatric dental assessment.\nDent Clin North Am. 1994 Jul; 38(3): 499–523.\nSheehy C, Gaffney K, Mukhtyar C. Standardized grip strength as an outcome measure in early\nrheumatoid arthritis. Scand J Rheumatol. 2013; 42(4): 289–293.\nSheiham A, Steele JG, Marcenes W, Lowe C, Finch S, Bates CJ, Prentice A, Walls AW. The\nrelationship among dental status, nutrient intake, and nutritional status in older people. J\nDent Res. 2001 Feb; 80(2): 408–413.\nSheikh JI, Yesavange JA. Geriatric Depression Scale (GDS). Recent evidence and\ndevelopment of a shorter version. In: Bring T (ed). Clinical gerontology: a guide to\nassessment and interventions. New York: Haworth Press. 1986: 165–173.\nShepherd AM, Hewick DS, Moreland TA, Stevenson IH. Age as a determinant of sensitivity to\nwarfarin. Br J Clin Pharmacol. 1977 Jun; 4(3): 315–320.\nShet UK, Oh HK, Kim HJ, Chung HJ, Kim YJ, Kim OS, Choi HR, Kim OJ, Lim HJ, Lee SW.\nQuantitative analysis of periodontal pathogens present in the saliva of geriatric subjects. J\nPeriodontal Implant Sci. 2013 Aug; 43(4): 183–190.\nShip JA, Pillemer SR, Baum BJ. Xerostomia in the geriatric patient. J Am Geriatr Soc. 2002\nMar; 50(3): 535–543.\nShulman KI. Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry.\n2000 Jun; 15(6): 548–561.\nShuman SK, Bebeau MJ. Ethical issues in nursing home care: practice guidelines for difficult\nsituations. Special Care Dentist. 1996 Jul–Aug; 16(4): 170–176.\nSihvo S, Klaukka T, Martikainen J, Hemminki E. Frequency of daily over-the-counter drug use\nand potential clinically significant over-the-counter prescription drug interactions in the\nFinnish adult population. Eur J Clin Pharmacol. 2000 Sep; 56(6–7): 495–499.\nSjögren P, Nilsson E, Forsell M, Johansson O, Hoogstraate J. A systematic review of the"
  },
  {
    "page": 442,
    "content": "preventive effect of oral hygiene on pneumonia and respiratory tract infection in elderly\npeople in hospitals and nursing homes: effect estimates and methodological quality of\nrandomized controlled trials. J Am Geriatr Soc. 2008 Nov; 56(11): 2124–2130.\nSlade GD, Spencer AJ. Development and evaluation of the Oral Health Impact Profile.\nCommunity Dent Health. 1994 Mar; 11(1): 3–11.\nSlade GD. Assessment of oral health related quality of life. In: Inglehart MR, Bagramian RA\n(eds). Oral health related quality of life. Chicago: Quintessence. 2002.\nSlagter KW, Raghoebar GM, Vissink A. Osteoporosis and edentulous jaws. Int J Prosthodont.\n2008 Jan–Feb; 21(1): 19–26.\nSlotte C, Grønningsæter A, Halmøy AM, Öhrnell LO, Stroh G, Isaksson S, Johansson LÅ,\nMordenfeld A, Eklund J, Embring J. Four-millimeter implants supporting fixed partial\ndental prostheses in the severely resorbed posterior mandible: two-year results. Clin\nImplant Dent Relat Res. 2012 May;14(Suppl 1): e46–e58.\nSoehardi A, Meijer GJ, Manders R, Stoelnga PJ. An inventory of mandibular fractures\nassociated with implants in atrophic edentulous mandibles: a survey of Dutch oral and\nmaxillofacial surgeons. Int J Oral Maxillofac Implants. 2010 Sep–Oct; 26(5): 1087–1093.\nSoteriades ES, Evans JC, Larson MG, Chen MH, Chen L, Benjamin EJ, Levy D. Incidence and\nprognosis of syncope. N Engl J Med. 2002 Sep 19; 347(12): 878–885.\nSreebny LM, Schwartz SS. A reference guide to drugs and dry mouth—2nd edition.\nGerodontology. 1997 Jul; 14(1): 33–47.\nSrinivasan M, Vazquez L, Rieder P, Moraguez O, Bernard JP, Belser UC. Survival rates of\nshort (6 mm) micro-rough surface implants: a review of literature and meta-analysis. Clin\nOral Implants Res. 2014 May; 25(5): 539–545. (a)\nSrinivasan M, Schimmel M, Riesen M, Ilgner A, Wicht MJ, Warncke M, Ellwood RP,\nNitschke I, Müller F, Noack MJ. High-fluoride toothpaste: a multicenter randomized\ncontrolled trial in adults. Community Dent Oral Epidemiol. 2014 Aug; 42(4): 333–340. (b)\nSrinivasan M, Makarov NA, Herrmann FR, Müller F. Implant survival in 1- versus 2-implant\nmandibular overdentures: a systematic review and meta-analysis. Clin Oral Implants Res.\n2016 Jan; 27(1): 63–72.\nStamberger H. Functional endoscopic sinus surgery. Philadelphia: Mosby Year Book/BC\nDecker. 1991.\nStanford CM. Dental implants. A role in geriatric dentistry for the general practice? J Am\nDent Assoc. 2007 Sep; 138(Suppl): 34S–40S."
  },
  {
    "page": 443,
    "content": "Stanford CM. Surface modification of biomedical and dental implants and the processes of\ninflammation, wound healing and bone formation. Int J Mol Sci. 2010 Jan 25; 11(1): 354–\n369.\nStarr ME, Saito H. Sepsis in old age: review of human and animal studies. Aging Dis. 2014\nApr 1; 5(2): 126–136.\nStoehr GP, Ganguli M, Seaberg EC, Echement DA, Belle S. Over-the- counter medication use\nin an older rural community: the MoVIES Project. J Am GeriatrSoc. 1997 Feb; 45(2): 158–\n165.\nStone AA, Schwartz JE, Broderick JE, Deaton A. A snapshot of the age distribution of\npsychological well-being in the United States. Proc Natl Acad Sci U.S.A. 2010 Jun;\n107(22): 9985–9990.\nStrippoli GF, Palmer SC, Ruospo M, Natale P, Saglimbene V, Craig JC, Pellegrini F, Petruzzi\nM, De Benedittis M, Ford P, Johnson DW, Celia E, Gelfman R, Leal MR, Torok M,\nStroumza P, Bednarek-Skublewska A, Dulawa J, Frantzen L, Ferrari JN, del Castillo D,\nHegbrant J, Wollheim C, Gargano L. Oral disease in adults treated with hemodialysis:\nprevalence, predictors, and association with mortality and adverse cardiovascular events:\nthe rationale and design of the ORAL Diseases in hemodialysis (ORAL-D) study, a\nprospective, multinational, longitudinal, observational, cohort study. BMC Nephrology.\n2013 Apr 19; 14: 90.\nStuck AE, Beers MH, Steiner A, Aronow HU, Rubenstein LZ, Beck JC. Inappropriate\nmedication use in community-residing older persons. Arch Intern Med. 1994 Oct 10;\n154(19), 2195–2200.\nSummers RB. Sinus floor elevation with osteotomes. J Esthet Dent. 1998; 10(3): 164-171.\nSweeney MP, Williams C, Kennedy C, Macpherson LM, Turner S, Bagg J. Oral health care\nand status of elderly care home residents in Glasgow. Community Dent Health. 2007 Mar;\n24(1): 37–42.\nSwelem AA, Gurevich KG, Fabrikant EG, Hassan MH, Aqou S. Oral health-related quality of\nlife in partially edentulous patients treated with removable, fixed, fixed-removable, and\nimplant-supported prostheses. Int J Prosthodont. 2014 Jul–Aug; 27(4): 338–347.\nSwift ME, Burns AL, Gray KL, DiPietro LA. Age-related alterations in the inflammatory\nresponse to dermal injury. J Invest Dermatol. 2001 Nov; 117(5): 1027–1035.\nSyrjälä AM, Ylöstalo P, Ruoppi P, Komulainen K, Hartikainen S, Sulkava R, Knuuttila M.\nDementia and oral health among subjects aged 75 years or older. Gerodontology. 2012 Mar;\n29(1): 36–42."
  },
  {
    "page": 444,
    "content": "Taguchi T, Fukuda K, Sekine H, Kakizawa T. Intravenous sedation and hemodynamic changes\nduring dental implant surgery. Int J Oral Maxillofac Implants. 2011 Nov–Dec; 26(6): 1303–\n1308.\nTahmaseb A, Wismeijer D, Coucke W, Derksen W. Computer technology applications in\nsurgical implant dentistry: a systematic review. Int J Oral Maxillofac Implants. 2014;\n29(Suppl): 25–42.\nTaji T, Yoshida M, Hiasa K, Abe Y, Tsuga K, Akagawa Y. Influence of mental status on\nremovable prosthesis compliance in institutionalized elderly persons. Int J Prosthodont.\n2005 Mar–Apr; 18(2): 146–149.\nTallgren A. The continuing reduction of the residual alveolar ridges in complete denture\nwearers: a mixed-longitudinal study covering 25 years. J Prosthet Dent. 1972 Feb; 27(2):\n120–132.\nTan K, Pjetursson BE, Lang NP, Chan ES. A systematic review of the survival and\ncomplication rates of fixed partial dentures (FPDs) after an observation period of at least 5\nyears. Clin Oral Implants Res. 2004 Dec; 15(6): 654–666.\nTan WC, Lang NP, Zwahlen M, Pjetursson BE. A systematic review of the success of sinus\nfloor elevation and survival of implants inserted in combination with sinus floor elevation.\nPart II: transalveolar technique. J Clin Periodontol. 2008 Sep; 35(8 Suppl): 241–254.\nTepper G, Haas R, Zechner W, Krach W, Watzek G. Three-dimensional finite element analysis\nof implant stability in the atrophic posterior maxilla: a mathematical study of the sinus floor\naugmentation. Clin Oral Implants Res. 2002 Dec; 13(6): 657–665.\nTepper G, Haas R, Mailath G, Teller C, Bernhart T, Monov G, Watzek G. Representative\nmarketing-oriented study on implants in the Austrian population. II. Implant acceptance,\npatient-perceived cost and patient satisfaction. Clin Oral Implants Res. 2003 Oct; 14(5):\n634–642.\nTerpenning MS, Taylor GW, Lopatin DE, Kerr CK, Dominguez BL, Loesche WJ. Aspiration\npneumonia: dental and oral risk factors in an older veteran population. J Am Geriatr Soc.\n2001 May; 49(5): 557–563.\nThiel CP, Evans DB, Burnett RR. Combination syndrome associated with a mandibular\nimplant-supported overdenture: a clinical report. J Prosthet Dent. 1996 Feb; 75(2): 107–\n113.\nThomas DR. Age-related changes in wound healing. Drugs Aging. 2001; 18(8): 607–620.\nThomason JM, Feine J, Exley C, Moynihan P, Müller F, Naert I, Ellis JS, Barclay C,"
  },
  {
    "page": 445,
    "content": "Butterworth C, Scott B, Lynch C, Stewardson D, Smith P, Welfare R, Hyde P, McAndrew R,\nFenlon M, Barclay S, Barker D. Mandibular two implant-supported overdentures as the first\nchoice standard of care for edentulous patients—the York Consensus Statement. Br Dent J.\n2009 Aug; 207(4): 185–186.\nThompson R, Phillips J, McCauley S, Elliott JR, Moran CG. Atypical femoral fractures and\nbisphosphonate treatment. Journal of Bone and Joint Surgery. 2012 Mar; 94(3): 385–390.\nTinetti ME, Bogardus ST, Agostini JV. Potential pitfalls of disease-specific guidelines for\npatients with multiple conditions. N Engl J Med. 2004 Dec 30; 351(27): 2870–2874.\nTjia J, Velten SJ, Parsons C, Valluri S, Briesacher BA.. Studies to reduce unnecessary\nmedication use in frail older adults: a systematic review. Drugs Aging. 2013 May; 30(5):\n285–307.\nToffler M. Osteotome-mediated sinus floor elevation: a clinical report. Int J Oral Maxillofac\nImplants. 2004 Mar–Apr; 19(2): 266–273.\nTokmakidis SP, Kalapotharakos VI, Smilios I, Parlavantzas A. Effects of detraining on muscle\nstrength and mass after high or moderate intensity of resistance training in older adults. Clin\nPhysiol Funct Imaging. 2009 Jul 29(4): 316–319.\nTomkinson A, Reeve J, Shaw RW, Noble BS. The death of osteocytes via apoptosis\naccompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab. 1997 Sep;\n82(9): 3128–3135.\nTorres J, Tamimi F, Garcia I, Herrero A, Rivera B, Sobrino JA, Hernández G. Dental implants\nin a patient with Paget disease under bisphosphonate treatment: a case report. Oral Surg\nOral Med Oral Pathol Oral Radiol Endod. 2009 Mar; 107(3): 387–392.\nTrisi P, Rao W. Bone classification: clinical histomorphometric comparison. Clin Oral\nImplants Res. 1999 Feb; 10(1): 1–7.\nTsao C, Darby I, Ebeling PR, Walsh K, O’Brien-Simpson N, Reynolds E, Borromeo G. Oral\nhealth risk factors for bisphosphonate-associated jaw osteonecrosis. J Oral Maxillofac\nSurg. 2013 Aug; 71(8): 1360–1366.\nTurkyilmaz I, Company AM, McGlumphy EA. Should edentulous patients be constrained to\nremovable complete dentures? The use of dental implants to improve the quality of life for\nedentulous patients. Gerodontology. 2010 Mar; 27(1): 3–10.\nTurner MD, Ship JA. Dry mouth and its effects on the oral health of elderly people. J Am Dent\nAssoc. 2007 Sep; 138(Suppl): 15S–20S. [Erratum: J Am Dent Assoc. 2008 Mar; 139(3):\n252–253.]"
  },
  {
    "page": 446,
    "content": "Tymstra N, Raghoebar GM, Vissink A, Meijer HJ. Maxillary anterior and mandibular\nposterior residual ridge resorption in patients wearing a mandibular implant-retained\noverdenture. J Oral Rehabil. 2011 Jul; 38(7): 509–516.\nTzakis MG, Osterberg T, Carlsson GE. A study of some masticatory functions in 90-year old\nsubjects. Gerodontology. 1994 Jul; 11(1): 25–29.\nUeda M, Kaneda T. Maxillary sinusitis caused by dental implants: report of two cases. J Oral\nMaxillofa Surg. 1992 Mar; 50(3): 285–287.\nUngar A, Morrione A, Rafanelli M, Ruffolo E, Brunetti MA, Chisciotti VM, Masotti G, Del\nRosso A, Marchionni N. The management of syncope in older adults. Minerva Med. 2009\nAug; 100(4): 247–258.\nUnited Nations, Department of Economic and Social Affairs, Population Division. World\nPopulation Ageing 2013. 2013. United Nations publication ST/ESA/SER.A/348.\nVahtsevanos K, Kyrgidis A, Verrou E, Katodritou E, Triaridis S, Andreadis CG, Boukovinas\nI, Koloutsos GE, Teleioudis Z, Kitikidou K, Paraskevopoulos P, Zervas K, Antoniades K.\nLongitudinal cohort study of risk factors in cancer patients of bisphosphonate-related\nosteonecrosis of the jaw. Journal of Clinical Oncology. 2009 Nov 10; 27(32): 5356–5362.\nValenti G, Ferrucci L, Lauretani F, Ceresini G, Bandinelli S, Luci M, Ceda G, Maggio M,\nSchwartz RS. Dehydroepiandrosterone sulfate and cognitive function in the elderly: The\nInCHIANTI Study. J Endocrinol Invest. 2009 Oct; 32(9): 766–772.\nvan den Akker M, Buntinx F, Roos S, Knottnerus JA. Problems in determining occurrence\nrates of multimorbidity. J Clin Epidemiol. 2001 Jul; 54(7): 675–679.\nvan den Bergh JP, Bruggenkate ten CM, Disch FJ, Tuinzing DB. Anatomical aspects of sinus\nfloor elevations. Clin Oral Implants Res. 2000 Jun; 11(3): 256-265.\nvan der Bilt A, van Kampen FM, Cune MS. Masticatory function with mandibular implant-\nsupported overdentures fitted with different attachment types. Eur J Oral Sci. 2006 Jun;\n114(3): 191–196.\nvan der Bilt A, Burgers M, van Kampen FM, Cune MS. Mandibular implant-supported\noverdentures and oral function. Clin Oral Implants Res. 2010 Nov; 21(11): 1209–1213.\nvan der Maarel-Wierink CD, Vanobbergen JN, Bronkhorst EM, Schols JM, de Baat C. Meta-\nanalysis of dysphagia and aspiration pneumonia in frail elders. J Dent Res. 2011 Dec;\n90(12): 1398–1404.\nVan der Sleen MI, Slot DE, Van Trijffel E, Winkel EG, Van der Weijden GA. Effectiveness of\nmechanical tongue cleaning on breath odour and tongue coating: a systematic review. Int J"
  },
  {
    "page": 447,
    "content": "Dent Hyg. 2010 Nov; 8(4): 258–268.\nvan Kampen FM, van der Bilt A, Cune MS, Fontijn-Tekamp FA, Bosman F. Masticatory\nfunction with implant-supported overdentures. J Dent Res. 2004 Sep; 83(9): 708–711.\nvan Steenberghe D, Vanherle GV, Fossion E, Roelens J. Crohn’s disease of the mouth, report\nof case. J Oral Surg. 1976 Jul; 34(7): 635–638.\nvan Steenberghe D, Jacobs R, Desnyder M, Maffei G, Quirynen M. The relative impact of\nlocal and endogenous patient-related factors on implant failure up to the abutment stage. Clin\nOral Implants Res. 2002 Dec; 13(6): 617–622.\nvan Steenberghe D, Quirynen M, Molly L, Jacobs R. Impact of systemic diseases and\nmedication on osseointegration. Periodontol 2000. 2003; 33: 163–171.\nVandone AM, Donadio M, Mozzati M, Ardine M, Polimeni MA, Beatrice S, Ciuffreda L,\nScoletta M. Impact of dental care in the prevention of bisphosphonate-associated\nosteonecrosis of the jaw: A single-center clinical experience. Ann Oncol. 2012 Jan; 23 (1):\n193–200.\nVercruyssen M, Marcelis K, Coucke W, Naert I, Quirynen M. Long-term, retrospective\nevaluation (implant and patient-centred outcome) of the two-implants-supported overdenture\nin the mandible. Part 1: survival rate. Clin Oral Implants Res. 2010 Apr; 21(4): 357–365.\n(a)\nVercruyssen M, Quirynen M. Long-term, retrospective evaluation (implant and patient-centred\noutcome) of the two-implant-supported overdenture in the mandible. Part 2: marginal bone\nloss. Clin Oral Implants Res. 2010 May; 21(5): 466–472. (b)\nVernamonte S, Mauro V, Vernamonte S, Messina AM. An unusual complication of osteotome\nsinus floor evaluation: benign paroxysmal positional vertigo. Int J Oral Maxillofac Surg.\n2011 Feb; 40(2): 216–218.\nVernooij-Dassen M, Leatherman S, Rikkert MO. Quality of care in frail older people: the\nbalance between receiving and giving. BMJ. 2011 Mar 25; 342: 1062–1063.\nVigild M. Benefit related assessment of treatment need among institutionalised elderly people.\nGerodontology. 1993 Jul; 10(1): 10–15.\nVisentin GP, Liu CY. Drug-induced thrombocytopenia. Hematol Oncol Clin North Am. 2007\nAug; 21(4): 685–696, vi.\nVisser A, Raghoebar GM, Meijer HJ, Vissink A. Implant-retained maxillary overdentures on\nmilled bar suprastructures: a 10-year follow-up of surgical and prosthetic care and\naftercare. Int J Prosthodont. 2009 Mar–Apr; 22(2): 181–192."
  },
  {
    "page": 448,
    "content": "Visser A, de Baat C, Hoeksema AR, Vissink A. Oral implants in dependent elderly persons:\nblessing or burden? Gerodontology. 2011 Mar; 28(1): 76–80.\nVitlic A, Khanfer R, Lord JM, Carroll D, Phillips AC. Bereavement reduces neutrophil\noxidative burst only in older adults: role of the HPA axis and immunesenescence. Immun\nAgeing. 2014 Aug 29; 11: 13.\nVogeli C, Shields AE, Lee TA, Gibson TB, Marder WD, Weiss KB, Blumenthal D. Multiple\nchronic conditions: prevalence, health consequences, and implications for quality, care\nmanagement, and costs. J Gen Intern Med. 2007 Dec; 22(Suppl. 3): 391–395.\nvon Wowern N, Melsen F. Comparative bone morphometric analysis of mandibles and iliac\ncrests. Scand J Dent Res. 1979 Oct; 87(5): 351–357.\nvon Wowern N, Storm TL, Olgaard K. Bone mineral content by photon absorptiometry of the\nmandible compared with that of the forearm and the lumbar spine. Calcif Tissue Int. 1988\nMar; 42(3): 157–161.\nvon Wowern N, Gotfredsen K. Implant-supported overdentures, a prevention of bone loss in\nedentulous mandibles? A 5-year follow-up study. Clin Oral Implants Res. 2001 Feb; 12(1):\n19–25.\nVos T et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries\n1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet.\n2012 Dec 15; 380(9859): 2163–2196. [Erratum: Lancet. 2013 Feb 23; 381(9867): 628.]\nWagner W, Esser E, Ostkamp K. Osseointegration of dental implants in patients with and\nwithout radiotherapy. Acta Oncol. 1998; 37(7–8): 693–696.\nWalton JN, MacEntee MI, Glick N. One-year prosthetic outcomes with implant overdentures:\na randomized clinical trial. Int J Oral Maxillofac Implants. 2002 May–Jun; 17(3): 391–398.\nWalton JN, MacEntee MI. Choosing or refusing oral implants: a prospective study of\nedentulous volunteers for a clinical trial. Int J Prosthodont. 2005 Nov–Dec; 18(6): 483–488.\nWalton JN, Glick N, Macentee MI. A randomized clinical trial comparing patient satisfaction\nand prosthetic outcomes with mandibular overdentures retained by one or two implants. Int J\nProsthodont. 2009 Jul–Aug; 22(4): 331–339.\nWang HL, Weber D, McCauley LK. Effect of long-term oral bisphosphonates on implant\nwound healing: literature review and a case report. J Periodontol. 2007 Mar; 78(3): 584–\n594.\nWarrer K, Buser D, Lang NP, Karring T. Plaque-induced peri-implantitis in the presence or\nabsence of keratinized mucosa. An experimental study in monkeys. Clin Oral Implants Res."
  },
  {
    "page": 449,
    "content": "1995 Sep; 6(3): 131–138.\nWatson RM, Jemt T, Chai J, Harnett J, Heath MR, Hutton JE, Johns RB, Lithner B, McKenna\nS, McNamara DC, Naert I, Taylor R. Prosthodontic treatment, patient response, and the need\nfor maintenance of complete implant-supported overdentures: an appraisal of 5 years of\nprospective study. Int J Prosthodont. 1997 Jul–Aug; 10(4): 345–354.\nWawruch M, Kuzelova M, Foltanova T, Ondriasova E, Luha J, Dukat A, Murin J, Shah R.\nCharacteristics of elderly patients who consider over-the-counter medications as safe. Int J\nClin Pharm. 2013 Feb; 35(1): 121–128.\nWeinlander M, Krennmair G, Piehslinger E. Implant prosthodontic rehabilitation of patients\nwith rheumatic disorders: a case series report. Int J Prosthodont. 2010 Jan–Feb; 23(1): 22–\n28.\nWeischer T, Mohr C. Ten-year experience in oral implant rehabilitation of cancer patients:\ntreatment concept and proposed criteria for success. Int J Oral Maxillofac Implants. 1999\nJul–Aug; 14(4): 521–528.\nWeiss RE, Gorn AH, Nimni ME. Abnormalities in the biosynthesis of cartilage and bone\nproteoglycans in experimental diabetes. Diabetes. 1981 Aug; 30(8): 670–677.\nWeiss A, Beloosesky Y, Boaz M, Yalov A, Kornowski R, Grossman E. Body mass index is\ninversely related to mortality in elderly subjects. J Gen Intern Med. 2008 Jan; 23(1): 19–24.\nWelsh G, Grey N, Potts S. The use of liaison psychiatry service in restorative dentistry. CPD\nDent. 2000; 1(1): 32–34.\nWelte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired\npneumonia among adults in Europe. Thorax. 2012 Jan; 67(1): 71–79.\nWennström JL, Derks J. Is there a need for keratinized mucosa around implants to maintain\nhealth and tissue stability? Clin Oral Implants Res. 2012 Oct; 23(Suppl 6): 136–146.\nWerbitt MJ, Goldberg PV. The immediate implant: bone preservation and bone regeneration.\nInt J Periodontics Restorative Dent. 1992; 12(3): 206–217.\nWeyant RJ, Pandav RS, Plowman JL, Ganguli M. Medical and cognitive correlates of denture\nwearing in older community-dwelling adults. J Am Geriatr Soc. 2004 Apr; 52(4): 596–600.\nWhite H. Weight change in Alzheimer’s disease. J Nurt Health Aging. 1998; 2(2): 110–112.\nWhitfield LR, Schentag JJ, Levy G. Relationship between concentration and anticoagulant\neffect of heparin in plasma of hospitalized patients: magnitude of predictability of\ninterindividual differences. Clin Pharmacol Ther. 1982 Oct; 32(4): 503–516."
  },
  {
    "page": 450,
    "content": "WHO Definition of palliative care. 1990. http://www.who.int/cancer/palliative/definition/en/.\nLast accessed November 23, 2015.\nWilliams S, Malatesta K, Norris K. Vitamin D and chronic kidney disease. Ethn Dis. 2009\nAutumn; 19(4 Suppl 5): S5–8–11.\nWiltfang J, Schultze-Mosgau S, Merten HA, Kessler P, Ludwig A, Engelke W. Endoscopic and\nultrasonographic evaluation of the maxillary sinus after combined sinus floor augmentation\nand implant insertion. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000 Mar;\n89(3): 288–291.\nWinkler S, Garg AK, Mekayarajjananonth T, Bakaeen LG, Khan E. Depressed taste and smell\nin geriatric patients. J Am Dent Assoc. 1999 Dec; 130(12): 1759–1765.\nWinwood K, Zioupos P, Currey JD, Cotton JR, Taylor M. The importance of the elastic and\nplastic components of strain in tensile and compressive fatigue of human cortical bone in\nrelation to orthopaedic biomechanics. J Musculoskelet Neuronal Interact. 2006 Apr–Jun;\n6(1): 134–141.\nWiseman M. The treatment of oral problems in the palliative patient. J Can Dent Assoc. 2006\nJun; 72(5): 453–458.\nWismeijer D, VanWaas MAJ, Vermeeren J, Mulder J, Kalk W. Patient satisfaction with\nimplant-supported mandibular overdentures. A comparison of three treatment strategies with\nITI-dental implants. Int J Oral Maxillofac Surg. 1997 Aug 26(4): 263–267.\nWismeijer D, Tawse-Smith A, Payne AG. Multicentre prospective evaluation of implant-\nassisted mandibular bilateral distal extension removable partial dentures: patient\nsatisfaction. Clin Oral Implants Res. 2013 Jan; 24(1): 20–27.\nWolfe M, Lichtenstein D, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory\ndrugs. N Engl J Med. 1999 Jun 17; 340(24): 1888–1889.\nWolff B, Berger T, Frese C, Max R, Blank N, Lorenz HM, Wolff D. Oral status in patients with\nearly rheumatoid arthritis: a prospective, case-control study. Rheumatology (Oxford). 2014\nMar; 53(3): 526–431.\nWood J, Bonjean K, Ruetz S, Bellahcène A, Devy L, Foidart JM, Castronovo V, Green JR.\nNovel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol\nExp Ther. 2002 Sep; 302(3): 1055–1061.\nWood MR, Vermilyea SG; Committee on Research in Fixed Prosthodontics of the Academy of\nFixed Prosthodontics. A review of selected dental literature on evidence-based treatment\nplanning for dental implants: report of the Committee on Research in Fixed Prosthodontics"
  },
  {
    "page": 451,
    "content": "of the Academy of Fixed Prosthodontics. J Prosthet Dent. 2004 Nov; 92(5): 447–462.\nWorld Health Organization. Statistical Dataset. 2000.\nhttp://www.who.int/respiratory/copd/burden/en/index.html. Last accessed Jan 1, 2015.\nWorld Health Organization. Global status report on noncommunicable diseases 2010. 2011.\nhttp://www.who.int/nmh/publications/ncd_report_full_en.pdf.\nWurtman JJ, Lieberman H, Tsay R, Nader T, Chew B. Caloric and nutrient intake of elderly\nand young subjects measured under identical conditions. J Gerontol. 1988 Nov; 43(6):\nB174–B180.\nXiao W, Li Z, Shen S, Chen S, Wang Y, Wang J. Theoretical role of adjunctive implant\npositional support in stress distribution of distal-extension mandibular removable partial\ndentures. Int J Prosthodont. 2014 Nov–Dec; 27(6): 579–581.\nYacoub N, Ismail YH, Mao JJ. Transmission of bone strain in the craniofacial bones of\nedentulous human skulls upon dental implant loading. J Prosthet Dent. 2002 Aug; 88(2):\n192–199.\nYoneyama T, Yoshida M, Matsui T, Sasaki H. Oral care and pneumonia. Oral Care Working\nGroup. Lancet. 1999 Aug; 354(9177): 515.\nYoon V, Maalouf NM, Sakhaee K. The effects of smoking on bone metabolism. Osteoporos Int.\n2012 Aug; 23(8): 2081–2092.\nZarb GA, Schmitt A. Implant therapy alternatives for geriatric edentulous patients.\nGerodontology. 1993 Jul 1; 10(1): 28–32.\nZembic A, Kim S, Zwahlen M, Kelly JR. Systematic review of the survival rate and incidence\nof biologic, technical, and esthetic complications of single implant abutments supporting\nfixed prostheses. Int J Oral Maxillofac Implants. 2014; 29(Suppl): 99–116. (a)\nZembic A, Wismeijer D. Patient-reported outcomes of maxillary implant-supported\noverdentures compared with conventional dentures. Clin Oral Implants Res. 2014 Apr;\n25(4): 441–450.\nZermansky AG, Alldred DP, Petty DR, Raynor DK, Freemantle N, Eastaugh J, Bowie P.\nClinical medication review by a pharmacist of elderly people living in care homes—\nrandomised controlled trial. Age Ageing. 2006 Nov; 35(6): 586–591.\nZimmer CM, Zimmer WM, Williams J, Liesener J. Public awareness and acceptance of dental\nimplants. Int J Oral Maxillofac Implants. 1992 Summer; 7(2): 228–232.\nZitzmann NU, Sendi P, Marinello CP. An economic evaluation of implant treatment in"
  },
  {
    "page": 452,
    "content": "edentulous patients: preliminary results. Int J Prosthodont. 2005 Jan–Feb; 18(1): 20–27.\nZitzmann NU, Hagmann E, Weiger R. What is the prevalence of various types of prosthetic\ndental restorations in Europe? Clin Oral Implants Res. 2007 Jun; 18(Suppl 3): 20–33.\nZitzmann NU, Staehelin K, Walls AW, Menghini G, Weiger R, Zemp Stutz E. Changes in oral\nhealth over a 10-yr period in Switzerland. Eur J Oral Sci. 2008 Feb; 116(1): 52–59. (a)\nZitzmann NU, Berglundh T (2008). Definition and prevalence of peri-implant diseases. J Clin\nPeriodontol. 2008 Sep; 35(8 Suppl): 286–291. (b)\nZou H, Zhao X, Sun N, Zhang S, Sato T, Yu H, Chen Q, Weber HP, Dard M, Yuan Q, Lanske B.\nEffect of chronic kidney disease on the healing of titanium implants. Bone. 2013 Oct; 56(2):\n410–415."
  }
]